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ABSTRACT 
 
The design, synthesis and characterization of organic electronic materials, in 
particular luminescent conjugated polymers, with structural motifs that allow for the 
controlled modulation of their photophysical properties are presented. In Chapter 1, the 
synthesis of new heterocyclic oligo(phenylene) analogues based on soluble, non-
aggregating 1,2-diazines is reported. Palladium-catalyzed reductive coupling methods 
were developed to allow for the preparation of large quantities of iptycene-derived 
bipyridazines and biphthalazines, and the controlled synthesis of well-defined oligomers 
up to sexipyridazine. Crystallographic, spectroscopic and computational evidence 
indicate that in these analogues, hindrance at the ortho position is relaxed relative to 
poly(phenylene)s, which can favor planarization and extension of conjugation. New 
poly(aryl ether)s that incorporate iptycene-derived pyridazines have been prepared by 
three different synthetic routes, including a novel reductive polymerization of poly(aryl 
alkyl ether)s (Chapter 2). Some of these polymers exhibit low dielectric constants due to 
the introduction of internal free volume. Iptycene-derived pyridazines were also 
incorporated in conjugated organic materials that show thermotropic liquid crystalline 
properties and in platinum-based monomers for conjugated phosphorescent polymers that 
exhibit high luminescence efficiency under ambient conditions (Chapter 3). The 
luminescent properties of these platinum complexes are attributed to the introduction of 
 4 
steric bulk that prevents the formation of quenched aggregates. The donor-acceptor 
strategy to bandgap engineering was applied to the preparation of a highly selective 
fluorescent probe for thiol bioimaging (Chapter 4), and to the synthesis of conjugated 
luminescent polymers that incorporate new electron deficient monomers based on 2,1,3-
benzothiadiazole and 2,1,3-benzooxazole bearing solubilizing side-chains (Chapter 5). 
The exquisite control over conformation and surface density offered in Langmuir 
monolayers of amphiphilic poly(phenylene ethynylene)s at the air-water interface was 
exploited in spectroscopic studies of energy transfer to perylene monoimide end-groups 
(Chapter 6). In these, planarization increases the efficiency of intramolecular energy 
transfer at low surface densities, and intermolecular energy transfer pathways become 
predominant at high surface densities. The modulation of energy transfer at dipolar 
interfaces provides a transduction mechanism that makes these polymers attractive 
platforms for the development of new biosensors for surface interactions. 
 
Thesis Supervisor: Timothy M. Swager 
Title: John D. MacArthur Professor of Chemistry and Department Head 
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Chapter 1 
Iptycene-Derived Pyridazines and 
Phthalazines 
 
 
 
 
Adapted and reproduced in part with permission from: 
Bouffard, J.; Eaton, R. F.; Müller, P.; Swager, T. M. J. Org. Chem., in press
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1.1 Introduction and Design Considerations 
 
 Molecules of the iptycene family, as exemplified by their simplest member 
triptycene, have been the object of much interest by numerous research groups, including 
our own. In particular, iptycenes have been incorporated in organic materials and 
polymers for applications that include conjugated polymer sensors,1 high mechanical 
performance polymers,2 liquid crystals,3 low-κ dielectrics,4 gas absorption / storage,5 and 
host-guest chemistry.6 In the bulk of these examples, the introduction of molecular voids, 
or internal free volume, has been proposed to be at the origin of the exceptional materials 
properties.  
 
Triptycene Pentiptycene Side view
Molecular void:
Internal free 
volume
 
Figure 1.1. Iptycenes and internal free volume 
 
By contrast, only a few heterocyclic members of the iptycene family have been 
prepared and explored for materials applications. Iptycene-derived thiophenes and 
pyrroles have been incorporated in conjugated polymers,7 porphyrins,8 phthalocyanines9 
and related macrocycles.10 Iptycene-derived pyridines have also been reported,11 but, to 
the best of our knowledge, have yet to be elaborated into larger functional molecules or 
assemblies. We are aware of three reports of iptycene-derived pyridazines (Scheme 
1.1),12 but details regarding their preparation, characterization and properties are scarce. 
In this chapter, we present the synthesis and characterization of iptycene-derived 
pyridazines and phthalazines, and their elaboration into building blocks for materials 
applications. 
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Scheme 1.1. Previously reported iptycene-derived pyridazines12 
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Our interest in the development of 1,2-diazine-derived building blocks for 
materials applications spawned from three principal design considerations. First, electron-
poor building blocks can confer a number of attractive characteristics, including 
resistance to (photo)oxidation13 and a lowered barrier to electron injection (n-doping),14 
which can translate to devices operating at lower voltages and with extended lifetimes.  
These characteristics make new 1,2-diazine-derived materials attractive candidates to 
replace 9,9-dialkylfluorene-based materials as privileged blue-light sources in OLEDs 
and PLEDs (Organic and Polymer Light Emitting Devices).15 The latter materials, 
including poly(9,9-dioctylfluorene) as a prominent member, offer good initial 
performance but can significantly degrade under operating conditions over the lifetime of 
the devices to give rise to a red-shifted (green to yellow) emission band that has attributed 
to oxidative defects.16  Consequently, there is a growing need for oxidation-resistant 
organic electronic materials and polymers.17 
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Figure 1.2. Oxidative degradation of poly(9,9-alkylfluorene)s giving rise to a red-shifted 
emission band in PLEDs. 
 
Second, as part of a long-standing interest toward the control of conformation in 
conjugated polymers, 18  we hypothesized that when compared to the analogous 
poly(phenylene)s bearing hydrogens in ortho positions, poly(1,2-diazine)s would exhibit 
less steric hindrance and would favor, with potential hydrogen bonding, coplanarization 
and therefore more extended π-conjugation19 (Scheme 1.2). Consequently, iptycene-
derived poly(1,2-diazine)s could exhibit a fully coplanar conjugated backbone, yet 
remain soluble due to the limited propensity of iptycene-derived molecules to aggregate 
and π-stack in the solid state.  
 
Scheme 1.2. Conformational hypothesis for bi(1,2-diazines). 
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Third, and finally, we can exploit the coordination sites of the heterocyclic 
nitrogen atoms20 for the preparation of metal-containing materials and polymers, with a 
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special interest towards the design of phosphorescent conjugated polymers for lighting 
and sensing applications.21, 22 
 
Scheme 1.3. Proposed targets of iptycene-derived pyridazine-based transition metal 
complexes of interest for the development of new phosphors. 
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 Finally, it is noteworthy that 1,2-diazines are exceptional among the diversity of 
synthetically accessible arenes and heterocycles in that they have seldom been used in the 
field of conjugated organic materials and polymers. Claims to the oxidative 
electrochemical preparation of poly(pyridazine) have been reported,23 however, the lack 
of structural characterization and the fact that the oxidative polymerization is carried 
under electrode potentials that are far higher than the breakdown potentials of the 
solvents, electrodes and electrolytes used - above 2.0V vs. Ag/Ag+ in MeCN and as high 
as 4-8V -  raise some serious doubts regarding the composition of the reported 
"polymers". Others24 have claimed the oxidative polymerization of pyridazine with 
halogens (Br2, I2) or quinones though once again incomplete characterization of the 
products raises skepticism, especially in view of earlier reports of stable pyridazine-
iodine charge-transfer complexes.25 We are aware of only five reports describing the 
introduction of the pyridazine ring in conjugated organic materials or polymers.19d, 26 
 
1.2 Synthesis of Iptycene-derived Pyridazines 
Our initial synthetic approach focused on the Diels-Alder cycloaddition between 
anthracene and dimethylacetylene dicarboxylate (DMAD),27 followed by treatment with 
hydrazine and halogenation with a phosphorus(V) halide. However, as indicated in a 
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previous report,28 treatment of the adduct 1a with hydrazine under various reaction 
conditions exclusively afforded the reduced 5-membered N-aminoimide 7a (Scheme 1.4). 
Following the procedure of Mizzoni and Spoerri,29 reaction of the bicyclic maleic 
anhydride 3a, obtained from the adduct 1a after saponification with sodium hydroxide 
and dehydration with oxalyl chloride, with hydrazine monohydrochloride in refluxing 
acetic acid afforded the desired 6-membered cyclic hydrazide 4a in excellent yields. 
Treatment with neat phosphorus oxychloride or molten phosphorus oxybromide afforded 
the dihalides 5a, d in good yields. Due to the high cost of phosphorus oxybromide and 
the requirement of several equivalents of the reagent for a reaction in the melt, large-scale 
preparation of the dibromide may benefit from the alternate use of phosphorus pentoxide 
and tetra n-butylammonium bromide in toluene,30 a preparation that offered yields 
comparable to that of phosphorus oxybromide in the melt. Selective SNAr reaction with 
sodium methoxide in tetrahydrofuran31 affords the methoxy chloride 6 in excellent yield. 
It is worthy of note that the entire sequence of reactions up to the methoxy chloride 6 
does not require chromatographic purification beyond that of a simple plug filtration, 
allowing for the expeditious preparation of large quantities (multigram) of these building 
blocks. 
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Scheme 1.4. Synthesis of iptycene-derived pyridazines. 
DMAD
79-81%
COOMe
COOMe
1
1) NaOH
2) HCl
99-100%
COOH
COOH
2
(COCl)2, 
cat. DMF
96-100%
O
O
O
3
NH2NH2•HCl
82-100%
NH
NH
O
O
4
POX3
62-86%
N
N
X
X
5a, 5b, 5c: X = Cl
5d: R1 = R2 = H; X = Br
NaOMe
61-99%
N
N
Cl
OMe
6
R1
R1
R2
R2
R2
R1
R2
R1
R2
R1
R2
R1
R2
R1
R2
R1
R2
R1
R1
R2
R2
R1
R2
R1
R2
R1
R2
R1
a) R1 = R2 = H
b) R1 = H; R2 = tBu
c) R1, R2 =
N
O
O
7a
NH2
NH2NH2
57%
NH2NH2
Cl
Cl
+
8
3
TiCl4
85%
 
More soluble analogues of the pyridazine building blocks (1b,c-6b,c) were obtained 
through the same synthetic route starting with alkylated anthracenes. Friedel-Crafts 
akylations of anthracene with tertiary alcohols in the presence of acid are often the 
method of choice upon which the preparation of soluble analogues of iptycene derivatives 
relies, but it has the significant drawback of generating mixtures of 2,6- and 2,7-
dialkylanthracenes for which the isolation and purification of each isomer can be tedious. 
In our hands, the alkylation of anthracene with tert-butanol in trifluoroacetic acid yields a 
mixture of 2,6- and 2,7-di-tert-butylanthracene, which, after isolation and purification, 
affords at most 30-35% of the pure 2,6- isomer (m. p. 248-252˚C), in stark contrast with 
the original and often cited report claiming that the procedure affords exclusively the 2,6-
di-tert-butylated isomer (m. p. 151-152.5˚C) in good yields (72%).32 Our observations 
have been corroborated in two other reports,33 and consequently, a note of caution to the 
experimentalists is warranted. Since 2,6-di-tert-butylanthracene is not easily obtained in 
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large quantities, and results in racemic mixtures of the chiral intermediate iptycenes (e.g. 
1b-6b), we sought to prepare symmetrically 2,3,6,7-tetrasubstituted anthracenes bearing 
solubilizing alkyl groups. Only a few symmetrically 2,3,6,7-tetrasubstituted anthracenes, 
such as 2,3,6,7-tetramethylanthracene34 and 2,3,6,7-tetramethoxyanthracene,35 are readily 
available in large quantities at a minimal synthetic or monetary cost. Given the 
uncertainty that these analogues would provide the desired improvement in solubility of 
the resulting building blocks, we optimized a double Friedel-Crafts annulation route that 
provides the exceptionally soluble octamethyloctahydropentacene 8 in large quantities 
(up to 50 g) and in excellent yield in a single step starting from the readily available 9,10-
dihydroanthracene and 2,5-dichloro-2,5-dimethylhexane (Scheme 1.4).  
 
1.3 Synthesis of Iptycene-derived Phthalazines 
A synthesis of iptycene-derived phthalazines that parallels that of iptycene-
derived pyridazines has been developed (Scheme 1.5). The Diels-Alder cycloaddition of 
the exocyclic diene 9a with dimethyl acetylenedicarboxylate (DMAD),36 followed by an 
oxidative rearomatization with potassium permanganate in the presence of a phase-
transfer catalyst, 37  afforded the dimethyl phthalate 11a. Unlike the corresponding 
dimethyl maleate 1a, this compound reacts with hydrazine to yield the desired 
phthalhydrazide 12a, which undergoes chlorination with phosphorus oxychloride to give 
13a. Subsequent treatment with sodium methoxide affords the methoxy chloride 14a. A 
more soluble, alkylated analogue was prepared starting from the previously reported 
Diels-Alder adduct 15.8c The exocyclic diene 9b was obtained after a series of functional 
group transformations and carried through the previously described synthetic route to 
prepare the alkylated phthalazine 13b. Two of the chiral intermediates in the synthesis of 
the alkylated phthalazine 13b also exhibit some interesting properties of their own. Diol 
16 was found to be a potent organogelator of hexanes in concentrations as low at 
0.3% (w/v). Diene 9b undergoes a radical 1,4-polymerization upon thermolysis38 at 
180˚C for 1 h to yield a high molecular weight polymer (Mn: 135 000 g mol-1, 
Mw: 630 000 g mol-1). The polymer exhibits optical rotatory power in solution ([α]D21 = -
63˚ (c 0.64 in CHCl3) that is 20 times that of the monomer. However, this value remains 
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too low to constitute stong evidence that the chiral iptycene backbone has imparted a 
helical structure to the polymer in this solvent.39 
 
Scheme 1.5. Synthesis of iptycene-derived phthalazines. 
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1.4 Symmetrical and Unsymmetrical Cross-Couplings 
 Transition metal-catalyzed cross-coupling reactions, especially with Ni0 and Pd0 
are the pinnacle of methodologies for the construction of conjugated materials. 
Consequently, we explored cross-coupling reactions with newly synthesized 
halopyridazines (5a-d, 6a-c) to generate symmetrically or unsymmetrically 3,6-
disubstituted iptycene-derived pyridazines (Scheme 1.6 and Table 1.1). The pyridazine 
ring was found to be sufficiently electron-deficient and activated for oxidative addition 
with standard palladium catalysts even the nominally less reactive chlorides. 
Concomitantly, the high degree of electronic activation of the chloropyridazines 
accelerates nucleophilic aromatic substitution by nucleophiles such as amines, hydroxide 
or alkoxides. These side reactions prevent Suzuki-Miyaura cross-coupling reactions of 
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the chloropyridazines under typical biphasic reactions conditions (e.g. toluene-aqueous 
base) without significant competing hydrolysis. The Suzuki-Miyaura couplings proceed 
smoothly, however, in anhydrous dioxane in the presence of cesium fluoride as a base. 
These reaction conditions also appear optimal for Stille cross-coupling reactions. A 
nickel-catalyzed Negishi cross-coupling reaction was also adequate for the preparation of 
the 3,6-bis(bithienyl) derivative 20 in yields comparable to those obtained with the 
corresponding Stille reaction. Improved reactivity with increased electron-rich character 
of the nucleophilic cross-coupling partner was observed in most cases. Thus, forcing 
conditions40 are required for the reaction between the chloromethoxypyridazine 6a and 
2,4-difluorobenzeneboronic acid, and the desired cross-coupling product 23 is only 
obtained in poor yield. We also observe a counter-statistical bias during cross-coupling of 
the dichloride 5a with less than one equivalent of the organometallic reagent, which 
precludes the clean formation of the mono cross-coupled products (e.g. 25). Therefore, it 
was found to be preferable to perform the cross-coupling of the chloromethoxypyridazine 
6a, and to subsequently convert the intermediate 22 to the corresponding 
chloropyridazine (Scheme 1.7). Alternately, if one requires a monosubstituted pyridazine, 
hydrodechlorination of the chloromethoxypyridazine 6a followed by deprotection and 
chlorination yields the chloropyridazine 30. 
 
Scheme 1.6. Symmetrical and unsymmetrical cross-couplings. 
N
N
X2
X1
Ar M
PdLn or NiLn
conditions
X = Cl, Br, OMe
5a, 6a, 30
N
N
Z
Y
18-25  
 31 
Table 1.1. Cross-coupling reactions 
X1, X2 Ar-M Conditionsa Product 
X1 = X2 = Cl 
(5a)  
3 eq. PhSnMe3 A 
Y = Z = Ph   
(18) (54%) 
 
X1 = X2 = Cl 
(5a) 
3 eq. PhB(OH)2 B 
Y = Z = Ph   
(18) (83%) 
 
X1 = X2 = Cl 
(5a) 3 eq. S SnBu3 
A 
Y = Z = 2-thienyl 
(19) (95%) 
 
X1 = X2 = Cl 
(5a) 4 eq. S ZnCl
S
 C 
Y = Z = 2,2'-bithiophen-5-yl 
(20) (77%) 
 
X1 = X2 = Cl 
(5a) 4 eq. S SnBu3
S
 A 
Y = Z = 2,2'-bithiophen-5-yl 
(20) (86%) 
 
X1 = X2 = Cl 
(5a) 4 eq. S SnBu3
OO
 
A 
Y = Z = 3,4-ethylenedioxythiophen-2-yl 
(21) (85%) 
 
X1 = OMe;  
X2 = Cl 
(6a) 
1.8 eq. PhB(OH)2 A 
Y = OMe; Z = Ph 
(22) (91%) 
 
X1 = OMe;  
X2 = Cl 
(6a) 2 eq. 
F
F B(OH)2 
D 
Y = OMe 
Z =  
F
F  
(23) (37%) 
 
X1 = H;  
X2 = Cl 
(30) 
2 eq. PhB(OH)2 A 
Y = H; Z = Ph 
(24) (64%) 
 
X1 = H;  
X2 = Cl 
(30) 
2 eq. S SnBu3 A 
Y = H; Z = 2-thienyl 
(25) (78%) 
aConditions (see experimental section for details): (A) 5% Pd(PPh3)4, CsF, p-dioxane, 
100-110˚C; (B) 1.5% Pd2(dba)3, 6% tBu3P·HBF4, CsF, p-dioxane, 100-110˚C; (C) 5% 
Ni(dppp)Cl2, THF, 60˚C; (D) 5% Pd2(dba)3, 12% tBu3P·HBF4, CsF, Ag2O, DMF, 100˚C.
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Scheme 1.7. Synthesis of unsymmetrical iptycene-derived pyridazines. 
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The electrochemical properties of the thiophene derivatives 19, 20, and 21 were 
investigated. Cyclic voltammetry (CV) was performed using a platinum button working 
electrode with solutions of the thiophene derivatives in dichloromethane containing 
0.1 M tetra-n-butylammonium hexafluorophosphate as supporting electrolyte. In this 
experiment, bithienyl moieties are oxidized to radical cations at the electrode surface that 
couple to form a dicationic quaterthiophene, followed by deprotonation. The resulting 
conducting polymer deposed on the electrode surface can then be reversibly oxidized and 
reduced. Only the bithienyl derivative 20 is cleanly electropolymerized under these 
conditions, as illustrated on the CV presented in Figure 1.3. The CV also clearly shows a 
reduction wave centered at ca. -0.55V that is attributed to election injection (n-doping) in 
the electron-poor pyridazine ring. The lack of electrochemical activity of compounds 19 
and 21 is unexpected in regard of the electrochemical behavior of 20. The 2-thienyl 
derivative 19 appears to possess an unusually high oxidation potential for a di(2-
thienyl)arene, as no oxidation was found to occur within the potential window allowed by 
the solvent and supporting electrolyte. It is postulated that the strong electron-
withdrawing effect of the pyridazine ring shifts the oxidation potential of 19 to a more 
positive value. By contrast, a broad, ill-defined oxidation wave has been found for the 
di(3,4-ethylenedioxy-2-thienyl) derivative 21, but the CV suffered from poor reversibility 
(charge trapping) and no conductive polymer film growth on the electrode could be 
detected. In the case of 21, the poor electrochemical behavior is attributed to the lack of 
electronic delocalization and conjugation due to its non-planar conformation (vide infra).  
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Figure 1.3. Cyclic voltammetry of compound 20 in CH2Cl2 / 0.1 M nBu4NPF6: 
electropolymerization (left), scan rate dependence (right) and scheme of 
electropolymerization reaction (bottom).  
 
1.5 Reductive Dimerizations 
We have explored chemistries that would allow dimerization, and ultimately 
polymerization of the novel iptycene-derived diazines. Having demonstrated that the 
chloro, and bromo diazines are good electrophilic partners in cross-coupling reactions, 
we sought to prepare the corresponding nucleophilic cross-coupling partners. Many 
attempts for the preparation of iptycene-derived pyridazines metalated at the 3- and/or the 
6- position to yield the corresponding Kumada, Negishi, Stille or Suzuki-Miyaura 
reagents were unsuccessful. Attempts to homopolymerize the dihalopyridazines 5a-d 
with bis(boronates)41 or bis(stannanes)19d, 42 were similarly unsuccessful. These limitations 
are likely the result of the known instability and/or susceptibility to protodemetalation of 
metalated electron-poor nitrogen heterocycles.43 In fact, although 3-halopyridazines are 
commonly employed as electrophilic partners in cross-coupling reactions, we are only 
aware of two reports where pyridazines metallated in the 3- position are used as 
nucleophilic partners in standard cross-coupling reactions.26b, 44 Furthermore, to address 
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the difficulties associated with electron deficient heterocyclic couplings, alternate 
methods based on the direct arylation of pyridazine N-oxides with aryl halides through C-
H bond activation have been developed.45 Nevertheless, we considered these alternate 
methodologies to be ill-suited for our targets. Inspired by reports of nickel- and 
palladium-mediated reductive homocoupling of chloropyridazines, 46  the reductive 
homopolymerization of the dihalopyridazines 5a-d was explored. Reductive 
homopolymerizations attempts under Yamamoto conditions (Ni(cod)2, bpy)47 did not 
yield the desired homopolymers and dehalogenated low molecular weight materials were 
the dominant products. Various attempts directed at the improvement of this reaction by 
varying the transition metal (pre)catalyst48 and stoichiometric reductant49 were similarly 
unsuccessful. 
 
 Prompted by the observations that electron-poor arenes or heteroarenes were poor 
nucleophilic partners in cross-coupling reactions with the halopyridazines (vide supra), 
and that oxidative addition to the halopyridazine electrophilic partner did not appear to be 
limiting, the dimerization of the 3-chloropyridazines 6a-c bearing an electron-donating 
methoxy group at the para position was explored. Homocoupling of 6a following the 
protocol described by Lehn and Baxter,46a using 30% NiBr2(PPh3)3, nBu4NI and zinc dust 
in N,N-dimethylformamide afforded only 11 % of dimer 31a. Addition of 2,2'-bipyridine 
as a ligand and increasing the catalyst loading to 300 mol% resulted in a moderate yield 
(60-65%) of the dimer 31a, with significant quantities of the hydrodehalogenated 
methoxypyridazine 28 as a byproduct. These observations suggest that catalytic turnover 
is very limited in this system. However, it was found that the use of catalytic amounts of 
a palladium precatalyst with zinc dust as the stoichiometric reductant50 enabled the 
reductive homocoupling to efficiently afford the dimer 31a. Further optimization of the 
reaction conditions (5% Pd(PPh3)2Cl2, 10% PPh3, Zn, DMF, 100˚C) enabled the 
homocoupling to proceed reliably and cleanly in excellent yields (93-95%). Interestingly, 
after screening a variety of ligands and precatalysts for this transformation, we found the 
use of either Pd(PPh3)2Cl2/PPh3 or Pd(PPh3)4 to be optimal, and the use of advanced 
catalytic systems (e.g. bulky trialkylphosphines, biaryldialkylphosphines, NHCs, etc.) did 
not result in an improvement of the reaction.  
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Scheme 1.8. Synthesis of iptycene-derived bipyridazines. 
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 Since the alkylated methoxy chloride 6b has been prepared as an unresolved 
mixture of enantiomers, the reductive homocoupling resulted in the diastereoisomeric 
dimethoxy dimers 31b, Ci and rac-31b, C2 (Scheme 1.8). The isomers are obtained in a 
1:1 ratio, and may be separated by column chromatography. Despite their remarkably 
similar structures, the diastereomers exhibit distinct spectroscopic features. The 1H-NMR 
spectra of the mixture of diastereomers shows the four distinct, well-resolved resonances 
of each of the chemically nonequivalent tert-butyl groups, the two distinct resonances of 
the methoxy groups, and although the signals of the two 'external' bridgehead proton 
overlap, the pair of 'internal' bridgehead proton signals are spaced more than 0.2 ppm 
apart. Attempts at obtaining X-ray quality single crystals of either isomer of 31b, 32b, 
and 33b were unsuccessful. Moreover, while COSY and NOE 1H-NMR experiments 
gave self-consistent results, it has been impossible to unequivocally assign the structure 
of each isomer. The chiral HPLC analysis of the two isomers 31b was also investigated 
as a means of assigning the correct structure to each isomer. Under suitable conditions for 
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the separation of enantiomers, the chromatogram of the Ci isomers would present a single 
peak, while the chromatogram of the racemic C2 isomer mixture would present 2 peaks 
corresponding to the two possible enantiomers of 31b, C2. However, screening of chiral 
HPLC conditions (stationary & mobile phases) did not achieve the required resolution, 
and only a single peak could be observed on each chromatogram. Reductive coupling of 
the alkylated methoxy chloride 6c gave the symmetrically alkylated dimer 31c. The 
isolation and purification of 31c were hindered by its limited solubility in most organic 
solvents with the exception of hot toluene, carbon disulfide and heavier chlorinated 
solvents (e.g. tri- and tetrachloroethylene, tetrachloroethane). It is surprising that, while 
the symmetrically alkylated anthracene 8 and monomeric intermediates 1c-6c are 
considerably more soluble in typical organic solvents than either of their parent 
compounds 1a-6a  or tert-butyl substituted 1b-6b  counterparts, the dimers 31c, 32c, and 
33c are markedly less soluble than their parent compounds 31a-33a or tert-butyl 
substituted counterparts 31b-33b.  This observation stresses the importance not only of 
three dimensional structural elements that prevent stacking (e.g. iptycenes, spiro 
compounds, etc.) but also of flexible side-chains or freely rotating groups that provide a 
greater entropic term to the driving force for dissolution. 
 
 The dimethoxy dimers 31a-c could be converted to the corresponding dihalides by 
cleavage of the methoxy groups with hydrobromic acid in acetic acid, followed by 
treatment with a phosphorus(V) oxyhalide to give the dihalo dimers 33a-d in moderate to 
good yields. Treatment of the dichloride 33a with sodium methoxide in THF afforded the 
chloro methoxy dimer 34 in low yield (28%, 47% based on recovered starting material). 
The nucleophilic substitution of 5a-c to 6a-c, is selective for the monomethoxy product 
due to the deactivating effect of the first methoxy group for further ring substitution. By 
contrast, the conversion from 33a to 34 shows little selectivity, and, consequently, a 
mixture of the starting dichloro dimer 33a, the chloro methoxy dimer 34 and the 
dimethoxy dimer 31a  is obtained.  
 
In a new effort to assign the structures of the two diastereomers of compounds 
31b-33b, the derivatization of 33b with a chiral enantioenriched nucleophilic reagent was 
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attempted. Upon reaction with (R)-(+)-α-methylbenzylamine (96% ee) as the chiral 
nucleophile, a double aromatic nucleophilic substitution reaction with 33b, Ci was 
predicted to yield a single product while the same reaction with rac-33b, C2 was 
predicted to yield two possible diastereomers (Scheme 1.9).  
 
Scheme 1.9. (R)-(+)-α-methylbenzylamine derivatives of 33b. 
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Experimental results did not support our predictions. A first isomer of 33b, 
tentatively assigned to rac-33b, C2, affords 2 isomers after reaction with (R)-(+)-α-
methylbenzylamine. The two are obtained in a ~1:1 ratio after chromatographic 
separation (Isomers 1-1 and 1-2, 27% and 29% yield), and their characterization data are 
consistent with the double nucleophilic substitution product. The second isomer of 33b 
affords, after reaction with (R)-(+)-α-methylbenzylamine and isolation by 
chromatography, a product for which characterization data are consistent with the double 
nucleophilic substitution product of 33b, Ci in 50% yield (Isomer 2-1). However, the 1H- 
and 13C-NMR spectra shows exactly twice the number of signals expected for this 
product, and no evidence for the coalescence of the signals can be observed up to 60˚C. 
The NMR data could suggest that the isolated product is in fact a ~1:1 mixture of two 
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diastereomers that were not separated by chromatography. However, according to our 
hypothesis, a maximum of 3 doubly substituted products could be obtained from the 
reaction between 33b, Ci, rac-33b, C2 and (R)-(+)-α-methylbenzylamine. The NMR data  
is also consistent with a ~1:1 mixture of rotamers of the chiral derivative of 33b, Ci that 
are not interconvertible on the NMR timescale up to 60˚C. However, this interpretation 
would require a justification for the fact that the rotamers of the chiral derivatives of 33b, 
Ci do not interconvert on the NMR timescale, while those of the chiral derivatives of 33b, 
C2 do. An inspection of the structures of the derivatives does not easily support larges 
differences in barriers to rotations for the different isomers. Consequently, the chiral 
derivatization experiment was inconclusive, and the two diastereomers of 33b remain 
unassigned. 
 
The reductive coupling of dichlorophthalazine 13a and chloromethoxyphthalazine 
14a was similarly explored (Scheme 1.10). In parallel with what was observed with the 
corresponding pyridazines (5a-c, 6a-c), the dichlorophthalazine 13a did not participate in 
reductive homopolymerization under the reaction conditions surveyed. The reductive 
dimerization of the chloromethoxyphthalazine 14a was best accomplished with zinc dust 
in N,N-dimethylformamide in the presence of a catalytic amount of a palladium 
precatalyst. The isolated yields of the dimethoxybiphthalazine 35 were poor (17%) in 
comparison to the analogous reaction carried out with the chloromethoxypyridazine 6a 
(up to 95%). Furthermore, under these reaction conditions the reaction mixture rapidly 
displayed a deep purple hue, which disappeared upon aqueous workup. By contrast, no 
coloration develops in the reductive dimerization of the pyridazines 6a-c. This intriguing 
difference in the chemical behavior of otherwise similarly behaved species is highlighted 
by the isolation of 2,3-dicyanotriptycene (36)51 in 23% yield from the reaction mixture 
when 13a is used as a starting material.  
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Scheme 1.10. Reductive coupling of iptycene-derived phthalazines. 
N
N
X
Cl
13a: X = Cl
14a: X = OMe
N
N
MeO
N
N
OMe
35
N
N
36
X = OMe
17%
10% Pd(PPh3)2Cl2, 
20% PPh3, Zn, 
DMF
X = Cl
23%
 
 The transformation of a chlorophthalazine into a 1,2-dicyanobenzene is not 
unprecedented. Yanilkin and co-workers52 have reported that both the chemical reduction 
with metallic potassium and the electrochemical reduction of 1-chloro-4-X-phthalazines 
(X = Cl, OPh, OMe, OEt, OiPr) in N,N-dimethylformamide yield the radical anion of 
phthalonitrile. The situation observed with the chlorophthalazines 13a and 14a appears 
slightly more complex. While treatment of 13a with zinc dust in DMF in the absence of a 
palladium catalyst affords 2,3-dicyanotriptycene 36, the reaction is much slower than in 
the presence of 0.1 eq. Pd(PPh3)2Cl2 and 0.2 eq. PPh3. In the latter case, the deep blue-
purple hue attributed to the radical anion of 2,3-dicyanotriptycene 36 appears within 2 
hours at 60˚C. By contrast, in the absence of a palladium catalyst, the color only arises 
after several hours at 120˚C. The reaction with the more electron rich 
chloromethoxyphthalazine 14a is markedly slower.  In the absence of a palladium 
catalyst, 14a is only slowly degraded with zinc dust in DMF at 120˚C, and 2,3-
dicyanotriptycene 36 and the protodehalogenated 1-methoxyphthalazine are the only 
identifiable trace byproducts (3% and 5%, respectively). Finally, the reaction of 14a with 
zinc dust in DMF in the presence of a palladium catalyst (0.1 eq. Pd(PPh3)2Cl2 and 0.2 eq. 
PPh3) requires a reaction temperature higher than that for 13a (100˚C) to yield dimethoxy 
dimer 35 as the sole identifiable product by 1H-NMR. The deep purple color of the 
reaction mixture suggests that traces of 2,3-dicyanotriptycene 36 are nonetheless 
generated. These constitute evidence for the involvement of the palladium catalyst in the 
reductive heterocyclic ring-opening reactions, though the exact nature of this involvement 
has not been elucidated. These competing side-reactions were directly observed with the 
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iptycene-derived phthalazines (13a, 14a), but not with the analogous pyridazines (5a-c, 
6a-c), possibly because they might show a more negative reduction potential. One is 
tempted to speculate that, were such competing pathways to occur undetected, they 
might, along with proto-dehalogenation, be significant limitations to the synthesis of 
homopolymers of 5a-d through reductive coupling routes (vide supra).  
 
1.6 Higher Oligopyridazines Through Controlled Approaches 
Optimized reductive coupling conditions were applied to the preparation of 
extended oligopyridazines (Scheme 1.11). Under these conditions, the reductive coupling 
of the chloro methoxy dimer 34 proceeds smoothly in good yield (76%) to afford the 
quaterpyridazine 37. Unlike previously reported quaterpyridazines, which showed poor 
solubility,46a the tetramer 37 is freely soluble in a variety of common organic solvents, 
such as chloroform, dichloromethane, toluene, ethyl acetate, tetrahydrofuran and acetone. 
The comparatively high solubility of 37 is attributed to the iptycene scaffold, which 
prevents the strong π-π stacking interactions in the solid state that impede dissolution. 
When an excess (4 eq.) of the chloro methoxy dimer 34 is reductively coupled in the 
presence of the dichloro dimer 33a, the tetramer 37 (24%) and small quantities of the 
hexamer 38 (~10-15%) can be obtained after chromatographic separation. This hexamer 
represents, to the best of our knowledge, the first example of a fully characterized 
sexipyridazine.  Interestingly, the solubility of the hexamer 38 is qualitatively comparable 
to that of tetramer 37. 
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Scheme 1.11. Synthesis of iptycene-derived quaterpyridazine and sexipyridazine. 
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1.7 Planarity and Conjugation of Biaryls Obtained from Iptycene-derived 
Pyridazines and Phthalazines 
 We have used this collection of compounds containing iptycene-derived 
pyridazines and phthalazines to test our hypothesis that coplanarity of the biaryl linkages 
will be the preferred conformation. The vast majority of the compounds herein described 
are crystalline, and as a result a number of structures were determined by X-ray 
crystallography. NMR spectroscopy and computational studies also provide additional 
insight into the conformations of these molecules. We expected that a fully coplanar 
conformation about the biaryl linkage at the 3-position of the pyridazine or phthalazine 
would be at least accessible, if not energetically favored through increased conjugation, 
for pyridazines and phthalazines attached to five-membered ring heterarenes and six-
membered ring heterarenes bearing no ortho substituents (e.g. 2-thienyl, 3-pyridazinyl, 
etc.). Furthermore, we postulated that a secondary hydrogen-bonding interaction between 
the heteroatom of a heteraryl group and the bridgehead hydrogen of the iptycene 
framework might provide an additional enthalpic stabilization term.  
 
1.7.1 X-Ray Crystallography  
We examined the structure of several of the iptycene-derived diazine building 
blocks by X-ray crystallography to ascertain the validity of the coplanarization 
hypotheses. In conducting this analysis it is important to bear in mind that intermolecular 
interactions and close-packing can affect the conformation of molecules in the solid state 
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such that they are not necessarily representative of their "free" (or solvated) preferred 
conformations. The structures obtained for seven compounds are presented in Figure 1.4. 
The 2-thienyl derivative 19 adopts a quasi-coplanar  conformation of the teraryl fragment, 
as predicted (N-C-C-S dihedral angles: 5.05(15)˚ and 8.4(2)˚). Interestingly, a cisoid, 
synperiplanar (N-C-C-S) rotamer is observed, as opposed to the predicted transoid, 
antiperiplanar rotamer, illustrating at once the negligible steric clash between the 
bridgehead hydrogen of the iptycene and the adjacent hydrogen on the 5-membered ring, 
and the absence of involvement of a stabilizing S-H hydrogen bonding interaction.53 
Furthermore, within the crystal structure of 19 is also present another rotamer where the 
teraryl fragment is not planar but oblique (N-C-C-S dihedral angles: 29.84(16)˚ and 
120.30(19)˚), as is observed for the bis(3,4-ethylenedioxy)thiophene-2-yl derivative 21 
(N-C-C-S dihedral angles: 33.79(16)˚ and 37.54(15)˚). These observations suggest that 
the 2-thienyl group can freely - or with a minimal energy barrier - rotate about the biaryl 
linkage. In contrast, and as expected, a phenyl substituent, as in the 2,4-difluorophenyl 
derivative 23, does not adopt a coplanar conformation about the biaryl linkage (N-C-C-
C(F) dihedral angle 127.56(10)˚).  
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31a 
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35 
 
37 
 
Figure 1.4. X-ray crystal structures of iptycene-derived pyridazines and phthalazines. 
50% Probability thermal ellipsoids. Hydrogens and solvent molecules were omitted for 
clarity. See experimental section and appendix for details. 
 
 The pyridazine and phthalazine dimers 31a, 33a and 35, do not adopt a coplanar 
conformation about the biaryl linkages, despite the predicted stabilization through 
increased conjugation and the possibility of weak N-H intramolecular hydrogen bonding. 
The inclination of the diazine rings with respect to another varies greatly in this series, 
from the dimethoxy dimer 31a (N-C-C-N dihedral angle 113.70(13)˚) to the dichloro 
dimer 33a (N-C-C-N dihedral angle 135.07(15)˚), with an intermediate value for the 
phthalazine dimer 35 (N-C-C-N dihedral angle 127.4(2)˚). For the former pair of 
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compounds, it is unlikely that the steric and electronic parameters are affected by the 
substitution of a methoxy group for a chlorine atom at a position remote to the biaryl 
linkage. These results suggest that - at least within this bracket of torsion angles - the 
potential energy curve for rotation about the biaryl linkage must be shallow enough that 
intermolecular interactions and close packing overcome an inherently preferred rotamer. 
Finally, the structure of the tetramer 37 reveals that a further extension of the conjugation 
might favor coplanarization of the oligoheteraryl segments, even though an overall loss of 
linearity of the structure due to bending is witnessed (N-C-C-N dihedral angles 
141.58(17)˚, 141.07(17)˚, 141.51(16)˚). It should finally be stressed that X-ray 
crystallography provided no evidence of intramolecular hydrogen bonding between the 
iptycene and a proximal heteroatom in any of the structures herein described. 
 
1.7.2 NMR Spectroscopy 
The 1H-NMR resonance of the bridgehead hydrogen of triptycene appears at 
5.41 ppm in CDCl3. This value is unusually high for a sp3-hybridized hydrocarbon, as 
expected due to the inductive effects and ring current anisotropy of the three aromatic 
rings of the triptycene molecule. This peak is not split by any adjacent nucleus, and is in a 
region that is free of other signals, hence it is a key diagnostic in NMR identification of 
compounds. We sought to take advantage of local ring current anisotropy to provide an 
indirect way of evaluating the coplanarity of the iptycene-derived pyridazine and 
phthalazine structures in solution. For a simple arylated iptycene-derived pyridazine 
(e.g. 18), were the aryl groups to be completely coplanar with the pyridazine ring, one 
would expect the bridgehead hydrogen to experience the influence of ring current 
anisotropy induced by the three arenes of the iptycene-derived pyridazine scaffold, in 
addition to that induced by the pendant aryl group. The resulting NMR signal would be 
shifted downfield, in a situation reminiscent of the "bay" protons in phenanthrene and 
other fused polycyclic aromatic hydrocarbons. Conversely, if the pendant aryl group lies 
predominantly perpendicular to the plane of the pyridazine ring, the bridgehead hydrogen 
signal should shift upfield (Scheme 1.12). 
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Scheme 1.12. Influence of pendant arene conformation on bridgehead proton 1H-NMR 
signal. 
N
N
H
Bridgehead hydrogen in the 
plane of the pendant arene:
Higher chemical shift
Bridgehead hydrogen facing 
the plane of the pendant arene:
Lower chemical shift
N
N
H
 
 In the monomeric iptycene-derived pyridazines bearing non-carbon substituents at 
the 3,6-positions (5a-d, 6a-c, 28, 30), the observed chemical shift54 of the proximal 
bridgehead hydrogens are within a narrow range (δ = 5.61-5.85 ppm). This range is even 
narrower (δ = 5.72-5.85 ppm) if the outlying signals corresponding to the sterically 
congested 5c, 6c (δ = 5.61-5.69 ppm) and the pyridazines unsubstituted at the 6- position, 
such as in 28 and 30 (δ = 5.56-5.60 ppm), are excluded. The fact that the chemical shift 
of the bridgehead hydrogen in iptycene-derived pyridazines is ~ 0.2-0.4 ppm higher than 
that of simple triptycenes likely reflects the electron-deficient nature of the pyridazine 
ring. Unsymmetrically 1,4-disubstituted iptycene-derived pyridazines (6a-c, 22-30) show 
two singlets corresponding to each of the bridgehead hydrogens, but the chemical shift 
difference between the two can be minimal, as observed for the bridgehead hydrogens 
proximal to the chloro and the methoxy substituents in 6a (∆δ ≤ 0.03 ppm). In order to 
confirm the assignment of the bridgehead and adjacent hydrogen signals, especially in 
compounds that possess more than one set of chemically equivalent bridgehead hydrogen 
signals, NOE experiments were performed (Figure 1.5). The structure of the iptycenes 
enforces short distances between the bridgehead protons and adjacent protons on the 
iptycene, and between bridgehead protons and protons ortho to arene substituents in 3-or 
6- to the pyridazine ring, resulting in strong NOE signals (~10% enhancement).  
 
 Substitution by a phenyl group (18, 22, 24, 27) results only in a minimal shift of 
the signal assigned to the bridgehead hydrogen proximal to the phenyl substituent relative 
to those next to a halogen or a methoxy group (∆δ = -0.08 to +0.08 ppm). This suggests 
either that the influence of the additional ring current anisotropy does not affect the 
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proximal bridgehead hydrogen, or that the average influence of the rotamer population 
distribution within the NMR timescale gives no change in the chemical shift of phenyl 
substituted iptycene-derived pyridazines. The latter is plausible considering that a phenyl 
ring will likely prefer to be oblique or gauche with respect to the plane of the pyridazine 
ring to avoid the eclipsing of the ortho hydrogens by the proximal bridgehead hydrogen. 
Substitution by a 3,4-ethylenedioxythiophen-2-yl group (21) has a similar effect (e.g. 
5a→21 ∆δ = +0.12 ppm). This is in agreement with the solid-state structure in which the 
substituent group is synclinal with respect to the plane of the pyridazine ring (N-C-C-S 
dihedral angle ~ 35˚). 
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Figure 1.5. Summary of NOE data. (e.g. H-H: 10.4%: NOE enhancement of the 1H-
NMR signal of hydrogen H by 10.4% upon irradiation of the 1H-NMR signal of 
hydrogen H.) 
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 Substitution by the 2,4-difluorophenyl group (23) results in a more significant 
upfield shift of the proximal bridgehead hydrogen (e.g. 6a→23 ∆δ = -0.36 ppm to 
5.43 ppm). This is the lowest chemical shift observed for bridgehead hydrogens among 
all of the iptycene-derived pyridazines herein reported. A coplanar conformation of the 
pendant arene and the pyridazine ring in 23 would be energetically demanding due to the 
steric clash between the ortho fluorine and the proximal bridgehead hydrogen for the 
antiperiplanar (N-C-C-C(F)) rotamer, and due to electronic and dipole-dipole repulsion for 
the synperiplanar rotamer. Among the compounds studied, the fluorinated derivative 23 is 
the most likely to show a predominantly perpendicular orientation between the pendant 
arene ring and the pyridazine ring (vide infra). A real, although weak, NOE signal 
enhancement (1.0%) of the ortho proton of the difluorophenyl ring upon irradiation of the 
proximal bridgehead hydrogen supports both the assignment of the proximal bridgehead 
hydrogen, and a preferred or time-averaged rotamer in which the fluorinated arene is 
perpendicular to the plane of the pyridazine. The NMR signal assignment for 23 is further 
evidenced by the presence of through-space 1H-19F coupling (J ≈ 4 Hz), where the 
proximal bridgehead hydrogen is split by the ortho fluorine of the aromatic ring 
(Figure 1.6), a feature previously studied in fluorinated iptycenes.55 We also observe 
through-space 13C-19F coupling where the proximal bridgehead carbon is split by the 
ortho fluorine (J ≈ 4-5 Hz). These through-space couplings are indicative of the short  H-
F (2.541 Å) and C-F (2.9965(12) Å) distances imposed by the molecular architecture as 
revealed in the X-ray structure for 23, which are shorter than the sum of the van der 
Waals radii. 
 
 In a third series, wherein the pendant arene is a 5- or 6-membered heterocycle 
devoid of a substituent in at least one ortho position, such as 2-thienyl or 3-pyridazinyl, 
the bridgehead hydrogen resonance is shifted downfield. Iptycene-derived pyridazines 
bearing a 2-thienyl substituent (e.g. 19, 20, 25) experience a dramatic shift (e.g. 5a→19 
∆δ = +0.43 ppm to 6.27 ppm) consistent with the hypothesis that a coplanar rotamer is 
favored. This is also supported by the observation of the same rotamer by X-ray 
crystallography for 19 (vide supra). Iptycene-derived pyridazine dimers (31a-c, 33a-d, 
34), and higher oligomers (37, 38) also show a similar behavior. The signal assigned to 
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the 'internal' bridgehead hydrogens, which are proximal to the second pyridazine ring, are 
also shifted considerably downfield compared to the 'external' bridgehead hydrogens that 
are proximal to a methoxy group or a halogen.  For example, the 'internal' bridgehead 
hydrogen of the dichloro dimer 33a has a chemical shift of δ = 6.37 ppm, while the 
'external' bridgehead hydrogen resonates at δ = 5.99 ppm (Figure 1.6). Furthermore, 
spectra of the unsymmetrical dimer (34) and the higher oligomers (37, 38) are consistent 
with the hypothesis that the shift is caused by the ring current anisotropy of an adjacent 
coplanar arene. The dimer 34 displays 2 downfield signals above 6.20 ppm and 2 upfield 
signals around 6.00 ppm, the tetramer 37 displays 3 'internal' downfield signals and 1 
'external', upfield signal, and finally the hexamer 38, shows 5 'internal',  downfield signals 
and 1 'external', upfield signal. The extent of this chemical shift difference varies between 
the different compounds, ranging from ∆δ = +0.07 ppm to 1.00 ppm. The two highest 
values (∆δ = +0.69 ppm and 1.00 ppm) belong to the symmetrically alkylated dimers 33c 
and 31c, which are expected to greatly favor an antiperiplanar or anticlinal (N-C-C-N) 
rotamer due to the additional steric clash between the alkyl groups that a synclinal 
rotamer would incur. 
 
 
Figure 1.6. Comparative 1H-NMR spectra of the iptycene bridgehead region illustrating 
the shifts experienced by hydrogens that are proximal to a coplanar arene (20, 33a 
'internal' H), and by the hydrogens that are proximal to an oblique (27) or perpendicular 
(23) arene. 
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The iptycene-derived phthalazine dimer 35 may not be directly compared to the 
other molecules of the series, due to the greater distance between the bridgehead 
hydrogen and the aryl substituent. Parallel conclusions can nonetheless be made on the 
basis of its 1H-NMR spectrum. The monomers 13a and 14a display 1H-NMR signals 
assigned to the bridgehead hydrogens at 5.79, 5.72 and 5.69 ppm, while the proximal 
phthalazine hydrogens are assigned to signals at 8.25, 8.16 and 8.13 ppm. In the dimeric 
iptycene-derived phthalazine 35, the corresponding signals are observed at 8.29, 7.82, 
5.67 and 5.45 ppm. NOE enhancements between bridgehead protons and proximal 
iptycene and phthalazine hydrogens allow for the identification of two sets of signals that 
either face inward or outward the dimer 35. The actual assignment of each of these sets to 
either the 'internal" or 'external' face must however rely on a chemical shift argument. On 
the basis of these assignments, and under the assumption that the signals that experience 
the more dramatic shifts correspond to the internal protons of the dimer, it appears that a 
significant shielding occurs for both the internal bridgehead hydrogen (∆δ = -0.24 ppm) 
and the internal phthalazine hydrogen (∆δ = -0.31 ppm). Thus, we conclude that the 
preferred (or averaged) rotamer of 35 is not synperiplanar but instead oblique or 
perpendicular, as for 23.  
  
1.7.3 Modeling 
 To further support the hypothesis that coplanarization and conjugation may be 
favored or at the minimum less disfavored in aryl substituted, iptycene-derived, 
pyridazine- or phthalazine-based molecular materials, ab initio calculations were 
performed as follows.56 Molecular geometries (gas phase) were first minimized with the 
B3LYP functional and the 6-31G+(d,p) basis set (6-31G(d,p) for the iptycene dimers). 
The energies of the rotamers about the biaryl linkage were then individually calculated 
every 5˚ with the B3LYP functional and the 6-31G+(d,p) basis set, and the energy of the 
coplanar rotamer is reported relative to that of the minimum energy conformation. 
Calculations were also performed on a series of model compounds for the purpose of 
comparison, and the results are summarized in Table 1.2. These results do not necessarily 
provide an accurate estimate of the barrier to atropisomerization. The calculated barrier to 
rotation about the C-C biaryl linkage does not account for other molecular motion 
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(torsion, stretching, bending, etc.) that, when combined with rotation can provide 
additional lower energy pathways to atropisomeric inversion. As an illustration, the 
energy of the coplanar rotamer of binaphthyl L relative to that of the minimum energy 
conformation is of ~128 kcal/mol, while the experimental value is of 23.5 kcal/mol.57 
Nonetheless, these calculations provide a means of comparison and facilitate the 
investigation of structure-property relationships with respect to the ease of 
coplanarization. 
 
 The bipyridazine A illustrates the working hypothesis for coplanarization, and 
favors a coplanar and flat conformation with an antiperiplanar (transoid) orientation with 
respect to the torsion angle formed by the N-C-C-N atoms of the biaryl junction. A 
second local energy minimum, which is 8 kcal/mol less stable, that parallels the preferred 
rotamer of biphenyl B is found between 45˚ and 50˚. The iptycene-derived pyridazine 
dimers (31a and 33a) do not minimize in a perfectly coplanar structure. The iptycene 
bridgehead hydrogen creates a slight steric clash, resulting in a coplanar rotamer that is 
less stable by 3-4 kcal/mol, a value comparable to the barrier to rotation about the C-C 
bonds of substituted or branched alkanes. The torsion angle at the energy minimum is of 
~145˚, a value greater than that observed in the crystal structures of 31a and 33a, but 
approaching those found in the crystal structure of 37. We take this to be additional 
evidence that the preferred conformation of these molecules in a free or solvated state is 
more coplanar than in the crystal. It is noteworthy that the relative energy of the coplanar 
rotamer remains lower than in the analogous pyridazine bearing an ortho methyl group 
(F, 6 kcal/mol) or than in the corresponding biphthalazine (H, 8 kcal/mol), and this fact is 
attributed to the 'tying back' of the bridgehead hydrogen within the iptycene scaffold. The 
relative energy of the coplanar rotamer is also far lower than in molecules with one (22, 
20 kcal/mol; 23, 25 kcal/mol) or two (J, 53 kcal/mol; K, 83 kcal/mol) of the pyridazine 
rings replaced by the corresponding aromatic hydrocarbon. A significant lowering of the 
relative energy of the coplanar rotamer is also encountered with 2-thienyl substituents, as 
corroborated by X-ray crystal structures and NMR spectroscopy. The relative energy of 
the coplanar rotamer is no more than 4 kcal/mol less stable for D, while for the analogous 
2-thienyl arene G the difference is 7 kcal/mol. The difference remains lower in the 
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unsubstituted 2-phenylthiophene B (0.6 kcal/mol), paralleling that observed between 33a 
(or 31a) and C. Significant reduction of the relative energy of the coplanar conformer is 
also present in the bi(phthalazines) (H, 8 kcal/mol; 35, 7 kcal/mol) relative to the 
hydrocarbon analogues (L, 128 kcal/mol; M, 126 kcal/mol).  
 
Table 1.2. Computational modeling results 
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 K L M  
Dihedral 107.7˚ 74.8˚ 66.9˚  
Erel 82.9 127.7 125.8  
B3LYP 6-31G+(d,p) results. a Dihedral angle at energy minimum. b Relative energy of 
the coplanar rotamer with respect to that of the minimum energy conformation, in 
kcal/mol. c Energy minimum. 
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1.7.4 UV-Vis and IR Spectroscopy 
We have postulated the possibility of a stabilizing hydrogen-bonding interaction 
between the bridgehead hydrogen and a proximal heteroatom. A close inspection of the 
infrared spectra of a selection of the compounds58 did not reveal evidence for these types 
of interactions. Given that neither computational modeling nor crystallography indicates 
such an interaction, we conclude that the involvement of hydrogen bonding is at best a 
very small stabilizing effect. The limited degree of stabilization by hydrogen-bonding, if 
present at all, is attributed to the weak acidity of the bridgehead hydrogen (pKa > 20) as a 
hydrogen-bond donor and the low basicity of the pyridazine nitrogen (pKa ~ 2-3) as a 
hydrogen-bond acceptor. Biaryls and oligoaryls in which coplanar rotamers are favored 
generally exhibit extended π-conjugation. In oligo p-phenylenes, the extended 
conjugation caused by the addition of additional aryl rings results in a bathochromic shift 
of the absorption maxima and in an increase of the molar absorptivity.59 This situation is, 
however, not paralleled in the iptycene-derived pyridazine oligomers suggesting that the 
pyridazine rings displays less efficient electron delocalization (Figure 1.7).  
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Figure 1.7. UV-Vis spectra of iptycene-derived pyridazines in THF. Full UV-Vis  
spectra (top) and vertical expansion (bottom). 
 
Furthermore, the fact that the most of the new compounds presented herein are 
nonfluorescent, with the notable exception of the thiophene derivatives (e.g. 19, 20) that 
are strongly fluorescent,19d also supports a lack of efficient electron delocalization.26a 
Hence, there would appear to be a minimal electronic driving force for planarization. To 
verify the efficiency of electron delocalization in these molecules, the donor-acceptor dye 
45 was prepared, and its photophysical properties were compared to that of the 
hydrocarbon analogue 42. Donor-acceptor chromophores are characterized by a strong 
N
N
H3CO
OCH3
n
n = 1, 2, 4, 6
N
N
Cl
OCH3
6a
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transition dipole and intramolecular charge transfer component to their excited state. 
Their photophysical properties are governed by the strength of the electron-donating 
group, the efficiency of electronic delocalization in the π-conjugated bridge and the 
strength of the electron-accepting group, and these all contribute to a hyper- and 
bathochromic shifts of their absorption wavelengths.60 The dyes 42 and 45 differ only in 
their π-conjugated bridge and therefore provide a way to evaluate the efficiency of 
electronic delocalization in iptycene-derived pyridazines as compared that of biphenyl.  
 
 The dyes were prepared according to the synthetic route presented in 
Scheme 1.13. Aminobromobiphenyl 3961 was prepared according to literature procedures. 
Condensation with the ditosylate of 1,4-butanediol provides the arylpyrrolidine 40, which 
is cross-coupled with 5-formylthiophen-2-ylboronic acid to provide the intermediate 41 
in excellent yields. Knovenagel condensation with 2-(3-cyano-4,5,5-trimethylfuran-
2(5H)-ylidene)propanedinitrile (TCF) in a Dean-Stark apparatus using piperidine and 
piperidinium acetate as catalysts provides the donor-acceptor chromophore 42 as a dark 
purple solid. The synthesis of the pyridazine analogue 45 follows a parallel route starting 
from pyrrolidine 43, obtained by nucleophilic aromatic substitution from the dichloride 
33a. Key to the success of these syntheses are modifications to the Suzuki-Miyaura cross-
coupling protocol reported by the Buchwald group.62  
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Scheme 1.13. Synthesis of donor-acceptor dyes 42 and 45. 
1) HNO3, AcOH (51%)
2) Br2, AcOH (53%)
3) Fe0, EtOH-HCl (94%)
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The UV-Vis spectra of 42 and 45 in chloroform solution are presented in 
Figure 1.8. Clear evidence for less efficient electronic delocalization iptycene-derived 
bipyridazines (45, λmax = 464 nm) as compared to biphenyls (42, λmax = 574 nm) is 
provided. Consequently, while iptycene-derived pyridazines were shown to exhibit 
reduced barriers to coplanarization, the thermodynamic impetus for coplanarization is 
limited. 
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Figure 1.8. UV-Vis spectra of 42 and 45 in CHCl3. 
 
1.8 Conclusions 
In conclusion, we have reported a practical, scalable synthesis of attractive 
heterocyclic iptycene building blocks. These methods permit the introduction of 
solubilizing groups, the general application of cross-coupling reactions for the 
preparation of (het)aryl-substituted iptycene-derived 1,2-diazines, and finally the access 
to dimers and higher oligomers through reductive couplings. The relaxation of steric 
hindrance at the ortho positions is supported by crystallographic, spectroscopic and 
computational studies. The incorporation of these building blocks as structural 
components poly(aryl ether)s will be presented in Chapter 2, and their incorporation in 
liquid crystals and as cyclometallating ligands for transition metals in Chapter 3. 
 
1.9 Experimental Section 
Materials 
All solvents were of ACS reagent grade or better unless otherwise noted.  Anhydrous 
toluene, diethyl ether, dichloromethane and tetrahydrofuran were dried on a solvent 
column purification system. p-Dioxane was dried over activated type 4X molecular sieves 
prior to storage in dry, air-free vessels. N,N-Dimethylformamide was dried by standing 
with BaO, followed by distillation and storage over activated molecular sieves. Silica gel 
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(40-63 µm) was obtained from SilliCycle Inc. All other reagents, compounds and 
chemicals were obtained from commercial suppliers and were used without further 
purification. 
 
General methods, instrumentation and measurements 
Synthetic manipulations that required an inert atmosphere (where noted) were carried out 
under nitrogen or argon using standard Schlenk techniques or in an inert-atmosphere 
glovebox. NMR (1H and 13C) spectra were recorded on 300, 400 and 500 MHz 
spectrometers. The chemical shift data for each signal are given in units of δ (ppm) 
relative to tetramethylsilane (TMS) where δ (TMS) = 0, and referenced to the residual 
solvent resonances. Splitting patterns are denoted as s (singlet), d (doublet), t (triplet), q 
(quartet), m (multiplet), and br (broad).  High-resolution mass spectra (HR-MS) were 
obtained at the MIT Department of Chemistry Instrumentation Facility using electron 
impact ionization (EI) with a voltage of 70 V or electrospray ionization (ESI). Optical 
rotations were measured using a 1 dm cell. Melting point (m.p.) determination was 
performed using open capillaries and are reported uncorrected.  
 
Details of X-Ray crystal structures63 
Low temperature (100 K) diffraction data were collected on a Siemens Platform three-
circle diffractometer coupled to a Bruker-AXS Smart Apex CCD detector with graphite-
monochromated Mo Kα radiation (λ = 0.71073 Å), performing φ- and ω-scans. Data 
reduction for all datasets was performed with the program SAINT version 7.1264 and 
semi-empirical absorption correction was performed using SADABS.65 All structures 
were solved by direct methods using SHELXS66 and refined against F2 on all data by full-
matrix least squares with SHELXL-97. 67  All non-hydrogen atoms were refined 
anisotropically. All hydrogen atoms were included into the model at geometrically 
calculated positions and refined using a riding model. The isotropic displacement 
parameters of all hydrogen atoms were fixed to 1.2 times the U value of the atoms they 
are linked to (1.5 times for methyl groups).  
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Dimethyl 9,10-dihydro-9,10-etheno-11,12-anthracenedicarboxylate (1a).27 This 
literature compound was prepared by an adaptation of published procedures. Anthracene 
(65 g, 365 mmol) and dimethyl acetylene dicarboxylate (65 g, 458 mmol) were placed in 
a septum-capped 250-mL round-bottom flask, and the mixture was purged by bubbling 
nitrogen in for ca. 30 mins. The resulting mixture was then stirred at ~170-180˚C for 1 h. 
Upon warming the reagents dissolve to form a homogenous phase, which darkens slightly 
during the course of the reaction. The mixture was then cooled to ~90-100˚C and poured 
while still warm in a 2-L Erlenmeyer flask containing ca. 1.8 L of MeOH. The crude 
precipitate was directly recrystallized from this volume of MeOH to yield (1) (93.5 g, 
80%) as pale beige crystals over two crops. 1H-NMR (500 MHz; CDCl3): δ = 7.41-7.38 
(dd, 4H, J = 5.5, 3.3 Hz), 7.05-7.02 (dd, 4H, J = 5.5, 3.3 Hz), 5.49 (s, 2H), 3.80 (s, 6H); 
13C-NMR (125 MHz; CDCl3): δ = 166.0, 147.1, 143.8, 125.5, 123.9, 52.5, 52.4 
 
Dimethyl (±)-2,6-di-tert-butyl-9,10-dihydro-9,10-etheno-11,12-
anthracenedicarboxylate (1b).27 2,6-Di-tert-butylanthracene32, 33 (14.5 g, 50 mmol) and 
dimethyl acetylenedicarboxylate (11.5 g, 78 mmol) were placed in a septum-capped 100-
mL round-bottom flask, and the mixture was purged by bubbling in nitrogen for ca. 
30 mins. The resulting mixture was stirred at ~170-180˚C for 1.5 h. The mixture was then 
cooled to ~90-100˚C and poured while still warm in MeOH. The crude precipitate was 
recrystallized from MeOH to yield (1b) (17.3 g, 79%) as pale beige crystals over two 
crops. m. p. = 178-179˚C; 1H-NMR (500 MHz; CDCl3): δ = 7.41 (d, 2H, J = 1.5 Hz), 
7.32-7.30 (d, 2H, J = 8.0 Hz), 7.04-7-02 (dd, 2H, J = 7.5, 1.5 Hz), 5.42 (s, 2H), 3.80 (s, 
6H), 1.28 (s, 18H); 13C-NMR (125 MHz; CDCl3): δ = 166.4, 148.6, 147.5, 144.0, 141.1, 
123.3, 122.1, 121.4, 121.3, 52.6, 34.8, 31.7; HR-MS (ESI): calc. for C28H32O4 [M+Na]+ 
455.2193, found 455.2193. 
 
Dimethyl 1,1,4,4,8,8,11,11-octamethyl-1,2,3,4,6,8,9,10,11,13-decahydro-6,13-etheno-
15,16-pentacenedicarboxylate (1c). 1,1,4,4,8,8,11,11-Octamethyl-1,2,3,4,8,9,10,11-
octahydropentacene (8a) (19.9 g, 50 mmol),  dimethyl acetylenedicarboxylate (22.2 g, 
150 mmol) and ca. 25 mL of xylenes were placed in a teflon-capped, thick-walled glass 
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pressure vessel, and the headspace was flushed with a stream of argon for ca. 15 mins 
before the vessel was sealed. The resulting mixture was heated at 180˚C overnight. The 
mixture was then cooled and poured in MeOH. The crude precipitate was purified by 
trituration in boiling MeOH to yield (1c) (22.1 g, 81%) as a white solid. m. p. = 330-
332˚C; 1H-NMR (300 MHz; CDCl3): δ = 7.26 (s, 4H), 5.30 (s, 2H), 3.78 (s, 6H), 1.61 (s, 
8H), 1.24 (s, 12H), 1.20 (s, 12H); 13C-NMR (75 MHz; CDCl3): δ = 166.5, 147.5, 141.6, 
140.9, 52.6, 52.2, 35.3, 34.5, 32.2, 32.0; HR-MS (ESI): calc. for C36H44O4 [M+Na]+ 
563.3132, found 563.3123. 
 
9,10-Dihydro-9,10-etheno-11,12-anthracenedicarboxylic acid (2a).27 This literature 
compound was prepared by an adaptation of published procedures. Dimethyl 9,10-
dihydro-9,10-etheno-11,12-anthracenedicarboxylate (1a) (93 g, 290 mmol) and NaOH 
(30 g, 750 mmol) were refluxed for 1 h in a solution of 360 mL MeOH and 120 mL H2O. 
The resulting mixture was then cooled for several hours in a refrigerator. Solids were 
filtered, washed with small portions of cold methanol, and redissolved in water 
(ca. 700 mL). The diacid 2a precipitates upon acidification with concentrated 
hydrochloric acid, is isolated by filtration, washed with small portions of water and dried 
under reduced pressure for several hours to yield (2a) as a white solid (83.7 g, 99%). 1H-
NMR (500 MHz; (CD3)2SO): δ = 12-9 (br, 2H), 7.44-7.42 (dd, 4H, J = 5.1, 3.0 Hz), 7.03-
7.00 (dd, 4H, J = 5.1, 3.0 Hz), 5.62 (s, 2H); 13C-NMR (125 MHz (CD3)2SO): δ = 166.4, 
147.5, 144.6, 124.9, 123.7, 52.0. 
 
(±)-2,6-Di-tert-butyl-9,10-dihydro-9,10-etheno-11,12-anthracenedicarboxylic acid 
(2b). Dimethyl ester (1b) (15.0 g, 35 mmol) and NaOH (6 g, 150 mmol) were refluxed 
for 2 hrs in a solution of 150 mL MeOH and 50 mL H2O. The resulting mixture was then 
cooled for several hours in a refrigerator. Solids were filtered, washed with small portions 
of cold methanol, and redissolved in water. The diacid 2b precipitates upon acidification 
with concentrated hydrochloric acid, is isolated by filtration, washed with small portions 
of water and dried under reduced pressure for several hours to yield (2b) as an off-white 
solid (14.2 g, 100%). m. p. = 270-275˚C (dec); 1H-NMR (500 MHz; (CD3)2SO): δ = 7.47 
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(d, 2H, J = 1.5 Hz), 7.34-7.32 (d, 2H, J = 7.5 Hz), 7.02-7.00, (dd, 2H, J = 7.5, 1.5 Hz) 
5.49 (s, 2H), 1.22 (s, 18H). (note: acid COOH unseen); 13C-NMR (125 MHz (CD3)2SO): 
δ = 166.9, 147.7, 146.5, 144.5, 141.6, 123.1, 121.4, 120.7, 51.3, 34.3, 31.3; HR-MS 
(ESI): calc. for C26H28O4 [M+Na]+ 427.1880,  found 427.1862. 
 
1,1,4,4,8,8,11,11-Octamethyl-1,2,3,4,6,8,9,10,11,13-decahydro-6,13-etheno-15,16-
pentacenedicarboxylic acid (2c). Dimethyl ester (1c) (27.3 g, 51 mmol) and NaOH (9 g, 
225 mmol) were refluxed overnight in a solution of 225 mL MeOH and 75 mL H2O. The 
resulting mixture was then cooled for several hours in a refrigerator. Solids were filtered, 
washed with small portions of cold methanol, and redissolved in water. The diacid 2c 
precipitates upon acidification with concentrated hydrochloric acid, is isolated by 
filtration, washed with small portions of water and dried under reduced pressure for 
several hours to yield (2c) as an off-white solid (26.7 g, 100%). m. p. > 330˚C; 1H-NMR 
(300 MHz; (CD3)2SO): δ = 7.33 (s, 4H), 5.41 (s, 2H), 1.56 (s, 8H), 1.20 (s, 12H), 1.14 (s, 
12H). (note: acid COOH unseen); 13C-NMR (125 MHz (CD3)2SO): δ = 166.9, 146.5, 
141.4, 140.7, 121.3, 51.0, 34.7, 33.9, 31.7, 31.6; HR-MS (ESI): calc. for C34H40O4 
[M+Na]+ 535.2819,  found 535.2831 
 
9,10-Dihydro-9,10-etheno-11,12-anthracenedicarboxylic acid, anhydride (3a).27 This 
literature compound was prepared by a modification of published procedures. 9,10-
Dihydro-9,10-etheno-11,12-anthracenedicarboxylic acid (2a) (58.4 g, 200 mmol) was 
suspended in a solution of CH2Cl2 (2.5 L) and DMF (1.5 mL), and cooled in an ice-water 
bath to 0˚C. To the cooled suspension was added dropwise (COCl)2 (20 mL, 235 mmol). 
A slow gas release indicates the beginning of the reaction. The reaction mixture, vented 
by a connection to an oil bubbler, was stirred and let to warm up to room temperature 
overnight, during which period the suspension turns into a clear solution. After 
evaporation of the solvents under reduced pressure, the resulting solid was recrystallized 
from toluene to yield (3a) as large beige crystals (52.7 g, 96%) over three crops. 1H-NMR 
(500 MHz; CDCl3): δ = 7.48-7.44 (dd, 4H, J = 5.2, 3.2 Hz), 7.11-7.08 (dd, 4H, J = 5.0,  
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3.5 Hz), 5.56 (s, 2H); 13C-NMR (125 MHz; CDCl3): δ = 160.4, 159.6, 142.9, 126.2, 
125.0, 47.9. 
 
(±)-2,6-Di-tert-butyl-9,10-dihydro-9,10-etheno-11,12-anthracenedicarboxylic acid, 
anhydride (3b). Diacid (2b) (12.3 g, 30 mmol) was suspended in a solution of CH2Cl2 
(700 mL) and DMF (0.5 mL), and cooled in an ice-water bath to 0˚C. To the cooled 
suspension was added dropwise (COCl)2 (2.75 mL, 32 mmol). A slow gas release 
indicates the beginning of the reaction. The reaction mixture, vented by a connection to 
an oil bubbler, was stirred and let to warm up to room temperature overnight, during 
which period the suspension turns into a clear solution. Evaporation of the solvents under 
reduced pressure results in the crude 3b as a pale yellow solid (12.3 g, 100%) that is pure 
enough for the next synthetic step, but may be repurified by passing on a SiO2 plug with 
CH2Cl2. m. p. = 278-280˚C (dec); 1H-NMR (300 MHz; CDCl3): δ = 7.50 (d, 2H, 
J = 1.2 Hz), 7.43-7.40 (d, 2H, J = 7.8 Hz), 7.12-7.09 (dd, 2H, J = 7.8, 1.5 Hz), 5.52 (s, 
2H), 1.30 (s, 18H); 13C-NMR (125 MHz; (CD3)2SO): δ = 166.7, 147.6, 144.6, 141.7, 
123.1, 121.4, 120.7, 51.5, 34.3, 31.3; HR-MS (ESI): calc. for C26H26O3 [M+Na]+ 
409.1774,  found 409.1786 
 
1,2,3,4,6,8,9,10,11,13-Decahydro-1,1,4,4,8,8,11,11-octamethyl-6,13-etheno-15,16-
pentacenedicarboxylic acid, anhydride (3c). Diacid (2c) (25.6 g, 50 mmol) was 
suspended in a solution of CH2Cl2 (1400 mL) and DMF (0.5 mL), and cooled in an ice-
water bath to 0˚C. To the cooled suspension was added dropwise (COCl)2 (4.8 mL, 55 
mmol). A slow gas release indicates the beginning of the reaction. The reaction mixture, 
vented by a connection to an oil bubbler, was stirred and let to warm up to room 
temperature overnight, during which period the suspension turns into a clear solution. 
Evaporation of the solvents under reduced pressure results in crude 3c as a pale yellow 
solid (25.0 g, 100%) that is pure enough for the next synthetic step. m. p. = 325˚C (dec); 
1H-NMR (500 MHz; CDCl3): δ = 7.34 (s, 2H), 5.39 (s, 2H), 1.65-1.63 (m, 8H), 1.26 (s, 
12H), 1.24 (s, 12H); 13C-NMR (75 MHz; CDCl3): δ = 160.9, 159.9, 142.6, 139.9, 123.2, 
47.6, 35.1, 34.6, 32.1, 31.8; HR-MS (ESI): calculated for C34H38O3 [M+Na]+ 517.2713,  
found 517.2716. 
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9,10-Dihydro-9,10-etheno-11,12-anthracenedicarboxylic acid, cyclic hydrazide (4a). 
Crystals of anhydride 3a (41.1 g, 150 mmol) were crushed in a mortar, and then added to 
a refluxing solution of NH2NH2·HCl (23 g, 336 mmol) in AcOH (800 mL). The resulting 
mixture is refluxed overnight to yield a colorless, clear solution. The reaction mixture is 
cooled, and poured in ca. 3 L of H2O. The resulting precipitate is filtered and dried under 
reduced pressure to yield 4a as a white solid (43.6 g, 100%). m.p. > 330˚C; 1H-NMR 
(500 MHz; (CD3)2SO): δ = 11.99 & 11.40 (2 br, 2H), 7.54-7.51 (dd, 4H, J = 5.3, 3.2 Hz), 
7.06-7.03 (dd, 4H, , J = 5.4, 3.2 Hz), 5.85 (s, 2H); 13C-NMR (125 MHz; (CD3)2SO): 
δ = ~157 (br) & ~150 (br) & ~147 (br) (C=O tautomers in solution), 144.0, 125.4, 124.4, 
47.2; IR (KBr): 3435, 3069, 1642, 718; HR-MS (ESI): calc. for C18H12 N2O2 [M+H]+ 
289.0972, found 289.0978. 
 
(±)-2,6-Di-tert-butyl-9,10-dihydro-9,10-etheno-11,12-anthracenedicarboxylic acid, 
cyclic hydrazide (4b). Following the procedure for hydrazide (4a), using anhydride (3b) 
(11.8 g, 30 mmol) and NH2NH2·HCl (4.2 g, 60 mmol) in AcOH (200 mL). The hydrazide 
(4b) is obtained as an off-white solid (9.94 g, 82%). m. p. > 330˚C; 1H-NMR (500 MHz; 
(CD3)2SO): δ = 12.2-11.2 (2 br peaks, 2H), 7.53 (s, 2H), 7.40-7.38 (d, 2H, J = 7.5 Hz), 
7.02-7.00 (dd, 2H, J = 7.5, 1.5 Hz), 5.75 (br s, 2H), 1.20 (s, 18H); 13C-NMR (125 MHz; 
(CD3)2SO): δ = 148.1, 144.0 (br), 141.1 (br), 123.8, 121.8, 121.4, 47.0 (br), 34.4, 31.3. 
Note: C=O carbon unseen; HR-MS (ESI): calc. for C26H28 N2O2 [M+H]+ 401.2229, found 
401.2231; calc. for C26H28 N2O2 [M+Na]+ 423.2043, found 423.2046. 
 
1,2,3,4,6,8,9,10,11,13-Decahydro-1,1,4,4,8,8,11,11-octamethyl-6,13-etheno-15,16-
pentacenedicarboxylic acid, cyclic hydrazide (4c). Following the procedure for 
hydrazide (4a), using anhydride (3c) (24.7 g, 50 mmol) and NH2NH2·HCl (6.9 g, 100 
mmol) in AcOH (350 mL). The hydrazide (4c) is obtained as an off-white solid (24.8 g, 
98%).  m. p. > 330˚C; 1H-NMR (500 MHz; CDCl3): δ = 14-12 (2 br, 2H), 7.37 (s, 4H), 
5.71 (s, 2H), 1.62 (s, 8H), 1.23 (s, 12H), 1.21 (s, 12H); 13C-NMR (75 MHz; CDCl3): 
δ = 157.1, 148.7, 142.1, 140.4, 122.8, 47.7, 35.2, 34.5, 32.1, 32.0; HR-MS (ESI): calc. for 
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C34H40N2O2 [M+H]+ 509.3168, found 509.3154, calc. for C34H40N2O2 [M+Na]+ 531.2982, 
found 531.2976. 
 
1,4-Dichloro-9,10-dihydro-9,10-[1',2']benzeno-2,3-diazaanthracene (5a). Cyclic 
hydrazide 4a (11.52 g, 40 mmol) was refluxed overnight in neat POCl3 (125 mL).  The 
mixture was cooled, and the excess POCl3 was evaporated under reduced pressure. The 
brown gummy residue was redissolved in PhMe (ca. 100 mL), and evaporated again 
under reduced pressure to eliminate more of the residual POCl3. The residue was then 
dissolved in CH2Cl2 (ca. 200 mL), triturated with neutral alumina for 1 h, filtered over a 
neutral alumina plug and eluted first with CH2Cl2 then with EtOAc. Evaporation of the 
solvents under reduced pressure yields 5a as an off-white solid (11.19 g, 86%). 
m. p. = 227-228˚C; 1H-NMR (500 MHz; CDCl3): δ = 7.56-7.54 (dd, 4H, J = 5.4, 3.2 Hz), 
7.15-7.13 (dd, 4H, J = 5.4, 3.2 Hz), 5.84 (s, 2H); 13C-NMR (75 MHz; CDCl3): δ = 151.5, 
147.4, 142.0, 126.8, 125.2, 50.4; IR (KBr): 3072, 3050, 2987, 1528, 1459, 1308, 1195; 
HR-MS (EI): calc. for C18H10Cl2N2 [M]+ 324.0221, found 324.0216. 
 
(±)-5',6-Di-tert-butyl-1,4-dichloro-9,10-dihydro-9,10-[1',2']benzeno-2,3-
diazaanthracene (5b). Following the procedure for dichloride (5a), using hydrazide (4b) 
(9.5 g, 24 mmol) in neat POCl3 (~150 mL), yields dichloride (5b) as a pale yellow solid 
(8.61 g, 83%). m. p. = 171-173˚C; 1H-NMR (500 MHz; CDCl3): δ = 7.55 (d, 2H, J = 1.5 
Hz), 7.46-7.45 (d, 2H, J = 8.0 Hz), 7.15-7.13 (dd, 2H, J = 7.5, 1.5 Hz), 5.79 (s, 2H), 1.29 
(s, 18H); 13C-NMR (75 MHz; CDCl3): δ = 151.5, 150.1, 147.8, 142.1, 139.2, 124.6, 
123.4, 122.4, 50.4, 35.0, 31.6; HR-MS (ESI): calc. for C26H26Cl2N2 [M+H]+ 437.1551, 
found 437.1577; calc. for C26H26Cl2N2 [M+Na]+ 459.1365, found 459.1382. 
 
1,4-Dichloro-5',6',7,7',8,8',9,10-octahydro-5',5'7,7,8',8',10,10-octamethyl-5,12-
[2',3']naphthaleno-2,3-diazatetracene (5c). Following the procedure for dichloride (5a), 
using hydrazide (4c) (20 g, 39 mmol) in neat POCl3 (~250 mL), yields the crude 
dichloride (5c) as a pale yellow solid. Recrystallization from PhMe yields the pure (5c) as 
an off-white solid (13.37 g, 62%). m. p. >330˚C; 1H-NMR (300 MHz; CDCl3): δ = 7.42 
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(s, 4H), 5.69 (s, 2H), 1.63 (s, 8H), 1.26 (s, 12H), 1.24 (s, 12H); 13C-NMR (75 MHz; 
CDCl3): δ = 151.5, 147.8, 143.2, 139.0, 123.2, 50.0, 35.1, 34.6, 32.0; HR-MS (ESI): calc. 
for C34H38Cl2N2 [M+H]+ 545.2490, found 545.2474; calc. for C34H38Cl2N2 [M+Na]+ 
567.2304, found 567.2302  
 
1,4-Dibromo-9,10-dihydro-9,10-[1',2']benzeno-2,3-diazaanthracene (5d). A mixture 
of the dicarboxylic hydrazide (4a) (288 mg, 1.0 mmol) and phosphorus oxybromide 
(861 mg, 3.0 mmol) was stirred overnight (ca. 16 h) at 80˚C under a nitrogen atmosphere. 
The mixture was then cooled to room temperature, and the residue is dissolved in 
dichloromethane (ca. 40 mL). A few hundred milligrams of neutral alumina are added to 
the solution and, after triturating at room temperature for ca. 1 h, the solution is filtered 
on a neutral alumina plug, and rinsed with several copious portions of ethyl acetate. The 
combined solvent fractions are evaporated under vacuum to yield the dibromide (5d) as 
aan off-white solid (334 mg, 81%). Analytical samples may be obtained after 
recrystallization from di-n-butyl ether. m. p. = 227-229˚C; 1H-NMR (500 MHz; CDCl3): 
δ = 7.55 (4 H, dd, J = 5.2, 3.2 Hz), 7.15 (4 H, dd, J = 5.6, 3.2 Hz), 5.81 (2 H, s); 13C-
NMR (125 MHz; CDCl3): δ = 149.2, 144.4, 141.9, 126.7, 125.1, 52.5; HR-MS (EI): calc. 
for C18H10Br2N2 411.9205, found 411.9207 
 
1,4-Dibromo-9,10-dihydro-9,10-[1',2']benzeno-2,3-diazaanthracene (5d) (alternate 
preparation). A suspension of the dicarboxylic hydrazide (4a) (288 mg, 1.0 mmol), 
phosphorus pentoxide (710 mg, 5.0 mmol) and  tetra-n-butylammonium bromide 
(966 mg, 3.0 mmol) in toluene (10 mL) was refluxed overnight. After cooling to room 
temperature, the toluene is decanted and the gummy residue (presumably polyphoshoric 
acid) is extracted or washed with several portions of toluene. The combined organic 
fractions are washed with sat. aq. NaHCO3, followed by brine, dried over MgSO4. 
Solvents are evaporated under reduced pressure to yield the dibromide (5d) as a beige 
solid (273 mg, 66%). The characterization data are identical as for the preceding 
preparation. 
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1-Chloro-9,10-dihydro-4-methoxy-9,10-[1',2']benzeno-2,3-diazaanthracene (6a). In a 
septum-capped Schlenk flask is placed the dichloride 5a (11.00 g, 33.8 mmol) and solid, 
dry NaOMe (2.38 g, 44.1 mmol). The flask is evacuated and back-filled with argon 5 
times, and dry tetrahydrofuran (ca. 200 mL) is then added. The resulting mixture is 
rapidly stirred at room temperature for ca. 22h, after which TLC indicates complete 
consumption of the starting material. The cloudy reaction mixture is poured in sat. 
NaHCO3 (ca. 150 mL). The organic phase is separated, and the aqueous layer is extracted 
with three portions of ethyl acetate (ca. 50 mL). The combined organic layers are washed 
with brine, dried over anhydrous magnesium sulfate and filtered. Evaporation of the 
solvents under reduced pressure yields 6a a fluffy white solid (10.72 g, 99%). 
m. p. = 181-183˚C; 1H-NMR (500 MHz; CDCl3): δ = 7.50-7.47 (m, 4H), 7.09-7.07 (m, 
4H), 5.79 (d, 2H), 4.16 (s, 3H); 13C-NMR (125 MHz; CDCl3): δ = 160.7, 147.7, 147.5, 
143.1, 143.0, 138.1, 126.2, 126.1, 124.9, 124.8, 55.4, 50.5, 47.2; IR (KBr): 3045, 2949, 
1568, 1458, 1305, 1208, 730; HR-MS (ESI): calc. for C19H13ClN2O [M+H]+ 321.0789, 
found 321.0790. 
 
(±)-5',6-Di-tert-butyl-1-chloro-9,10-dihydro-4-methoxy-9,10-[1',2']benzeno-2,3-
diazaanthracene (6b). Following the procedure for methoxy chloride (6a), using 
dichloride (5b) (8.74 g, 20 mmol) and NaOMe (27 mmol, from 0.62 g Na in 30 mL 
MeOH) in dry THF (~100 mL) for 48 h. The crude product is purified by column 
chromatography on SiO2 using a progressively more polar 95:5 -> 90:10 hexanes : ethyl 
acetate (v/v) mobile phase to yield methoxy chloride (6b) as a white solid (5.29 g, 61%). 
m. p. = 158-160˚C; 1H-NMR (500 MHz; CDCl3): δ = 7.50 (dd, 2H, J = 4.1, 1.7 Hz), 7.42-
7.39 (t, 2H, J = 7.4 Hz), 7.10-7.08 (dt, 2H, J = 7.8, 1.6 Hz), 5.74 (s, 1H), 5.72 (s, 1H), 
4.16 (s, 3H), 1.28 (s, 18H); 13C-NMR (125 MHz; CDCl3): δ = 160.6, 149.5, 149.4, 148.1, 
147.4, 143.2, 143.1, 140.3, 140.2, 138.5, 124.3, 124.2, 122.8, 122.7, 122.2, 122.1, 55.4, 
50.4, 47.1, 34.9, 31.6; HR-MS (ESI): calc. for C27H29ClN2O [M+H] 433.2047, found 
433.2063; calc. for C27H29ClN2O [M+Na]+ 455.1861, found 455.1875 
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1-Chloro-5',6',7,7',8,8',9,10-octahydro-5',5'7,7,8',8',10,10-octamethyl-4-methoxy-
5,12-[2',3']naphthaleno-2,3-diazatetracene (6c). Following the procedure for methoxy 
chloride (6a), using dichloride (5c) (10.92 g, 20 mmol) and NaOMe (1.46 g, 27 mmol) in 
dry THF (~100 mL) overnight. The crude product is purified by column chromatography 
on SiO2 using a progressively more polar 10:4:1 to 5:4:1 
hexanes : dichloromethane : ethyl acetate (v/v/v) mobile phase to yield methoxy chloride 
(6c) as a white solid (9.28 g, 85%). m. p. > 330˚C; 1H-NMR (500 MHz; CDCl3): δ = 7.38 
(s, 2H), 7.37 (s, 2H), 5.64 (s, 1H), 5.61 (s, 1H), 4.14 (s, 3H), 1.63 (m, 8H), 1.25-1.23 (m, 
24H); 13C-NMR (125 MHz; CDCl3): δ = 160.6, 148.1, 147.5, 142.52, 142.48, 140.2, 
140.1, 138.6, 122.9, 122.8, 122.0, 55.3, 50.0, 46.7, 35.2, 34.6, 32.11, 32.07, 32.03 (2); 
HR-MS (ESI): calc. for C35H41ClN2O [M+Na]+ 563.2800, found 563.2812.  
 
N-Amino-9,10-dihydro-9,10-ethano-11,12-dicarboximide (7a).28,68 To a stirred mixture 
of dimethyl 9,10-dihydro-9,10-etheno-11,12-anthracenedicarboxylate (1a) (987 mg, 
3 mmol) in EtOH (20 mL), hydrazine monohydrate (7.5 mL, 155 mmol) was added 
dropwise. The reaction was refluxed for 6 h, resulting in a yellow solution that yielded a 
white precipitate upon cooling to room temperature. The EtOH was removed under 
reduced pressure, leaving a light brown solid that was suspended in CH2Cl2 and isolated 
by vacuum filtration. After washing with CH2Cl2 and cold EtOH, (7) was obtained as a 
white powder (504 mg, 57%). 1H-NMR (300 MHz; (CD3)2SO): δ = 9.24 (br, 2H), 7.28 (d, 
2H, 7 Hz), 7.16 (d, 2H, 7 Hz), 7.04 (m, 4H), 4.50 (s, 2H), 3.10 (s, 2H); 13C-NMR 
(125 MHz; (CD3)2SO): δ = 171.2, 143.4, 140.6, 125.5, 125.4, 124.8, 123.1, 47.5, 45.3; IR 
(KBr) cm-1 : 3322, 3023, 1647; MS (EI): calc. for C18H14 N2O2 290.11, found 290.11 
 
1,1,4,4,8,8,11,11-Octamethyl-1,2,3,4,8,9,10,11-octahydropentacene (8). 9,10-
Dihydroanthracene (27 g, 150 mmol) and 2,5-dichloro-2,5-dimethylhexane (75 g, 
410 mmol) were placed in a 1-L Schlenk flask, and the contents were evacuated and 
back-filled with argon 5 times. Dry CH2Cl2 (ca. 600 mL) was added to the flask and the 
resulting solution was then cooled to -78˚C in a dry ice / acetone bath, at which point the 
contents turned into a loose sludge or slurry. To the reaction mixture was then slowly 
added TiCl4 (86 g, 450 mmol) over the course of ca. 10-20 minutes. The reaction mixture 
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was stirred overnight as it was allowed to slowly warm up to room temperature. As the 
reaction progresses gases (presumably HCl) are slowly evacuated through a connection to 
an oil bubbler. The contents of the reaction mixture were poured over crushed ice 
(~600 mL), and extracted with CH2Cl2. The combined organic layers were washed with 
sat. NaHCO3, dried over MgSO4 and the solvent was evaporated under reduced pressure. 
The crude solid was purified by passage through a SiO2 plug first with hexanes, then with 
CH2Cl2 as eluant. After evaporation of the solvents the resulting solid was further purified 
by suspending and triturating in boiling EtOH (ca. 1.5 L). After isolation by filtration and 
drying under vacuum, the anthracene 8 is obtained as a pale yellow solid (50.9 g, 85% 
over two crops). m. p. = 255-256˚C; 1H-NMR (300 MHz; CDCl3): δ = 8.21 (s, 2H), 7.90 
(s, 4H), 1.81 (s, 8H), 1.45 (s, 24H); 13C-NMR (75 MHz; CDCl3): δ = 143.8, 130.7, 124.7, 
123.9, 35.3, 34.9, 32.9; HR-MS (EI): calc. for C30H38 [M]+ 398.2968,  found 398.2973. 
 
(9S,10S)-2,6-Di-tert-butyl-9,10-dihydro-11,12-dimethylene-9,10-ethanoanthracene 
(9b). Ditosylate (17) (13.74 g, 20 mmol) and solid KOtBu (6.72 g, 60 mmol) were placed 
in a Schlenk flask, and the contents were evacuated and back-filled with argon 5 times. 
Dry THF (ca. 175 mL) was added and the resulting deep green solution was then stirred 
at room temperature for ca. 20 hrs, during which period it became thicker and deep blue 
in color. The contents were poured on ice (~150 mL), and extracted with ethyl ether. The 
combined organic layers were washed with brine, dried over MgSO4 and the solvents 
were evaporated under reduced pressure taking care to avoid warming the contents above 
40˚C. The crude solid was purified by column chromatography on silica gel using 95:5 
hexanes : dichloromethane as the mobile phase to yield (9b) as a white solid upon 
evaporation of the solvents (820 mg, 12%). m. p. = polym. above 180˚C;38 [α]D21 = -3 
(c 0.34, CHCl3); 1H-NMR (300 MHz; CDCl3): δ = 7.26 (s, 2H), 7.17-7.15 (d, 2H, 
J = 7.8 Hz), 7.06-7.04 (d, 2H, J = 6.6 Hz), 5.20 (s, 2H), 5.04 (s, 2H), 4.75 (s, 2H), 1.19 (s, 
18H); 13C-NMR (75 MHz; CDCl3): δ = 149.5, 144.5, 141.8, 139.1, 123.3, 122.9, 120.7, 
105.2, 55.3, 34.8, 31.8; HR-MS (EI): calc. for C26H30 342.2342,  found 342.2353. 
 
Poly((9S,10S)-2,6-Di-tert-butyl-9,10-dihydro-11,12-dimethylene-9,10-
ethenoanthracene-11,12-diyl) (poly(9b)). Diene 9b (70 mg, 0.20 mmol) was placed in a 
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Schlenk flask equipped with a magnetic stirring bar. Contents were evacuated and back-
filled with argon five times and were then stirred at ca. 180˚C for 1hr. Contents were then 
cooled, dissolved in a minimum of chloroform and precipitated in a large excess of 
methanol. The poly(9b) is isolated after centrifugation, decantation and drying under 
vacuum as a white amorphous solid (34 mg, 49%). [α]D21 = -63 (c = 0.64, CHCl3);  1H-
NMR (500 MHz; CDCl3): δ = 7.34 (br, 2H), 7.16 (br, 2H), 7.00 (br, 2H), 4.82 (br, 2H), 
2.37-2.19 (br m, 4H), 1.27 (br, 18H); GPC (THF, PS standards): Mn = 135 000 g mol-1, 
Mw - 630 000 g mol-1. 
 
Dimethyl 1,4,9,10-tetrahydro-9,10-[1',2']benzenoanthracene-2,3-dicarboxylate 
(10a).36 Diene (9a) (6.9 g, 30 mmol) and dimethyl acetylenedicarboxylate (4.7 g, 33 
mmol) were refluxed overnight in toluene (50 mL) under a nitrogen atmosphere. After 
cooling to room temperature, the solvent was evaporated under reduced pressure and the 
crude product was recrystallized from methanol to yield (10a) as a white solid (10.3 g, 
92% over 3 crops). 1H-NMR (500 MHz; CDCl3): δ = 7.30-7.28 (dd, 4H, J = 8.0, 3.5 Hz), 
7.00-6.98 (dd, 4H, J = 5.5, 3.0 Hz), 4.82 (s, 2H), 3.76 (s, 6H), 3.30 (s, 4H); 13C-NMR 
(75 MHz; CDCl3): δ = 168.3, 145.6, 138.4, 132.8, 124.8, 122.9, 54.0, 52.4, 30.4. 
 
Dimethyl (9S,10S)-5',6-di-tert-butyl-1,4,9,10-tetrahydro-9,10-
[1',2']benzenoanthracene-2,3-dicarboxylate (10b). Diene (9b) (685 mg, 2.0 mmol) and 
dimethyl acetylenedicarboxylate (350 mg, 2.5 mmol) were refluxed overnight in toluene 
(3 mL) under a nitrogen atmosphere. After cooling to room temperature, the solvent was 
evaporated under reduced pressure and the crude product was triturated in hot methanol 
to yield (10b) as a white solid (868 mg, 90% over 2 crops). m. p. = 325-328˚C melt & 
dec.; [α]D21 = -47 (c 0.60, CHCl3); 1H-NMR (500 MHz; CDCl3): δ = 7.33 (d, 2H, J = 1.5 
Hz), 7.22-7.21 (d, 2H, J = 7.5 Hz), 7.00-6.99 (dd, 2H, J = 7.5, 1.5 Hz),  4.77 (s, 2H), 3.76 
(s, 6H), 3.31 (s, 4H), 1.30 (s, 18H); 13C-NMR (125 MHz; CDCl3): δ = 168.5, 147.8, 
145.6, 142.9, 138.6, 132.9, 122.2, 121.2, 120.4, 54.0, 52.4, 34.7, 31.7, 30.5; HR-MS 
(ESI): calc. for C32H36O4 [M+Na]+ 507.2506,  found 507.2506 
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Dimethyl 9,10-dihydro-9,10-[1',2']benzenoanthracene-2,3-dicarboxylate (11a).36, 69 
This literature compound was prepared by an adaptation of literature procedures.37 
Adduct (10a) (7.44 g, 20 mmol) was added to a stirred suspension of ground KMnO4 
(3.16 g, 20 mmol) and Adogen 464 (8.1 g, ca. 20 mmol) in PhMe (200 mL). The resulting 
mixture was stirred at room temperature for ca. 30 mins, then passed on a SiO2 plug and 
eluted with EtOAc. Evaporation of the solvents under reduced pressure followed by 
recrystallization of the crude product from MeOH yields (11a) as a white solid (6.24 g, 
84%). 1H-NMR (500 MHz; CDCl3): δ = 7.74 (s, 2H), 7.41-7.39 (dd, 4H, J = 5.0, 3.0 Hz), 
7.04-7.02 (dd, 4H, J = 5.5, 3.0 Hz), 5.51 (s, 2H), 3.86 (s, 6H); 13C-NMR (125 MHz; 
CDCl3): δ = 168.2, 148.9, 144.1, 129.3, 125.9, 124.2, 124.1, 54.0, 52.8. 
 
Dimethyl (9S,10S)-5',6-di-tert-butyl-9,10-dihydro-9,10-[1',2']benzenoanthracene-2,3-
dicarboxylate (11b). Adduct (10b) (730 mg, 1.5 mmol) was added to a stirred 
suspension of ground KMnO4 (356 mg, 2.3 mmol) and Adogen 464 (1 g, ca. 2.5 mmol) in 
PhMe (20 mL). The resulting mixture was stirred at room temperature for ca. 60 mins, 
then passed on a SiO2 plug and eluted with EtOAc. Evaporation of the solvents under 
reduced pressure followed by recrystallization of the crude product from MeOH yields 
(11b) as a white solid (654 mg, 90%). m. p. = 325˚C (dec.); [α]D21 = +26 (c 0.52, CHCl3); 
1H-NMR (500 MHz; CDCl3): δ = 7.72 (s, 2H), 7.42 (s, 2H), 7.33-7.31 (d, 2H, J = 8.0 
Hz), 7.04-7.02 (d, 2H, J = 7.5 Hz), 5.45 (s, 2H), 3.86 (s, 6H), 1.26 (s, 18H); 13C-NMR 
(125 MHz; CDCl3): δ = 168.3, 149.5, 148.9, 144.1, 141.3, 129.1, 124.0, 123.5, 122.4, 
121.4, 53.9, 52.8, 34.8, 31.7; HR-MS (ESI): calc. for C32H34O4 [M+Na]+ 505.2349,  found 
505.2345. 
 
9,10-Dihydro-9,10-[1',2']benzenoanthracene-2,3-dicarboxylic acid, cyclic hydrazide 
(12a). Anhydrous hydrazine (6.0 mL, ca. 190 mmol) was added to a refluxing solution of 
phthalate 11a (4.50 g, 12 mmol) in EtOH (60 mL) under a nitrogen atmosphere. The 
resulting mixture was then refluxed overnight. After cooling to room temperature and 
evaporation of the solvents under reduced pressure, trituration of the crude product in 
water followed by filtration and drying under vacuum yields the cyclic hydrazide 12a as a 
white solid (4.03 g, 98%). m. p. >330˚C; 1H-NMR (500 MHz; (CD3)2SO): δ = 8.12 (s, 
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2H), 7.51-7.49 (dd, 4H, J = 8.5, 5.5 Hz), 7.05-7.04 (dd, 4H, J = 5.5, 3.5 Hz), 5.95 (s, 2H). 
13C-NMR (125 MHz; (CD3)2SO): δ = 155.6, 149.1, 144.2, 125.7, 125.5, 124.1, 119.8, 
52.4; HR-MS (ESI): calc. for C22H14N2O2 [M+H]+ 339.1128,  found 339.1118. 
 
(9S,10S)-5',6-Di-tert-butyl-9,10-dihydro-9,10-[1',2']benzenoanthracene-2,3-
dicarboxylic acid, cyclic hydrazide (12b). Anhydrous hydrazine (1.0 mL, ca. 31 mmol) 
was added to a refluxing suspension of phthalate (11b) (600 mg, 1.2 mmol) in EtOH (10 
mL) under a nitrogen atmosphere. The resulting mixture was then refluxed overnight. 
After cooling to room temperature and evaporation of the solvents under reduced 
pressure, trituration of the crude product in water followed by filtration and drying under 
vacuum yields the hydrazide (12b) as an off-white solid (492 mg, 88%). m. p. > 330˚C; 
[α]D21 = +57 (c 0.41, CHCl3); 1H-NMR (500 MHz; (CD3)2CO): δ = 12.1 (br s, 2H), 8.26 
(s, 2H), 7.60 (s, 2H), 7.47 (d, 2H, J = 7.5 Hz), 7.05 (d, 2H, J = 7.5 Hz), 5.94 (s, 2H), 1.17 
(s, 18H); 13C-NMR (125 MHz; (CD3)2CO): δ = 157.6, 152.3, 149.6, 145.1, 142.3, 125.9, 
124.6, 123.1, 122.2, 120.6, 54.3, 35.2, 31.8; HR-MS (ESI): calc. for C30H30N2O2 [M+Na]+ 
473.2199,  found 473.2206. 
 
1,4-Dichloro-6,11-dihydro-6,11-[1',2']benzeno-2,3-diazatetracene (13a). Cyclic 
hydrazide 12a (3.38g, 10 mmol) was refluxed overnight in neat POCl3 (35 mL). After 
cooling to room temperature, the excess POCl3 was evaporated under reduced pressure 
and the residue was redissolved in ca. 35 mL PhMe. Solvents were again evaporated 
under reduced pressure, and the residue was dissolved in CH2Cl2 (~100 mL). Few grams 
of neutral alumina were added, and the resulting suspension was triturated for 1 h. 
Contents were then passed through an alumina plug and eluted first with CH2Cl2, then 
EtOAc. Evaporation of the solvents yields the crude dichloride which may be further 
purified by column chromatography on SiO2 using progressively more polar 15:4:1 -> 
10:4:1 hexanes : dichloromethane : ethyl acetate (v/v/v) as the mobile phase to yield 13a 
as a yellow solid (1.86 g, 50%). m. p. = 330˚C (dec.); 1H-NMR (500 MHz; CDCl3): 
δ = 8.25 (s, 2H), 7.53-7.51 (dd, 4H, J = 5.0, 3.0 Hz), 7.12-7.10 (dd, 4H, J = 5.5, 3.5 Hz), 
5.79 (s, 2H); 13C-NMR (125 MHz; CDCl3): δ = 154.8, 151.9, 142.8, 126.5, 126.1, 124.5, 
119.7, 54.0; HR-MS (ESI): calc. for C22H12N2Cl2 [M+Na]+ 397.0270,  found 397.0271. 
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(6S,11S)-5',8-Di-tert-butyl-1,4-dichloro-6,11-dihydro-6,11-[1',2']benzeno-2,3-
diazatetracene (13b). Hydrazide (12b) (225 mg, 0.5 mmol) was refluxed overnight in 
neat POCl3 (15 mL). After cooling to room temperature, the excess POCl3 was evaporated 
under reduced pressure and the residue was redissolved in ca. 15 mL PhMe. Solvents 
were again evaporated under reduced pressure, and the residue was dissolved in CH2Cl2 
(~50 mL). About one gram of neutral alumina was added, and the resulting suspension 
was triturated for 1 h. Contents were then passed over an alumina plug and eluted first 
with CH2Cl2, then EtOAc. Evaporation of the solvents yields (13b) as a tan solid 
(158 mg, 65%). m. p. > 330˚C; [α]D21 = +64 (c 0.78, CHCl3); 1H-NMR (500 MHz; 
CDCl3): δ = 8.23 (s, 2H), 7.54 (s, 2H), 7.44-7.43 (d, 2H, J = 8.0 Hz), 7.14-7.12 (d, 2H, 
J = 7.5 Hz), 5.73 (s, 2H), 1.28 (s, 18H); 13C-NMR (125 MHz; CDCl3): δ = 154.8, 152.5, 
149.8, 142.8, 140.0, 126.1, 124.0, 123.2, 121.8, 119.5, 54.0, 34.9, 31.6; HR-MS (ESI): 
calc. for C30H28N2Cl2 [M+Na]+ 509.1522,  found 509.1514.  
 
1-Chloro-6,11-dihydro-4-methoxy-6,11-[1',2']benzeno-2,3-diazatetracene (14a). 
Dichloride 13a (750 mg, 2.0 mmol) and solid NaOMe (140 mg, 2.6 mmol) were placed in 
a Schlenk flask, and the contents were evacuated and back-filled with argon 5 times. Dry 
THF (10 mL) was added and the resulting mixture was stirred at room temperature 
overnight. The reaction mixture was then dumped in an excess of sat. NaHCO3, and 
extracted with EtOAc. The combined organic layers were washed with brine, dried with 
MgSO4 and the solvents were evaporated under reduced pressure to yield a crude product 
that was purified by column chromatography on SiO2 using progressively more polar 
15:4:1 -> 10:4:1 hexanes : dichloromethane : ethyl acetate (v/v/v) to afford 14a as an off-
white solid (559 mg, 76%). m. p. = 289˚C (dec.); 1H-NMR (500 MHz; CDCl3): δ = 8.16 
(s, 1H), 8.13 (s, 1H), 7.50-7.46 (dq, 4H), 7.09-7.07 (m, 4H), 5.72 (s, 1H), 5.69 (s, 1H), 
4.23 (s, 3H); 13C-NMR (125 MHz; CDCl3): δ = 160.9, 150.4, 150.1, 143.40, 143.39, 
126.3, 126.2, 124.4, 124.3. 119.9, 119.3, 117.7, 55.3, 54.2, 54.1; HR-MS (ESI): calc. for 
C23H15ClN2O [M+H]+ 371.0946, found 371.0943. 
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(9S,10S,11S,12S)-(2,6-Di-tert-butyl-9,10-dihydro-9,10-ethanoanthracene-11,12-
diyl)dimethanol (16). A solution of the diester 158c (20.46 g, 30 mmol) in dry THF 
(~60 mL) was added to a suspension of LiAlH4 (6.84 g, 180 mmol) in dry THF (~80 mL), 
and the resulting mixture was refluxed for 3 h. The mixture was then cooled to 0˚C, 
carefully quenched with water, then 2N HCl, and extracted with Et2O. The combined 
organic layers were washed with saturated aqueous NaHCO3, brine, dried over Na2SO4, 
and the solvents were evaporated under reduced pressure. Purification by column 
chromatography on SiO2 using progressively more polar 8:2 -> 1:1 hexanes : ethyl 
acetate (v/v) as the mobile phase afforded the diol (16) as a white solid (9.05 g, 80%). 
m. p. = 134-135˚C; [α]D21 = -110 (c 0.50, CHCl3); 1H-NMR (500 MHz; CDCl3): δ = 7.30 
(s, 2H), 7.17-7.15 (d, 2H, J = 8.0 Hz), 7.12-7.10 (dd, 2H, J = 7.5, 1.5 Hz), 4.14 (s, 2H), 
3.51-3.49 (dd, 2H, J = 9.5, 5.0 Hz), 3.04 (s, 2H), 3.04-2.98 (m, 2H), 1.70 (br, 2H), 1.31 
(s, 18H); 13C-NMR (125 MHz; CDCl3): δ = 149.1, 143.6, 137.8, 124.5, 122.4, 120.5, 
66.4, 46.6. 46.4, 34.8. 31.8; HR-MS (ESI): calc. for C26H3402 [M+Na]+ 401.2451,  found 
401.2450. 
 
(9S,10S,11S,12S)-(2,6-Di-tert-butyl-9,10-dihydro-9,10-ethanoanthracene-11,12-
diyl)bis(methylene)bis(4-toluenesulfonate) (17). To a stirred solution of the diol (16) 
(8.50 g, 22 mmol) and a small crystal of 4-dimethylaminopyridine (DMAP) in CH2Cl2 
(50 mL) and Et3N (25 mL) at 0˚C was added dropwise a solution of TsCl (9.42 g, 49 
mmol) in CH2Cl2 (30 mL). After the addition was completed, the mixture was let to stir 
overnight as it warmed up to room temperature. The reaction mixture was then 
sequentially washed with i) 2N HCl, ii) sat. NaHCO3, iii) sat. NaCl. To the organic layer 
was added a few grams of activated charcoal, and the suspension was filtered on a SiO2 
plug. Evaporation of the solvents under reduced pressure yields (17) as a fluffy white 
solid (15.33 g, 99%). Analytical samples were obtained after recrystallization from 
iPrOH. m. p. = 131-132˚C; [α]D21 = -7 (c 0.55, CHCl3); 1H-NMR (300 MHz; CDCl3): 
δ = 7.78-7.76 (d, 4H, J = 8.0 Hz), 7.37-7.36 (d, 4H, J = 8.0 Hz), 7.21-7.20 (d, 2H, 
J = 1.8 Hz), 6.98-6.95 (dd, 2H, J = 7.8, 1.8 Hz), 6.88-6.85 (d, 2H, J = 7.8 Hz), 4.16 (s, 
2H), 3.73-3.71 (dd, 2H, J = 9.0, 4.0 Hz), 3.36-3.33 (t, 2H, J = 9.0 Hz), 2.49 (s, 6H), 1.58 
(br, 2H), 1.26 (s, 18H); 13C-NMR (75 MHz; CDCl3): δ = 149.6, 145.2, 142.1, 136.4, 
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132.7, 130.2, 128.2, 125.2, 122.9, 120.9, 71.7, 44.7, 42.4, 34.7, 31.7, 21.9; HR-MS (ESI): 
calc. for C40H46O6S2 [M+Na]+ 709.2628,  found 709.2606. 
 
9,10-Dihydro-1,4-diphenyl-9,10-[1',2']benzeno-2,3-diazaanthracene (18). In a Schlenk 
flask were added the dichloride (5a) (325 mg, 1.0 mmol), CsF (608 mg, 4.0 mmol) and 
Pd(PPh3)4 (58 mg, 0.05 mmol). The flask was evacuated and back-filled with argon 5 
times, then dry dioxane (6 mL) was added, followed by PhSnMe3 (0.55 mL, 3.0 mmol). 
Contents were then stirred at 105˚C for ca. 48 h, cooled, passed on a SiO2 plug with 
EtOAc as eluant, and the solvents were evaporated under reduced pressure. Trituration of 
the crude solid residue in hexanes followed by filtration and drying under vacuum 
afforded the diphenyl derivative (18) as a white solid (220 mg, 54%). m. p. = 252-254˚C; 
1H-NMR (500 MHz; CDCl3): δ = 7.82-7.80 (dd, 4H, J = 8.0, 3.5 Hz), 7.69-7.65 (t, 4H, 
J = 7.5 Hz), 7.63-7.59 (tt, 2H, J = 7.0, 1.5 Hz), 7.48-7.45 (dd, 4H, J = 5.5, 3.0 Hz), 7.12-
7.09 (dd, 4H, J = 5.5, 3.5 Hz), 5.92 (s, 2H); 13C-NMR (125 MHz; CDCl3): δ = 155.4, 
143.7, 143.5, 136.6, 129.7, 129.3, 129.0, 126.3, 124.7, 49.9; IR (KBr): 3060, 1552, 1460, 
1444, 1376, 674; HR-MS (ESI): calc. for C30H20N2 [M+H]+ 409.1705,  found 409.1702; 
calc. for C30H20N2 [M+Na]+ 431.1519,  found 431.1516. 
 
9,10-Dihydro-1,4-diphenyl-9,10-[1',2']benzeno-2,3-diazaanthracene (18) (alternate 
preparation). In a Schlenk flask were added the dichloride (5a) (108 mg, 0.33 mmol), 
PhB(OH)2 (122 mg, 1.0 mmol), CsF (202 mg, 1.33 mmol),  Pd2(dba)3 (5 mg, 0.005 
mmol) and tBu3P·HBF4 (6 mg, 0.02 mmol) . The flask was evacuated and back-filled with 
argon 5 times, then dry dioxane (2 mL) was added. Contents were then stirred at 105˚C 
for ca. 48 h, cooled, passed on a SiO2 plug with EtOAc as eluant, and the solvents were 
evaporated under reduced pressure. Trituration of the crude solid residue in hexanes 
followed by filtration and drying under vacuum afforded the diphenyl derivative (18) as a 
white solid (113 mg, 83%). The characterization data are identical as for the preceding 
preparation. 
 
9,10-Dihydro-1,4-di(2-thienyl)-9,10-[1',2']benzeno-2,3-diazaanthracene (19). In a 
Schlenk flask were added the dichloride (5a) (325 mg, 1.0 mmol), CsF (608 mg, 
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4.0 mmol) and Pd(PPh3)4 (58 mg, 0.05 mmol). The flask was evacuated and back-filled 
with argon 5 times, then dry dioxane (6 mL) was added, followed by 2-ThSnBu3 
(0.95 mL, 3.0 mmol). Contents were then stirred at 105˚C for ca. 48 h, cooled, passed on 
a SiO2 plug with EtOAc as eluant, and the solvents were evaporated under reduced 
pressure. Trituration of the crude solid residue in hexanes followed by filtration and 
drying under vacuum afforded the dithienyl derivative (19) as a white solid (397 mg, 
95%). m. p. = 272-273˚C; 1H-NMR (500 MHz; CDCl3): δ = 7.78 (dd, 2H, J = 3.7, 1.1 
Hz), 7.62 (dd, 2H, J = 5.2, 1.1 Hz), 7.53 (dd, 4H, J = 5.3, 3.2 Hz), 7.33 (dd, 2H, J = 5.1, 
3.6 Hz), 7.11 (dd, 4H, J = 5.4, 3.1 Hz), 6.27 (s, 2H); 13C-NMR (125 MHz; CDCl3): 
δ = 149.3, 143.1, 142.9, 139.4, 128.9, 128.6, 128.0, 126.4, 124.8, 49.7; HR-MS (ESI): 
calc. for C26H16N2S2 [M+H]+ 421.0828,  found 421.0824. 
 
1,4-Di(2,2'-bithiophen-5-yl)-9,10-dihydro-9,10-[1',2']benzeno-2,3-diazaanthracene 
(20). In a first Schlenk flask were added the dichloride (5a) (108 mg, 0.33 mmol) and 
Ni(dppp)Cl2 (9 mg, 0.017 mmol). The flask was evacuated and back-filled with argon 5 
times, then dry THF (1 mL) was added. In a second Schlenk flask was placed bithiophene 
(221 mg, 1.33 mmol). The flask was evacuated and back-filled with argon 5 times, then 
dry THF (2 mL) was added. The resulting solution was cooled to -78˚C in a dry ice - 
acetone bath, and nBuLi (0.46 mL @ 2.87 M in hexanes, 1.33 mmol) was added 
dropwise, and let to stir at -78˚C for one hour. To the lithiated bithiophene solution was 
then added dropwise ZnCl2 (2.66 mL @ 0.5 M in THF, 1.33 mmol). The solution was 
allowed to warm up to room temperature, and its contents were then cannulated under 
argon into the first Schlenk flask containing the dichloride (5a) and the nickel precatalyst. 
The solution was stirred for a few minutes at room temperature, and then warmed to 60˚C 
overnight. After cooling to room temperature, the reaction was quenched with an excess 
of sat. aq. NH4Cl, extracted with EtOAc, washed with brine, and the solvents were 
evaporated under reduced pressure. Purification of the crude product by column 
chromatography on SiO2 using progressively more polar 75:25 -> 0:100 
hexanes : dichloromethane (v/v) as the mobile phase afforded the di(bithienyl) derivative 
(20) as a yellow solid exhibiting intense blue-green fluorescence in the solid state 
(151 mg, 77%). m. p. = 236-238˚C; 1H-NMR (500 MHz; CDCl3): δ = 7.72 (d, 2H, 
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J = 3.7 Hz), 7.56-7.54 (dd, 4H, J = 5.0, 3.2 Hz), 7.38 (d, 2H, J = 3.7 Hz), 7.36 (d, 2H, 
J = 3.2 Hz), 7.31 (d, 2H, J = 4.9 Hz), 7.13 (dd, 4H, J = 5.0, 3.1 Hz), 7.10 (dd, 2H, J = 5.0, 
3.7 Hz), 6.29 (s, 2H); 13C-NMR (125 MHz; CDCl3): δ = 148.8, 143.0, 142.7, 140.9, 
138.1, 137.0, 129.2, 128.2, 126.5, 125.5, 124.9, 124.8, 124.5, 49.6; IR (KBr): 3070, 2954, 
2920, 2868, 1535, 1461, 1371, 1349, 706; HR-MS (ESI): calc. for C34H20N2S4 [M+H]+ 
585.0582,  found 585.0595 
 
1,4-Di(2,2'-bithiophen-5-yl)-9,10-dihydro-9,10-[1',2']benzeno-2,3-diazaanthracene 
(20) (alternate preparation). In a Schlenk flask were added the dichloride (5a) (108 mg, 
0.33 mmol), CsF (202 mg, 1.33 mmol) and Pd(PPh3)4 (19 mg, 0.017 mmol). The flask 
was evacuated and back-filled with argon 5 times, then dry dioxane (2 mL) was added, 
followed by 2,2'-bithiophen-5-yltributylstannane70 (0.6 mL, ca. 1.33 mmol). The solution 
was stirred at 105˚C overnight. After cooling to room temperature, the reaction was 
quenched with an excess of sat. aq. NH4Cl, extracted with CH2Cl2, washed with brine, 
and the solvents were evaporated under reduced pressure. Purification of the crude 
product by column chromatography on SiO2 using progressively more polar 75:25 -> 
0:100 hexanes : dichloromethane (v/v) as the mobile phase afforded the di(bithienyl) 
derivative (20) as a yellow solid exhibiting intense blue-green fluorescence in the solid 
state (168 mg, 86%). The characterization data is identical as for the preceding 
preparation. 
 
1,4-Di(3,4-ethylenedioxythien-2-yl)-9,10-dihydro-9,10-[1',2']benzeno-2,3-
diazaanthracene (21). In a Schlenk flask were added the dichloride (5a) (108 mg, 0.33 
mmol), CsF (202 mg, 1.33 mmol) and Pd(PPh3)4 (19 mg, 0.017 mmol). The flask was 
evacuated and back-filled with argon 5 times, then dry dioxane (2 mL) was added, 
followed by 3,4-ethylenedioxythiophen-2-yltributylstannane70 (0.6 mL, ca. 1.33 mmol). 
The solution was stirred at 105˚C overnight. After cooling to room temperature, the 
reaction was quenched with an excess of sat. aq. NH4Cl, extracted with CH2Cl2, washed 
with brine, and the solvents were evaporated under reduced pressure. Purification of the 
crude product by column chromatography on SiO2 using progressively more polar 75:25 
to 0:100 hexanes : dichloromethane (v/v) then 5% MeOH in CH2Cl2 as the mobile phase 
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afforded the di(ethylenedioxythienyl) derivative (21) as a pale beige solid (115 mg, 85%). 
m. p. = slowly decomposes upon warming with no clear transition; 1H-NMR (300 MHz; 
CDCl3): δ = 7.43-7.40 (dd, 4H, J = 5.4, 3.3 Hz), 7.07-7.04 (dd, 4H, J = 5.1 Hz, 3.0 Hz), 
6.66 (s, 2H), 5.96 (s, 2H), 4.44 (s, 8H); 13C-NMR (125 MHz; CDCl3): δ = 148.3, 143.9, 
143.7, 141.6, 139.7, 125.9, 124.8, 122.1, 103.3, 65.1, 64.8, 50.6; IR (KBr): 3109, 3069, 
2981, 2926, 2872, 1540, 1496, 1437, 1362, 1062, 909; HR-MS (ESI): calc. for 
C30H20N2O4S2 [M+H]+ 537.0937,  found 537.0921. 
 
9,10-Dihydro-1-methoxy-4-phenyl-9,10-[1',2']benzeno-2,3-diazaanthracene (22). In a 
Schlenk flask were added the methoxy chloride 6a (3.00 g, 9.35 mmol), PhB(OH)2 (2.1 g, 
17.2 mmol), CsF (4.6 mg, 30 mmol) and Pd(PPh3)4 (600 mg, 0.52 mmol). The flask was 
evacuated and back-filled with argon 5 times, then dry dioxane (25 mL) was added. The 
solution was stirred at 115˚C for 48h. After cooling to room temperature, the reaction 
mixture was passed on a SiO2 plug and eluted with EtOAc. Evaporation of the solvents 
yields a crude product that was purified by column chromatography on SiO2 using 
progressively more polar 90:10 -> 75:25 hexanes : ethyl acetate (v/v) to afford 22 as a 
white solid (3.09 g, 91%). m. p. = 213-215˚C; 1H-NMR (500 MHz; CDCl3): δ = 7.72-
7.70 (d, 2H, J = 7.0 Hz), 7.63-7.60 (t, 2H, J = 7.3 Hz), 7.58-7.56 (d, 1H, J = 7.0 Hz), 
7.53-7.52 (d, 2H, J = 6.5 Hz), 7.42-7.40 (d, 2H, J = 6.0 Hz), 7.10-7.04 (m, 4H), 5.90 (s, 
1H), 5.81 (s, 1H), 4.20 (s, 3H); 13C-NMR (125 MHz; CDCl3): δ = 160.1, 153.8, 147.1, 
143.85, 143.79, 136.6, 135.2, 129.4, 129.0, 128.9, 126.0, 125.9, 124.8, 124.5, 55.1, 50.4, 
46.8; IR (KBr): 3043, 2945, 1570, 1458, 1315, 1265, 736; HR-MS (ESI): calc. for 
C25H18N2O [M+H]+ 363.1492, found 363.1485. 
 
4-(2,4-Difluorophenyl)-9,10-dihydro-1-methoxy-9,10-[1',2']benzeno-2,3-
diazaanthracene (23). Inside a nitrogen glove box were added into a Schlenk flask the 
methoxy chloride (6a) (160 mg, 0.50 mmol), 2,4-difluorophenylboronic acid (158 mg, 
1.0 mmol), CsF (304 mg, 2.0 mmol), Ag2O (278 mg, 1.2 mmol), Pd2(dba)3 (23 mg, 0.025 
mmol) and tBu3P·HBF4 (18 mg, 0.062 mmol).40 To the flask was then added dry DMF 
(3 mL), and the reaction mixture was stirred at 100˚C for 48h. After cooling to room 
temperature, contents were passed on a celite plug and eluted / washed with EtOAc. The 
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combined organic fractions were washed with brine, dried with MgSO4 and the solvents 
were evaporated under reduced pressure to yield a crude product that was purified by 
column chromatography on SiO2 using 85 : 15 hexanes : ethyl acetate (v/v) as the mobile 
phase to yield (23) as a white solid (74 mg, 37%). m. p. = 218-221˚C; 1H-NMR (500 
MHz; CDCl3): δ = 7.65-7-60 (m, 1H), 7.50-7.48 (d, 2H, J = 6.5 Hz), 7.38-7.37 (d, 2H, 
J = 6.5 Hz), 7.13-7.08 (m, 1H), 7.08-7.02 (m, 4H), 5.87 (s, 1H), 5.43 (d, 1H, J = 4.0 
Hz)*, 4.23 (s, 3H); 13C-NMR (125 MHz; CDCl3): δ = [164.99, 164.89, 162.99, 162.89] 
(dd, J = 251, 12 Hz), [161.25, 161.16, 159.26, 159.17] (dd, J = 250, 12 Hz), 160.5, 148.5, 
148.2, 143.61, 143.58, 134.9, [133.42, 133.38, 133.34, 133.30] (dd, J = 10, 5 Hz), 126.0, 
125.9, 124.9, 124.6, [120.87, 120.84, 120.75, 120.71] (dd, J = 15, 4 Hz), [112.66, 112.63, 
112.49, 112.47] (dd, J = 21, 4 Hz), [104.60, 104.39, 104.19] (t, J = 26 Hz), 55.2, [50.99, 
50.95] (d, J = 4.5 Hz), 46.7; 19F-NMR (282 MHz; CDCl3): δ = -108.7 (m), -110.7 (d, 
J = 5.6 Hz); HR-MS (ESI): calc. for C25H16N2F2O [M+H]+ 399.1303,  found 399.1305. 
 
9,10-Dihydro-1-phenyl-9,10-[1',2']benzeno-2,3-diazaanthracene (24). In a Schlenk 
flask were added the chloropyridazine (30) (291 mg, 1.0 mmol), PhB(OH)2 (245 mg, 2.0 
mmol), CsF (456 mg, 3.0 mmol) and Pd(PPh3)4 (60 mg, 0.05 mmol). The flask was 
evacuated and back-filled with argon 5 times, then dry dioxane (5 mL) was added. The 
solution was stirred at 110˚C for 48h. After cooling to room temperature, the reaction 
mixture was passed on a SiO2 plug and eluted with EtOAc. Evaporation of the solvents 
yields a crude product that was purified by column chromatography on SiO2 using 1:1:1 
hexanes : dichloromethane : ethyl acetate (v/v/v) to afford (24) as an off-white solid 
(213 mg, 64%). m. p. = 251-253˚C; 1H-NMR (500 MHz; CDCl3): δ = 9.30 (s, 1H), 7.75 
(d, 2H, J = 7.0 Hz), 7.65 (t, 2H, J = 7.3 Hz), 7.60 (t, 1H, J = 7.3 Hz), 7.52-7.50 (dd, 2H, 
J = 6.5, 1.8 Hz), 7.43-7.42 (dd, 2H, J = 6.3, 1.8 Hz), 7.11-7.06 (m, 4H), 5.84 (s, 1H), 5.65 
(s, 1H); 13C-NMR (125 MHz; CDCl3): δ = 156.6, 145.72, 145.68, 143.6, 143.4, 143.1, 
136.4, 129.6, 129.4, 129.0, 126.3, 126.2, 124.7, 124.6, 51.0, 49.7; HR-MS (ESI): calc. for 
C24H16N2 [M+H]+ 333.1386, found 333.1375. 
 
9,10-Dihydro-1-(2-thienyl)- 9,10-[1',2']benzeno-2,3-diazaanthracene (25). In a 
Schlenk flask were added the chloropyridazine (30) (291 mg, 1.0 mmol), CsF (456 mg, 
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3.0 mmol) and Pd(PPh3)4 (60 mg, 0.05 mmol). The flask was evacuated and back-filled 
with argon 5 times, then dry dioxane (5 mL), and 2-tributylstannylthiophene (0.65 mL, 
2.0 mmol) were added. The solution was stirred at 110˚C for 48h. After cooling to room 
temperature, the reaction mixture was passed on a SiO2 plug and eluted with EtOAc. 
Evaporation of the solvents yields a crude product that was purified by column 
chromatography on SiO2 using 1:1:1 hexanes : dichloromethane : ethyl acetate (v/v/v) to 
afford (25) as an off-white solid (265 mg, 78%). m. p. = 218-219˚C; 1H-NMR (500 MHz; 
CDCl3): δ = 9.21 (s, 1H), 7.76 (d, 1H, J = 3.0 Hz), 7.61 (d, 1H, J = 4.4 Hz), 7.50-7.49 (m, 
4H), 7.32 (dd, 1H, J = 5.0, 3.7 Hz), 7.11-7.07 (m, 4H), 6.19 (s, 1H), 5.62 (s, 1H); 13C-
NMR (125 MHz; CDCl3): δ = 150.8, 145.9, 145.3, 143.3, 142.8, 142.5, 139.1, 128.9, 
128.7, 128.0, 126.35, 126.28, 124.8, 124.7, 51.0, 49.4; HR-MS (ESI): calc. for C22H14N2S 
[M+H]+ 339.0950, found 339.0956. 
 
9,10-Dihydro-4-phenyl-9,10-[1',2']benzeno-2,3-diazaanthracene-1(2H)-one (26). A 
suspension of the methoxy phenyl derivative (22) (2.00 g, 55 mmol) in HBr in AcOH 
(20 mL, 33% by wt.) was stirred at 90˚C overnight. Dissolution of the starting material 
and a violent release of gases (possibly MeBr and HBr) occurs upon warming. After 
cooling to room temperature, contents were poured in a large volume of water and the 
resulting precipitates were filtered, washed with water and dried under vacuum to yield 
the pyridazinone (26) as an off-white solid (1.39 g, 72%). m. p. > 330˚C; 1H-NMR 
(500 MHz; (CD3)2SO): δ = 13.3, (s, 1H), 7.67-7.48 (m, 9H), 7.10-7.02 (m, 4H), 6.03 (s, 
1H), 5.75 (s, 1H); 13C-NMR (125 MHz; (CD3)2SO): δ = 158.3, 149.4, 145.6, 143.91, 
143.90, 143.4, 134.6, 129.1, 129.0, 128.5, 125.7, 125.5, 124.43, 124.38, 50.2, 46.5; HR-
MS (ESI): calc. for C24H16N2O [M+Na]+ 371.1155, found 371.1139. 
 
1-Chloro-9,10-dihydro-4-phenyl-9,10-[1',2']benzeno-2,3-diazaanthracene (27). 
Pyridazinone (26) (1.30 g, 37 mmol) was refluxed in neat POCl3 (25 mL) overnight. 
Reaction mixture was cooled, and the excess POCl3 was evaporated under reduced 
pressure. The residue was redissolved in PhMe (~10 mL) and the solvent was again 
evaporated under reduced pressure4. The residue was dissolved in CH2Cl2 (~50 mL) and 
triturated with a few grams of neutral alumina for one hour before filtration over a neutral 
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alumina plug and elution first with CH2Cl2, then with EtOAc. Evaporation of the solvents 
under reduced pressure yields the chloro derivative (27) as a white solid (1.23 g, 90%). 
m. p. = 221-222˚C; 1H-NMR (300 MHz; CDCl3): δ = 7.73-7.60 (m, 5H), 7.58-7.55 (dd, 
2H, J = 6.0, 2.4 Hz), 7.45-7.42 (dd, 2H, J = 5.7, 2.1 Hz), 7.16-7.08 (m, 4H), 5.95 (s, 1H), 
5.83 (s, 1H); 13C-NMR (125 MHz; CDCl3): δ = 156.5, 151.1, 146.3, 145.0, 142.9, 142.6, 
135.5, 129.7, 129.5, 129.1, 126.54, 126.51, 125.2, 124.7, 50.3, 50.1; HR-MS (ESI): calc. 
for C24H15ClN2 [M+H]+ 367.0997, found 367.1003. 
 
9,10-Dihydro-1-methoxy-9,10-[1',2']benzeno-2,3-diazaanthracene (28). In a round-
bottom flask were added the methoxy chloride (6a) (1284 mg, 4.0 mmol), ammonium 
formate (1.25 g, 20 mmol) and 5% palladium on charcoal (256 mg). The contents were 
suspended in ethanol (~60 mL) and refluxed overnight. After cooling to room 
temperature, the reaction mixture was filtered and the residue was washed with ethyl 
acetate. The solvents were evaporated under reduced pressure, the residue was dissolved 
in ethyl acetate and washed with water, followed by brine. The organic layer was dried 
over magnesium sulfate, and the solvents were evaporated under reduced pressure. The 
crude solid was then triturated in hexanes for several hours to afford, after filtration, the 
methoxypyridazine (28) as an off-white solid (1.15 g, quant.). m. p. = 249-250˚C; 1H-
NMR (500 MHz; CDCl3): δ = 9.00 (s, 1H), 7.48-7.47 (dd, 2H, J = 5.6, 2.9 Hz), 7.45-7.43 
(dd, 2H, J = 5.6, 2.9 Hz), 7.05 (dd, 4H, J = 5.4, 3.1 Hz), 5.81 (s, 1H), 5.56 (s, 1H), 4.20 
(s, 3H); 13C-NMR (125 MHz; CDCl3): δ = 160.9, 148.6, 143.9, 143.8, 143.4, 134.9, 
125.94, 125.92, 124.7, 124.5, 55.1, 50.9, 46.5; HR-MS (ESI): calc. for C19H14N2O 
[M+H]+ 287.1179, found 287.1168. 
 
9,10-Dihydro-9,10-[1',2']benzeno-2,3-diazaanthracene-(3H)-one (29). 
Methoxypyridazine (28) (1.00 g, 3.5 mmol) was suspended in hydrobromic acid in acetic 
acid (33% by wt., 12 mL), and the contents were stirred at 90˚C overnight. Dissolution of 
the starting material and a violent release of gases (possibly MeBr and HBr) occurs upon 
warming. The mixture was then cooled to room temperature, and the solvents were 
evaporated under reduced pressure. The resulting crude solid was triturated in an aqueous 
solution of sodium acetate for several hours. Filtration affords the pyridazinone (29) as an 
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off-white solid (0.99 g, quant.). m. p. > 330˚C; 1H-NMR (500 MHz; (CD3)2SO): δ = 13.2 
(br s, 1H), 8.27 (s, 1H), 7.53 (m, 4H), 7.05 (m, 4H), 5.96 (s, 1H), 5.86 (s, 1H); 13C-NMR 
(125 MHz; (CD3)2SO): δ = 158.9, 150.8, 144.9, 143.8, 134.9, 125.4, 125.3, 124.4, 124.3, 
49.9, 46.1; HR-MS (EI): calc. for C18H12N2O [M+Na]+ 295.0842,  found 295.0833. 
 
1-Chloro-9,10-dihydro-9,10-[1',2']benzeno-2,3-diazaanthracene (30). Pyridazinone 
(29) (900 mg, 3.3 mmol) was suspended in phosphorus oxychloride (25 mL), and the 
contents were refluxed overnight. The mixture was then cooled to room temperature and 
the excess phosphorus oxychloride was evaporated under reduced pressure. The residue 
was redissolved in PhMe (~25 mL) and the solvent was again evaporated under reduced 
pressure. The resulting crude product was triturated in dichloromethane in the presence of 
neutral alumina for 1 h. Filtration through a plug of neutral alumina and elution with 
dichloromethane, then ethyl acetate followed by evaporation of the solvents under 
reduced pressure affords the chloropyridazine (30) as an off-white solid (562 mg, 58%). 
m. p. = 261-262˚C; 1H-NMR (500 MHz; CDCl3): δ = 9.22 (s, 1H), 7.54-7.51 (m, 2H), 
7.49-7.46 (m, 2H), 7.11-7.09 (m, 4H), 5.85 (s, 1H), 5.60 (s, 1H); 13C-NMR (125 MHz; 
CDCl3): δ = 152.3, 148.1, 146.3, 145.0, 142.8, 142.2, 126.52, 126.48, 125.1, 124.8, 50.9, 
49.8; HR-MS (ESI): calc. for C18H11ClN2 [M+H]+ 291.0684,  found 291.0677. 
 
1,1'-Bi(9,10-dihydro-4-methoxy-9,10-[1'',2'']benzeno-2,3-diazaanthracenyl) (31a). In 
a septum-capped Schlenk flask are placed the methoxy chloride 6a (7.50 g, 23 mmol), 
activated zinc dust (9.1 g, 140 mmol), trans-dichlorobis(triphenylphosphine)palladium 
(II) (820 mg, 1.2 mmol) and triphenylphosphine (612 mg, 2.3 mmol). The flask is 
evacuated and back-filled with argon 5 times, and dry N,N-dimethylformamide (ca. 90 
mL) is added. The resulting mixture is stirred at 100˚C for ca. 20 h, after which TLC 
indicates complete consumption of the starting material. The reaction mixture is then 
poured in a large excess of aq. Na2EDTA, and triturated for a few hours. Filtration of the 
precipitates yields a crude product that is purified by column chromatography on silica 
gel using 10:4:1 hexanes : dichloromethane : ethyl acetate (v/v/v) as the mobile phase, to 
yield the pure 31a as a white solid (6.34 g, 95%). m. p. > 330˚C; 1H-NMR (500 MHz; 
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CDCl3): δ = 7.52-7.50 (d, 4H, J = 7 Hz), 7.41-7.40 (d, 4H, J = 7 Hz), 7.07-6.99 (m, 8H), 
6.14 (s, 2H), 5.93 (s, 2H), 4.36 (s, 6H); 13C-NMR (125 MHz; CDCl3): δ = 160.6, 150.2, 
149.4, 144.2, 143.7, 136.2, 126.0, 125.7, 125.4, 124.4, 55.4, 50.2, 46.8; IR (KBr): 3044, 
2949, 1568, 1457, 1347, 1263, 729; HR-MS (ESI): calc. for C38H26N4O2  [M+H]+ 
571.2129, found 571.2122.  
 
1,1'-Bi(5'',6-di-tert-butyl-9,10-dihydro-4-methoxy-9,10-[1'',2'']benzeno-2,3-
diazaanthracenyl) (31b) (1:1 mixture of  C2v and Ci isomers). In a septum-capped 
Schlenk flask are placed the methoxy chloride (6b) (3.00 g, 6.9 mmol), activated zinc dust 
(2.70 g, 42 mmol), trans-dichlorobis(triphenylphosphine)palladium (II) (243 mg,  0.35 
mmol) and triphenylphosphine (182 mg, 0.70 mmol). The flask is evacuated and back-
filled with argon 5 times, and dry N,N-dimethylformamide (ca. 30 mL) is then added. The 
resulting mixture is stirred at 100˚C for ca. 20 h, after which TLC indicates complete 
consumption of the starting material. The reaction mixture is then poured in a large excess 
of aqueous Na2EDTA, and triturated for ca. 1 h. Filtration of the precipitates yields a 
crude product that is then purified by column chromatography on silica gel using 
progressively more polar 9:1 -> 8:2 hexanes : ethyl acetate (v/v) as the mobile phase, 
yielding the a 1:1 mixture of the Ci and racemic C2 isomers of  (31b) as a white solid 
(2.48 g, 90%). A second separation by column chromatography on silica gel using 20:4:1 
hexanes : dichloromethane : ethyl acetate allows for the separation of the Ci and rac-C2 
isomers. 1st isomer (higher Rf on SiO2): m. p. = slowly dec. upon warming with no clear 
transition; 1H-NMR (500 MHz; CDCl3): δ = 7.61-7.59 (d, 2H, J = 8.0 Hz), 7.52-7.51 (d, 
2H, J = 1.5 Hz), 7.46-7.44 (d, 2H, J = 7.5 Hz), 7.28 (d, 2H, J = 1.5 Hz), 7.09-7.06 (td, 
4H, J = 7.5, 2.0 Hz), 6.29 (s, 2H), 5.86 (s, 2H), 4.35 (s, 6H), 1.29 (s, 18H), 1.17 (s, 18H); 
13C-NMR (75 MHz; CDCl3): δ = 160.5, 150.3, 149.7, 149.0, 148.5, 144.6, 143.6, 141.5, 
141.4, 136.6, 125.1, 123.8, 122.8, 122.5, 122.2, 121.5, 55.2, 50.2, 46.7, 34.82, 34.81, 
31.7, 31.6; HR-MS (ESI): calc. for C54H58N4O2  [M+H]+ 795.4633, found 795.4667. 2nd 
isomer (lower Rf on SiO2): m. p. = slowly dec. upon warming with no clear transition; 1H-
NMR (500 MHz; CDCl3): δ = 7.54 (d, 2H, J = 1.6 Hz), 7.46-7.44 (d, 2H, J = 7.5 Hz), 
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7.42 (d, 2H, J = 1.6 Hz), 7.33-7.31 (d, 2H, J = 8.0 Hz), 7.09-7-08 (m, 2H), 7.02-7.01 (dd, 
2H, J = 7.8, 1.8 Hz), 6.10 (s, 2H), 5.88 (s, 2H), 4.38 (s, 6H), 1.30 (s, 18H), 1.25 (s, 18H); 
13C-NMR (75 MHz; CDCl3): δ = 160.6, 150.4, 149.8, 149.0, 148.6, 144.3, 143.8, 141.5, 
140.9, 136.5, 124.6, 123.8, 122.6, 122.5, 122.3, 121.7, 55.3, 50.0, 46.7, 34.9, 34.8, 31.70, 
31.69; HR-MS (ESI): calc. for C54H58N4O2  [M+H]+ 795.4633, found 795.4506. 
 
1,1'-Bi(5'',6'',7,7'',8,8'',9,10-octahydro-5'',5''7,7,8'',8'',10,10-octamethyl-4-methoxy-
5,12-[2'',3'']naphthaleno-2,3-diazatetracenyl) (31c). In a septum-capped Schlenk flask 
are placed the methoxy chloride (6c) (2.71 g, 5.0 mmol), activated zinc dust (1.95 g, 30 
mmol), trans-dichlorobis(triphenylphosphine)palladium (II) (175 mg,  0.25 mmol) and 
triphenylphosphine (131 mg, 0.50 mmol). The flask is evacuated and back-filled with 
argon 5 times, and dry N,N-dimethylformamide (ca. 30 mL) is then added. The resulting 
mixture is stirred at 100˚C for ca. 40 h. The reaction mixture is then poured in a large 
excess of aqueous Na2EDTA, and triturated for ca. 1 h. Filtration of the precipitates 
yields a crude product that is then purified by column chromatography on silica gel using 
progressively more polar 1:0:0 -> 1:1:1 dichloromethane : ethyl acetate : toluene (v/v/v) as 
the mobile phase, yielding a crude solid that is recrystallized from PhMe-CHCl3 to yield  
(31c) as a white solid (1.06 g, 42%). m. p. > 330˚C; 1H-NMR (500 MHz; CS2 -
 (CD3)2SO): δ = 7.22 (s, 4H), 7.13 (s, 4H), 6.09 (s, 2H), 5.54 (s, 2H), 4.26 (s, 6H), 1.58-
1.52 (m, 16H), 1.20 (s, 12H), 1.18 (s, 12H), 1.14 (s, 12H), 1.05 (s, 12H); 13C-NMR (125 
MHz; CS2 - (CD3)2SO): δ = 159.0, 149.3, 148.1, 140.8, 140.7, 140.6, 140.2, 134.8, 122.7, 
121.9, 54.4, 48.9, 45.6, 35.2, 35.1, 33.8, 33.7, 31.7, 31.6, 31.5, 29.9; HR-MS (ESI): calc. 
for C70H82N4O2  [M+H]+ 1010.6511, found 1011.6550. 
 
1,1'-Bi(9,10-dihydro-9,10-[1'',2'']benzeno-2,3-diazaanthracenyl)-4,4'(3H,3'H)-dione 
(32a). Dimethoxy dimer 31a (6.00 g, 10.5 mmol) was added to a stirred solution of 
hydrogen bromide in acetic acid (33% by wt., 60 mL) and the mixture was heated to 90˚C 
overnight. Upon warming dissolution occurs and a violent gas release is observed. The 
mixture is then cooled and most of the solvent is evaporated under reduced pressure. The 
resulting solid is suspended and triturated for several hours in a solution of sodium 
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acetate (ca. 25 g in 200 mL H2O). Filtration affords 32a as a pale beige solid (5.20 g, 
91%). m. p. > 330˚C; 1H-NMR (500 MHz; (CD3)2SO): δ = 13.59 (s, 2H), 7.56-7.55 (d, 
4H, J = 7 Hz), 7.39-7.38 (d, 4H, J = 7 Hz), 7.00-6.99 (m, 8H), 6.03 (s, 2H), 5.98 (s, 2H); 
13C-NMR (125 MHz; (CD3)2SO): δ = 158.3, 150.4, 146.3, 143.9, 143.7, 138.4, 125.4, 
125.3, 124.8, 124.2, 49.7, 46.4; HR-MS (ESI): calc. for C36H22N4O2 [M+H]+ 543.1816, 
found 543.1838. 
 
1,1'-Bi(5'',6-di-tert-butyl-9,10-dihydro-9,10-[1'',2'']benzeno-2,3-diazaanthracenyl)-
4,4'(3H,3'H)-dione (32b) (1:1 mixture of isomers). Dimer (as a mixture of isomers) 
(31b) (1.59 g, 2.0 mmol) was added to a stirred solution of hydrogen bromide in acetic 
acid (33% by wt., 25 mL) and the mixture was heated to 95˚C overnight. Upon warming 
dissolution occurs and a violent gas release is observed. The mixture is then cooled and 
most of the solvent is evaporated under reduced pressure. The resulting solid is 
suspended and triturated for several hours in a solution of sodium acetate. Filtration 
affords a 1:1 mixture of the Ci and racemic C2 isomers of (32b) as a pale beige solid 
(1.48 g, 97%). 1H-NMR (500 MHz; (CD3)2SO): δ = 13.66 & 13.65 (br s, 4H), 7.57 (s, 
4H), 7.49 (d, 2H, J = 1.6 Hz), 7.45 (d, 2H, J = 1.7 Hz), 7.43 (d, 4H, J = 7.8 Hz), 7.36 (d, 
2H, J = 7.8 Hz), 7.30 (d, 2H, J = 7.8 Hz), 7.03 (dd, 2H, J = 7.8, 1.8 Hz), 7.01 (td, 6H, 
J = 4.0, 1.8 Hz), 6.97 (dd, 2H, J = 7.8, 1.8 Hz), 6.05 (s, 2H), 5.97 (s, 2H), 5.94 (s, 4H), 
1.22 (s, 18H), 1.21 (s, 18H), 1.18 (s, 18H), 1.15 (s, 18H); 13C-NMR (125 MHz; 
(CD3)2SO): δ = 158.40, 158.36, 150.6, 150.5, 148.1, 146.6, 146.5, 144.1, 143.95, 143.87, 
141.2, 141.13, 141.09, 138.4, 124.2, 124.1, 123.6, 122.0, 121.9, 121.7, 121.2, 49.74, 
49.69, 46.3, 34.4, 31.23, 31.20, 30.7. The Ci and racemic C2 isomers were also separately 
prepared form the isolated (32b) isomers following the same procedure. 1st isomer: 
m. p. > 330˚C; 1H-NMR (500 MHz; (CD3)2SO): δ = 13.7 (br s, 2H), 7.58 (s, 2H), 7.49 (s, 
2H), 7.44-7.43 (d, 2H, J = 6.0 Hz), 7.38-7.37 (d, 2H, J = 6.5 Hz), 7.02-7.00 (d, 4H, 
J = 6.0 Hz), 6.07 (s, 2H), 5.97 (s, 2H), 1.21 (s, 18H), 1.14 (s, 18H); 13C-NMR (125 MHz; 
(CD3)2SO): δ = 158.4, 150.5, 148.03, 148.02, 146.6, 144.0, 143.9, 141.2, 141.0, 138.4, 
124.2, 123.5, 121.9, 121.69, 121.68, 121.2, 49.8, 46.3, 34.29, 34.27, 31.2, 31.1; HR-MS 
(ESI): calc. for C52H54N4O2 [M+H]+ 767.4320, found 767.4344. 2nd isomer: m. p. > 330˚C; 
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1H-NMR (500 MHz; (CD3)2SO): δ = 13.6 (br s, 2H), 7.57 (d, 2H, J = 1.6 Hz), 7.45-7.44 
(d, 2H, J = 1.7 Hz), 7.42-7.41 (d, 2H, J = 7.8 Hz), 7.29 (d, 2H, J = 7.8 Hz), 7.04-7.02 (dd, 
2H, J = 7.8, 1.8 Hz), 6.98-6.96 (dd, 2H, J = 7.8, 1.8 Hz), 5.95 (s, 2H), 5.93 (s, 2H), 1.21 
(s, 18H), 1.18 (s, 18H); 13C-NMR (125 MHz; (CD3)2SO): δ = 158.5, 150.7, 148.12, 
148.10, 146.6, 144.1, 143.9, 141.2, 141.1, 138.6, 124.2, 123.7, 121.9, 121.83, 121.80, 
121.3, 49.8, 46.4, 34.38, 34.37, 31.28, 31.27; HR-MS (ESI): calc. for C52H54N4O2 [M+H]+ 
767.4320, found 767.4356. 
 
1,1'-Bi(5'',6'',7,7'',8,8'',9,10-octahydro-5'',5''7,7,8'',8'',10,10-octamethyl-5,12-
[2'',3'']naphthaleno-2,3-diazatetracenyl)-4,4'(3H,3'H)-dione (32c). Dimer (31c) 
(1.01 g, 1.0 mmol) was added to a stirred solution of hydrogen bromide in acetic acid 
(33% by wt., 20 mL) and the mixture was heated to 95˚C overnight. Upon warming 
dissolution occurs and a violent gas release is observed. The mixture is then cooled and 
most of the solvent is evaporated under reduced pressure. The resulting solid is 
suspended and triturated for several hours in a solution of sodium acetate. Filtration 
affords (32c) as an off-white solid (0.99 g, 100%). m. p. > 330˚C; 1H-NMR (500 MHz; 
CS2 - (CD3)2SO): δ = 13.39 (br s, 2H), 7.22 (s, 4H), 7.16 (s, 4H), 5.79 (s, 2H), 5.59 (s, 
2H), 1.54-1.51 (m, 16H), 1.21 (s, 12H), 1.18 (s, 12H), 1.12 (s, 12H), 1.08 (s, 12H); 13C-
NMR (125 MHz; CS2 - (CD3)2SO): δ = 158.0, 149.6, 146.1, 140.8, 140.53, 140.50, 
138.2, 122.7, 121.8, 49.6, 46.1, 35.25, 35.20, 33.82, 33.79, 31.7, 31.6, 31.5, 29.9; HR-MS 
(EI): calc. for C68H78N4O2 [M+H]+ 983.6198, found 983.6195. 
 
1,1'-Bi(4-chloro-9,10-dihydro-9,10-[1'',2'']benzeno-2,3-diazaanthracenyl) (33a). The 
deprotected dimer 32a (4.00 g, 74 mmol) was stirred overnight at 90˚C in ca. 80 mL of 
neat POCl3. The mixture was cooled, and the excess POCl3 was evaporated under reduced 
pressure. The brown gummy residue was redissolved in PhMe (ca. 50 mL), and 
evaporated again under reduced pressure to eliminate more of the residual POCl3. The 
residue was then dissolved in CH2Cl2 (ca. 80 mL), triturated with neutral alumina for 1 h, 
filtered through a neutral alumina plug, and eluted first with CH2Cl2,, then with EtOAc. 
Evaporation of the solvents under reduced pressure, followed by purification by 
chromatography on SiO2 using 10:4:1 hexanes : dichloromethane : ethyl acetate (v/v/v) as 
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the mobile phase yields the pure 33a as a white solid (2.84 g, 66%). m. p. > 330˚C; 1H-
NMR (500 MHz; CDCl3): δ = 7.58-7.56 (d, 4H, 7 Hz), 7.49-7.48 (d, 4H, 7 Hz), 7.13-7.06 
(m, 8H), 6.37 (s, 2H), 5.99 (s, 2H); 13C-NMR (75 MHz; CDCl3): δ = 152.4, 151.8, 149.2, 
146.6, 142.9, 142.4, 126.6, 126.4, 125.7, 124.9, 50.20, 50.17; IR (KBr): 3044, 2988, 
1531, 1459, 1287, 1194, 705; HR-MS (ESI): calc. for C36H20 Cl2N4 [M+H]+ 579.1138, 
found 579.1117. 
 
1,1'-Bi(5'',6-di-tert-butyl-4-chloro-9,10-dihydro-9,10-[1'',2'']benzeno-2,3-
diazaanthracenyl) (33b). Dione (as a mixture of isomers) (32b) (1.30 g, 1.7 mmol) was 
stirred overnight at 60˚C in ca. 20 mL of neat POCl3. The mixture was cooled, and the 
excess POCl3 was evaporated under reduced pressure. The brown gummy residue was 
redissolved in PhMe (ca. 20 mL), and evaporated under reduced pressure again to 
eliminate more of the residual POCl3. The residue was then dissolved in CH2Cl2 (ca. 50 
mL) and triturated with neutral alumina for 1 h, filtered through a neutral alumina plug, 
and eluted first with CH2Cl2,, then with EtOAc. Evaporation of the solvents yields a 1:1 
mixture of the Ci and racemic C2v isomers of (33b) as a white solid (1.03 g, 76%). 
Purification by column chromatography on SiO2 using 3:1 dichloromethane : hexanes 
allows for the separate isolation of the pure Ci and racemic C2 isomers. 1st isomer (higher 
Rf on SiO2): m. p. = slowly dec. above 280˚C with no clear transition.; 1H-NMR (500 
MHz; CDCl3): δ = 7.56 (d, 2H, J = 1.8 Hz), 7.55-7.53 (d, 2H, J = 7.8 Hz), 7.50-7.49 (d, 
2H, J = 7.8 Hz), 7.38 (d, 2H, J = 1.7 Hz), 7.13-7.11 (dd, 2H, J = 7.9, 1.7 Hz), 7.11-7.09 
(dd, 2H, J = 7.9, 1.7 Hz), 6.38 (s, 2H), 5.93 (s, 2H), 1.29 (s, 18H), 1.19 (s, 18H); 13C-
NMR (125 MHz; CDCl3): δ = 152.2, 151.9, 149.9, 149.6, 149.5, 147.0, 143.2, 142.4, 
140.2, 139.8, 125.4, 124.3, 123.4, 122.93, 122.89, 122.0, 50.21, 50.16, 34.9, 31.7, 31.6; 
HR-MS (ESI): calc. for C52H52Cl2N4 [M+H]+ 803.3642, found 803.3625. 2nd isomer 
(lower Rf on SiO2): m. p. > 330˚C; 1H-NMR (500 MHz; CDCl3): δ = 7.58 (d, 2H, 
J = 1.8 Hz), 7.49 (d, 2H, J = 7.8 Hz), 7.46 (d, 2H, J = 1.8 Hz), 7.36 (d, 2H, J = 7.8 Hz), 
7.13 (dd, 2H, J = 7.8, 1.8 Hz), 7.06 (dd, 2H, J = 7.8, 1.8 Hz), 6.24 (s, 2H), 5.94 (s, 2H), 
1.29 (s, 18H), 1.23 (s, 18H); 13C-NMR (125 MHz; CDCl3): δ = 152.3, 151.9, 149.9, 
149.7, 149.6, 146.9, 143.0, 140.2, 139.6, 125.0, 124.3, 123.3, 123.0, 122.1, 50.2, 50.0, 
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35.0, 34.9, 31.7, 31.6; HR-MS (ESI): calc. for C52H52Cl2N4 [M+H]+ 803.3642, found 
803.3625.  
 
Derivatization of 1,1'-Bi(5'',6-di-tert-butyl-4-chloro-9,10-dihydro-9,10-
[1'',2'']benzeno-2,3-diazaanthracenyl) (33b) with (R)-1-phenylethylamine: 
1,1'-Bi(5'',6-di-tert-butyl-9,10-dihydro-4-(N-(R)-1-(phenylethyl)amino)-9,10-
[1'',2'']benzeno-2,3-diazaanthracenyl) Dichloro dimer 33b, (1st isomer, 80 mg, 
0.10 mmol) is added to a Schlenk flask equipped with a magnetic stirrer. Contents are 
evacuated and back-filled with argon 5 times, then (R)-1-phenylethylamine (96% ee) 
(1 mL, 7.9 mmol) is added. Contents are evacuated and back-filled with argon 5 more 
times. The reaction mixture is stirred for 3 days at 130˚C, followed by 1 h at 160-180˚C. 
Upon cooling, excess amine is distilled at low temperature under high vacuum, and the 
solid residue is purified by column chromatography on silica gel using progressively 
more polar 10 : 4 : 1 to 5 : 4 : 1 hexanes / dichloromethane / ethyl acetate (v/v/v) to afford 
a first fraction containing the monosubstitution product (28 mg, 32%), then two distinct 
fractions containing respectively 26 mg (27%) and 28mg (29%) of two diastereomers of 
the double substitution product as amorphous off-white solids. Isomer 1-1 (higher Rf on 
SiO2): m. p. = 230˚C (softens); [α]D21 = -41 (c = 0.20, CHCl3);  1H-NMR (500 MHz; 
CDCl3): δ = 7.65 (d, 4H, J = 7.5 Hz), 7.52-7.46 (m, 6H), 7.39-7.31 (m, 8H), 7.07 (dd, 2H, 
J = 7.5, 1.5 Hz), 7.02 (dd, 2H, J = 7.5, 1.5 Hz), 6.22 (s, 2H), 5.72 (br, 2H), 5.43 (s, 2H), 
5.11 (br, 2H), 1.77 (d, 6H, J = 6.5 Hz), 1.29 (s, 18H), 1.18 (s, 18H); 13C-NMR (125 MHz; 
CDCl3): δ = 153.3, 149.0, 148.2, 147.9, 147.2, 145.1, 144.7, 143.4, 141.8, 141.0, 133.2, 
129.0, 127.5, 126.8, 125.0, 123.1, 122.8, 122.5, 122.0, 121.0, 51.4, 49.9, 47.3, 34.8 (2), 
31.7, 31.6, 23.4. HR-MS (ESI): calc. for C68H72N6 [M+H]+ 973.5891, found 973.5913. 
Isomer 1-2 (lower Rf on SiO2): m. p. = 246˚C (softens); [α]D21 = +52 (c = 0.52, CHCl3); 
1H-NMR (500 MHz; CDCl3): δ = 7.56 (d, 4H, J = 7.5 Hz), 7.50 (d, 2H, J = 7.5 Hz), 7.43-
7.40 (m, 6H), 7.34-7.31 (m, 6H), 7.05-7.02 (m, 4H), 6.23 (s, 2H), 5.71 (br, 2H), 5.43 (s, 
2H), 5.04 (br, 2H), 1.79 (d, 6H, J = 6.5 Hz), 1.26 (s, 18H), 1.19 (s, 18H); 13C-NMR (125 
MHz; CDCl3): δ = 153.4, 149.1, 148.3, 147.9, 147.1, 144.9, 144.7, 143.4, 141.8, 140.9, 
133.3, 128.9, 127.5, 126.7, 125.0, 123.3, 122.8, 122.5, 122.0, 120.9, 51.4, 50.0, 47.2, 
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34.82, 34.77, 31.7, 31.6, 23.1; HR-MS (ESI): calc. for C68H72N6 [M+H]+ 973.5891, found 
973.5855. 
Dichloro dimer 33b, (2nd isomer, 80 mg, 0.10 mmol) is added to a Schlenk flask 
equipped with a magnetic stirrer. Contents are evacuated and back-filled with argon 5 
times, then (R)-1-phenylethylamine (96% ee) (1 mL, 7.9 mmol) is added. Contents are 
evacuated and back-filled with argon 5 more times. The reaction mixture is stirred for 3 
days at 130˚C, followed by 1 h at 160-180˚C. Upon cooling, excess amine is distilled at 
low temperature under high vacuum, and the solid residue is purified by column 
chromatography on silica gel using progressively more polar 10 : 4 : 1 to 5 : 4 : 1 hexanes 
/ dichloromethane / ethyl acetate (v/v/v) to afford a first fraction containing the 
monosubstitution product (31 mg, 35%), then a single fractions containing 48 mg (29%) 
of the double substitution product as an amorphous off-white solids. Isomer 2-1: 
m. p. = 208˚C (softens); [α]D21 = +19 (c = 0.87, CHCl3); 1H-NMR (500 MHz; CDCl3): δ = 
7.64 (br d / unresolved dd, 4H, J = 7.5 Hz), 7.46 (m, 4H), 7.41 (d, 1H, J = 1.5 Hz), 7.38-
7.33 (m, 6H), 7.30 (d, 1H, J = 7.5 Hz), 7.24 (d, 1H, J = 7.5 Hz), 7.07 (dd, 1H, J = 8.0, 2.0 
Hz), 7.04 (dd, 1H, J = 7.5, 1.5 Hz), 7.00 (dd, 1H, J = 8.0, 2.0 Hz), 6.97 (dd, 1H, J = 7.5, 
1.5 Hz), 5.97 (s, 1H), 5.95 (s, 1H), 5.75 (br, 1H), 5.70 (br, 1H), 5.45 (s, 1H), 5.44 (s, 1H), 
5.15 (br, 1H), 5.06 (br, 1H), 1.82 (d, 3H, J = 6.5 Hz), 1.78 (d, 3H, J = 7.0 Hz), 1.29 (s, 
9H), 1.28 (s, 9H), 1.27 (s, 9H), 1.24 (s, 9H); 13C-NMR (125 MHz; CDCl3): δ = 153.6, 
153.5, 149.1, 149.0, 148.4, 148.3, 147.91, 147.89, 147.3, 147.2, 145.0, 144.9, 144.52, 
144.46, 143.6, 143.4, 141.7, 141.6, 140.8, 140.6, 133.2, 133.1, 128.93, 128.90, 127.5, 
126.8, 124.5, 124.4, 123.3. 123.2, 122.7, 122.6, 122.48, 122.46, 122.0, 121.11, 121.07, 
51.6, 51.3, 49.83, 49.81, 47.27, 47.25, 34.85, 34.83, 34.77 (2), 31.70 (2), 31.68 (2), 23.2, 
23.1; HR-MS (ESI): calc. for C68H72N6 [M+H]+ 973.5891, found 973.5859. 
 
1,1'-Bi(4-chloro-5'',6'',7,7'',8,8'',9,10-octahydro-5'',5''7,7,8'',8'',10,10-octamethyl-
5,12-[2'',3'']naphthaleno-2,3-diazatetracenyl) (33c). Dione (32c) (0.90 g, 0.91 mmol) 
was stirred overnight at 80˚C in ca. 20 mL of neat POCl3. The mixture was cooled, and 
the excess POCl3 was evaporated under reduced pressure. The brown gummy residue was 
redissolved in PhMe (ca. 20 mL), and evaporated under reduced pressure again to 
eliminate more of the residual POCl3. The residue was then dissolved in CH2Cl2 (ca. 50 
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mL) and triturated with neutral alumina for 1 h, filtered through a neutral alumina plug, 
and eluted first with CH2Cl2,, then with EtOAc. Evaporation of the solvents yields (33c) 
as an off-white solid (0.73 g, 79%). m. p. >330˚C; 1H-NMR (500 MHz; CS2 - (CD3)2SO): 
δ = 7.29 (s, 4H), 7.19 (s, 4H), 6.06 (s, 2H), 5.63 (s, 2H), 1.59-1.53 (m, 16H), 1.23 (s, 
12H), 1.21 (s, 12H), 1.14 (s, 12H), 1.07 (s, 12H); 13C-NMR (125 MHz; CS2 - (CD3)2SO): 
δ = 151.1, 151.0, 147.9, 145.2, 141.8, 141.6, 139.4, 139.0, 123.2, 122.4, 49.0, 48.9, 35.0, 
33.9, 33.8, 31.7, 31.62, 31.60, 31.5, 29.9; HR-MS (ESI): calc. for C68H76Cl2N4 [M+H]+ 
1019.5520, found 1019.5557.  
 
1,1'-Bi(4-bromo-9,10-dihydro-9,10-[1'',2'']benzeno-2,3-diazaanthracenyl) (33d). 
Dione (32a) (1.09 g, 2.0 mmol) and POBr3 (3.44 g, 12 mmol) were stirred overnight at 
90˚C in toluene (~20 mL). The mixture was cooled, and the solvent was evaporated under 
reduced pressure. The residue was then dissolved in CH2Cl2 (ca. 80 mL) and triturated 
with neutral alumina for 1 h, filtered over a neutral alumina plug, and eluted first with 
CH2Cl2,, then with EtOAc. Evaporation of the solvents under reduced pressure followed 
by purification by recrystallization from PhMe yields the pure (33d) an off-white solid 
(0.53 g, 39%). m. p. > 330˚C; 1H-NMR (500 MHz; CDCl3): δ = 7.58-7.55 (dd, 4H, 
J = 6.8, 1.7 Hz), 7.49-7.46 (dd, 4H, J = 7.1, 1.7 Hz), 7.12 (td, 4H, J = 7.4, 1.3 Hz), 7.07 
(td, 4H, J = 7.4, 1.2 Hz), 6.34 (s, 2H), 5.96 (s, 2H); 13C-NMR (125 MHz; CDCl3): 
δ = 152.0, 149.0, 148.7, 145.3, 142.9, 142.4, 126.7, 126.4, 125.7, 124.9, 52.5, 50.2; IR 
(KBr): 3070, 1520, 1459, 1284, 1165, 947, 688, 635; HR-MS (ESI): calc. for C36H20Br2N4 
[M+H]+ 667.0127, found 667.0108. 
 
6-Chloro-4,4',5,5'-bis(9,10-dihydroanthracen-9,10-diyl)-6'-methoxy-3,3'-
bipyridazine (34). Dichloro dimer 33a (1.16 g, 2.0 mmol) and solid NaOMe (125 mg, 
2.3 mmol) were placed in a Schlenk flask, and the contents were evacuated and back-
filled with argon 5 times. Dry THF (~50 mL) was added and the resulting mixture was 
stirred at room temperature for 2 days. Solvents were then evaporated under reduced 
pressure and the residue was purified by chromatography on SiO2 using 10:4:1 
hexanes : dichloromethane : ethyl acetate (v/v/v) as the mobile phase to yield first 
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unreacted starting material 33a (0.48g recovery), followed by the desired chloro methoxy 
dimer 34 as a white solid (0.32 g, 28% or 47% based on recovered starting material) and 
finally the dimethoxy dimer 31a (0.10 g). m. p. = 318˚C (dec.); 1H-NMR (500 MHz; 
CDCl3): δ = 7.59-7.57 (d, 2H, J = 7.0 Hz), 7.54-7.53 (d, 2H, J = 7.0 Hz), 7.51-7.50 (d, 
2H, J = 7.0 Hz), 7.45-7.44 (d, 2H, J = 7.0 Hz), 7.14-7.02 (m, 8H), 6.40 (s, 1H), 6.23 (s, 
1H), 6.01 (s, 1H), 5.96 (s, 1H), 4.36 (s, 3H); 13C-NMR (125 MHz; CDCl3): δ = 160.8, 
152.7, 151.9, 149.8, 149.3, 148.8, 146.3, 143.9, 143.5, 143.1, 142.5, 136.5, 126.5, 126.2, 
126.0, 125.8, 125.7, 125.4, 124.8, 124.5, 55.5, 50.3, 50.2. 50.0, 46.7; HR-MS (ESI): calc. 
for C37H23 ClN4O [M+H]+ 575.1633, found 575.1613. 
 
1,1'-Bi(6,11-dihydro-4-methoxy-6,11-[1'',2'']benzeno-2,3-diazatetracenyl) (35). In a 
septum-capped Schlenk flask are placed the methoxy chloride 14a (185 mg, 0.5 mmol), 
activated zinc dust (195 mg, 3.0 mmol), trans-dichlorobis(triphenylphosphine)palladium 
(II) (35 mg, 0.05 mmol) and triphenylphosphine (26 mg, 0.10 mmol). The flask is 
evacuated and back-filled with argon 5 times, and dry N,N-dimethylformamide (3 mL) is 
then added. The resulting mixture is stirred at 100˚C for ca. 20h, after which TLC 
indicates complete consumption of the starting material. The reaction mixture is poured in 
a large excess of aq. Na2EDTA, and triturated for a few hours. Filtration of the 
precipitates yields a crude product that is purified by column chromatography on silica 
gel using 5:1 dichloromethane : ethyl acetate (v/v) as the mobile phase, yielding the pure 
dimer 35 as a white solid (37 mg, 17%). m. p. > 310˚C (dec.); 1H-NMR (500 MHz; 
CDCl3): δ = 8.29 (s, 2H), 7.82 (s, 2H), 7.44-7.42 (d, 4H, J = 6.5 Hz), 7.32-7.31 (d, 4H, J 
= 7.0 Hz), 7.05-6.97 (m, 8H), 5.67 (s, 2H), 5.45 (s, 2H), 4.38 (s, 6H); 13C-NMR (125 
MHz; CDCl3): δ = 161.0, 152.4, 149.3, 149.1, 143.58, 143.55, 127.6, 126.04, 126.03, 
124.5, 124.1, 120.4, 118.8, 117.1, 55.3, 54.2, 53.9; HR-MS (ESI): calc. for C46H30N4O2  
[M+H]+ 671.2442, found 671.2446.  
 
2,3-Dicyanotriptycene (36).51 In a septum-capped Schlenk flask is placed dichloride 
(13a) (37 mg, 0.1 mmol), activated zinc dust (39 mg, 0.6 mmol), trans-
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dichlorobis(triphenylphosphine)palladium (II) (7 mg,  0.001 mmol) and 
triphenylphosphine (5 mg, 0.002 mmol). The flask is evacuated and back-filled with argon 
5 times, and dry N,N-dimethylformamide (1 mL) is then added. The mixture is stirred at 
100˚C for ca. 20h, during which it turns purplish, and after which TLC indicates complete 
consumption of the starting material. Evaporation of the solvent in vacuo yields a crude 
product that is then purified by column chromatography on silica gel using 15:4:1 
hexanes : dichloromethane : ethyl acetate (v/v/v) as the mobile phase, yielding the pure 
dicyanotriptycene (36) as a white solid (7 mg, 23%). m. p. = 269-272˚C (lit.51 262-
263˚C); 1H-NMR (500 MHz; CDCl3): δ = 7.76 (s, 2H), 7.46-7.44 (dd, 4H, J = 5.5, 
2.5 Hz), 7.10-7.08 (dd, 4H, J = 5.5, 3.5 Hz), 5.57 (s, 2H); 13C-NMR (125 MHz; CDCl3): 
δ = 151.5, 142.8, 128.2, 126.5, 125.5, 115.8, 113.2, 53.8; HR-MS (ESI): calc. for 
C22H12N2 [M+Na]+ 327.0898 , found 327.0900. 
 
Quaterpyridazine (37). In a septum-capped Schlenk flask are placed the chloro methoxy 
dimer 34 (115 mg, 0.20 mmol), activated zinc dust (78 mg, 1.2 mmol), trans-
dichlorobis(triphenylphosphine)palladium (II) (14 mg,  0.02 mmol) and 
triphenylphosphine (11 mg, 0.04 mmol). The flask is evacuated and back-filled with argon 
5 times, and dry N,N-dimethylformamide (3 mL) is then added. The resulting mixture is 
stirred at 100˚C for ca. 20h. After cooling to room temperature, the mixture is diluted 
with dichloromethane (~5 mL) and SiO2 (~300 mg) is added. Evaporation of the solvents 
under reduced pressure affords a crude product dispersed on silica gel that is purified by 
column chromatography on silica gel using progressively more polar 10:4:1 -> 5:4:1 
hexanes : dichloromethane : ethyl acetate (v/v/v) as the mobile phase, yielding the pure 
tetramer 37 as a pale yellow solid (82 mg, 79%). m. p. > 210˚C (dec.); 1H-NMR (500 
MHz; CDCl3): δ = 7.58-7.56 (m, 4H), 7.52-7.50 (m, 4H,), 7.46-7.44 (m, 4H), 7.43-7.41 
(m, 4H), 7.13-7-07 (m, 16H), 6.41 (s, 2H), 6.18 (s, 2H), 6.09 (s, 2H), 6.01 (s, 2H), 4.44 
(s, 6H); 13C-NMR (125 MHz; CDCl3): δ = 160.9, 152.7, 152.6, 150.3, 150.0, 147.8, 
147.4, 144.1, 143.7, 143.5, 143.3, 136.4, 126.3, 126.2, 126.1, 125.9, 125.4, 125.3, 125.2, 
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124.6, 55.5, 50.5, 50.0, 49.8, 46.9; IR (KBr): 3043, 2951, 1569, 1459, 1379, 1299, 730; 
HR-MS (ESI): calc. for C74H46N8O2 [M+H]+ 1079.3816, found 1079.3782. 
 
Sexipyridazine (38). In a septum-capped Schlenk flask are placed the chloro methoxy 
dimer 34 (230 mg, 0.40 mmol), the dichloro dimer 33a (58 mg, 0.10 mmol), activated 
zinc dust (235 mg, 3.6 mmol), trans-dichlorobis(triphenylphosphine)palladium (II) (42 
mg,  0.06 mmol) and triphenylphosphine (32 mg, 0.12 mmol). The flask is evacuated and 
back-filled with argon 5 times, and dry N,N-dimethylformamide (3 mL) is then added. The 
resulting mixture is stirred at 100˚C for ca. 24h. After cooling down to room temperature, 
the mixture is diluted with dichloromethane (~5 mL) and SiO2 (~300 mg) is added. 
Evaporation of the solvents under reduced pressure affords a crude product dispersed on 
silica gel that is purified by column chromatography on silica gel using progressively more 
polar 10:4:1 -> 5:4:1 hexanes : dichloromethane : ethyl acetate (v/v/v) as the mobile phase, 
yielding first fractions containing the tetramer 37, followed by fractions of lower Rf 
containing the hexamer 38. Further purification by preparative thin layer chromatography 
on SiO2 using 8:8:2 hexanes : dichloromethane : ethyl acetate (v/v/v) as the mobile phase 
affords the hexamer 38 as a pale yellow solid (20 mg, 13%) with an estimated purity of 
90-95% by NMR that could not be further upped by chromatography or crystallization. 
m. p. > 330˚C; 1H-NMR (500 MHz; CDCl3): δ = 7.61-7.57 (m, 4H), 7.56-7.55 (m, 4H), 
7.53-7.48 (m, 16H), 7.16-7.11 (m, 24H), 6.45 (s, 2H), 6.24 (s, 2H), 6.22 (s, 2H), 6.21 (s, 
2H), 6.17 (s, 2H), 6.04 (s, 2H), 4.47 (s, 6H); 13C-NMR (125 MHz; CDCl3): δ = 161.0, 
153.1, 152.9, 152.8, 152.5, 150.3, 150.0, 148.1, 148.0, 147.9, 147.5, 144.1, 143.8, 143.5, 
143.4, 143.3, 136.5, 126.5, 126.4, 126.3, 126.1, 125.9, 125.5, 125.5, 125.4, 125.3, 125.2, 
124.6, 55.6, 50.6, 50.1 (3), 49.8, 46.9; IR (KBr): 3042, 2950, 2926, 1570, 1459, 1374, 
1297, 729; HR-MS (ESI): calc. for C110H66N12O2 [M+2H]2+ 794.2789, found 794.2773. 
 
9,10-Dihydro-1,4-dimethoxy-9,10-[1',2']benzeno-2,3-diazaanthracene. 1-Chloro-9,10-
dihydro-4-methoxy-9,10-[1',2']benzeno-2,3-diazaanthracene (6a) (0.160 g, 0.50 mmol) 
and solid, dry NaOMe (0.270 g, 5.0 mmol) were stirred overnight (~18h) at 60˚C in a 
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mixture of tetrahydrofuran (2.5 mL) and methanol (2.5 mL). The contents were cooled, 
then passed on short silica gel plug with ethyl acetate as eluant. Evaporation of the 
solvents under reduced pressure affords the desired dimethoxy pyridazine as a white solid 
(0.157 g, ~100%). Analytical samples were obtained after recrystallization from 
methanol. m. p. = 257-260˚C; 1H-NMR (300 MHz; CDCl3): δ = 7.48-7.45 (dd, 4H, 
J = 5.4, 3.3 Hz), 7.06-7.03 (dd, 4H, J = 5.4, 3.0 Hz), 5.77 (s, 2H), 4.10 (s, 6H); 13C-NMR 
(75 MHz; CDCl3): δ = 158.4, 143.9, 139.3, 125.7, 124.6, 54.7, 47.3; HR-MS (ESI): calc. 
for C20H16N2O2 [M+H]+ 317.1285, found 317.1274. 
 
1-(4'-Bromophen-4-yl)pyrrolidine (40). A solution of 4'-bromophenyl-4-amine (39) 
(12.41 g, 50 mmol), prepared from biphenyl according to literature procedures,61 1,4-
butanediol ditosylate (19.93 g, 50 mmol) and N,N-diisopropylethylamine (22 mL, 
127 mmol) in toluene (75 mL) was degassed by bubbling nitrogen through for ~20 mins 
and the contents were then refluxed overnight. After cooling, the mixture was poured in 
an excess of water, extracted with Et2O, washed with brine and dried with anh. MgSO4. 
Solvents were evaporated under reduced pressure to yield a crude solid that was purified 
by trituration in boiling EtOH to afford pyrrolidine 40 as a beige solid (12.95 g, 86% over 
2 crops). m. p. = 244-246˚C; 1H-NMR (500 MHz, CDCl3): δ = 7.51 (d, 2H, J = 8.5 Hz), 
7.47 (d, 2H, J = 8.5 Hz), 7.43 (d, 2H, J = 8.5 Hz), 6.64 (d, 2H, J = 9.0 Hz), 3.43 (t, 4H, 
J = 6.5 Hz), 2.04 (m, 4H). 13C-NMR (125 MHz; CDCl3): δ = 147.7, 140.6, 131.8, 127.9, 
127.8, 126.8, 119.8, 112.1, 47.8, 25.7; HR-MS (ESI): calc. for C16H16BrN [M+H]+ 
302.0539, found 302.0553. 
 
5-(4'-(Pyrrolidin-1-yl)biphenyl-4-yl)thiophene-2-carbaldehyde (41). Pyrrolidine 40 
(30 mg, 0.10 mmol), 5-formylthiophen-2-ylboronic acid (20 mg, 0.13 mmol), potassium 
phosphate (42 mg, 0.20 mmol), palladium acetate (0.5 mg,  0.002 mmol) and the Xphos 
ligand62b (1.9 mg, 0.004 mmol) were placed in a Schlenk flask. Contents were evacuated 
and back-filled with argon 5 times, and tert-amyl alcohol (1.0 mL) was added. After 5 
more evacuation / back-fill cycles, the mixture was stirred at 100˚C for ca. 15 h. A yellow 
color develops within minutes upon warming. Contents were cooled, filtered on a short 
silica gel plug and eluted with CH2Cl2. Upon evaporation of the solvents under reduced 
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pressure the aldehyde 41 is obtained as a bright orange solid (34 mg, ~100%). Analytical 
samples may be obtained after recrystallization from PhMe. m. p. > 320˚C; 1H-NMR 
(500 MHz, CDCl2CDCl2): δ = 9.90 (s, 1H), 7.75 (d, 1H, J = 4.0 Hz), 7.71 (d, 2H, J = 8.0 
Hz), 7.63 (d, 2H, J = 8.5 Hz), 7.55 (d, 2H, J = 8.5 Hz), 7.42 (d, 1H, J = 4.0 Hz), 6.66 (d, 
2H, J = 9.0 Hz), 3.36 (t, 4H, J = 6.5 Hz), 2.04 (m, 4H). 13C-NMR (125 MHz; CDCl3): δ = 
183.1, 154.6, 147.7, 142.5, 141.7, 138.2, 130.1, 127.8, 126.8, 126.5, 126.2, 123.9, 112.1, 
47.7, 25.6; HR-MS (ESI): calc. for C21H19NOS [M+H]+ 334.1260, found 334.1274. 
 
(E)-2-(3-cyano-5,5-dimethyl-4-(2-(5-(4'-(pyrrolidin-1-yl)biphenyl-4-yl)thiophen-2-
yl)vinyl)furan-2(5H)-ylidene)propanedinitrile (42). Aldehyde 41 (33 mg, 0.10 mmol), 
and 2-(3-cyano-4,5,5-trimethylfuran-2(5H)-ylidene)propanedinitrile 71  (TCF, 26 mg, 
0.13 mmol), piperidine (~2 µL, 0.02 mmol) and piperidinium acetate (2 mg, 0.014 mmol) 
were refluxed in 1:1 (v/v) benzene-ethanol (6 mL) in a Dean-Stark apparatus for ca. 48 h. 
Contents were cooled, and the solvents were evaporated under reduced pressure. The 
resulting solid was purified by column chromatography on silica gel using CH2Cl2 as the 
mobile phase to afford the dye 42 as a dark purple solid (45 mg, 88%). Analytical 
samples can be obtained by recrystallization from MeCN. m. p. = 220˚C (dec); 1H-NMR 
(500 MHz, CDCl3): δ = 7.83 (d, 1H, J = 16 Hz), 7.70 (d, 2H, J = 8.5 Hz), 7.65 (d, 2H, 
J = 9.0 Hz), 7.56 (d, 1H, J = 9.0 Hz), 7.49 (d, 1H, J = 4.0 Hz), 7.43 (s, 1H, J = 4.0 Hz), 
6.68 (d, 1H, J = 15.0 Hz), 6.66 (d, 2H, J = 8.5 Hz), 3.36 (t, 4H, J = 6.5 Hz), 2.05 (m, 4H), 
1.79 (s, 6H); 13C-NMR (125 MHz; CDCl3): δ = 173.3, 154.0, 148.1, 143.2, 139.8, 138.7, 
137.4, 130.0, 127.9, 126.9, 126.7, 126.4, 124.9, 112.6, 112.2, 111.5, 111.0, 97.4, 47.8, 
26.7, 25.7; HR-MS (ESI): calc. for C32H26N4OS [M+H]+ 515.1900, found 515.1894. 
 
6-Chloro-4,4',5,5'-bis(9,10-dihydroanthracen-9,10-diyl)-6'-(pyrrolidin-1-yl)-3,3'-
bipyridazine (43).  Dichloride 33b (116 mg, 0.20 mmol), and pyrrolidine (25 µL, 
0.30 mmol), were stirred overnight in N,N-dimethylformamide (1 mL) at 110˚C. Contents 
were cooled, diluted with CH2Cl2 and directly purified by column chromatography on 
silica gel using 5:4:1 hexanes : dichloromethane : ethyl acetate (v/v/v) as the mobile 
phase to afford 43 as an amorphous off-white solid (59 mg, 48%). m. p. = 225˚C 
(softens), 260˚C (dec.); 1H-NMR (500 MHz, CDCl3): δ = 7.56 (d, 2H, J = 7.1 Hz), 7.45 (t 
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- unresolved dd, 4H, J = 8.1 Hz), 7.36 (d, 2H, J = 6.7 Hz), 7.11-7.00 (m, 8H), 6.28 (s, 
1H), 6.06 (s, 1H), 6.02 (s, 1H), 5.98 (s, 1H), 4.03 (t, 4H, J = 6.5 Hz), 2.14 (m, 4H); 13C-
NMR (75 MHz; CDCl3): δ = 156.0, 153.5, 151.4, 148.7, 146.1, 145.6, 144.2, 143.9, 
143.3, 142.6, 133.0, 126.4, 126.1, 126.0, 125.68, 125.66, 125.2, 124.4, 123.8, 50.7, 50.2, 
50.0 (2), 49.7, 26.2; HR-MS (ESI): calc. for C40H28ClN5 [M+H]+ 614.2106, found 
614.2145. 
 
4,4',5,5'-bis(9,10-dihydroanthracen-9,10-diyl)-6-(5-formylthiophen-2-yl)-6'-
(pyrrolidin-1-yl)-3,3'-bipyridazine (44). Pyrrolidine 43 (41 mg, 0.067 mmol), 5-
formylthiophen-2-ylboronic acid (21 mg, 0.13 mmol), potassium phosphate (42 mg, 
0.20 mmol), palladium acetate (0.75 mg,  0.003 mmol) and the Sphos ligand62a (1.4 mg, 
0.003 mmol) were placed in a Schlenk flask. Contents were evacuated and back-filled 
with argon 5 times, and THF (0.5 mL) and water (25µL) were added. After 5 more 
evacuation / back-fill cycles, the mixture was stirred at room temperature for ca. 36 h. 
Contents were poured in sat. NaHCO3 (aq.), extracted with CH2Cl2, dried over anh. MgSO4. 
After evaporation of the solvents under reduced pressure, the resulting crude solid was 
purified by column chromatography on silica gel using progressively more polar 5:4:1 to 
3:3:1 hexanes : dichloromethane : ethyl acetate as the mobile phase to yield the aldehyde 
44 as an amorphous pale yellow solid (47 mg, ~100%). m. p. = 250˚C (softens), 260˚C 
(dec.); 1H-NMR (500 MHz, CDCl3): δ = 10.11 (s, 1H), 8.00 (d, 1H, J = 4.0 Hz), 7.94 (d, 
1H, J = 4.0 Hz), 7.53 (d, 2H, J = 7.0 Hz), 7.46 (d, 2H, J = 7.0 Hz), 7.43 (d, 2H, J = 6.5 
Hz), 7.35 (d, 2H, J = 7.0 Hz), 7.10-6.99 (m, 8H), 6.25 (s, 1H), 6.24 (s, 1H), 6.08 (s, 1H), 
6.01 (s, 1H), 4.04 (t, 4H, J = 6.5 Hz), 2.15 (m, 4H); 13C-NMR (125 MHz; CDCl3): δ = 
183.4, 155.9, 153.1, 148.9, 148.2, 147.8, 146.5, 146.1, 145.6, 144.7, 144.2, 143.9, 143.5, 
142.7, 136.6, 132.9, 129.8, 126.5, 126.1, 126.0, 125.69, 125.68, 125.3, 124.5, 123.8, 50.7, 
50.0, 49.8, 49.7, 49.6, 26.2; HR-MS (ESI): calc. for C45H31N5OS [M+H]+ 690.2322, found 
690.2326. 
 
Dye (45). Aldehyde 44 (31 mg, 0.045 mmol), and 2-(3-cyano-4,5,5-trimethylfuran-
2(5H)-ylidene)propanedinitrile79 (TCF, 10 mg, 0.050 mmol), piperidine (~1 µL, 
0.01 mmol) and piperidinium acetate (1.5 mg, 0.010 mmol) were refluxed in 1:1 (v/v) 
 96 
benzene-ethanol (56 mL) in a Dean-Stark apparatus for ca. 48 h. Contents were cooled, 
and the solvents were evaporated under reduced pressure. The resulting solid was purified 
by column chromatography on silica gel using progressively more polar 95:5 to 90:10 
CH2Cl2 : EtOAc (v/v) as the mobile phase to afford the dye 44 as an amorphous orange-
red solid (20 mg, 51%, estimated purity ~85-95% by NMR). m. p. = dec. 280˚C; 1H-
NMR (500 MHz, CDCl3): δ = 8.05 (d, 1H, J = 16.0 Hz), 7.91 (d, 1H, J = 4.0 Hz), 7.73 
(m, 1H), 7.53 (m, 2H), 7.46 (d, 2H, J = 6.5 Hz), 7.43 (d, 2H, J = 6.5 Hz), 7.33 (d, 2H, 
J = 6.5 Hz), 7.11-6.99 (m, 8H), 6.88 (d, 1H, J = 16.0 Hz), 6.24 (s, 1H), 6.21 (s, 1H), 6.07 
(s, 1H), 5.98 (s, 1H), 4.04 (t, 4H, J = 6.5 Hz), 2.16 (m, 4H), 1.81 (s, 6H); 13C-NMR (125 
MHz; CDCl3): δ = 175.6, 173.1, 155.9, 153.0, 148.5, 147.9, 147.3, 146.6, 146.0, 144.4, 
144.2, 143.9, 143.5, 142.6, 142.3, 139.5, 135.4, 132.9, 130.2, 126.6, 126.2, 126.0, 125.80, 
125.75 (2), 125.2, 124.4, 123.9, 114.6, 111.9, 111.1, 110.8, 97.8, 50.7, 50.0, 48.8, 49.73, 
49.67, 26.6, 26.2 ; HR-MS (ESI): calc. for C56H38N8OS [M+H]+ 871.2962, found 
871.2965. 
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Figure 1.A.1. 1H-NMR Spectrum of 1b in CDCl3 (500 MHz).  
 
Figure 1.A.2. 13C-NMR Spectrum of 1b in CDCl3 (125 MHz). 
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Figure 1.A.3. 1H-NMR Spectrum of 1c in CDCl3 (500 MHz).  
 
Figure 1.A.4. 13C-NMR Spectrum of 2c in CDCl3 (125 MHz). 
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Figure 1.A.5. 1H-NMR Spectrum of 2b in (CD3)2SO (500 MHz). 
 
Figure 1.A.6. 13C-NMR Spectrum of 2b in (CD3)2SO (125 MHz). 
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Figure 1.A.7. 1H-NMR Spectrum of 2c in (CD3)2SO (500 MHz). 
 
Figure 1.A.8. 13C-NMR Spectrum of 2c in (CD3)2SO (125 MHz). 
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Figure 1.A.9. 1H-NMR Spectrum of 3b in (CD3)2SO (500 MHz).  
 
Figure 1.A.10. 13C-NMR Spectrum of 3b in (CD3)2SO (125 MHz). 
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Figure 1.A.11. 1H-NMR Spectrum of 3c in CDCl3 (500 MHz).  
 
Figure 1.A.12. 13C-NMR Spectrum of 3b in CDCl3 (75 MHz). 
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Figure 1.A.13. 1H-NMR Spectrum of 4a in (CD3)2SO (500 MHz). 
 
Figure 1.A.14. 13C-NMR Spectrum of 4a in (CD3)2SO (125 MHz). 
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Figure 1.A.15. 1H-NMR Spectrum of 4b in (CD3)2SO (500 MHz). 
 
Figure 1.A.16. 13C-NMR Spectrum of 4b in (CD3)2SO (125 MHz). 
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Figure 1.A.17. 1H-NMR Spectrum of 4c in CDCl3 (500 MHz).  
 
Figure 1.A.18. 13C-NMR Spectrum of 4c in CDCl3 (75 MHz). 
 
4c
NH
NH
O
O
 113 
Figure 1.A.19. 1H-NMR Spectrum of 5a in CDCl3 (300 MHz). 
 
Figure 1.A.20. 13C-NMR Spectrum of 5a in CDCl3 (75 MHz). 
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Figure 1.A.21. 1H-NMR Spectrum of 5b in CDCl3 (500 MHz). 
 
Figure 1.A.22. 13C-NMR Spectrum of 5b in CDCl3 (125 MHz). 
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Figure 1.A.23. 1H-NMR Spectrum of 5c in CDCl3 (300 MHz). 
 
Figure 1.A.24. 13C-NMR Spectrum of 5c in CDCl3 (75 MHz). 
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Figure 1.A.25. 1H-NMR Spectrum of 5d in CDCl3 (500 MHz). 
 
Figure 1.A.26. 13C-NMR Spectrum of 5d in CDCl3 (125 MHz). 
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Figure 1.A.27. 1H-NMR Spectrum of 6a in CDCl3 (500 MHz). 
 
Figure 1.A.28. 13C-NMR Spectrum of 6a in CDCl3 (125 MHz). 
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Figure 1.A.29. 1H-NMR Spectrum of 6b in CDCl3 (500 MHz). 
 
Figure 1.A.30. 13C-NMR Spectrum of 6b in CDCl3 (125 MHz). 
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Figure 1.A.31. 1H-NMR Spectrum of 6c in CDCl3 (500 MHz). 
 
Figure 1.A.32. 13C-NMR Spectrum of 6c in CDCl3 (75 MHz). 
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Figure 1.A.33. 1H-NMR Spectrum of 8 in CDCl3 (300 MHz). 
 
Figure 1.A.34. 13C-NMR Spectrum of 8 in CDCl3 (75 MHz). 
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Figure 1.A.35. 1H-NMR Spectrum of 9b in CDCl3 (300 MHz).  
 
Figure 1.A.36. 13C-NMR Spectrum of 9b in CDCl3 (75 MHz). 
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Figure 1.A.37. 1H-NMR Spectrum of poly(9b) in CDCl3 (500 MHz).  
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Figure 1.A.38. 1H-NMR Spectrum of 10b in CDCl3 (500 MHz).  
 
Figure 1.A.39. 13C-NMR Spectrum of 10b in CDCl3 (75 MHz). 
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Figure 1.A.40. 1H-NMR Spectrum of 11b in CDCl3 (500 MHz).  
 
Figure 1.A.41. 13C-NMR Spectrum of 11b in CDCl3 (125 MHz). 
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Figure 1.A.42. 1H-NMR Spectrum of 12a in (CD3)2SO (500 MHz). 
 
Figure 1.A.43. 13C-NMR Spectrum of 12a in (CD3)2SO (125 MHz). 
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Figure 1.A.44. 1H-NMR Spectrum of 12b in (CD3)2CO (500 MHz).  
 
Figure 1.A.45. 13C-NMR Spectrum of 12b in (CD3)2CO (125 MHz). 
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Figure 1.A.46. 1H-NMR Spectrum of 13a in CDCl3 (500 MHz). 
 
Figure 1.A.47. 13C-NMR Spectrum of 13a in CDCl3 (125 MHz). 
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Figure 1.A.48. 1H-NMR Spectrum of 13b in CDCl3 (500 MHz).  
 
Figure 1.A.49. 13C-NMR Spectrum of 13b in CDCl3 (75 MHz). 
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Figure 1.A.50. 1H-NMR Spectrum of 14a in CDCl3 (500 MHz). 
 
Figure 1.A.51. 13C-NMR Spectrum of 14a in CDCl3 (125 MHz). 
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Figure 1.A.52. 1H-NMR Spectrum of 16 in CDCl3 (500 MHz).  
 
Figure 1.A.53. 13C-NMR Spectrum of 16 in CDCl3 (125 MHz). 
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Figure 1.A.54. 1H-NMR Spectrum of 17 in CDCl3 (300 MHz).  
 
Figure 1.A.55. 13C-NMR Spectrum of 17 in CDCl3 (75 MHz). 
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Figure 1.A.56. 1H-NMR Spectrum of 18 in CDCl3 (500 MHz). 
 
Figure 1.A.57. 13C-NMR Spectrum of 18 in CDCl3 (125 MHz). 
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Figure 1.A.58. 1H-NMR Spectrum of 19 in CDCl3 (500 MHz).  
 
Figure 1.A.59. 13C-NMR Spectrum of 19 in CDCl3 (125 MHz). 
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Figure 1.A.60. 1H-NMR Spectrum of 20 in CDCl3 (500 MHz). 
 
Figure 1.A.61. 13C-NMR Spectrum of 20 in CDCl3 (125 MHz). 
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Figure 1.A.62. 1H-NMR Spectrum of 21 in CDCl3 (500 MHz).  
 
Figure 1.A.63. 13C-NMR Spectrum of 21 in CDCl3 (125 MHz). 
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Figure 1.A.64. 1H-NMR Spectrum of 22 in CDCl3 (500 MHz).  
 
Figure 1.A.65. 13C-NMR Spectrum of 22 in CDCl3 (125 MHz). 
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Figure 1.A.66. 1H-NMR Spectrum of 23 in CDCl3 (500 MHz).  
 
Figure 1.A.67. 13C-NMR Spectrum of 23 in CDCl3 (125 MHz). 
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Figure 1.A.68. 1H-NMR Spectrum of 24 in CDCl3 (300 MHz).  
 
Figure 1.A.69. 13C-NMR Spectrum of 24 in CDCl3 (125 MHz). 
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Figure 1.A.70. 1H-NMR Spectrum of 25 in CDCl3 (300 MHz).  
 
Figure 1.A.71. 13C-NMR Spectrum of 25 in CDCl3 (125 MHz). 
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Figure 1.A.72. 1H-NMR Spectrum of 26 in (CD3)2SO (500 MHz).  
 
Figure 1.A.73. 13C-NMR Spectrum of 26 in (CD3)2SO (125 MHz). 
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Figure 1.A.74. 1H-NMR Spectrum of 27 in CDCl3 (500 MHz).  
 
Figure 1.A.75. 13C-NMR Spectrum of 27 in CDCl3 (125 MHz). 
 
N
N
Ph
Cl
27
 142 
Figure 1.A.76. 1H-NMR Spectrum of 28 in CDCl3 (500 MHz).  
 
Figure 1.A.77. 13C-NMR Spectrum of 28 in CDCl3 (125 MHz). 
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Figure 1.A.78. 1H-NMR Spectrum of 29 in (CD3)2SO (500 MHz).  
 
Figure 1.A.79. 13C-NMR Spectrum of 29 in (CD3)2SO (125 MHz). 
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Figure 1.A.80. 1H-NMR Spectrum of 30 in CDCl3 (500 MHz). 
 
Figure 1.A.81. 13C-NMR Spectrum of 30 in CDCl3 (125 MHz). 
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Figure 1.A.82. 1H-NMR Spectrum of 31a in CDCl3 (500 MHz).  
 
Figure 1.A.83. 13C-NMR Spectrum of 31a in CDCl3 (125 MHz). 
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Figure 1.A.84. 1H-NMR Spectrum of 31b (1:1 mixture of Ci and C2 isomers) in CDCl3 
(500 MHz). 
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Figure 1.A.85. 13C-NMR Spectrum of 31b (1:1 mixture of Ci and C2 isomers) in CDCl3 
(125 MHz). 
 
Figure 1.A.86. 1H-NMR Spectrum of 31b (1st isomer) in CDCl3 (500 MHz). 
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Figure 1.A.87. 13C-NMR Spectrum of 31b (1st isomer) in CDCl3 (75 MHz). 
 
Figure 1.A.88. 1H-NMR Spectrum of 31b (2nd isomer) in CDCl3 (500 MHz). 
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Figure 1.A.89. 13C-NMR Spectrum of 31b (2nd isomer) in CDCl3 (75 MHz). 
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Figure 1.A.90. 1H-NMR Spectrum of 31c in CS2-(CD3)2SO (500 MHz). 
 
Figure 1.A.91. 13C-NMR Spectrum of 31c in CS2-(CD3)2SO (125 MHz). 
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Figure 1.A.92. 1H-NMR Spectrum of 32a in (CD3)2SO (500 MHz).  
 
Figure 1.A.93. 13C-NMR Spectrum of 32a in (CD3)2SO (125 MHz). 
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Figure 1.A.94. 1H-NMR Spectrum of 32b (1:1 mixture of Ci and C2 isomers) in 
(CD3)2SO (500 MHz). 
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Figure 1.A.95. 13C-NMR Spectrum of 32b (1:1 mixture of Ci and C2 isomers) in 
(CD3)2SO (125 MHz). 
 
Figure 1.A.96. 1H-NMR Spectrum of 32b (1st isomer) in (CD3)2SO (500 MHz). 
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Figure 1.A.97. 13C-NMR Spectrum of 32b (1st isomer) in (CD3)2SO (125 MHz). 
 
Figure 1.A.98. 1H-NMR Spectrum of 32b (2nd isomer) in (CD3)2SO (500 MHz). 
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Figure 1.A.99. 13C-NMR Spectrum of 32b (2nd isomer) in (CD3)2SO (75 MHz). 
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Figure 1.A.100. 1H-NMR Spectrum of 32c in CS2-(CD3)2SO (500 MHz). 
 
 
Figure 1.A.101. 13C-NMR Spectrum of 32c in CS2-(CD3)2SO (125 MHz). 
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Figure 1.A.102. 1H-NMR Spectrum of 33a in CDCl3 (500 MHz).  
 
Figure 1.A.103. 13C-NMR Spectrum of 33a in CDCl3 (75 MHz). 
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Figure 1.A.104. 1H-NMR Spectrum of 33b (1:1 mixture of Ci and C2 isomers) in CDCl3 
(500 MHz). 
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Figure 1.A.105. 13C-NMR Spectrum of 33b (1:1 mixture of Ci and C2 isomers) in 
CDCl3 (125 MHz). 
 
Figure 1.A.106. 1H-NMR Spectrum of 33b (1st isomer) in CDCl3 (500 MHz). 
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Figure 1.A.107. 13C-NMR Spectrum of 33b (1st isomer) in CDCl3 (125 MHz). 
 
Figure 1.A.108. 1H-NMR Spectrum of 33b (2nd isomer) in CDCl3 (500 MHz). 
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Figure 1.A.109. 13C-NMR Spectrum of 33b (2nd isomer) in CDCl3 (125 MHz). 
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Figure 1.A.110. 1H-NMR Spectrum of the (R)-1-phenylethylamine derivative of 33b 
(isomer 1-1) in CDCl3 (500 MHz). 
 
Figure 1.A.111. 13C-NMR Spectrum of the (R)-1-phenylethylamine derivative of 33b 
(isomer 1-1) in CDCl3 (125 MHz). 
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Figure 1.A.112. 1H-NMR Spectrum of the (R)-1-phenylethylamine derivative of 33b 
(isomer 1-2) in CDCl3 (500 MHz). 
 
Figure 1.A.113. 13C-NMR Spectrum of the (R)-1-phenylethylamine derivative of 33b 
(isomer 1-2) in CDCl3 (125 MHz). 
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Figure 1.A.114. 1H-NMR Spectrum of the (R)-1-phenylethylamine derivative of 33b 
(isomer(s) 2-1) in CDCl3 (500 MHz). 
 
Figure 1.A.115. 13C-NMR Spectrum of the (R)-1-phenylethylamine derivative of 33b 
(isomer(s) 2-1) in CDCl3 (125 MHz). 
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Figure 1.A.116. 1H-NMR Spectrum of 33c in CS2-(CD3)2SO (500 MHz). 
 
Figure 1.A.117. 13C-NMR Spectrum of 33c in CS2-(CD3)2SO  (125 MHz). 
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Figure 1.A.118. 1H-NMR Spectrum of 33d in CDCl3 (500 MHz). 
 
Figure 1.A.119. 13C-NMR Spectrum of 33d in CDCl3  (75 MHz). 
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Figure 1.A.120. 1H-NMR Spectrum of 34 in CDCl3 (500 MHz).  
 
Figure 1.A.121. 13C-NMR Spectrum of 34 in CDCl3  (75 MHz). 
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Figure 1.A.122. 1H-NMR Spectrum of 35 in CDCl3 (500 MHz). 
 
Figure 1.A.123. 13C-NMR Spectrum of 35 in CDCl3  (125 MHz). 
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Figure 1.A.124. 1H-NMR Spectrum of 36 in CDCl3 (500 MHz). 
 
Figure 1.A.125. 13C-NMR Spectrum of 36 in CDCl3  (125 MHz). 
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Figure 1.A.126. 1H-NMR Spectrum of 37 in CDCl3 (500 MHz).  
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Figure 1.A.127. 13C-NMR Spectrum of 37 in CDCl3  (125 MHz). 
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Figure 1.A.128. 1H-NMR Spectrum of 38 in CDCl3 (500 MHz). 
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Figure 1.A.129. 13C-NMR Spectrum of 38 in CDCl3  (125 MHz). 
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Figure 1.A.130. 1H-NMR Spectrum of 9,10-dihydro-1,4-dimethoxy-9,10-
[1',2']benzeno-2,3-diazaanthracene in CDCl3 (300 MHz).  
 
Figure 1.A.131. 13C-NMR Spectrum of 9,10-dihydro-1,4-dimethoxy-9,10-
[1',2']benzeno-2,3-diazaanthracene in CDCl3 (75 MHz). 
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Figure 1.A.132. 1H-NMR Spectrum of 40 in CDCl3 (500 MHz). 
 
Figure 1.A.133. 13C-NMR Spectrum of 40 in CDCl3 (125 MHz). 
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Figure 1.A.134. 1H-NMR Spectrum of 41 in CDCl3 (500 MHz). 
 
Figure 1.A.135. 13C-NMR Spectrum of 41 in CDCl2CDCl2 (125 MHz). 
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Figure 1.A.136. 1H-NMR Spectrum of 42 in CDCl3 (500 MHz).  
 
Figure 1.A.137. 13C-NMR Spectrum of 42 in CDCl3 (125 MHz). 
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Figure 1.A.138. 1H-NMR Spectrum of 43 in CDCl3 (500 MHz).  
 
Figure 1.A.139. 13C-NMR Spectrum of 43 in CDCl3 (75 MHz). 
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Figure 1.A.140. 1H-NMR Spectrum of 44 in CDCl3 (500 MHz). 
 
Figure 1.A.141. 13C-NMR Spectrum of 44 in CDCl3 (125 MHz). 
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Figure 1.A.142. 1H-NMR Spectrum of 45 in CDCl3 (500 MHz). 
 
Figure 1.A.143. 13C-NMR Spectrum of 45 in CDCl3 (125 MHz). 
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Figure 1.A.144. FT-IR spectrum of 5a (KBr). 
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Figure 1.A.145. FT-IR spectrum of 6a (KBr). 
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Figure 1.A.146. FT-IR spectrum of 18 (KBr). 
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Figure 1.A.147. FT-IR spectrum of 20 (KBr). 
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Figure 1.A.148. FT-IR spectrum of 21 (KBr). 
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Figure 1.A.149. FT-IR spectrum of 22 (KBr). 
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Figure 1.A.150. FT-IR spectrum of 31a (KBr). 
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Figure 1.A.151. FT-IR spectrum of 33a (KBr). 
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Figure 1.A.152. FT-IR spectrum of 33d (KBr). 
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Figure 1.A.153. FT-IR spectrum of 37 (KBr). 
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Figure 1.A.154. FT-IR spectrum of 38 (KBr). 
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Figure 1.A.155. Computation results for molecule A. 
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Minimization. B3LYP 6-31G+(d,p) 
Minimized energy E(RB+HF-LYP). -756.50414692 hartrees 
Dihedral angle at energy minimum (N-C-C-N): 180.0˚  
Rotamer energy profile: B3LYP 6-31G+(d,p) 
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Figure 1.A.156. Computation results for molecule B. 
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Minimization: B3LYP 6-31G+(d,p) 
Minimized energy E(RB+HF-LYP): -784.09009372 hartrees 
Dihedral angle at energy minimum (C-C-C-S): 29.9˚  
Rotamer energy profile: B3LYP 6-31G+(d,p) 
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Figure 1.A.157. Computation results for molecule C. 
  
 
Minimization: B3LYP 6-31G+(d,p) 
Minimized energy E(RB+HF-LYP): -463.3390668 hartrees 
Dihedral angle at energy minimum (C-C-C-C): 40.4˚  
Rotamer energy profile: B3LYP 6-31G+(d,p) 
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Figure 1.A.158. Computation results for molecule 33a. 
N
N
Cl
N
N
Cl
  
 
Minimization: B3LYP 6-31G(d,p) 
Minimized energy E(RB+HF-LYP): -2523.25899986 hartrees 
Dihedral angle at energy minimum (N-C-C-N): 144.5˚  
Rotamer energy profile: B3LYP 6-31G+(d,p) 
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Figure 1.A.159. Computation results for molecule 31a. 
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Minimization: B3LYP 6-31G(d,p) 
Minimized energy E(RB+HF-LYP): -1833.14403574 hartrees 
Dihedral angle at energy minimum (N-C-C-N): 145.2˚  
Rotamer energy profile: B3LYP 6-31G+(d,p) 
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Figure 1.A.160. Computation results for molecule D. 
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Minimization: B3LYP 6-31G+(d,p) 
Minimized energy E(RB+HF-LYP): -1469.01795865 hartrees 
Dihedral angle at energy minimum (N-C-C-S): 31.6˚  
Rotamer energy profile: B3LYP 6-31G+(d,p) 
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Figure 1.A.161. Computation results for molecule E. 
F
F   
 
Minimization: B3LYP 6-31G+(d,p) 
Minimized energy E(RB+HF-LYP): -661.81662306 hartrees 
Dihedral angle at energy minimum (C-C-C-C(F)): 45.2˚  
Rotamer energy profile: B3LYP 6-31G+(d,p) 
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Figure 1.A.162. Computation results for molecule F. 
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Minimization: B3LYP 6-31G+(d,p) 
Minimized energy E(RB+HF-LYP): -835.14172881 hartrees 
Dihedral angle at energy minimum (N-C-C-N): 132.4˚  
Rotamer energy profile: B3LYP 6-31G+(d,p) 
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Figure 1.A.163. Computation results for molecule G. 
S
H3C
  
 
Minimization: B3LYP 6-31G+(d,p) 
Minimized energy E(RB+HF-LYP): -823.40669466 hartrees 
Dihedral angle at energy minimum (C(Me)-C-C-S): 60.4˚  
Rotamer energy profile: B3LYP 6-31G+(d,p) 
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Figure 1.A.164. Computation results for molecule H. 
N
N
N
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Minimization: B3LYP 6-31G+(d,p) 
Minimized energy E(RB+HF-LYP): -1063.80462386 hartrees 
Dihedral angle at energy minimum (N-C-C-N): 132.2˚  
Rotamer energy profile: B3LYP 6-31G+(d,p) 
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Figure 1.A.165. Computation results for molecule 35. 
N
N
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N
N
OMe
  
 
Minimization: B3LYP 6-31G(d,p) 
Minimized energy E(RB+HF-LYP): -2140.44565883 hartrees 
Dihedral angle at energy minimum (N-C-C-N): 137.1˚  
Rotamer energy profile: B3LYP 6-31G+(d,p) 
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Figure 1.A.166. Computation results for molecule 22. 
N
N
OCH3
  
 
Minimization: B3LYP 6-31G+(d,p) 
Minimized energy E(RB+HF-LYP): -1148.26184137 hartrees 
Dihedral angle at energy minimum (N-C-C-C): 45.7˚  
Rotamer energy profile: B3LYP 6-31G+(d,p) 
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Figure 1.A.167. Computation results for molecule 23. 
N
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F
  
 
Minimization: B3LYP 6-31G+(d,p) 
Minimized energy E(RB+HF-LYP): -1346.7458849 hartrees 
Dihedral angle at energy minimum (N-C-C-C(F)): 129.8˚  
Rotamer energy profile: B3LYP 6-31G+(d,p) 
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Figure 1.A.168. Computation results for molecule I. 
F
F
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Minimization: B3LYP 6-31G+(d,p) 
Minimized energy E(RB+HF-LYP): -701.13532162 hartrees 
Dihedral angle at energy minimum (C(Me)-C-C-C(F)): 65.2˚  
Rotamer energy profile: B3LYP 6-31G+(d,p) 
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Figure 1.A.169. Computation results for molecule J. 
CH3
H3C
  
 
Minimization: B3LYP 6-31G+(d,p) 
Minimized energy E(RB+HF-LYP): -541.97486198 hartrees 
Dihedral angle at energy minimum (C(Me)-C-C-C(Me)): 89.0˚  
Rotamer energy profile: B3LYP 6-31G+(d,p) 
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Figure 1.A.170. Computation results for molecule K. 
  
 
Minimization: B3LYP 6-31G+(d,p) 
Minimized energy E(RB+HF-LYP): -1540.03648983 hartrees 
Dihedral angle at energy minimum (C(H)-C-C-C(H)): 107.7˚  
Rotamer energy profile: B3LYP 6-31G+(d,p) 
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Figure 1.A.171. Computation results for molecule L. 
  
 
Minimization: B3LYP 6-31G+(d,p) 
Minimized energy E(RB+HF-LYP): -770.6354514 hartrees 
Dihedral angle at energy minimum (C(H)-C-C-C(H)): 74.8˚  
Rotamer energy profile: B3LYP 6-31G+(d,p) 
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Figure 1.A.172. Computation results for molecule M. 
  
 
Minimization: B3LYP 6-31G(d,p) 
Minimized energy E(RB+HF-LYP): -1847.28480516 hartrees 
Dihedral angle at energy minimum (C(H)-C-C-C(H)): 66.9˚  
Rotamer energy profile: B3LYP 6-31G+(d,p) 
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Table 1.A.1. Crystallographic Data. 
 19 21 23 31a 
Empirical formula C26H16N2S2 C30H20N2O4S2 C25H16F2N2O C46H42N4O4 
cryst growth vapor diffusion of n-
pentane into a DCM 
solution of 19 
vapor diffusion of n-
pentane into a MeCN 
solution of 21 
vapor diffusion of 
n-pentane into a 
THF solution of 23 
vapor diffusion of 
n-pentane into a 
THF solution of 
31a 
fw 420.559 536.632 398.412 714.864 
space group P2(1)/c Pccn P2(1)/c C2/c 
a (Å) 9.9888 21.0801 14.5625 26.0086 
b (Å) 15.1872 13.9059 10.0487 8.1958 
c (Å) 27.0849 16.2990 14.4914 19.5052 
α (deg) 90.000 90.000 90.000 90.000 
β (deg) 100.294 90.000 114.652 119.245 
γ (deg) 90.000 90.000 90.000 90.000 
V (Å3) 4042.69 4777.85 1927.31 3627.80 
Z 8 8 4 4 
dcalc (g cm-3) 1.382 1.492 1.373 1.309 
µ (mm-1) 0.279 0.266 0.098 0.084 
θmax (deg) 29.57 29.57 29.57 29.57 
Reflections collected 78075 89876 41876 34966 
unique data 11322  
[R(int) = 0.0354] 
6722 
 [R(int) = 0.0391] 
5403  
[R(int) = 0.0286] 
5093  
[R(int) = 0.0241] 
Completeness (%) 99.9 100 100 100 
GOF 1.030 1.038 1.028 1.039 
R1 [I > 2σ(I)],  
wR2 (all data) 
0.0446, 0.1194 0.0382, 0.1051 0.0421, 0.1207 0.0450, 0.1286 
∆ρmax,min (e•A-3) 0.601 and -0.422 0.561 and -0.280 0.468 and -0.258 0.586 and -0.353 
 
 33a 35 37 
Empirical formula C48H30Cl4N4 C51.41H41.17N4O2 C90H80N8O2 
cryst growth vapor diffusion of n-
pentane into a PhCl 
solution of 33a 
vapor diffusion of 
n-pentane into a 
PhMe solution of 
35 
vapor diffusion of 
n-pentane into a 
PhMe solution of 
37 
fw 804.604 747.008 1305.678 
space group C2/c I-4 P-1 
a (Å) 11.7138 19.1978 13.0807 
b (Å) 15.9349 19.1978 17.8589 
c (Å) 21.1920 22.0008 18.2895 
α (deg) 90.000 90.000 114.970 
β (deg) 101.380 90.000 93.023 
γ (deg) 90.000 90.000 109.798 
V (Å3) 3877.89 8108.52 3547.02 
Z 4 8 2 
dcalc (g cm-3) 1.378 1.224 1.223 
µ (mm-1) 0.347 0.075 0.047 
θmax (deg) 29.57 29.57 25.04 
Reflections collected 42741 95861 58596 
unique data 5442  
[R(int) = 0.0347] 
5843  
[R(int) = 0.0659] 
12544  
[R(int) = 0.0389] 
Completeness (%) 100 100 100 
GOF 1.047 1.023 1.027 
R1 [I > 2σ(I)],  
wR2 (all data) 
0.037, 0.101 0.047, 0.125 0.0624, 0.1352 
∆ρmax,min (e•A-3) 0.528 and -0.246 0.309 and -0.248 0.465 and -0.379 
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Figure 1.A.173. Thermal ellipsoid representation of 19. 
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Figure 1.A.174. Thermal ellipsoid representation of 21. 
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Figure 1.A.175. Thermal ellipsoid representation of 23. 
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Figure 1.A.176. Thermal ellipsoid representation of 31a. 
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Figure 1.A.177. Thermal ellipsoid representation of 33a. 
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Figure 1.A.178. Thermal ellipsoid representation of 35. 
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Figure 1.A.179. Thermal ellipsoid representation of 37. 
 
 
 
 
 
 
 
 
Chapter 2 
Three Syntheses of Iptycene-Derived 
Poly(pyridazinyl ether)s 
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2.1 Introduction 
 
 In Chapter 1, we have introduced molecular building blocks that incorporate 
iptycene-derived pyridazines. In this chapter, we describe the incorporation of these 
building blocks as monomers in poly(aryl ether)s. Earlier, a survey of the reactivity of the 
dihalo(bi)pyridazines (e.g. 5, 9), described in Chapter 1, led to the conclusion that 
palladium- or nickel-catalyzed reductive coupling polymerizations of these monomers do 
not produce high molecular weight conjugated polymers (Scheme 2.1, top). 
Dehalogenated, low molecular weight materials were found to be the dominant products. 
Together with an insufficient degree of conversion, competing protodehalogenation 
(reduction) and a chain-termination pathway that involves the reductive ring opening of 
the heterocycles were proposed as justification for the poor performance of these 
polymerizations.  
 
Scheme 2.1. Polymers that incorporate iptycene-derived pyridazines. 
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Halopyridazines are very electron-poor heterocycles and are consequently highly 
activated toward nucleophilic aromatic substitution. In Chapter 2, this reaction is 
exploited for the preparation of poly(pyridazinyl ether)s by the step-growth 
polycondensation of iptycene-derived pyridazines with diols (AA + BB). A preparation of 
poly(pyridazinyl ether)s by two other synthetic routes, a AB nucleophilic aromatic 
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substitution polymerization and a ABA reductive homocoupling polymerization, is also 
described.   
 
2.1.1 Characteristics of Step-Growth Polymerizations (Polycondensations) 
 
 The efficiency of a step-growth polymerization (polycondensation), that is, the 
ability to prepare high molecular weight materials, depends primarily on two factors, the 
degree of conversion (p) and the stoichiometric ratio (r) of reacting functional groups. 
For a AA + BB polycondensation, the degree of conversion is the ratio of the number of 
functional groups that have reacted with each other (e.g. A-B bond formation) to their 
initial numbers, and the stoichiometric ratio is the ratio of the number of functional 
groups A to that of functional groups B. The degree of conversion may be correlated to 
the yield per step of a conventional reaction. Under idealized conditions, the average 
degree of polymerization (xn) can be calculated from Carothers' equation:1 
! 
xn =
1+ r
1+ r " 2rp
 (eq. 1) 
 Carothers' equation highlights the stringent requirements for an efficient step-
growth polymerization. High molecular weight polymers require quantitative conversions 
(e.g. p >> 0.98), and a perfect stoichiometric balance (e.g. r = 1) between the monomers. 
In turn, stoichiometric balance requires absolutely pure monomers, as monofunctional 
compounds (e.g. RA instead of AA) terminate chain growth, and the presence of inert 
impurities biases the measurement (e.g. weighing) of the monomers. Simple numerical 
modeling illustrates the dependence of polymerizations on these two parameters (Figure 
2.1).  
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Figure 2.1. Influence of p and r on the degree of polymerization. 
 
 Despite these stringent requirements, the step-growth, nucleophilic aromatic 
substitution polymerization of bisphenols and activated (hetero)aryl dihalides is one of  
the most popular methods for the preparation of a number of engineering thermoplastics 
of the poly(aryl ether) family, such as poly(ether ether ketone) (PEEK) and 
polysulphone.2  Diazines have been incorporated in a number of poly(aryl ether)s.3 
However, due to the fact that the second nucleophilic aromatic substitution is much 
slower than the first,4 3,6-dihalo-1,2-diazines are seldom employed as biselectrophiles.3e 
Instead, the preferred approach is to prepare a biselectrophilic (or bisnucleophilic) 
macromonomer that incorporate the desired heterocycle (Scheme 2.2), thereby resulting 
in polymers that have a lower heterocyclic content. 
 
Scheme 2.2. Biselectrophilic macromonomers that incorporate 1,2-diazines.3 
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2.1.2 Low-κ Dielectric Materials and Internal Free Volume 
 
The polymerization of iptycene-derived 1,2-diazines is part of an ongoing research effort 
in the Swager laboratory directed at the development of new materials that exhibit low 
relative dielectric constants (κ = ε/ε0).5 Solids that possess a low dielectric constant 
(κ < 4, deemed "low-κ" or "low-k" materials) are of crucial importance in the 
microelectronics industry. These materials act as insulators of electromagnetic flux and 
capacitance between closely spaced circuit lines. As two electrical conductors are placed 
closer to each other, the EM interference that is generated from current passing in a first 
conductor can disrupt the signal carried through the second. For macroscopic electrical 
circuit, these interferences, or crosstalk, are generally minor. However, as the density of 
circuit elements is increased, following "Moore's Law", crosstalk becomes more 
important. The interconnect delay (RC) induced by crosstalk can be calculated as: 
! 
RC = 2"##
0
4L
2
P
2
+
L
2
T
2
$ 
% 
& 
' 
( 
)  (eq. 2) 
where R is the resistance, C the capacitance, ρ the resistance of the conductor, ε the 
dielectric constant of the insulating material, ε0 the dielectric constant of vacuum, and the 
parameters L (length), T (thickness), P (distance between circuit lines) refer to the 
geometry of a given circuit. 6  Thus, to reduce interconnect delay, better electrical 
conductors and better dielectric insulators are needed. The transition from aluminum 
(2.65 µΩ cm) to the better conductor copper (1.67 µΩ cm) has largely been adopted by 
the microelectronics industry to address the first need. Among the pure metals, only silver 
(1.59 µΩ cm) has a better conductivity, but its widespread use is economically 
prohibitive. 7  Consequently, to meet the demand for high-speed processing, low-κ 
materials are increasingly sought after.  
 
Silicon dioxide (κ ~ 4) coated by vapor deposition techniques has long been the 
material of choice for low-κ applications, and has more recently been supplanted by 
fluorine- or carbon-doped silicon dioxide formulations (κ ~ 2.7-3.2). The dielectric 
constant of a material is related to its electronic polarizability. Lighter, more 
electronegative atoms and stronger bonds (e.g. C-F) contribute to lower the dielectric 
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constant. 8  In this regard, organic polymers in general and fluorinated polymers in 
particular present dielectric constants  (κ ~ 2-3) that are attractive for these applications. 
Another approach for lowering the effective dielectric constant of materials is the 
introduction of porosity. In effect, the dielectric constant of porous material containing 
air-filled voids is a weighed composite of that of air (κ ~ 1) and that of the bulk material. 
However, the introduction of pores, especially at high volume fractions, has important 
drawbacks. Variations in spatial and pore-size distributions throughout the material affect 
the dielectric properties, and must be tightly controlled. At the high pore concentrations 
required for ultra-low-κ applications, contiguous networks of voids can form and let 
materials diffuse from one layer to another, which is obviously detrimental to insulation 
purposes. Finally and most importantly, the mechanical properties (strength and modulus, 
resistance to abrasion and etching, adhesion, thermal expansion coefficient and stability) 
of porous coatings are often quite poorer than which of the bulk. 
 
Previous work from the Swager laboratory has demonstrated that polymers 
containing rigid scaffolds (e.g. iptycenes) that introduce internal free volume are in effect 
nanoporous and have lower dielectric constants than ordinary organic polymers (Scheme 
2.3).5 Due to this unique design, nanoporous polymers do not suffer from many of the 
drawbacks associated with microporous structures. Part of the work presented in this 
chapter was motivated by the desire to verify if the iptycene-derived pyridazine 
monomers could also lower the dielectric constant of polymers that incorporate them. 
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Scheme 2.3. Iptycene-containing polymers previously shown to have comparatively low 
dielectric constants (κ).5 
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2.2 Synthesis and Characterization of Iptycene-Derived Poly(pyridazinyl ether)s 
 
2.2.1 Poly(aryl pyridazinyl ether)s by Nucleophilic Aromatic Substitution Polymerization 
 
 We first investigated the nucleophilic aromatic substitution polymerization of 
bisphenols and dichloropyridazine 5 in the presence of a base in polar aprotic solvents. 
The preparation of the heterocyclic monomers has been described in details in Chapter 1,9 
and is summarized in Scheme 2.4. Dichloropyridzine 5 is obtained in 65% yield over 5 
steps from anthracene and dimethyl acetylenedicarboxylate. It is worth noting that 
chromatographic purification is not required for this sequence, allowing for the rapid 
preparation of large quantities (>10g) of the monomer. Final recrystallization from di-n-
butyl ether affords a monomer of polymerization-grade purity. Commercially available 
bisphenols AF and M, triptycene hydroquinone (1,4-dihydroxytriptycene) 10  and 
pentiptycene hydroquinone (pentiptycene-6,13-diol)11 were selected as diol comonomers 
in the polymerizations. A screening of reaction conditions identified the use of potassium 
carbonate in N,N-dimethylacetamide at elevated temperatures (160˚C) for 2-3 days to be 
optimal for the polycondensations. Results are summarized in Table 2.1 and Scheme 2.5. 
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Scheme 2.4. Synthesis of iptycene-derived pyridazine monomers. 
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(a) DMAD, 180˚C, 1h, 80%; (b) i. NaOH, MeOH-H2O, 100˚C, 1h; ii. HCl, H2O, 99%; (c) 
(COCl)2, cat. DMF, CH2Cl2, 0˚C to 23˚C, 16h, 96%; (d) NH2NH2·HCl, AcOH, 115˚C, 
16h, 99%; (e) POCl3, 125˚C, 16h, 86%; (f) NaOMe, THF, 23˚C, 22h, 99%; (g) Zn, 5%. 
Pd(PPh3)3Cl3, 10% PPh3, DMF, 100˚C, 20h, 95%; (h) i. HBr, AcOH, 90˚C, 16h, 91%; (j) 
POCl3, 90˚C, 16h, 66% 
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Scheme 2.5. Iptycene-derived poly(pyridazine ether)s by nucleophilic aromatic 
substitution polymerization. 
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Table 2.1. Summary of polymer characterization. 
HerX2 Ar(OH)2 Polymer 
Yield 
(%) 
Mnb  
(103 g mol-1) 
Mwb  
(103 g mol-1) 
PDIb DPnb η2 c 
5 Bis. AF P1 25 5.2 6.3 1.2 9 3.11 
5 Bis. M P2 30 29.0 39.4 1.4 48 2.58 
5 Trip. HQ P3 35 5.7 11.0 1.9 11 d 
5 Pent. HQ a 0 - - - - - 
9 Bis. AF P4 27 4.4 6.5 1.5 5 2.58 
9 Bis. M P5 19 8.6 11.1 1.3 10 d 
9 Trip. HQ a 0 - - - - - 
9 Pent. HQ P6 7 6.5 8.3 1.3 7 3.32 
a No polymers were isolated. b Determined by GPC against PS standards (fraction soluble in THF). c 
η2(633nm) ~ κ, determined by VASE. d Polymer film quality was too poor for VASE. 
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Our results indicate that the nucleophilic aromatic substitution polymerization of 
dichloropyridazine 5 with bisphenols is rather inefficient. Nonetheless, polymers P1 to 
P3 could be obtained in low yields. For most combinations of monomers only modest 
molecular weights were obtained. It has been suggested that the slow rate of the second 
nucleophilic aromatic substitution limits the polymerizations of 3,6-dichloropyridazines.3d 
The high selectivity for monosubstitution observed in small-molecule reactions supports 
this conclusion.8 To address this issue, we have used the iptycene-derived 6,6'-dichloro-
3,3'-bipyridazine (9), which is a far more reactive monomer due to the influence of the 
second electron-withdrawing heterocycle. Monosubstitution of 9 with a first alkoxy group 
does not significantly deactivate this monomer towards the second substitution, as 
evidenced by the low selectivity observed in small-molecule reactions.9 As a result of its 
greater reactivity, polymerizations using monomer 9 require much lower temperatures 
(90-100˚C) than those using monomer 5. Despite showing increased reactivity, the 
degrees of polymerization obtained for polymers P4-P6 that incorporate monomer 9 were 
comparable to that obtained for polymers P1-P3 with 5 as comonomer. Our observations 
suggest that the solubility of the growing polymer chains is the critical factor for 
obtaining high molecular weight polymers under these conditions. For both monomers, 
copolymerization with bisphenol M resulted in the highest degrees of polymerization, 
with a value approaching 50 for P2. Unlike other polymers in the series that are isloated 
as hard white powders, P2 is a glassy translucent solid that easily forms high quality thin 
films.  Both polymers P2 and P5 that incorporate the flexible comonomer bisphenol M 
are also quite soluble in a number of common organic solvents (CH2Cl2, CHCl3, THF), 
unlike the other polymers that are readily dispersed as colloidal suspensions but have 
limited solubilities in these solvents. Clearly, scaffolds that limit strong intermolecular 
interactions and π-π stacking in the solid state and (e. g. iptycenes) are insufficient to 
confer high solubilities, and flexible, soft comonomers are required.  
 
The square of the refractive index of a material is a good approximation of its 
dielectric constant at high (e.g. light) frequencies. The refractive indices of thin films of 
polymers spin-coated on silicon wafers were determined by variable angle spectroscopic 
ellipsometry (VASE). For the polymers that provided films of sufficient quality for 
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VASE measurements (P1, P2, P4, P6), values of η2 at 633 nm ranged from 2.58 to 3.32. 
These values are too high to make these polymers suitable candidates for low-κ materials. 
In addition, the polymers were found to be thermally unstable above 335˚C (DSC), 
rendering them inadequate for microelectronics device integration. However, these 
dielectric constants are comparable to that of most non-fluorinated poly(aryl ether)s (κ ~ 
2.8-3.0),6, 8 and are unusually low for organic polymers bearing with polar functional 
groups. Furthermore, the incorporation of pyridazine rings is usually found to increase 
the dielectric constants of polymers by comparison to their non-heretocyclic analogues. 
Higher dielectric constants have been reported for poly(imide pyridazine amide)s 
compared to poly(imide amide)s, for poly(ether imide pyridazine)s compared to 
poly(ether imide)s and for poly(ether ketone pyridazines)s compared to poly(ether 
ketone)s, all of which have dielectric constants between 3.2 and 4.0.3c, d We interpret these 
results to signify that despite the presence of the polar and polarizable pyridazine rings, 
the introduction of internal free volume by the iptycene scaffolds results in materials with 
dielectric constants that remain lower or comparable to that of non-fluorinated poly(aryl 
ether)s.  
 
2.2.2 Poly(alkyl pyridazinyl ether)s by Nucleophilic Aromatic Substitution 
Polycondensation 
 
 As part of our efforts to prepare new polymers that incorporate iptycene-derived 
pyridazines, the synthesis of poly(alkyl pyridazinyl ether)s was explored. Polymers of the 
poly(alkyl aryl ether) family are less common than either poly(alkyl ether)s (e.g. 
poly(ethylene oxide), poly(tetrahydrofuran)) or poly(aryl ether)s (e.g. PEEK, 
polysulphone, poly(phenylene oxide)). To the best of our knowledge, only a small 
number of poly(alkyl aryl ether)s have been prepared and studied for their liquid 
crystalline properties.12,13 Due to the lower reactivity and nucleophilicity of aliphatic 
alkoxides compared to that of phenoxides, the polymerization of dichloropyridazine 5 
and aliphatic diols (AA+BB) in the presence of a strong base did not yield high molecular 
weight materials. To improve this reaction, we took advantage of the selectivity of 
monomer 5 for single nucleophilic aromatic substitution and prepared the extended AB 
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monomer 11 (Scheme 2.6). The difunctional monomer 11 undergoes 
homopolymerization upon deprotonation with a suitable base to afford polymer P7. The 
degree of polymerization as estimated by gel permeation chromatography (DPn ~ 8) and 
by 1H-NMR end-group analysis (DPn ~ 9-10) remains modest. Unlike poly(aryl 
pyridazinyl) ethers (P1-P6), polymer P7 is highly soluble in most organic solvents, and 
thus solubility is unlikely to be a limiting factor in the homopolymerization of monomer 
11. It is hypothesized that the lower reactivity alkoxy-substituted pyridazines combined 
with the lower nucleophilicity of the alkoxide results in a lower degree of conversion and 
consequently a lower molecular weight. 
 
Scheme 2.6. Preparation of poly(alkyl pyridazinyl ether)s by AB nucleophilic aromatic 
substitution. 
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(a) 1.2 eq. 1,10-decanediol, 1.2 eq. NaH, THF, 70˚C, 16h, 43%; (b) 1.1 eq. NaH, DMF, 
60˚C to 100˚C, 48h, 33% 
 
2.2.3 Poly(alkyl pyridazinyl ether)s and Poly(aryl pyridazinyl ether)s by Palladium-
catalyzed Reductive Homocoupling Polymerization. 
 
 A close inspection of the structure of poly(aryl pyridazinyl ether)s that incorporate 
bipyridazine 9 (e.g. P4-P6) suggest that, in addition to a nucleophilic aromatic 
substitution polymerization (e.g. C-O bond formation), the same polymers could be 
obtained by a reductive homocoupling polymerization (e.g. biaryl C-C bond formation), 
as in the preparation of homodimer 7 from methoxypyridazine 6 (Scheme 2.4). While 
nickel-catalyzed reductive homocoupling polymerizations have successfully been applied 
to the preparation of a large number of polymers, 14  palladium-catalyzed reductive 
homocoupling polymerization have seldom been reported.15 This alternate polymerization 
method would also alleviate the problem of lower reactivity in the preparation poly(alkyl 
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pyridazinyl ether)s. Since near-quantitative yields are obtained for this reaction with 
small molecules, the ABA homocoupling polymerization was investigated.16 Monomers 
were prepared from difunctional nucleophiles (diols, diamine, dithiol) and a small excess 
of dichloropyridazine 5. Reductive palladium-catalyzed homopolymerizations were 
carried under the conditions optimized for the synthesis of 7 (10% Pd(PPh3)4, Zn, DMF, 
100˚C)17 (Scheme 2.7, Table 2.2). 
 
Scheme 2.7. Poly(pyridazinyl ether)s by reductive coupling polymerization. 
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Table 2.2. Summary of polymer characterization. 
Monomer Polymer 
Yield 
(%) 
Mnb  
(103 g mol-1) 
Mwb  
(103 g mol-1) 
PDIb DPnb DPnc 
12a P8a 70 10.6 20.4 1.9 16 20 
12b P8ba a - - - - - 
12c P8c 30 2.3 5.3 2.3 3-4 2 
12d P8d 72 10.0 14.9 1.5 12 16 
12e P8e 60 4.6 7.7 1.7 5 5 
12f P8f 30 2.4 3.7 1.5 3 4 
12g P8gd 45 > 3.5d > 4.1d d d d 
13 e - - - - - - 
a A mixture of monomer, dimer and trimer was obtained b Determined by GPC against PS standards 
(fraction soluble in THF). c Determined by 1H-NMR end-group analysis. d Reaction product was too 
insoluble for reliable analysis. GPC for fraction soluble in THF. e No polymers were obtained. 
 
 The palladium-catalyzed reductive homocoupling polymerization affords 
poly(alkyl pyridazinyl ether) P8a and a number of poly(aryl pyridazinyl ether)s (P8d-
P8g) in moderate to good yields. Those conditions are not compatible, however, with 
amine- or thiol-linked pyridazines, as exemplified by the results obtained with monomers 
12b and 12c. In these systems, more basic monomers may tightly bind the palladium 
catalyst, resulting in deactivation. Alternatively, chloropyridazines bearing these stronger 
electron-donating substituents could suffer from lower rates of oxidative addition to 
palladium(0), thereby limiting the efficiency of the catalytic cycle. For the ether-linked 
monomers (12a, 12d-g), the degree of polymerization is a function of the solubility of the  
polymers. While the soluble polymers P8a and P8d show molecular weights as high as 
104 g/mol, polymers P8f-g that lack flexible segments and/or solubilizing chains 
precipitate as short oligomers from the reaction mixture. In the case of the more soluble 
systems, the degree of polymerization is likely to be limited by the efficiency of the 
reductive coupling reaction. There is a good agreement between the optimized yields of 
the reductive dimerization for 7 (typically 93-95%), and the estimated degree of 
conversion reached in the polymerization (92-95%) as calculated from the DP (12-20 by 
GPC or 1H-NMR) using Carothers' equation. End-group analysis by 1H-NMR is 
facilitated by the large differences in the chemical shifts of the iptycene bridgehead 
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protons upon dimerization (Figure 2.2).9 For P8a, the clear shift of the alkoxy methylene 
group upon dimerization can also serve as a NMR handle for end-group integration. 1H-
NMR analysis indicates that hydrodechlorination (reduction) is the dominant chain-
terminating side-reaction (~ 2% pyridazine-H in P8a and P8d). Consequently, 
improvements in the catalytic system are likely to result in dramatic improvements of the 
molecular weights for highly soluble polymers like P8a.18  
 
 
Figure 2.2. 1H-NMR endgroup analysis of P8a. 
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Interestingly, the reductive coupling polymerization conditions for the iptycene-
derived chloropyridazines are not applicable to the polymerization of the hydrocarbon 
analogue 13, and only unreacted starting material and hydrodebrominated (reduced) by-
products were isolated from the reaction mixture. 
 
Scheme 2.8. Attempted reductive homocoupling polymerization of 13. 
O
O
Br
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No polymers
13
10% Pd(PPh3)4, 
Zn, DMF, 100˚C
 
 
2.3 Conclusions 
 
 New polymers that incorporate iptycene-derived pyridazines have been 
synthesized by three different approaches. Soluble polymers of molecular weights as high 
as 29 000 g·mol-1 have been obtained. Iptycene-derived poly(aryl pyridazinyl ether)s were 
shown to have dielectric constants (κ) much lower (2.6-3.3) than previously reported 
pyridazine polymers lacking iptycene scaffolds, offering further evidence that the 
introduction of internal free volume is an effective strategy for the design of low-κ 
materials. Palladium-catalyzed reductive homocoupling polymerization of ether-linked 
chloropyridazines yields poly(alkyl pyridazinyl ether)s that are not readily accessible by 
other polymerization methods. 
 
2.4 Experimental Section 
 
Materials 
All solvents were of ACS reagent grade or better unless otherwise noted. Anhydrous 
tetrahydrofuran was dried on a solvent column purification system. N,N-
Dimethylformamide and N,N-dimethylacetamide were dried by standing with BaO, 
followed by distillation and storage over activated molecular sieves. Silica gel (40-63 µm) 
was obtained from SiliCycle Inc. Iptycene-derived pyridazines9 (5, 9, both recrystallized 
from n-Bu2O), triptycene hydroquinone10 (recrystallized from AcOH), pentiptycene 
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hydroquinone11 and 1,10-bis(4-bromophenoxy)decane19 (13) were prepared according to 
the reported procedures. All other reagents, compounds and chemicals were obtained 
from commercial suppliers and used without further purification. 
 
General methods, instrumentation and measurements 
Synthetic manipulations that require an inert atmosphere (where noted) were carried out 
under nitrogen or argon using standard Schlenk techniques or in an inert-atmosphere 
glovebox. NMR (1H and 13C) spectra were recorded on 300 and 500 MHz spectrometers. 
The chemical shift data for each signal are given in units of δ (ppm) relative to 
tetramethylsilane (TMS) where δ (TMS) = 0, and referenced to the residual solvent 
resonances. Splitting patterns are denoted as s (singlet), d (doublet), t (triplet), q (quartet), 
m (multiplet), and br (broad).  High-resolution mass spectra (HR-MS) were obtained at 
the MIT Department of Chemistry Instrumentation Facility using electron impact 
ionization (EI) with a voltage of 70 V or electrospray ionization (ESI). Melting point 
(m.p.) determination was performed using open capillaries and measurements are 
reported uncorrected. Polymer molecular weights were determined in THF solutions on 
an Agilent 1100 series HPLC/GPC system with three PLgel columns (103, 104, 105 Å) in 
series against narrow polystyrene standards. Polymer thin films were spun-cast from ~1% 
weight CHCl3 solutions on microscope coverslips or Si wafers using an EC101DT 
photoresist spinner (Headway Research, Inc.) at a 1000 rpm rate for 60 s. Refractive 
indices of polymer films spin-coated on a Si wafer were determined by VASE (Variable 
Angle Spectroscopic Ellipsometry) on J. A. Woollam ellipsometer. Where applicable, 
film thickness was determined by profilometry on a Veeco profilometer. TGA and DSC 
analyses were performed under nitrogen at a 10°C min-1 heating rate using TA 
Instruments-Waters equipment, TGAQ50 TA 5008 and DSCQ10 TA 5008 respectively. 
 
General procedure for the preparation of poly(aryl pyridazinyl ether)s by 
nucleophilic aromatic substitution polymerization. (P1-P6) Dichloro(bi)pyridazine (5 
or 9) (0.3 mmol), diol (0.3 mmol) and potassium carbonate (1.3 mmol) are placed in a 
Schlenk flask equipped with a magnetic stirrer. Contents of the flask are evacuated and 
back-filled with argon 5 times, and dry N,N-dimethylacetamide (DMAc, 2 mL) is added. 
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After 5 vacuum / back-fill cycles, the flask is sealed and contents are stirred at 160˚C 
(100˚C with 9) for three days. The reaction mixture is cooled to room temperature, and 
poured in an excess of MeOH-H2O (1:1 v/v). After isolation by centrifugation, the 
polymers are redissolved in a minimum of chloroform and reprecipitated in acetone (or 
methanol or hexanes for acetone-soluble samples). The polymer is then isolated after 
centrifugation and drying under vacuum. 
 
Polymer P1. Prepared from 1,4-dichloro-9,10-dihydro-9,10-[1',2']benzeno-2,3-
diazaanthracene (5) (97.5 mg, 0.30 mmol), 4,4'-(hexafluoroisopropylidene)diphenol 
(bisphenol AF, 100.8 mg, 0.30 mmol) and potassium carbonate (180 mg, 1.3 mmol) in 
DMAc (4 mL) at 160˚C for 3 days. Polymer P1 is isolated as a white solid (45 mg, 25%). 
GPC (THF vs. PS): Mn = 5200, Mw = 6300; 1H-NMR (300 MHz, (CDCl3): δ = 7.52 (dd, 
4H, J = 5.7, 3.3 Hz); 7.36 (d, 4H, J = 8.7 Hz), 7.12-7.09 (m, 8H), 5.90 (s, 2H).  
 
Polymer P2. Prepared from 1,4-dichloro-9,10-dihydro-9,10-[1',2']benzeno-2,3-
diazaanthracene (5) (97.5 mg, 0.30 mmol), 4,4'-(1,3-
phenylenediisopropylidene)bisphenol (bisphenol M, 103.8 mg, 0.30 mmol) and 
potassium carbonate (180 mg, 1.3 mmol) in DMAc (2 mL) at 160˚C for 3 days. Polymer 
P2 is isolated as a colorless glassy solid (55 mg, 30%). GPC (THF vs. PS): Mn = 29 000, 
Mw = 39 000; 1H-NMR (300 MHz, (CDCl3): δ = 7.45 (dd, 4H, J = 5.1, 3.3 Hz); 7.26 (br 
s, 1H), 7.17 (d, 4H, J = 8.7 Hz), 7.13 (d, 2H, J = 6.3 Hz), 7.07-7.01 (m, 8H), 6.98 (br s, 
1H), 5.87 (s, 2H), 1.62 (s, 12H). 
 
Polymer P3. Prepared from 1,4-dichloro-9,10-dihydro-9,10-[1',2']benzeno-2,3-
diazaanthracene (5) (65 mg, 0.20 mmol), triptycene hydroquinone (57 mg, 0.20 mmol) 
and potassium carbonate (120 mg, 0.9 mmol) in DMAc (2 mL) at 160˚C for 3 days. 
Polymer P3 is isolated as a white solid (38 mg, 35%). GPC (THF vs. PS): Mn = 5700, 
Mw = 11 000; 1H-NMR (500 MHz, (CDCl3): δ = 7.46 (br s, 4H), 7.14 (br s, 4H), 7.03 (br 
s, 4H), 6.85 (br s, 4H), 6.59 (s, 2H), 5.84 (s, 2H), 5.67 (s, 2H). 
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Polymer P4. Prepared from 1,1'-bi(4-chloro-9,10-dihydro-9,10-[1'',2'']benzeno-2,3-
diazaanthracenyl) (9) (57.9 mg, 0.10 mmol), 4,4'-(hexafluoroisopropylidene)diphenol 
(bisphenol AF, 33.6 mg, 0.10 mmol)  and potassium carbonate (90 mg, 0.6 mmol) in 
DMAc (2 mL) at 100˚C for 3 days. Polymer P4 is isolated as a white solid (23 mg, 27%). 
GPC (THF vs. PS): Mn = 4400, Mw = 6500; 1H-NMR (300 MHz, (CDCl3): δ = 7.60 (br 
d, 4H, J = 7.5 Hz), 7.46 (br d, 4H, J = 6.0 Hz), 7.42-7.36 (m, 8H), 7.02-6.96 (m, 8H), 
6.37-6.32 (m, 2H), 5.97 (br s, 2H). 
 
Polymer P5. Prepared from 1,1'-bi(4-chloro-9,10-dihydro-9,10-[1'',2'']benzeno-2,3-
diazaanthracenyl) (9) (57.9 mg, 0.10 mmol), 4,4'-(1,3-
phenylenediisopropylidene)bisphenol (bisphenol M, 34.6 mg, 0.10 mmol)  and potassium 
carbonate (90 mg, 0.6 mmol) in DMAc (2 mL) at 100˚C for 3 days. Polymer P5 is 
isolated as a white solid (16 mg, 19%). GPC (THF vs. PS): Mn = 8600, Mw = 11 100; 
1H-NMR (300 MHz, (CDCl3): δ = 7.44 (d, 4H, J = 6.9 Hz), 7.40 (d, 4H, J = 7.5 Hz), 7.34 
(d, 4H, J = 8.7 Hz), 7.27 (overlaps with CHCl3 , 1H), 7.20 (d, 4H, J = 8.7 Hz), 7.13 (d, 
2H, J = 7.8 Hz), 7.02-6.95 (m, 9H), 6.34 (s, 2H), 5.97 (s, 2H). 
 
Polymer P6. Prepared from 1,1'-bi(4-chloro-9,10-dihydro-9,10-[1'',2'']benzeno-2,3-
diazaanthracenyl) (9) (57.9 mg, 0.10 mmol), pentiptycene hydroquinone (46.2 mg, 0.10 
mmol)  and potassium carbonate (90 mg, 0.6 mmol) in DMAc (2 mL) at 100˚C for 3 
days. Polymer P6 is isolated as a white solid (7 mg, 7%). GPC (THF vs. PS): Mn = 6500, 
Mw = 8300; 1H-NMR (300 MHz, (CDCl3): n/a solubility and molecular weights are too 
low for a reliable analysis.  
 
10-(4-Chloro-9,10-dihydro-9,10-[1',2']benzeno-2,3-diazaanthracen-1-yl)-decan-1-ol 
(11). In a Schlenk flask are placed 1,10-decanediol (631 mg, 3.6 mmol) and sodium 
hydride (60% dispersion in mineral oil, 145 mg, 3.6 mmol). The flask is evacuated and 
back-filled with argon 5 times, and dry tetrahydrofuran (ca. 20 mL) is then added. After 
the solids have dissolved, solid 1,4-dichloro-9,10-dihydro-9,10-[1',2']benzeno-2,3-
diazaanthracene (5) (975 mg, 3.0 mmol) is added to the flask in one portion. Contents are 
stirred at room temperature for 1 h, then stirred at 70˚C for ca. 16 h. The reaction mixture 
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is cooled, poured in an excess of sat. aq. NaHCO3, extracted with EtOAc, washed with 
brine and dried over anh. MgSO4. After evaporation of the solvents under reduced 
pressure, the crude product is purified by column chromatography on silica gel using 8:2 
hexanes : ethyl acetate (v/v) to first afford fractions containing 12a (367 mg, 33%), then 
11. Further purified by recrystallization from hexanes to afford pure 11 as a white solid 
(594 mg, 43%). m. p. = 138-139˚C; 1H-NMR (300 MHz; CDCl3): δ = 7.53-7.45 (m, 4H), 
7.11-7.05 (m, 4H), 5.79 (s, 1H), 5.78 (s, 1H), 4.51 (t, 2H, J = 6.9 Hz), 3.66 (t, 2H, J = 6.6 
Hz), 1.89 (q, 2H, J = 6.9 Hz), 1.70 (br, 1H), 1.59 (t, 2H, J = 6.6 Hz), 1.55-1.33 (m, 14H); 
13C-NMR (125 MHz; CDCl3): δ = 160.6, 147.6, 147.0, 143.2, 143.0, 138.0, 126.15. 
126.10, 124.9, 124.7, 68.3, 63.1, 50.4, 47.1, 32.9, 29.69, 29.65, 29.6, 29.5, 29.0, 26.1, 
25.9; HR-MS (ESI): calc. for C28H31ClN2O2 [M+H]+ 463.2147, found 463.2142. 
 
Polymer P7. In a Schlenk flask is placed 10-(4-chloro-9,10-dihydro-9,10-[1',2']benzeno-
2,3-diazaanthracen-1-yl)-decan-1-ol (11) (46 mg, 0.10 mmol). Contents are evacuated 
and back-filled with argon 5 times, and dry N,N-dimethylformamide (1 mL) is added. 
After dissolution is completed, sodium hydride (60% dispersion in mineral oil, 4 mg, 
0.11 mmol) is added. Contents are stirred for ca. 15 minutes at room temperature, 
followed by 60˚C for ca. 12 h, 100˚C for ca. 8 h, and finally 125˚C for ca. 16 h. The 
reaction mixture is cooled, and poured in an excess of MeOH. The polymer is isolated by 
centrifugation and dried under vacuum for several hours to afford polymer P7 as a white 
solid (14 mg, 33%). GPC (THF vs. PS): Mn = 3500, Mw = 4700; 1H-NMR (500 MHz, 
(CDCl3): δ = 7.48-7.42 (m, 4H), 7.08-7.00 (m, 4H), 5.79 (s, ~0.1H endgroup), 5.76 (s, 
2H), 4.52 (t, ~0.25H endgroup), 4.44 (t, 4H, J = 6.5 Hz), 3.66 (t, ~0.25H endgroup), 1.88 
(m, 4H), 1.60-1.34 (m, 16H) 
 
1,10-Bis(4-chloro-9,10-dihydro-9,10-[1',2']benzeno-2,3-diazaanthracen-1-yloxy)-
decane (12a). In a Schlenk flask are placed 1,4-dichloro-9,10-dihydro-9,10-
[1',2']benzeno-2,3-diazaanthracene (5) (270 mg, 0.83 mmol), 1,10-decanediol (60 mg, 
0.34 mmol) and sodium hydride (60% dispersion in mineral oil, 30 mg, 0.75 mmol). The 
flask is evacuated and back-filled with argon 5 times, and dry tetrahydrofuran (3 mL) is 
then added. The mixture is stirred at room temperature for ca. 16h. When reaction has 
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reached completion (TLC), about 1g of silica gel is added, and the solvents are 
evaporated under reduced pressure. The crude product absorbed on silica gel is purified 
by column chromatography on silica gel using 85:15 hexanes : ethyl acetate (v/v) to 
afford 12a as a white solid, that is further purified by recrystallization from hexanes 
(120 mg, 46%). m. p. = 171-173˚C; 1H-NMR (500 MHz; CDCl3): δ = 7.49-7.46 (m, 8H), 
7.08-7.06 (m, 8H), 5.78 (s, 2H), 5.77 (s, 2H), 4.51 (t, 4H, J = 7.0 Hz), 1.89 (m, 4H), 1.50 
(m, 4H), 1.41-1.36 (m, 8H); 13C-NMR (125 MHz; CDCl3): δ = 160.7, 147.6, 147.1, 143.2, 
143.1, 138.0, 126.20, 126.15, 124.9, 124.8, 68.3, 50.5, 47.1, 29.8, 29.6, 29.0, 26.2; HR-
MS (ESI): calc. for C46H40Cl2N4O2 [M+H]+ 751.2601, found 751.2595. 
 
N1,N10-Bis(4-chloro-9,10-dihydro-9,10-[1',2']benzeno-2,3-diazaanthracen-1-
yl)decane-1,10-diamine (12b). In a Schlenk flask are placed 1,4-dichloro-9,10-dihydro-
9,10-[1',2']benzeno-2,3-diazaanthracene (5) (325 mg, 1.0 mmol), 1,10-diaminodecane 
(57 mg, 0.33 mmol) and potassium carbonate (184 mg, 1.33 mmol). The flask is 
evacuated and back-filled with argon 5 times, and dry N,N-dimethylformamide (1.5 mL) 
is then added. The mixture is stirred at 120˚C for ca. 16h, and is then cooled to room 
temperature. Ethyl acetate (~5 mL) and silica gel (~1g) are added, and the solvents are 
evaporated under reduced pressure. The crude product absorbed on silica gel is purified 
by column chromatography on silica gel using progressively more polar 3:1 to 1:1 
hexanes : ethyl acetate (v/v) to first afford 12b as an amorphous white solid (87 mg, 
35%). m. p. = ~160˚C (softens), 267˚C (dec.); 1H-NMR (500 MHz; (CD3)2SO): δ = 7.55 
(br s, 4H), 7.47 (br s, 4H), 6.18 (s, 2H), 5.87 (s, 2H), (NH unseen); 13C-NMR (125 MHz; 
(CD3)2SO): δ =154.4, 144.3, 143.4, 143.3, 141.6, 135.5, 125.73, 125.68, 124.57, 124.3, 
49.0, 45.6, 41.2, 28.9, 28.8, 28.4, 26.6, ; HR-MS (ESI): calc. for C46H42Cl2N6 [M+H]+ 
749.2921, found 749.2913. 
 
1,10-Bis(4-chloro-9,10-dihydro-9,10-[1',2']benzeno-2,3-diazaanthracen-1-ylthio)-
hexane (12c). In a Schlenk flask are placed 1,4-dichloro-9,10-dihydro-9,10-
[1',2']benzeno-2,3-diazaanthracene (5) (270 mg, 0.83 mmol) and sodium hydride (60% 
dispersion in mineral oil, 30 mg, 0.75 mmol). The flask is evacuated and back-filled with 
argon 5 times, and dry tetrahydrofuran (3 mL) is then added. 1,6-hexanedithiol (51 µL, 
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0.33 mmol) is added by syringe and the mixture is stirred at room temperature for ca. 
16h. When reaction has reached completion (TLC), about 1g of silica gel is added, and 
the solvents are evaporated under reduced pressure. The crude product absorbed on silica 
gel is purified by column chromatography on silica gel using 8:2 hexanes : ethyl acetate 
(v/v) to afford 12c as a white solid, that then is further purified by recrystallization from 
ethanol (140 mg, 46%). m. p. = 182-184˚C; 1H-NMR (500 MHz; CDCl3): δ = 7.49 (dd, 
8H, J = 8.0, 4.0 Hz), 7.10-7.08 (m, 8H), 5.80 (s, 2H), 5.66 (s, 2H), 3.33 (t, 4H, J = 7.5 
Hz), 1.77 (m, 4H), 1.51 (m, 4H); 13C-NMR (125 MHz; CDCl3): δ = 156.8, 149.6, 146.6, 
143.7, 142.6, 142.5, 126.4, 124.93, 124.87, 124.8, 50.0, 49.6, 30.3, 29.1, 28.6; HR-MS 
(ESI): calc. for C42H32Cl2N4S2 [M+H]+ 727.1518, found 727.1530. 
 
General procedure for the preparation of the aromatic ether-linked monomers (12d-
g). In a Schlenk flask are placed 1,4-dichloro-9,10-dihydro-9,10-[1',2']benzeno-2,3-
diazaanthracene (5) (2.5-3.0 eq.), potassium carbonate (4 eq.) and the bisphenol (1 eq.). 
The flask is evacuated and back-filled with argon 5 times, and dry N,N-
dimethylformamide (~ 6 mL / mmol bisphenol) is then added. The mixture is stirred at 
the indicated temperature for ca. 16h, and is then cooled to room temperature. Contents 
are poured in water,  extracted with ethyl acetate, washed with brine and the solvents are 
evaporated under reduced pressure to yield the crude monomer. Details of the purification 
are indicated for each monomer.  
 
4,4'-(4,4'-(Hexafluoroisopropylidene)bis(1,4-phenylene))bis(oxy)bis(1-chloro-9,10-
dihydro-9,10-[1',2']benzeno-2,3-diazaanthracene) (12d). From dichloropyridazine 5 
(270 mg, 0.83 mmol), 4,4'-(hexafluoroisopropylidene)diphenol (bisphenol AF, 112 mg, 
0.33 mmol)  and potassium carbonate (184 mg, 1.33 mmol) in DMF (3 mL) at 60˚C. 
Purified by column chromatography on silica gel using progressively more polar 85:15 to 
70:30 hexanes : ethyl acetate (v/v) to afford 12d as an amorphous white solid (100 mg, 
33%). m. p. = 190-194˚C; 1H-NMR (500 MHz; CDCl3): δ = 7.55 (m, 4H), 7.51-7.48 (m, 
8H), 7.21 (d, 4H, J = 8.5 Hz), 7.15-7.11 (m, 8H), 5.89 (s, 2H), 5.87 (s, 2H); 13C-NMR 
(125 MHz; CDCl3): δ = 160.4, 154.4, 149.0, 148.9, 142.6, 139.0, 132.0, 130.8, 130.0, 
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126.52, 126.48, 125.1, 125.0, 120.6, 50.6, 47.5; HR-MS (ESI): calc. for C51H28Cl2F6N4O2 
[M+Na]+ 935.1365, found 935.1386. 
 
1,3-Bis(2-(4-(4-chloro-9,10-dihydro-9,10-[1',2']benzeno-2,3-diazaanthracen-1-
yloxy)phenyl)propan-2-yl)benzene (12e). From dichloropyridazine 5 (325 mg, 1.0 
mmol), 4,4'-(1,3-phenylenediisopropylidene)bisphenol (bisphenol M, 115 mg, 
0.33 mmol)  and potassium carbonate (184 mg, 1.33 mmol) in DMF (1.5 mL) at 120˚C. 
Purified by column chromatography on silica gel using progressively more polar 3:1 to 
1:1 hexanes : ethyl acetate (v/v) to afford 12e as a white solid (224 mg, 73%). 
m. p. = 160-162˚C (dec.); 1H-NMR (500 MHz; CDCl3): δ = 7.52 (d, 4H, J = 6.0 Hz), 7.47 
(d, 4H, J = 6.0 Hz), 7.27-7.18 (m, 5H), 7.10-7.04 (m, 15H), 5.88 (s, 2H), 5.84 (s, 2H); 
13C-NMR (125 MHz; CDCl3): δ =160.9, 151.7, 150.1, 148.6, 148.3, 147.8, 142.81, 
142.75, 138.8, 128.3, 127.8, 126.4, 126.3, 125.0 (2), 124.7, 120.1, 50.5, 47.4, 43.0, 31.1; 
HR-MS (ESI): calc. for C60H44Cl2N4O2 [M+H]+ 923.2914, found 923.2955. 
 
1,4-Bis(4-chloro-9,10-dihydro-9,10-[1',2']benzeno-2,3-diazaanthracen-1-yloxy)-9,10-
dihydro-9,10-[1',2']benzenoanthracene (12f). From dichloropyridazine 5 (325 mg, 
1.0 mmol), triptycene hydroquinone (95 mg, 0.33 mmol) and potassium carbonate 
(184 mg, 1.33 mmol) in DMF (1.5 mL) at 120˚C. Purified by column chromatography on 
silica gel using progressively more polar 3:1 to 1:1 hexanes : ethyl acetate (v/v) to afford 
12f as a white solid, that is further purified by trituration in hot iPrOH (216 mg, 75%). 
m. p. > 330˚C; 1H-NMR (500 MHz; CDCl3): δ = 7.57 (dd, 4H, J = 5.0, 2.5 Hz), 7.53 (dd, 
4H, J = 5.5, 2.5 Hz), 7.23 (dd, 4H, J = 5.0, 3.0 Hz), 7.16-7.13 (m, 8H), 7.02 (dd, 4H, 
J = 5.5, 3.0 Hz), 6.63 (s, 2H), 5.91 (s, 2H), 5.88 (s, 2H), 5.59 (s, 2H); 13C-NMR (125 
MHz; CDCl3): δ = 160.9, 149.0, 148.8, 146.2, 142.7, 142.6, 139.1, 138.8, 126.6, 126.4, 
125.7, 125.1 (2), 124.2, 118.8, 50.6, 48.7, 47.7; HR-MS (ESI): calc. for C56H32Cl2N4O2 
[M+H]+ 863.2053, found 863.2027. 
 
6,13-Bis(4-chloro-9,10-dihydro-9,10-[1',2']benzeno-2,3-diazaanthracen-1-yloxy)-
5,7,12,14-tetrahydro-5,14[1',2']-7,12[1",2"]-dibenzenopentacene (12g). From 
dichloropyridazine 5 (325 mg, 1.0 mmol), pentiptycene hydroquinone (154 mg, 
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0.33 mmol)  and potassium carbonate (184 mg, 1.33 mmol) in DMF (3 mL) at 120˚C. 
Purified by column chromatography on silica gel using progressively more polar 3:1:1 to 
1:1:1 hexanes : chloroform: ethyl acetate (v/v), and further purified by recrystallization 
from hexanes-THF and/or trituration in hot iPrOH to yield 12g as a white solid (107 mg, 
31%). m. p. > 330˚C; 1H-NMR (500 MHz; CDCl3): δ = 7.78 (d, 4H, J = 6.0 Hz), 7.66 (d, 
4H, J = 5.5 Hz), 7.22 (br s, 8H), 6.94-6.82 (br s, 16H) 6.30 (s, 2H), 6.00 (s, 2H), 5.29 (s, 
4H);  13C-NMR (125 MHz; CDCl3): δ = 160.9, 148.8, 148.5, 144.6, 143.0 (2), 141.8, 
137.9, 126.73, 126.69, 125.4 (2), 125.0, 123.8, 50.8, 49.1, 47.9; HR-MS (ESI): calc. for 
C70H40Cl2N4O2 [M+H]+ 1039.2601, found 1039.2601. 
 
General procedure for the preparation of poly(pyridazinyl ether)s by reductive 
coupling polymerization. (P8a-P8g) Bis(chloropyridazine) (12a-g) (1 eq.), activated 
zinc dust (6 eq.) and tetrakis(triphenylphosphine)palladium(0) (0.1 eq.) are placed in a 
Schlenk flask equipped with a magnetic stirrer. Contents of the flask are evacuated and 
back-filled with argon 5 times, and dry N,N-dimethylformamide (DMF) is added. After 5 
vacuum / back-fill cycles, the flask is sealed and contents are stirred at 90˚C for ca. 16h, 
and at 100˚C for an additional ca. 24h. The reaction mixture is cooled to room 
temperature, and poured in an excess of MeOH. After isolation by centrifugation, the 
polymers are redissolved in a minimum of chloroform, filtered, and reprecipitated in 
acetone (or methanol or hexanes for acetone-soluble samples). The polymer is then 
isolated after centrifugation and drying under vacuum. 
 
Polymer P8a. Prepared from monomer 12a (38 mg, 0.05 mmol), zinc (20 mg, 0.30 
mmol)  and Pd(PPh3)4 (6 mg, 0.005 mmol) in DMF (1 mL). Polymer P8a is isolated as a 
white solid (7 mg, 7%). GPC (THF vs. PS): Mn = 10 600, Mw = 20 400; 1H-NMR (500 
MHz, (CDCl3): δ = 7.50 (d, 4H, J = 7.5 Hz), 7.39 (d, 4H, J = 7.5 Hz), 7.05-6.97 (m, 8H), 
6.14 (s, 2H), 5.92 (s, 2H), 4.73 (t, 4H, J = 6.5 Hz), 2.04 (m, 4H), 1.66-1.44 (m, 12H). 
 
Polymer P8b. Prepared from monomer 12b (37 mg, 0.05 mmol), zinc (20 mg, 0.30 
mmol)  and Pd(PPh3)4 (6 mg, 0.005 mmol) in DMF (1 mL). No polymers were isolated. 
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Polymer P8c. Prepared from monomer 12c (37 mg, 0.05 mmol), zinc (20 mg, 0.30 
mmol)  and Pd(PPh3)4 (6 mg, 0.005 mmol) in DMF (1 mL). The mixture of short 
oligomers P8c is isolated as a off-white solid (10 mg, 30%). GPC (THF vs. PS): 
Mn = 2300, Mw = 5300. 
 
Polymer P8d. Prepared from monomer 12d (18 mg, 0.02 mmol), zinc (8 mg, 0.12 mmol)  
and Pd(PPh3)4 (2 mg, 0.002 mmol) in DMF (1 mL). Polymer P8d is isolated as a white 
solid (12 mg, 72%). GPC (THF vs. PS): Mn = 10 000, Mw = 14 900; 1H-NMR (500 
MHz, (CDCl3): δ = 7.61 (d, 4H, J = 8.5 Hz), 7.48 (d, 4H, J = 7.0 Hz), 7.44 (d, 4H, J = 7.0 
Hz), 7.38 (d, 4H, J = 9.0 Hz), 7.07-6.97 (m, 8H), 6.36 (s, 2H), 5.98 (s, 2H). 
 
Polymer P8e. Prepared from monomer 12e (46 mg, 0.05 mmol), zinc (20 mg, 0.3 mmol)  
and Pd(PPh3)4 (6 mg, 0.005 mmol) in DMF (1 mL). Polymer P8e is isolated as a white 
solid (25 mg, 60%). GPC (THF vs. PS): Mn = 4600, Mw = 7700; 1H-NMR (500 MHz, 
(CDCl3): δ = 7.45 (d, 4H, J = 7.0 Hz), 7.40 (d, 4H, J = 7.0 Hz), 7.21 (d, 4H, J = 9.0 Hz), 
7.13 (d, 2H, J = 7.5 Hz), 7.08-6.95 (m, 10H), 6.34 (s, 2H), 5.97 (s, 2H), 1.76 (s, 12H). 
 
Polymer P8f. Prepared from monomer 12f (18 mg, 0.02 mmol), zinc (8 mg, 0.12 mmol)  
and Pd(PPh3)4 (2 mg, 0.002 mmol) in DMF (1 mL). P8f is isolated as a off-white solid 
(7 mg, 30%) that is composed of a mixture of short oligomers. GPC (THF vs. PS): Mn = 
2400, Mw = 3700 
 
Polymer P8g. Prepared from monomer 12g (26 mg, 0.025 mmol), zinc (10 mg, 0.15 
mmol)  and Pd(PPh3)4 (3 mg, 0.0025 mmol) in DMF (1 mL). P8f is isolated as a white 
largely insoluble solid of undefined composition, likely to be a mixture of short 
oligomers (11 mg, 45%). GPC (THF vs. PS): Mn = 3500, Mw = 4100 
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1H-NMR and 13C-NMR Spectra 
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Figure 2.A.1. 1H-NMR Spectrum of P1 in CDCl3 (500 MHz).  
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Figure 2.A.2. 1H-NMR Spectrum of P2 in CDCl3 (500 MHz).  
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Figure 2.A.3. 1H-NMR Spectrum of P3 in CDCl3 (500 MHz).  
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Figure 2.A.4. 1H-NMR Spectrum of P4 in CDCl3 (500 MHz).  
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Figure 2.A.5. 1H-NMR Spectrum of P5 in CDCl3 (500 MHz).  
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Figure 2.A.6. 1H-NMR Spectrum of P6 in CDCl3 (500 MHz).  
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Figure 2.A.7. 1H-NMR Spectrum of 11 in CDCl3 (500 MHz).  
 
Figure 2.A.8. 13C-NMR Spectrum of 11 in CDCl3 (125 MHz). 
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Figure 2.A.9. 1H-NMR Spectrum of P7 in CDCl3 (500 MHz).  
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Figure 2.A.10. 1H-NMR Spectrum of 12a in CDCl3 (500 MHz).  
 
Figure 2.A.11. 13C-NMR Spectrum of 12a in CDCl3 (125 MHz). 
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Figure 2.A.12. 1H-NMR Spectrum of 12b in (CD3)2SO (500 MHz).  
 
Note: * Water; * DMSO. 
 
Figure 2.A.13. 13C-NMR Spectrum of 12b in (CD3)2SO (125 MHz). 
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Figure 2.A.14. 1H-NMR Spectrum of 12c in CDCl3 (500 MHz).  
 
Figure 2.A.15. 13C-NMR Spectrum of 12c in CDCl3 (125 MHz). 
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Figure 2.A.16. 1H-NMR Spectrum of 12d in CDCl3 (500 MHz).  
 
Note: * Water; * EtOAc. 
 
Figure 2.A.17. 13C-NMR Spectrum of 12d in CDCl3 (125 MHz). 
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Figure 2.A.18. 1H-NMR Spectrum of 12e in CDCl3 (500 MHz).  
 
Figure 2.A.19. 13C-NMR Spectrum of 12e in CDCl3 (125 MHz). 
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Figure 2.A.20. 1H-NMR Spectrum of 12f in CDCl3 (500 MHz). 
 
Note: * Water; * iPrOH. 
 
Figure 2.A.21. 13C-NMR Spectrum of 12f in CDCl3 (125 MHz). 
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Figure 2.A.22. 1H-NMR Spectrum of 12g in CDCl3 (500 MHz). 
 
Note: * Water; * iPrOH. 
 
Figure 2.A.23. 13C-NMR Spectrum of 12g in CDCl3 (125 MHz). 
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Figure 2.A.24. 1H-NMR Spectrum of P8a in CDCl3 (500 MHz).  
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Figure 2.A.25. 1H-NMR Spectrum of P8d in CDCl3 (500 MHz).  
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Figure 2.A.26. 1H-NMR Spectrum of P8e in CDCl3 (500 MHz).  
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Conjugated Materials Based on Iptycene-
Derived Pyridazines and their 
Applications to Liquid Crystals and 
Phosphorescent Polymers 
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3.1 Introduction 
 
 In Chapter 1, we have introduced molecular building blocks that incorporate 
iptycene-derived pyridazines, and in Chapter 2, we have described their incorporation 
into non-conjugated polymers (poly(aryl ether)s). In this chapter, we present their 
elaboration into conjugated materials that exhibit liquid crystalline properties (section 
3.2) and into platinum-based phosphorescent materials (section 3.3). 
 
3.2 Liquid Crystals based on Iptycene-derived Pyridazines 
 
3.2.1 Nematic Liquid Crystals and Iptycene-based Liquid Crystals 
 
 The liquid crystalline state has often been referred to as a fourth state of matter 
with properties intermediate between those of liquids and those of solids. More precisely, 
as defined by Goodby and Gray, the liquid crystalline state is: 
 
"... a mesomorphic state having long-range orientational order and 
either partial positional order or complete positional disorder."2 
 
 One of the simplest liquid crystalline phases is the nematic phase of calamitic 
(rod-shaped) mesogens. In nematic liquid crystals, the long axis of the calamitic 
mesogens are oriented, on average, parallel to that of a director vector, while higher order 
characteristics such as fixed positions, rotational order along the long axis, translational 
order and layer formation are absent (Figure 3.1). Due to the optical anisotropy of 
nematic LCs, optical switching can be accomplished if an external stimulus such as an 
external electric field reorients the LC director. Reorientation of the LC director must 
occur by rotation along an axis perpendicular to the long axis the calamitic mesogen, and 
thus require a great torque and reorganization of the surroundings. Consequently, 
switching times are relatively slow. However, if the cylindrical symmetry of calamitic 
mesogen is broken, giving rise to restricted rotation about the main axis of the calamitic, 
a biaxial nematic phase can arise. This phase could offer tremendous potential in 
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applications that include fast optical switching, but only a small number of materials have 
been unequivocally shown to exhibit a biaxial nematic liquid crystalline phase.3 
 
Figure 3.1. Nematic (uniaxial) and Biaxial Nematic LCs. 
 
 Previous work from the Swager laboratory has included a strategy targeted 
towards breaking the symmetry of classical bis(phenylethynyl)benzene nematic LC cores 
by appending iptycene scaffolds.4 Through mesogen threading5 and rotational epitaxy 
induced by the shape-complementarity6 and the internal free volume of the iptycene, it 
has been postulated that these modified nematic liquid crystals could favor the formation 
of a biaxial nematic phase (Figure 3.2). Furthermore, the mutual imbrication of 
mesogens within the molecular voids of their neighbors could induce a degree of 
correlation in their rotational orientation through gearing effects that would affect 
switching behavior. However, among the LC candidates that were synthesized and 
studied (e.g. variants of Trip-1 and Trip-4 with side-chains of varying lengths, Scheme 
3.1), only monotropic - thermodynamically unstable though kinetically accessible - 
uniaxial nematic mesophases were displayed.  
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OC8H17
C8H17O
Trip-1  
Figure 3.2. Example of a previously reported iptycene-based nematic mesogen (left), and 
top view of a hypothetical arrangement of iptycene-based mesogen (e.g. such as Trip-1) 
in a biaxial nematic mesophase.  
 
The preparation of heterocyclic analogues of the previously reported iptycene-
based liquid crystals (e.g. Trip-1 and Trip-4) was undertaken, starting from the 
heterocyclic iptycene cores prepared earlier (Chapter 1),7. This study was carried to probe 
the effect of the introduction of these polar groups, longitudinal and lateral dipoles on the 
LC properties of iptycene-based liquid crystals. It was hypothesized that longitudinal 
dipole-dipole (e.g. head-to-tail, etc.) interactions could lead to a stabilization of the 
mesophases, and that lateral dipoles could introduce greater degree rotational order. If 
these hypotheses were to be correct, additional insight could be gained towards the design 
of single-component molecular candidates for thermotropic biaxial nematic liquid 
crystals. 
 
3.2.2 Synthesis of Liquid Crystals based on Iptycene-derived Pyridazines 
 
The synthesis of heterocyclic iptycene analogues of the previously reported 
mesogens Trip-1 and Trip-4 (e.g. 1 and 4, Scheme 3.1) was largely based on the 
approach described by Long and Swager.4 Symmetric calamitics incorporating the 
iptycene scaffold at their center (1, 2) were assembled by the double Sonogashira-
Hagihara cross-coupling of an iptycene-derived 3,6-dichloropyrdazine7 with the 
appropriate phenylethynyl side-arm (5, 6). The unsymmetric calamitic 4 incorporating the 
iptycene scaffold at one of its ends was assembled by the Sonogashira-Hagihara cross-
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coupling of alkoxychloropyridazine 3 with the phenylethynyl side-arm 6. 
Alkoxychloropyridazine 3 is prepared by a nucleophilic aromatic substitution of the 
dichloropyridazine with sodium n-octoxide that is selective for the monosubstituted 
product. The octyloxy side-chain was chosen for the mesogen candidates on the basis that 
for the parent hydrocarbon mesogens (Trip-1 and Trip-4), alkoxy chains of an 
intermediate length (C8-C10) were found to possess the broadest temperature range in 
which a nematic mesophase is accessible. Since only one side-chain length was used, the 
synthesis of 1 and 4 is more covergent than that of either Trip-1 or Trip-4. Iptycene-
derived dichloropyridazines were previously found to be excellent electrophilic cross-
coupling partners in Suzuki-Miyaura, Kumada, and Stille reactions using standard 
palladium catalysts and conditions (e.g. 5% Pd(PPh3)4).7 However, Sonogashira-Hagihara 
cross-couplings, even with the electron-rich alkynes 5 and 6, were sluggish, and required 
higher catalyst loadings and higher temperatures to afford the mesogen candidates 1 and 
2 in poor to moderate yields (35% and 15%, respectively). The more electron-rich 
alkoxychloropyridazine 3 was even less reactive, and could not be cross-coupled with 
phenylethynyl side-arm 6 using standard protocols. Instead, an improved copper-free 
catalyst system that necessitates the slow addition of the alkyne was required to obtain 
the unsymmetrical mesogen candidate 4 in moderate yield (40%). 8 
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Scheme 3.1.  Synthesis of calamitic LC candidates that incorporate heterocyclic 
iptycenes. 
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Scheme 3.2. Preparation of calamitic side-arms 5 and 6. 
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3.2.3 Liquid Crystalline Properties of LCs that Incorporate Iptycene-derived Pyridazines  
 
 Mesogen candidates 1, 2, and 4 were examined by differential scanning 
calorimetry (DSC) and polarized microscopy to ascertain their liquid crystalline 
properties. The symmetrical calamitic bearing the shorter phenylethynyl side-arm 1 does 
not show LC transitions, and simply melts at 162˚C, a temperature 15˚C lower than the 
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melting temperature of its hydrocarbon-core analogue Trip-1. Significant hysteresis for 
crystallization (44˚C at a rate of 10˚C/min) is observed on the cooling cycle. The 
unsymmetrical 4 does not show LC properties, though its thermogram differs from that of 
1. The DSC thermogram displays a glass transition (centered at 26-28˚C) followed by 
cold crystallization peaks on the heating cycle before melting at 134˚C. No significant 
exotherms were found on the cooling cycle, suggesting that 4 gets trapped in a glassy 
state. As for 1 compared to Trip-1, the melting temperature of the pyridazine analogue 4 
is significantly lower than that of hydrocarbon-core Trip-4, by 30˚C. The presence of a 
glass transition, cold crystallization exotherms and broad ill-defined transitions on the 
cooling cycles were also found for Trip-4 and other unsymmetrical mesogens of the 
hydrocarbon-core series.  
 
 The extended calamitic 2 is unique in the pyridazine series in exhibiting 
thermotropic liquid crystalline properties. The DSC thermogram of 2 features a crystal-
to-crystal transition at 208˚C, immediately followed by a transition to a nematic liquid 
crystalline phase at 214.5˚C (Figure 3.3). The nematic phase is stable until at least 
275˚C, temperature at which 2 begins to thermally decompose. The decomposition is 
complete before reaching the clearing temperature, which consequently could not be 
determined. On the cooling cycle, crystallization occurs with significant hysteresis at 
173-174˚C under a 10˚C/min cooling rate. The nature of the transitions and the liquid 
crystalline phase was confirmed upon inspection of the  textures exhibited under cross-
polarizers (Figure 3.4). The hydrocarbon-core analogue of 2 has not been reported, and 
therefore a pair-wise comparison of the two compounds is not possible at this time. 
Although 2 does present a nematic phase that is thermodynamically stable over a wide 
range of temperatures (≥100˚C), the need for elevated temperatures (>175˚C), thermal 
unstability and synthetic considerations seriously limit possible applications of this 
mesogen core (e.g. 2 and derivatives with side-chain modifications). 
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Figure 3.3. DSC Thermogram of 2. 
 
Figure 3.4. Polarized micrographs of 2: After crystal to crystal transition at 214˚C (left); 
Nematic phase marbled texture at 230˚C (center); Sheared nematic texture at 214˚C 
(cooling cycle, right). 
 
3.2.4 Conclusions 
 
 The synthesis of heterocyclic-core analogues (1, 2, 4) of iptycene-appended 
nematic liquid crystals (Trip-1, Trip-4) allowed direct comparisons to derive structure-
relationship properties with respect to the influence of internal longitudinal and lateral 
dipoles on the phase behavior of triptycene-containing bis(phenylethynyl)benzene 
nematic liquid crystals. Replacement of the aromatic core by a pyridazine ring resulted in 
lower clearing temperatures and in the destabilization and elimination of the nematic 
phase in the shorter mesogen candidates 1 and 4. An extended calamitic containing the 
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heterocyclic iptycene core (2) exhibits a uniaxial nematic phase at elevated temperatures, 
making it unsuitable for most applications. 
 
3.3 Phosphorescent Materials Based on Iptycene-derived Pyridazines 
 
3.3.1 Phosphorescent Conjugated Polymers 
 
 Luminescent organic conjugated polymers have emerged over the last 20 to 30 
years as a privileged class of materials for a range of applications, particularly in the 
fields of light emitting devices9 and chemical sensing.10 The vast majority of these 
materials are fluorescent (S1 → S0) emitters. Phosphorescence emission (T1 → S0) is 
formally forbidden by selection rules for it requires the inversion of a spin state. Materials 
in which this restriction is relaxed, exhibiting high phosphorescence quantum yields, 
offer significant advantages in certain applications.  
 
In electroluminescent devices, electrons and holes injected at the electrodes 
follow a random distribution of spins. Consequently, upon charge recombination within a 
fluorescent material, only the matched-spin combinations (e.g. singlet-singlet) will result 
in light emission. The energy spent injecting the other spin combinations will be lost 
through non-radiative pathways. However, electroluminescent devices that incorporate 
efficient phosphorescent emitters can harness both singlet and triplet pairs, resulting in a 
greater overall quantum efficiency.11  
 
A general strategy for increasing spin-orbit coupling and thus intersystem 
crossing rates is the introduction of heavy atoms, among which late third row transition 
metal complexes (Re, Os, Ir, Pt) are most predominantly exploited. Most often, a 
phosphorescent transition-metal complex is simply dispersed in a polymer matrix (e.g. 
conjugated such as poly(dialkylfluorenes) or non-conjugated such as poly(N-
vinylcarbazole)) for light-emitting device applications.12 More recently, a number of 
research groups have developed polymers in which a phosphorescent transition metal 
complex dopant is covalently attached to a conjugated polymer as a side-chain,13 or 
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directly on the main chain14 (Scheme 3.3, a-d). Rare are reports of phosphorescent 
conjugated polymers in which the transition metal complex is present in more than 
doping fractions. Only two groups of polymers have transition metal complexes present 
on every repeating unit (Scheme 3.3, e-f). The first of these, main-chain platinum 
acetylide polymers,15 offer high degrees of heavy metal incorporation and modular 
tunability (neutral ligand and diacetylene), but suffer form limited conjugation through 
the alkyne-Pt-alkyne linkages and rarely exhibit high phosphorescence efficiency under 
ambient conditions (e.g. room temperature). A second group of conjugated polymers that 
incorporate a heavy transition metal center for every repeating unit is described in a 
recent report from the Swager group (Scheme 3.3, f).16 Polymers that belong to this 
second group can be considered molecular hybrids between the preferred fluorescent 
conjugated polymers for PLEDs, polyfluorenes, and highly emissive phosphorescent 
cyclometallated heavy transition metal complexes. Despite promising properties, issues 
such a relatively low molecular weights, limited solubility, and poor solid-state properties 
remain significant with these phosphorescent conjugated polymers. 
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Scheme 3.3. Examples of previously reported phosphorescent conjugated polymers.13-16  
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 More recently, research performed in the Swager laboratory17 has resulted in the 
improvement of the main-chain cyclometallated platinum-based polymer design by the 
incorporation of extremely bulky, rigid, iptycene-derived monomers18 (Scheme 3.4). The 
new polymers were shown to offer improved solubility and solid-state properties. A 
number of polymers were also found to be highly phosphorescent in thin films at room 
temperature. Trends that correlate the introduction of bulky, rigid groups that prevent 
solid-state aggregation and significant improvements the solid-state phosphorescence 
quantum yields have been established for platinum and iridium small-molecule 
complexes.19 It is proposed that, as for fluorescent conjugated polymers,20 the iptycene-
derived monomers limit the π-π staking and possibly metal-metal interactions that result 
in the formation of non-emissive aggregates. 
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Scheme 3.4. New conjugated phosphorescent polymers developed in the Swager 
laboratory.  
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 Phosphorescent conjugated polymers offer interesting prospects for chemical 
sensing. The excited state lifetime of the triplet state being much longer than that of the 
singlet state, if exciton diffusion along the conjugated polymer backbone occurs as in 
fluorescent conjugated polymers,10, 21 greater analytical sensitivity in amplified chemical 
sensing schemes could be achieved. Phosphorescent materials are also the sensors of 
choice for the detection of triplet-state analytes, among which molecular oxygen is the 
most important, with relevant applications in cellular biology, food safety and industrial 
processes.22 In addition, the chemistry of the metal center of phosphorescent complexes 
has been exploited to in selective sensing schemes.23 Nonetheless, reports of applications 
of conjugated phosphorescent polymers in chemical sensing schemes have yet to appear, 
possibly due to the difficulty of designing and preparing conjugated polymers that are 
highly luminescent in the solid state under ambient conditions. 
 
3.3.2 Synthesis of Phosphorescent Complexes based on Iptycene-derived Pyridazines 
 
 The previously described polymers highlight the importance of structural 
elements that prevent close-packing of phosphorescent conjugated polymers to prevent 
self-quenching (Scheme 3.4). Importantly, empirical evidence indicates that the use of a 
smaller iptycene-derived comonomer, 6,13-diethynylpentiptycene is insufficient to give 
soluble polymers that are highly phosphorescent in thin films under ambient conditions. 
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This is unexpected since the incorporation of that comonomer is generally satisfactory in 
preventing solid-state aggregation of fluorescent poly(phenylene ethynylene)s.20 The 
expanded iptycene scaffolds presented in Scheme 3.4 thus show significant 
improvements, but are not readily synthesized. A close inspection of the polymer 
structures reveals that steric hindrance is predominantly located on the iptycene-derived 
comonomer, while the cyclometallated complexes do not benefit from this protection. It 
is not improbable that the latter polymer segments might closely associate with a 
neighboring complex in the solid state, resulting in quenched aggregates. It follows that 
the greater the distance from the metal center to the bulky scaffold, the bulkier this 
structural element must be in return to prevent quenching. Efforts directed at the 
identification of structural motifs that could introduce anti-stacking elements in close 
proximity to the transition metal center suggested that the previously described iptycene-
derived pyridazines7 could be elaborated into C∩N cyclometallating ligands that would 
achieve this goal. 
 
 Halogenated iptycene-derived pyridazines were used in the preparation of 
iptycene analogues (12, 19) of phenylpyridine (Scheme 3.4, left) and thienylpyridine 
(Scheme 3.4, right) platinum complexes monomers. Their synthesis is presented in 
Scheme 3.5 and Scheme 3.7. The synthetic strategy leading to the ligands and monomers 
is based on the arylation of the iptycene-derived halopyridazines by cross-coupling 
methods. The synthetic route is however complicated by the need for target monomers to 
bear either iodides or activated bromides to give monomers that are sufficiently reactive 
for cross-coupling polymerization. The synthesis and characterization of 12 and 19 were 
completed in collaboration with Dr. Koushik Venkatesan (Swager Laboratory).1 
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Scheme 3.5. Synthesis of the iptycene-containing phenylpyridazine platinum complex 
monomer (12). 
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As described in Chapter 1, these halogenated iptycene-derived pyridazines, even 
the nominally less reactive chlorides, are good electrophilic partners in Suzuki-Miyaura, 
Negishi and Stille cross-coupling reactions. Since cyclometallation reactions with 3,6-
diarylpyridazine can lead to mixtures of the mono- and dinuclear platinum complexes,24 
our efforts were focused on unsymmetrical arylpyridazines monomers. Stille cross-
coupling of the iptycene-derived 3-chloro-6-methoxypyridazine with an appropriate 
arylstannane affords the desired biaryls (e.g. 7, 14) in moderate to good yields. Reaction 
of the iptycene-derived 3-chloro-6-methoxypyridazine with a halogenated arylstannane 
(e.g. (4-bromophenyl)trialkylstannane) would reduce the overall synthetic length, but this 
was found to be unsuccessful as the halogenated arylstannane reacts with itself in a AB 
cross-coupling polymerization rather than with the chloropyridazine, resulting in complex 
reaction mixtures. The use of cesium fluoride to activate the Stille reagent was found to 
be beneficial in these reactions. Cesium fluoride may not be used in the synthesis of 7, 
however, due to the presence of the fluoride-sensitive aryltrimethylsilane group. 
Interestingly, in the synthesis of 7, significant methyl transfer from the 
aryltrimethylstannane giving rise to 13 is observed (Scheme 3.6). While alkyl transfer 
from an aryltrialkylstannane is not unprecedented, it is rare for aryltrialkylstannanes that 
do not bear ortho groups, and the ratios of alkyl to aryl transfers are seldom as high as 
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that herein described.25 This side-reaction is likely to be largely responsible for the lower 
yields of 7 compared to that of 14. 
 
Scheme 3.6. Methyl group transfer in the Stille cross-coupling leading to 13 
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 In a second step, the first of the two halides of the final monomers is installed. 
The thienyl derivative 14 (Scheme 3.7) is sufficiently reactive towards electrophilic 
bromination to directly and selectively afford the desired bromothiophene 15. The phenyl 
analogue may not be directly halogenated, due to the electron-withdrawing influence of 
the pyridazine ring and competitive reactivity of the iptycene arenes. However, placement 
of a trimethylsilyl group at the 4'-position of the biaryl 7 allows for a regioselective 
halogenation to proceed. Nonetheless, this substrate is markedly less reactive than a 
typical aryltrimethylsilyl group. The usual reagent of choice for the iododesilylation of 
aryltrimethylsilanes, iodine monochloride, is not sufficiently reactive to convert 7 to 8, 
and the starting material 7 is recovered quantitatively. Among a number of iodination 
agents screened (N-iodosuccinimide, combinations of iodine (or iodide) and oxidizing 
agents), only molecular iodine in the presence of soluble silver(I) salts results in the 
conversion to 8 in good yields. Cleavage of the methoxy group with hydrogen bromide in 
acetic acid affords the pyridazinones 9 and 16, which are converted to the 
bromopyridazines 10 and 17 by the action of neat molten phosphorus oxybromide. 
Gratifyingly, cyclometallation with potassium tetrachloroplatinate in ethoxyethanol 
affords the platinum chlorodimers 11 and 18 in moderate to good yields without affecting 
the halides on the ligand. Exchange of the chlorides with a di-t-butyl substituted 
acetylacetone ligand gives the monomers 12 and 19.  
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Scheme 3.7. Synthesis of the iptycene analogue (19) of the thienylpyridine platinum 
complex monomer. 
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The structure of monomer 19 was elucidated by X-ray crystallography (Figure 
3.5). 26  The platinum complex is essentially square planar, with minor deviations 
attributed to a slight bend upon packing (sum of angles around Pt = 370˚). The 
thienylpyridazine ligand is also almost perfectly coplanar about the biaryl linkage (N-C-
C-C torsion angle = 2.6˚), providing further evidence to the coplanarization hypotheses 
discussed in Chapter 1. The most striking features of the X-ray structure relate to the 
solid-state packing mode of 19. Cyclometallated platinum phenylpyridine complexes tend 
to form vertical π-stacks with short contacts between the planes of formed by the ligands 
(typical values ~3.5 Å, within the 3.3-3.8 Å attributed to π-π interactions), and short Pt-Pt 
distances.19, 27  These strong intermolecular interactions have been associated with 
diminished phosphorescence quantum yield, and the rise of long-wavelength excimers.  
In 19, the iptycene scaffold prevents stacking of the thienylpyridazine ligands, and forces 
the complexes in a face-to-face arrangement that maximizes the distance between the 
iptycenes and increases the distance between the mean planes defined by the 
thienylpyridazine ligands to 4.977 Å. This separation is greater than that reported the first 
and only reported platinum complex of this family for which separation between the 
plane of the ligands (4.203 Å) was greater than the upper limit of the to π-π stacking 
interactions (3.8 Å).19a The distance between the mean planes formed by platinum-ligand 
squares is slightly shorter (4.538 Å) due to the small deviations from ideal square 
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planarity, and the Pt-Pt distance (5.172 Å) is too large to allow significant Pt-Pt 
interactions, which level off beyond 3.5 Å.28 Iptycene-derived cyclometallated platinum 
arylpyridazine ligands therefore appear to be apt candidates to limit detrimental 
aggregation in phosphorescent conjugated polymers.  
 
  
  
Figure 3.5. X-ray structure of 19 (50% probability thermal ellipsoids): 1st quadrant: 
single molecule of 19; 2nd quadrant: packing, top view; 3rd quadrant: packing, 
perspective view; 4th quadrant: packing, side view. 
 
Soluble poly(arylene ethynylene)s and poly(phenylene)s were prepared from 
monomers 12 and 19 and the comonomers presented in Scheme 3.8, as part of an 
ongoing research effort in the Swager Laboratory. For polymers that incorporate 9,9-di-n-
octylfluorene comonomers, it was observed that a precipitate, possibly growing polymer 
and/or oligomer chains, develops in the biphasic toluene-water reaction mixture during 
Suzuki-Miyaura polymerizations. The amorphous Suzuki-Miyaura monomer 20 bearing 
branched side-chains has been prepared to improve the solubility of the polymers 
throughout the polymerization in hope of achieving higher molecular weights. (Scheme 
3.9). Research efforts directed at the improvement the molecular weights of these 
polymers, their photophysical characterization and their application them as oxygen 
sensors are currently being pursued (Dr. Koushik Venkatesan, Swager Laboratory).  
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Scheme 3.8. Comonomers employed in cross-coupling polymerizations with 12 and 19. 
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Scheme 3.9. Synthesis of the branched-chain solubilizing Suzuki-Miyaura monomer 20. 
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3.3.3 Conclusions 
 
 Iptycene-derived pyridazine building blocks have been introduced into 
phosphorescent cyclometallated platinum complexes. Iptycene incorporation prevents 
strong interactions in the solid state (e.g. π-π stacking) that are detrimental to the 
phosphors' photophysical properties. These complexes were also elaborated into 
functional monomers for cross-coupling polymerizations. Conjugated phosphorescent 
polymers that incorporate these monomers show promising properties, such as efficient 
phosphorescence in the solid state under ambient conditions.  
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3.4 Experimental Section 
 
Materials 
All solvents were of ACS reagent grade or better unless otherwise noted. Anhydrous 
tetrahydrofuran, toluene, diethyl ether, acetonitrile and dichloromethane were dried on a 
solvent column purification system. p-Dioxane was dried over activated type 4X 
molecular sieves. Silica gel (40-63 µm) was obtained from SiliCycle Inc. 1,4-Dichloro-
9,10-dihydro-9,10-[1',2']benzeno-2,3-diazaanthracene,7 1-ethynyl-4-octyloxybenzene, 29 
2,7-diiodofluorene, 30  1-bromo-3,7,11-trimethyldodecane 31  were prepared according to 
literature procedures or slight modifications thereof. All other reagents, compounds and 
chemicals were obtained from commercial suppliers and used without further purification. 
 
General methods, instrumentation and measurements 
Synthetic manipulations that required an inert atmosphere (where noted) were carried out 
under nitrogen or argon using standard Schlenk techniques or in an inert-atmosphere 
glovebox. NMR (1H and 13C) spectra were recorded on 300 and 500 MHz spectrometers. 
The chemical shift data for each signal are given in units of δ (ppm) relative to 
tetramethylsilane (TMS) where δ (TMS) = 0, and referenced to the residual solvent 
resonances. Splitting patterns are denoted as s (singlet), d (doublet), t (triplet), q (quartet), 
m (multiplet), and br (broad).  High-resolution mass spectra (HR-MS) were obtained at 
the MIT Department of Chemistry Instrumentation Facility using electron impact 
ionization (EI) with a voltage of 70 V or electrospray ionization (ESI). Melting point 
(m.p.) determination was performed using open capillaries and measurements are 
reported uncorrected. Polymer molecular weights were determined in THF solutions on 
an Agilent 1100 series HPLC/GPC system with three PLgel columns (103, 104, 105 Å) in 
series against narrow polystyrene standards. Polymer thin films were spin cast from ~1% 
by weight CHCl3 solutions on microscope coverslips or Si wafers using an EC101DT 
photoresist spinner (Headway Research, Inc.) at a 1000 rpm rate for 60 s. 
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1,4-Bis((4-octyloxyphenyl)ethynyl)-9,10-dihydro-9,10-[1',2']benzeno-2,3-
diazaanthracene (1). 1,4-Dichloro-9,10-dihydro-9,10-[1',2']benzeno-2,3-
diazaanthracene (0.108 g, 0.33 mmol), 1-ethynyl-4-octyloxybenzene (0.230 g, 1.00 
mmol), tetrakis(triphenylphosphine)palladium(0) (39 mg, 0.03 mmol), and copper(I) 
iodide (6 mg, 0.03 mg) are placed in a Schlenk flask equipped with a magnetic stirrer. 
Contents are evacuated and back-filled with argon 5 times, and a degassed mixture of 
toluene (1.5 mL) and N,N-diisopropylethylamine(0.5 mL) is added by syringe. After 5 
more vacuum / backfill cycles, contents are stirred at 75˚C for ca. 16h followed by 24h at 
100˚C. The reaction mixture is cooled, filtered on a short silica gel plus and rinsed with 
ethyl acetate. Evaporation of the solvents under reduced pressure yields a crude product 
that is purified first by column chromatography on silica gel using progressively more 
polar 30:4:1 to 10:4:1 hexanes : dichloromethane : ethyl acetate (v/v/v), and then by 
recyrstallization from ethanol to afford 1 an pale yellow needles (84 mg, 35%). 
m. p. = 160-162˚C (by DSC); 1H-NMR (500 MHz; CDCl3): δ = 7.70 (d, 4H, J = 8.5 Hz), 
7.53 (dd, 4H, J = 5.0, 3.0 Hz), 7.10 (dd, 4H, J = 5.0, 3.0 Hz), 6.99 (d, 4H, J = 8.5 Hz), 
5.90 (s, 2H), 4.04 (t, 4H, J = 6.5 Hz), 1.84 (m, 4H), 1.50 (m, 4H), 1.37-1.27 (m, 16H), 
0.92 (t, 6H, J = 6.5 Hz); 13C-NMR (125 MHz; CDCl3): δ = 160.5, 145.8, 142.8, 141.5, 
134.0, 126.4, 125.0, 115.0, 113.7, 98.3, 83.0, 68.4, 50.5, 32.0, 29.6, 29.45, 29.36, 26.2, 
22.9, 14.3; HR-MS (ESI): calc. for C50H52N2O2 [M+H]+ 713.4102, found 713.4104. 
 
1,4-Bis((4-((4-octyloxyphenyl)ethynyl)phenyl)ethynyl)-9,10-dihydro-9,10-
[1',2']benzeno-2,3-diazaanthracene (2). 1,4-Dichloro-9,10-dihydro-9,10-[1',2']benzeno-
2,3-diazaanthracene (0.108 g, 0.33 mmol), acetylene 6 (0.330 g, 1.00 mmol), 
tetrakis(triphenylphosphine)palladium(0) (39 mg, 0.03 mmol), and copper(I) iodide 
(6 mg, 0.03 mg) are placed in a Schlenk flask equipped with a magnetic stirrer. Contents 
are evacuated and back-filled with argon 5 times, and a degassed mixture of toluene (1.5 
mL) and N,N-diisopropylethylamine (0.5 mL) is added by syringe. After 5 more vacuum / 
backfill cycles, contents are stirred at 75˚C for ca. 16h followed by 24h at 100˚C. The 
reaction mixture is cooled, filtered on a short silica gel plug and rinsed with ethyl acetate. 
Evaporation of the solvents under reduced pressure yields a crude product that is purified 
first by column chromatography on silica gel using progressively more polar 90:10 to 
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80:20 hexanes : dichloromethane (v/v), and then by recyrstallization from acetone to 
afford 2 as fluffy yellow needles (45 mg, 15%). m. p. = 213-215˚C (by DSC); 1H-NMR 
(500 MHz; CDCl3): δ =7.71 (d, 4H, J = 8.0 Hz), 7.59 (d, 4H, J = 8.0 Hz), 7.56 (m, 4H), 
7.50 (d, 4H, J = 8.0 Hz), 7.13 (m, 4H), 6.91 (d, 4H, J = 8.0 Hz), 5.91 (s, 2H), 4.00 (t, 4H, 
J = 6.0 Hz), 1.81 (m, 4H), 1.48 (m, 4H), 1.35-1.31 (m, 16H), 0.91 (m, 6H); 13C-NMR 
(125 MHz; CDCl3): δ = 159.8, 146.2, 142.6, 141.2, 133.4, 132.3, 131.7, 126.5, 125.4, 
125.1, 121.1, 114.8, 97.6, 92.7, 87.8, 85.5, 68.3, 50.5, 32.0. 29.6, 29.5, 29.4, 26.2, 22.9, 
14.3; HR-MS (ESI): calc. for C66H60N2O2 [M+H]+ 913.4728, found 913.4760. 
 
1-Chloro-9,10-dihydro-4-octyloxy-9,10-[1',2']benzeno-2,3-diazaanthracene (3). In a 
first Schlenk flask is added 1,4-dichloro-9,10-dihydro-9,10-[1',2']benzeno-2,3-
diazaanthracene (1.300 g, 4.00 mmol). Contents are evacuated and back-filled with argon 
5 times, and then dry THF (10 mL) is added. In a second Schlenk flask is added NaH 
(60% dispersion in mineral oil, 208 mg, 5.20 mmol). Contents are evacuated and back-
filled with argon 5 times, and then dry THF (10 mL) is added. To the second flask is then 
added octanol (0.78 mL, 5.00 mmol) dropwise. The contents of the two flasks are stirred 
for a few minutes to fully dissolve, and then the contents of the second flask are 
cannulated into the first flask. The resulting reaction mixture is stirred at room 
temperature for ca. 16h. The reaction is stopped by pouring in an excess of sat. aq. 
NaHCO3, extracted with ethyl acetate, washed with brine and dried over anh. MgSO4. 
Solvents are evaporated under reduced pressure and the crude product is purified by 
column chromatography on silica gel using progressively more polar 95:5 to 90:10 
hexanes : ethyl acetate to afford 3 as a viscous colorless oil that slowly crystallizes upon 
standing (1.603 g, 96%). m. p. = 79-80˚C (by DSC); 1H-NMR (500 MHz; CDCl3): 
δ = 7.52-7.48 (m, 4H), 7.11-7.07 (m, 4H), 5.80 (s, 1H), 5.79 (s, 1H), 4.53 (t, 2H, J = 6.5 
Hz), 1.90 (q, 2H, J = 7.0 Hz), 1.51 (m, 2H), 1.44-1.30 (m, 8H), 0.93 (t, 3H, J = 6.5 Hz); 
13C-NMR (125 MHz; CDCl3): δ = 160.7, 147.6, 147.1, 143.2, 143.1, 138.0, 126.2, 126.1, 
124.9, 124.8, 68.3, 50.5, 47.1, 32.0, 29.52, 29.49, 29.0, 26.2, 22.9, 14.4; HR-MS (ESI): 
calc. for C26H27ClN2O [M+H]+ 419.1885, found 419.1876. 
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1-Octyloxy-4-((4-((4-octyloxyphenyl)ethynyl)phenyl)ethynyl)-9,10-dihydro-9,10-
[1',2']benzeno-2,3-diazaanthracene (4).  Chlorooclyloxypyridazine 3 (105 mg, 
0.25 mmol), dichlorobis(acetonitrile)palladium(II) (2 mg, 0.0075 mmol), X-phos ligand 
(12 mg, 0.025 mmol) and cesium carbonate (260 mg, 0.80 mmol) are placed in a Schlenk 
flask equipped with a magnetic stirrer. Contents are evacuated and back-filled with argon 
5 times, and dry MeCN (1 mL) is then added. After 5 more vacuum / argon cycles, the 
mixture is warmed to 90˚C, and a solution of acetylene 6 (107 mg, 0.32 mmol) in dry 
dioxane (1 mL) prepared under argon is slowly added by syringe pump over ca. 6h. When 
the addition is completed, the reaction mixture is stirred an additional ca. 16h at 90˚C. 
The mixture is cooled to room temperature, diluted with ethyl acetate, and silica gel (ca. 
1 g) is added. Solvents are evaporated under reduced pressure and the crude product 
adsorbed on silica gel is purified first by column chromatography on silica gel using 
90:10 hexanes : ethyl acetate (v/v) and then by recyrstallization from EtOH to afford 4 as 
yellow flakes (71 mg, 40%). m. p. = 134-136˚C (by DSC); 1H-NMR (300 MHz; CDCl3): 
δ = 7.70 (d, 2H, J = 8.1 Hz), 7.59 (d, 2H, J = 8.4 Hz), 7.53-7.47 (m, 6H), 7.08 (dd, 4H, J 
= 5.2, 1.8 Hz), 6.91 (d, 2H, J = 8.7 Hz), 5.86 (s, 1H), 5.80 (s, 1H), 4.58 (t, 2H, J = 6.9 
Hz), 4.00 (t, 2H, J = 6.6 Hz), 1.91 (m, 2H), 1.81 (m, 2H), 1.49-1.30 (m, 20H); 13C-NMR 
(125 MHz; CDCl3): δ = 159.7, 159.6, 143.5, 143.4, 139.7, 134.0, 133.3, 132.2, 131.7, 
126.04, 126.01, 124.9, 124.8, 124.7, 121.7, 114.85, 114.79, 94.4, 92.3, 87.9, 85.6, 68.3, 
68.2, 51.0, 46.6, 32.03, 32.01, 29.55, 29.50, 29.44, 29.37, 29.1, 26.2, 22.90, 22.87, 14.36, 
14.33; HR-MS (ESI): calc. for C50H52N2O2 [M+H]+ 713.4102, found 713.4099. 
 
Trimethyl((4-((4-octyloxyphenyl)ethynyl)phenyl)ethynyl)silane (5). 1-Ethynyl-4-
octyloxybenzene (2.415 g, 10.5 mmol), (4-bromophenylethynyl)trimethylsilane (2.530 g, 
10.0 mmol), dichlorobis(triphenylphosphine)palladium(II) (350 mg, 0.50 mmol) and 
copper(I) iodide (190 mg, 1.00 mmol) are placed in a Schlenk flask equipped with a 
magnetic stirrer. Contents are evacuated and back-filled with argon 5 times, and degassed 
toluene (45 mL) and N,N-diisopropylamine (15 mL) are added. The reaction mixture is 
stirred for ca. 16h at 75˚C, and then cooled to room temperature. Contents are filtered on 
a short silica gel plug, and the plug is rinsed with ethyl acetate. After evaporation of the 
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solvents under reduced pressure, the crude product is purified first by column 
chromatography on silica gel using progressively more polar 100:0 to 97:3 hexanes : ethyl 
acetate and then by recrystallization from MeOH to afford 5 as a pale yellow solid 
(2.259 g, 56%). m. p. = 95.5-97.0˚C; 1H-NMR (500 MHz; CDCl3): δ = 7.47-7.44 (m, 6H), 
6.67 (d, 2H, J = 9.0 Hz), 3.97 (t, 2H, J = 6.6 Hz), 1.79 (m, 2H), 1.45-1.30 (m, 10H), 0.90 
(t, 3H, J = 6.3 Hz), 0.26 (s, 9H); 13C-NMR (125 MHz; CDCl3): δ = 159.6, 133.3, 132.1, 
131.4, 124.0, 122.6, 115.0, 114.7, 105.0, 96.2, 91.8, 87.9, 68.3, 32.0, 29.6. 29.5, 29.4, 
26.2, 22.9, 14.3, 0.1; HR-MS (ESI): calc. for C27H34OSi [M+Na]+ 425.2271, found 
425.2271. 
 
1-Ethynyl-4((4-octyloxyphenyl)ethynyl)benzene (6). Trimethylsilyl-protected acetylene 
5 (2010 mg, 5.00 mmol) is dissolved in THF (25 mL) and MeOH (25 mL), and the 
solution is degassed by bubbling argon gas through for ca. 30 mins. To the mixture is 
then added potassium hydroxide (300 mg, 5.35 mmol), and contents are stirred at room 
temperature under argon for ca. 16 h. Methanol (50 mL) is then added and the resulting 
precipitate is filtered and washed with methanol to yield 6 as a pale yellow solid (1.489 g, 
90%). m. p. = 93.0-94.5˚C; 1H-NMR (300 MHz; CDCl3): δ = 7.47-7.43 (m, 6H), 6.88 (d, 
2H, J = 8.7 Hz), 3.98 (t, 2H, J = 6.3 Hz), 3.17 (s, 1H), 1.80 (q, 2H, J = 6.6 Hz), 1.47 (m, 
2H), 1.33-1.28 (m, 8H), 0.90 (t, 3H, J = 6.6 Hz); 13C-NMR (125 MHz; CDCl3): δ = 
159.6, 134.2, 133.3, 132.2, 131.5, 124.4, 121.6, 114.9, 114.81, 114.76, 91.8, 87.7, 83.6, 
78.9, 68.3, 32.0, 29.6, 29.5, 29.4, 26.2, 22.9, 14.3; HR-MS (ESI): calc. for C24H26O 
[M+H]+ 331.2056, found 331.2064. 
 
9,10-Dihydro-1-methoxy-4-(4-trimethylsilylphenyl)-9,10-[1',2']benzeno-2,3-
diazaanthracene (7). In a Schlenk flask are placed 1-chloro-9,10-dihydro-4-methoxy-
9,10-[1',2']benzeno-2,3-diazaanthracene7 (9.63 g, 30 mmol), trimethyl(4-
(trimethylstannyl)phenyl)silane 32  (11.74 g, 37.5 mmol) and 
tetrakis(triphenylphosphine)palladium(0) (1.74 g, 1.5 mmol). Contents are evacuated and 
back-filled with argon five times, and dry dioxane (100 mL) is then introduced before a 
second cycle of five evacuations / argon back-fills. The clear pale yellow solution is 
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stirred at 100˚C for 72h, then an additional 24h at 110˚C, during which time a cloudiness 
first develops before the reaction mixture darkens. The mixture is cooled to room 
temperature, triturated with a few grams of celite, filtered over a short silica gel plug and 
eluted with ethyl acetate. After evaporation of the solvents under reduced pressure, the 
crude product is purified by column chromatography on silica gel using progressively 
more polar 15:4:1 to 10:4:1 hexanes : dichloromethane : ethyl acetate (v/v/v) to yield 7 as 
a white solid (7.18 g, 55%), followed by the by-product 13 (3.52 g, 38%). Analytical 
samples may be obtained after recrystallization from MeOH. 7: m. p. = 243-245˚C; 1H-
NMR (500 MHz, CDCl3): δ = 7.77 (d, 2H, J = 8.1 Hz), 7.68 (d, 2H, J = 8.1 Hz), 7.51 (m, 
2H), 7.42 (m, 2H), 7.07 (m, 4H), 5.88 (s, 1H), 5.84 (s, 1H), 4.23 (s, 3H), 0.39 (s, 9H); 
13C-NMR (75 MHz, CDCl3): δ = 160.1, 153.8, 147.1, 143.9, 143.8, 141.4, 136.9, 135.2, 
133.8, 128.6, 126.0, 125.9, 124.8, 124.5, 51.1, 50.3, 46.8, -0.87; HR-MS (ESI): calc for 
C28H26N2OSi [M+H]+ 435.1887, found 435.1892. 13: m. p. = 223-225˚C; 1H-NMR (300 
MHz, CDCl3): δ = 7.49-7.42 (m, 4H), 7.06-7.04 (m, 4H), 5.80 (s, 1H), 5.59 (s, 1H), 4.15 
(s, 3H), 2.79 (s, 3H); 13C-NMR (125 MHz, CDCl3): δ = 160.2, 150.8, 147.6, 143.8, 143.7, 
134.5, 126.0, 125.8, 124.7, 124.4, 54.8, 50.1, 46.7, 19.2; HR-MS (ESI): calc for 
C20H16N2O [M+H]+ 301.1335, found 301.1337. 
 
9,10-Dihydro-4-(4-iodophenyl)-1-methoxy-9,10-[1',2']benzeno-2,3-diazaanthracene 
(8). Trimethylsilyl derivative 7 (7.00 g, 16 mmol) is dissolved by vigorous stirring in a 
solution of MeCN (300 mL) and CH2Cl2 (100 mL). Iodine (6.13 g, 25 mmol) is added 
and dissolved with stirring. To the resulting solution is then added a solution AgNO3 
(8.21g, 48 mmol) in MeCN (100 mL) in small (~2 mL) portions. The resulting mixture is 
stirred at room temperature overnight. Dichloromethane (~300 mL) is then added, and the 
mixture is filtered to remove AgI. The residue is washed with copious portions of CH2Cl2. 
The solvents are evaporated under reduced pressure and submitted to a 5% aq. NH3 / 
CH2Cl2 workup. The combined organic layers are washed with brine, dried over anh. 
MgSO4, and the solvents are evaporated under reduced pressure to afford the iodo 
derivative 8 as a pale yellow solid (7.70 g, 98%). Analytical samples may be obtained 
after recrystallization from MeOH. m. p. = 204-206˚C; 1H-NMR (500 MHz, CDCl3): δ = 
7.95 (d, 2H, J = 8.0 Hz), 7.51 (m, 2H), 7.43 (d, 2H, J = 8.5 Hz), 7.07 (m, 4H), 5.88 (s, 
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1H), 5.73 (s, 1H), 4.23 (s, 3H); 13C-NMR (75 MHz, CDCl3): δ = 160.2, 152.8, 147.0, 
143.63, 143.59, 138.1, 136.1, 135.3, 131.1, 126.1, 126.0, 124.8, 124.4, 95.3, 55.2, 50.3, 
46.7; HR-MS (ESI): calc for C25H17IN2O [M+H]+ 489.0458, found 489.0460. 
 
4-(4-Iodophenyl)-9,10-dihydro-9,10-[1',2']benzeno-2,3-diazaanthracene-1(2H)-one 
(9). A suspension of the iodo derivative 8 (7.50 g, 15 mmol) in a solution of HBr in 
AcOH (90 mL, 33% by wt.) is slowly, progressively warmed up to 80˚C. As the mixture 
warms up a violent release of gases (presumably HBr and MeBr) occurs and the iodo 
derivative goes into solution. The mixture is stirred at 80˚C overnight, then cooled and 
poured into ca. 1.2 L of H2O. The resulting suspension is neutralized to ~ pH 5 by the 
addition of ca. 100 g of NaOAc, and triturated for 1 h. The precipitate is then let to settle, 
filtered, washed with copious portions of H2O and dried in vacuo to afford 9 as a pale 
beige solid (6.80 g, 93%). Analytical samples may be obtained after recrystallization 
from EtOH. m. p. > 330˚C; 1H-NMR (500 MHz, (CD3)2SO): δ = 13.3 (s, 1H), 8.01 (d, 
2H, J = 8.0 Hz), 7.55 (m, 2H), 7.51 (m, 2H), 7.33 (m, 2H), 7.06 (m, 4H), 6.01 (s, 1H), 
5.75 (s, 1H); 13C-NMR (125 MHz, (CD3)SO): δ = 158.2, 149.0, 145.5, 143.7, 143.3, 
143.0, 137.7, 134.0, 130.5, 125.5, 125.4, 124.4, 124.29, 124.27, 95.9, 46.9, 46.3; HR-MS 
(ESI): calc for C24H15IN2O [M+Na]+ 497.0121, found 497.0102. 
 
1-Bromo-4-(4-iodophenyl)-9,10-dihydro-9,10-[1',2']benzeno-2,3-diazaanthracene 
(10). Pyridazinone 9 (6.50 g, 13.7 mmol) is stirred overnight at 80˚C in molten POBr3 
(35 g, 122 mmol) under a nitrogen atmosphere. The reaction mixture is cooled to room 
temperature and the solid residue is dissolved in ca. 400 mL CH2Cl2. The resulting 
solution is tritutarated for 1hr over neutral alumina (~150 g), then filtered over a short 
plug of neutral alumina (~150 g) and eluted first with CH2Cl2 then with EtOAc. Solvents 
are evaporated under reduced pressure and the crude product is purified by column 
chromatography on silica gel using progressively more polar 90:10 to 85:15 
dichloromethane : ethyl acetate (v/v) as the mobile phase to afford the iodo bromo 
monomer 10 as a pale beige solid (6.36 g, 86%). Analytical samples may be obtained 
after recrystallization from iPrOH or MeCN. m. p. 218-220˚C; 1H-NMR (500 MHz, 
CDCl3): δ = 8.00 (d, 2H, J = 8.0 Hz), 7.57 (m, 2H), 7.44 (d, 2H, J = 8.0 Hz), 7.42 (m, 
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2H), 7.12 (m, 4H), 5.92 (s, 1H), 5.75 (s, 1H); 13C-NMR (125 MHz, CDCl3): δ = 155.7, 
147.4, 145.7, 143.9, 142.6, 142.5, 138.3, 134.9, 131.2, 126.58, 126.56, 125.2, 124.6, 96.3, 
52.3, 50.2; HR-MS (ESI): calc for C24H14BrIN2 [M+H]+ 536.9458, found 536.9462. 
 
Cyclometallated Platinum Dimer (11). To K2PtCl4 (0.415 g, 0.1 mmol) and 
iodobromide 10 (1.07 g, 0.2 mmol) under argon, 2-ethoxyethanol (60 mL) and H2O 
(20 mL) were added. The reaction mixture was stirred at 100˚C for 20h after sparging 
with argon for 15 min. The reaction mixture was allowed to cool before pouring into H2O 
(200 mL) to precipitate the product. Filtration affords 11 (0.982 g, 64%) as an insoluble  
red-brown solid that was directly carried on to the next step without further purification. 
Its low solubility in all solvents tested, possibly due to its oligomeric nature, limits further 
characterization (e. g. NMR). m. p.: slowly decomposes with no distinct transition above 
290˚C 
 
Cyclometallated Platinum Monomer (12). To platinum dichlorodimer 11 (0.942 g, 
0.06 mmol), Na2CO3 (0.730 g, 0.61 mmol) and 2,2,6,6-tetramethyl-3,5-heptanedione 
(0.380 g, 0.20 mmol) under argon, 2-ethoxyethanol (25 mL) was added and the reaction 
mixture was stirred at 100˚C for 20h after sparging with argon for 15 min. After the 
reaction mixture was allowed to cool to room temperature, it was evaporated under 
reduced pressure to yield a brown oily residue. The residue was purified by column 
chromatography on silica gel with CH2Cl2 : hexane (1:2 v/v) as the eluent to afford 12 
(0.280 g, 49%) as an orange solid. Yellow colored X-ray quality single crystals were 
obtained by slow evaporation of the title compound from a CH2Cl2/pentane mixture. m. p. 
245˚C (dec); 1H-NMR (500 MHz, CDCl3): δ = 8.27 (t, 1H, J = 1.4 Hz), 7.88 (d, 1H, J = 
8.2 Hz), 7.70 (dd, 1H, J = 8.2, 0.8 Hz), 7.52 (m, 4H), 7.13 (m, 4H), 6.49 (s, 1H), 5.89 (s, 
1H), 5.78 (s, 1H), 1.27 (s, 9H), 1.25 (s, 9H); 13C-NMR (125 MHz, CDCl3): δ = 197.8, 
193.9, 164.5, 150.1, 147.0, 146.0, 142.22, 142.15, 141.1, 141.0, 138.8, 133.1, 128.0, 
127.5, 127.3, 125.6, 125.4, 99.5, 93.8, 53.2, 49.8, 42.5, 41.2, 29.4, 28.9; HR-MS (ESI): 
calc for C35H32BrIN2O2Pt [M+H]+ 915.0407, found 915.0427. 
 
9,10-Dihydro-4-methoxy-1-(2-thienyl)-9,10-[1',2']benzeno-2,3-diazaanthracene (14).  
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1-Chloro-9,10-dihydro-4-methoxy-9,10-[1',2']benzeno-2,3-diazaanthracene32 (6.0 g, 
18 mmol), 2-(tributylstannyl)thiophene (12.56 g, 33 mol), Pd(PPh3)4 (1.0 g, 0.9 mmol) 
and CsF (10.22 g, 67 mmol) were weighed into a Schlenk tube and 200 mL of dioxane was 
added. The reaction mixture was sparged for 15 minutes with argon. The reaction mixture 
was stirred at 100˚C for 36 h. The reaction mixture was cooled and was passed through a 
silica gel plug to remove the solids. The silica plug was eluted with ethyl acetate until 
there was no UV-active substance eluting through the column. The combined organic 
fractions were evaporated to yield a solid, which was chromatographed on silica gel with 
dichloromethane : hexane : ethyl acetate (4:10:1 v/v/v) as the eluent to yield 6.5 g (98%) 
of 14 as a white solid.m. p. 177-179˚C; 1H-NMR (500 MHz, CDCl3): δ = 7.65 (dd, 1H, J 
= 3.5, 0.9 Hz), 7.55 (dd, 1H, J = 5.1, 1.0 Hz), 7.52 (m, 2H), 7.48 (m, 2H), 7.29 (dd, 1H, J 
= 5.1, 3.5 Hz), 7.10-7.05 (m, 4H), 6.15 (s, 1H), 5.89 (s, 1H), 4.23 (s, 3H); 13C-NMR 
(125 MHz, CDCl3): δ = 160.5, 148.7, 147.0, 141.13, 141.12, 140.0, 136.0, 128.5, 128.3, 
128.0, 126.6, 126.5, 125.3, 125.2, 55.7, 50.7, 47.3; HR-MS (ESI): calc for C23H16N2OS 
[M+H]+ 369.1056, found 369.1061. 
 
9,10-Dihydro-4-methoxy-1-(5-bromothiophen-2-yl)-9,10-[1',2']benzeno-2,3-
diazaanthracene (15). To a solution of thienylpyridazine 14 (6.5 g, 17.6 mmol) in 
CH2Cl2 (85 mL), molecular bromine (5.63 g, 35 mmol) was added dropwise during 10 
min. The reaction mixture was stirred at room temperature for 2h. The reaction mixture 
was then poured into 10% NaOH solution (200 mL) and the organic layer was washed 
with water and sat. brine solution. The organic layer was dried over Na2SO4, filtered and 
evaporated under reduced pressure to yield a white solid. The solid was chromatographed 
on silica gel using dichloromethane as the eluent to yield 15 as a white solid. (5.9 g, 
75%). m. p. 195-198˚C; 1H-NMR (500 MHz, CDCl3): δ = 7.50 (m, 2H), 7.46 (m, 2H), 
7.40 (d, 1H, J = 3.8 Hz), 7.24 (d, 1H, J = 3.8 Hz), 7.08-7.05 (m, 4H), 6.06 (s, 1H), 5.86 
(s, 1H), 4.21 (s, 3H); 13C-NMR (125 MHz, CDCl3): δ = 160.5, 147.8, 146.8, 144.0, 143.9, 
141.8, 136.2, 131.2, 128.0, 126.7, 126.6, 125.3, 125.1, 115.9, 55.8, 50.5, 47.2; HR-MS 
(ESI): calc for C23H15BrN2OS [M+H]+ 447.0161, found 447.0158. 
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1-(5-Bromothiophen-2-yl)-9,10-dihydro-4-methoxy-9,10-[1',2']benzeno-2,3-
diazaanthracene-1(2H)-one (16). To solid bromothienylpyridazine 15 (5.7 g, 13 mmol) 
in a 200 mL round-bottom flask, was added a solution of hydrogen bromide in acetic acid 
(75 mL, 33% by wt.) and the reaction was stirred at 90 oC for 15h. The reaction mixture 
was allowed to cool to room temperature and evaporated under reduced pressure to yield 
a oily residue. Saturated sodium acetate (200 mL) solution was added to the oily residue 
and was allowed to stir at room temperature for 6h. The white solid was filtered and was 
washed several times with water. The solid was collected and dried in an oven at 60 oC to 
yield 16 (5.6 g, 98%). m. p. 326˚C (dec.); 1H-NMR (300 MHz, (CD3)2SO): δ = 13.35 (br 
s, 1H), 7.70-7.51 (m, 5H), 7.41 (d, 1H, J = 3.9 Hz), 6.17 (s, 1H), 6.00 (s, 1H); 13C-NMR 
(125 MHz, (CD3)2SO): δ = 157.9, 148.5, 146.3, 143.7, 143.3, 138.9, 137.4, 131.7, 128.8, 
125.7, 125.5, 124.6, 124.4, 113.8, 49.3, 46.5; HR-MS (ESI): calc for C22H13BrN2OS 
[M+H]+ 433.0005, found 433.0011. 
 
1-Bromo-4-(5-bromothiophen-2-yl)-9,10-dihydro-9,10-[1',2']benzeno-2,3-
diazaanthracene (17). A mixture of pyridazinone 16 (5.4 g, 12 mmol) in neat molten 
POBr3 (20 g) was stirred at 100 oC for 24 h. The reaction mixture was allowed to cool to 
room temperature. The solid residue was dissolved in CH2Cl2 and was triturated with 
neutral alumina for 12 h, and then flitered through a neutral alumina plug and was eluted 
with more CH2Cl2. The filtrate was evaporated under reduced pressure to afford an off-
white solid. This was further purified by chromatography on silica gel using 
CH2Cl2 : hexane (4:1) as the eluent to yield 17 (5.65 g, 92%) a pale yellow solid. m. p. 
151-154˚C; 1H-NMR (500 MHz, CDCl3): δ = 7.56  (m, 2H), 7.50 (m, 3H), 7.26 (d, 1H, J 
= 4.0 Hz), 7.15-7.10 (m, 4H), 6.10 (s, 1H), 5.89 (s, 1H); 13C-NMR (125 MHz, CDCl3): δ 
= 150.5, 148.2, 145.1, 143.8, 142.90, 142.85, 140.1, 131.6, 129.7, 127.20, 127.18, 125.7, 
125.4, 117.6, 52.9, 50.4; HR-MS (ESI): calc for C22H12Br2N2S [M+H]+ 494.9161, found 
494.9172. 
 
Cyclometallated Platinum Dimer (18). To K2PtCl4 (0.415 g, 0.1 mmol) and dibromide 
17 (1.1 g, 0.002 mol) under argon, 2-ethoxyethanol (60 mL) and H2O (20 mL) were 
added. The reaction mixture was stirred at 100oC for 20h after sparging with argon for 
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15 min. The reaction mixture was allowed to cool before pouring into H2O (200 mL) to 
precipitate the product. Filtration affords 18 (1.1 g, 76%) as an insoluble red-brown solid 
that was directly carried on to the next step without further purification. Its low solubility 
in all solvents tested, possibly due to its oligomeric nature, limits further characterization 
(e. g. NMR). m. p. ~ 310˚C (dec.) 
 
Cyclometallated Platinum Monomer (19). To platinum dichlorodimer 18 (1.0 g, 
0.07 mol), Na2CO3 (0.730 g, 0.7 mmol) and 2,2,6,6-tetramethyl-3,5-heptanedione 
(0.380 g, 0.2 mmol) under argon, 2-ethoxyethanol (25 mL) was added and the reaction 
mixture was stirred at 100oC for 20h after sparging with argon for 15 min. After the 
reaction mixture was allowed to cool to room temperature, it was evaporated under 
reduced to yield a brown oily residue. The residue was purified by column 
chromatography on silica gel with CH2Cl2 : hexane (1:1 v/v) as the eluent to afford 19 
(0.300 g, 50%) as an orange solid. Orange colored X-ray quality single crystals were 
obtained by slow evaporation of the title compound from a CH2Cl2/pentane mixture. 
m. p. ~290˚C (dec.); 1H-NMR (500 MHz, CDCl3): δ = 7.52 (m, 4H), 7.26 (s, 1H), 7.11 
(m, 4H), 5.96 (s, 1H), 5.82 (s, 1H), 5.80(s, 1H), 1.25 (s, 9H), 1.24 (s, 9H); 13C-NMR 
(125 MHz, CDCl3): δ = 197.1, 193.4, 161.2, 151.5, 150.3, 143.4, 142.4, 142.3, 135.6, 
134.2, 133.5, 127.3, 127.2, 125.5, 125.4, 119.0, 93.8, 53.1, 51.6, 42.5, 41.6, 29.3, 28.8; 
HR-MS (ESI): calc for C33H30Br2N2O2PtS [M+H]+ 875.0101, found 875.0090. 
 
2,2'-(9,9-Bis(3,7,11-trimethyldocedyl)-9H-fluorene-2,7-diyl)bis(4,4,5,5-tetramethyl-
1,3,2-dioxaborolane) - mixture of diastereomers (20). Dialkyldiiodofluorene 21 
(8.38 g, 10.0 mmol) is placed in a Schlenk flask equipped with a magnetic stirrer. 
Contents are evacuated and back-filled with argon 5 times, and dry THF (200 mL) is 
added. The resulting solution is cooled to -78˚C and a solution of n-butyllithium (19 mL, 
1.6M in hexanes, 30.4 mmol) is added dropwise. The mixture is stirred for 1h at -78˚C, 
and 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (7.15 mL, 35.1 mmol) is 
added in one portion. The mixture is stirred overnight as it slowly warms to room 
temperature. Contents are poured in water (ca. 250 mL), neutralized to pH ~ 4 with conc. 
HCl, extracted with diethyl ether, washed with brine, dried over anh. MgSO4 and the 
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solvents are evaporated under reduced pressure. Purification of the residue by column 
chromatography using progressively more polar 80:20 to 50:50 
hexanes : dichloromethane (v/v) to afford 20 as a colorless, viscous oil (1.82 g, 22%). 1H-
NMR (500 MHz, CDCl3): δ = 7.81 (d, 2H, J = 7.5 Hz), 7.76 (s, 2H), 7.73 (d, 2H, J = 7.5 
Hz), 2.20-1.90 (m, 4H), 1.56-1.44 (m, 2H), 1.39 (s, 24H), 1.36-0.90 (m, 30H), 0.86 (d, 
12H, J = 6.5 Hz), 0.77 (dd, 6H, J = 6.0, 3.5 Hz), 0.65 (d, 6H, J = 6.5 Hz), 0.60-0.36 (m, 
4H); 13C-NMR (125 MHz, CDCl3): δ = 150.6, 144.2, 138.9, 130.8, 129.2, 119.6, 83.9, 
55.2,  39.6, 37.6, 37.50, 37.49, 37.46, 36.92, 36.90, 30.8, 30.6, 28.2, 25.1, 25.02, 24.99, 
24.54, 24.51, 23.0, 22.9, 19.9, 19.8, 19.7, 19.6, ; HR-MS (EI): calc for C55H92B2O4 [M]+ 
838.7209, found 838.7211. 
 
2,7-Diiodo-9,9-bis(3,7,11-trimethyldodecyl)-9H-fluorene - mixture of diastereomers 
(21). A suspension of 2,7-diiodofluorene (8.36 g, 20.0 mmol), 1-bromo-3,7,11-
trimethyldodecane (mixture of diastereomers, 14.6 g, 50.2 mmol), and 
benzyltriethylammonium chloride (1.20 g, 5.2 mmol) in dimethylsulfoxide (60 mL) is 
degassed by bubbling nitrogen through for ca. 15 mins. To the stirred suspension is added 
50% aq. NaOH (4 g NaOH in 8 mL H2O, 100 mmol). A red color attributed to the 
fluorenenyl anion develops instantly upon addition. The suspension is stirred at room 
temperature for ca. 48 h, and is then poured in an excess of water. After neutralization 
with conc. HCl, the product is extracted with diethyl ether, and the solvents are 
evaporated under reduced pressure. The resulting crude product is redissolved in pyridine 
(100 mL) and refluxed overnight to quaternize excess alkyl bromide.33 After cooling to 
room temperature and evaporation of the solvent under reduced pressure, the residue is 
purified by column chromatography on silica gel using hexanes as the mobile phase to 
afford 21 as a pale viscous oil (11.91 g, 71%). 1H-NMR (300 MHz, CDCl3): δ =7.66 (m, 
4H), 7.42 (d, 2H, J = 8.7 Hz), 1.92 (m, 4H), 1.53 (m, 2H), 1.32-0.94 (m, 30H), 0.87 (d, 
12H, J = 6.6 Hz), 0.81 (dd, 6H, J = 6.3, 0.9 Hz), 0.71 (d, 6H, J = 6.3 Hz), 0.64-0.36 (m, 
4H); 13C-NMR (75 MHz, CDCl3): δ = 152.6, 140.0, 136.2, 132.2, 121.7, 93.3, 55.5, 39.6, 
37.6, 37.5, 36.8, 33.0, 32.9, 30.6, 30.4, 28.2, 25.04, 25.01, 24.5, 23.0, 22.9, 20.0, 19.9, 
19.7, 19.6; HR-MS (EI): calc for C43H68I2 [M]+ 838.3405, found 838.3429. 
 291 
 
                                                
3. 5 References and Notes 
 
1 Comments on attribution. The synthesis, characterization and studies of compounds 1-
6 (LC) were performed by J. Bouffard. The synthesis and characterization of compounds 
7-10, 13 was performed by J. Bouffard. The synthetic route to monomer 17 was designed 
by Dr. K. Venkatesan and J. Bouffard, and compounds 11-12, 14-19 were prepared and 
characterized by Dr. K. Venkatesan. Iptycene-derived pyridazine precursors were 
developed and prepared by J. Bouffard. Compounds 20 and 21 were synthesized and 
characterized by J. Bouffard. The preparation of phosphorescent conjugated polymers 
that incorporate monomers 12 and 19 is currently being investigated by Dr. Venkatesan. 
2 Goodby, J. W.; Gray, G. W. In Handbook of Liquid Crystals; Demus, D.; Goodby, J.; 
Gray, G. W.; Spiess, H.-W.; Vill, V., Eds.; Wiley-WCH, Weinheim, Germany, 1998, vol. 
1, p.18. 
3 (a) Luckhurst, G. R. Thin Solid Films 2001, 393, 40-52. (b) Yu, L. J.; Saupe, A. Phys. 
Rev. Lett. 1980, 45, 1000-1003.  
4 Long, T. M.; Swager, T. M. J. Mater. Chem. 2002, 3407-3412. 
5 Long, T. M.; Swager, T. M. J. Am. Chem. Soc. 2002, 124, 3826-3827. 
6 (a) Norvez, S.; Simon, J. J. Chem. Soc., Chem. Commun. 1990, 1398-1399. (b) Norvez, 
S. J. Org. Chem. 1993, 58, 2414-2418. (c) Norvez, S.; Simon, J. Liq. Cryst. 1993, 14, 
1389-1395. 
7 (a) See Chapter 1. (b) Bouffard, J.; Eaton, R. F.; Müller, P.; Swager, T. M. J. Org. 
Chem. in press. 
8 Gelman, D.; Buchwald, S. L. Angew. Chem. Int. Ed. 2003, 42, 5993-5996. 
9 Kraft, A.; Grimsdale, A. C.; Holmes, A. B. Angew. Chem. Int. Ed. 1998, 37, 402-428. 
10 (a) McQuade, D. T.; Pullen, A. E.; Swager, T. M. Chem. Rev. 2000, 100, 2537-2574. 
(b) Thomas, S. W., III; Joly, G. D.; Swager, T. M. Chem. Rev. 2007, 107, 1339-1386. 
11 (a) Baldo, M. A.; O'Brien, D. F.; You, Y.; Shoustikov, A.; Sibley, S.; Thompson, M. 
E.; Forrest, S. R. Nature 1998, 395, 151-154. (b) Holder, E.; Langeveld, B. M. W.; 
Schubert, U. S. Adv. Mater. 2005, 17, 1109-1121. (c) Wohlgenannt, M.; Vardeny, Z. V. 
J. Phys. Condens. Mater. 2003, 15, R83-R107. 
12 Kawamura, Y.; Yanigada, S.; Forrest, S. R. J. Appl. Phys. 2002, 92, 87-93. (b) Chen, 
F.-C.; He, G.; Yang, Y. Appl. Phys. Lett. 2003, 82, 1006-1008. (c) Chen, F.-C.; Chang, 
S.-C.; He, G.; Pyo, S.; Yang, Y.; Kurotaki, M.; Kido, J. J. Polym. Sci. B 2003, 41, 2681-
2690. (d) Vaeth, K. M.; Tang, C. W. J. Appl. Phys. 2002 92, 3447-3453. (e) Xia, H.; 
Zhang, C.; Liu, X.; Qiu, S.; Lu, P.; Shen, F.; Zhang, J.; Ma, Y. J. Phys. Chem. B 2004, 
108, 3185-3190. (f) You, Y.; An, C.-G.; Kim, J.-J.; Park, S. Y. J. Org. Chem. 2007, 72, 
6241-6246. (g) Zhu, W.; Lui, C.; Su, L.; Yang, W.; Yuan, M.; Cao, Y. J. Mater. Chem. 
2003, 13, 50-55. (h) Noh, Y.-Y.; Lee, C.-L.; Kim, J.-J.; Yase, K. J. Chem. Phys. 2003, 
118, 2853-2864. (i) Cho, J.-Y.; Domercq, B.; Barlow, S.; Suponitsky, K. Y.; Li, J.; 
Timofeeva, T. V.; Jones, S. C.; Hayden, L. E.; Kimyonok, A.; South, C. R.; Weck, M.; 
Kippelen, B.; Marder, S. R. Organometallics 2007, 26, 4816-4829.  
13 (a) Evans, N. R.; Devi, L. S.; Mak, C. S. K.; Watkins, S. E.; Pascu, S. I.; Köhler, A.; 
Friend, R. H.; Williams, C. K.; Holmes, A. B. J. Am. Chem. Soc. 2006, 128, 6647-6656. 
 292 
                                                                                                                                            
(b) Chen, X.; Liao, J.-L.; Liang, Y.; Ahmed, M. O.; Tseng, H.-E.; Chen, S.-A. J. Am. 
Chem. Soc. 2003, 125, 636-637.  
14 (a) Sandee, A. J.; Williams, C. K.; Evans, N. R.; Davies, J. E.; Boothby, C. E.; Köhler, 
A.; Friend, R. H.; Holmes, A. B. J. Am. Chem. Soc. 2004, 126, 7041-7048. (b) Ley, K. 
D.; Whittle, C. E.; Bartberger, M. D.; Schanze, K. S. J. Am. Chem. Soc. 1997, 119, 3423-
3424. (c) Schultz, G. L.; Chen, X.; Chen, S.-A.; Holdcroft, S. Macromolecules 2006, 39, 
9157-9165. (d) Zhang, M.; Lu, P.; Wang, X.; He, L.; Xia, H.; Zhang, W.; Yang, B.; Lui, 
L.; Yang, L.; Yang, M.; Ma, Y.; Feng, J.; Wang, D.; Tamai, N. J. Phys. Chem. B 2004, 
108, 13185-13190. (e) Zhen, H.; Jiang, C.; Yang, W.; Jiang, J.; Huang, F.; Cao, Y. Chem. 
Eur. J. 2005, 11, 5007-5016. 
15 (a) Hagihara, N.; Sonogashira, K.; Takahashi, S. Adv. Polym. Sci. 1980, 41, 149-179. 
(b) Chawdury, N.; Köhler, A.; Friend, R. H.; Younus, M.; Long, N. J.; Raithby, P. R.; 
Lewis, J. Macromolecules 1998, 31, 722-727. (c) Wittmann, H. F.; Friend, R. H.; Khan, 
M. S.; Lewis, J. J. Chem. Phys. 1994, 101, 2693-2698. (d) Köhler, A.; Wilson, J. S.; 
Friend, R. H.; Al-Suti, M. K.; Khan, M. S.; Gerhard, A.; Bässler, H. J. Chem. Phys. 2002, 
116, 9457-9462. (e) Uounus, M.; Köhler, A.; Cron, S.; Chawdhury, N.; Al-Mandhary, M. 
R. A.; Khan, M. S.; Lewis, J.; Long, N. J.; Friend, R. H.; Raithby, P. R. Angew. Chem. 
Int. Ed. 1998, 37, 3036-3039. (f) Wilson, J. S.; Köhler, A.; Friend, R. H.; Al-Suti, M. K.; 
Al-Mandhary, M. R. A.; Khan, M. S.; Raithby, P. R. J. Chem. Phys. 2000, 113, 7627-
7634. 
16 Thomas, S. W., III; Yagi, S.; Swager, T. M. J. Mat Chem. 2005, 15, 2829-2835.  
17 Venkatesan, K.; McNeil, A. J.; Zhao, D.; Swager, T. M. Unpublished results. 
18 (a) Zhao, D.; Swager, T. M. Org. Lett. 2005, 7, 4357-4360. (b) McNeil, A. J.; Müller, 
P.; Whitten, J. E.; Swager, T. M. J. Am. Chem. Soc. 2006, 128, 12426-12427. 
19 (a) Ionkin, A. S.; Marshall, M. J.; Wang, Y. Organometallics 2005, 24, 619-627. (b) 
Chou, P.-T.; Chi, Y. Chem. Eur. J. 2007, 13, 380-395. (c) Kavitha, J.; Chang, S.-Y.; Chi, 
Y.; Yu, J.-K.; Hu, Y.-H.; Chou, P.-T.; Peng, S.-M.; Lee, G.-H.; Tao, Y.-T.; Chien, C.-H.; 
Carty, A. J. Adv. Funct. Mater. 2003, 15, 223-229. (d) Xie, H. Z.; Liu, M. W.; Wang, O. 
Y.; Zhang, X. H.; Lee, C. S.; Hung, L. S.; Lee, S. T.; Teng, P. F.; Kwong, H. L.; Zheng, 
H.; Che, C. M. Adv. Mater. 2001, 13, 1245-1248. 
20 (a) Yang, J.-S.; Swager, T. M. J. Am. Chem. Soc. 1998, 120, 5321-5322. (b) Yang, J.-
S.; Swager, T. M. J. Am. Chem. Soc. 1998, 120, 11864-11873. 
21 (a) Swager, T. M. Acc. Chem. Res. 1998, 31, 201-207. (b) Zhou, Q.; Swager, T. M. J. 
Am. Chem. Soc. 1995, 117, 12593-12602.  
22 (a) Briñas, R. P.; Troxler, T.; Hochstrasser, R. M.; Vinogradov, S. A. J. Am. Chem. 
Soc. 2005, 127, 11851-11862. (b) Ruffolo, R.; Evans, C. E. B.; Liu, X.-H.; Ni, Y.; Pang, 
Z.; Park, P.; McWilliams, A. R.; Gu, X.; Lu, X.; Yekta, A.; Winnik, M. A.; Manners, I. 
Anal. Chem. 2000, 72, 1894-1904. (c) Liu, Y.-M.; Pereiro-Garcia, R.; Valencia-Gonzalez, 
M. J.; Diaz-Garcia, M. E.; Sanz-Medel, A. Anal. Chem. 1994, 66, 836-840. (d) Pang, Z.; 
Gu, X.; Yekta, A.; Masoumi, Z.; Coll, J. B.; Winnik, M. A.; Manners, I. Adv. Mater. 
1996, 8, 768-771. (e) Lowry, M. S.; Bernhard, S. Chem. Eur. J. 2006, 12, 7970-7977. (f) 
O'Donovan, C.; Hynes, J.; Yashunski, D.; Papkovsky, D. B. J. Mater. Chem. 2005, 15, 
2946-2951. (g) O'Riordan, T. C.; Voraberger, H.; Kerry, J. P.; Papkovsky, D. B. Anal. 
Chim. Acta 2005, 530, 135-141.(h) Costa-Fernandez, J. M.; Diaz-Garcia, M. E.; Sanz-
 293 
                                                                                                                                            
Medel, A. Anal. Chim. Acta 1998, 360, 17-26. (i) Papkovsky, D. B.; Desyaterik, I. V.; 
Ponomarev, G. V.; Kurochkin, I. N.; Korpela, T. Anal. Chim. Acta 1995, 310, 233-239. 
23 Thomas, S. W., III; Venkatesan, K.; Müller, P.; Swager, T. M. J. Am. Chem. Soc. 2006, 
128, 16641-16648. 
24 Slater, J. W.; Lyndon, D. P.; Alcock, N. W.; Rourke, J. P. Organometallics 2001, 20, 
4418-4423. 
25 (a) Farina, V.; Krishnan, B.; Marshall, D. R.; Roth, G. P. J. Org. Chem. 1993, 58, 
5434-5444. (b) Paintner, F. F.; Görler, K.; Voelter, W. Synlett 2003, 522-525. (c) 
Albrecht, B. K.; Williams, R. M. Tetrahedron Lett. 2001, 42, 2755-2757. (d) Yan, Z.; 
McCraken, T.; Xia, S.; Maslak, V.; Gallucci, J.; Hadad, C. M.; Badjic, J. D. J. Org. 
Chem. in press. (published online on 10/11/2007, DOI: 10.1021/jo701538g 
26 The crystal structure of 19 was solved by Dr. Peter Müller. 
27 Janiak, C. J. Chem. Soc., Dalton Trans. 2000, 3888-3896. 
28 Goshe, A. J.; Steele, I. M; Bosnich, B. J. Am. Chem. Soc. 2003, 125, 444-451 and 
references therein. 
29 Chang J. Y.; Baik, J. H.; Lee, C. B.; Han, M. J. J. Am. Chem. Soc. 1997, 119, 3197-
3198. 
30 Anemian, R.; Morel, Y.; Baldeck, P. L.; Paci, B.; Kretsch, K.; Nunzi, J.-M.; Andraud, 
C. J. Mater. Chem. 2003, 19, 2157-2163. 
31 (a) Schouten, P. G.; van der Pol, J. F.; Zwikker, J. W.; Drenth, W.; Picken, S. J. Mol. 
Cryst. Liq. Cryst. 1991, 195, 291-305. (b) Asawapirom, U.; Güntner, R.; Forster, M.; 
Farrell, T.; Scherf, U. Synthesis, 2002, 1136-1142. 
32 Nitschke, J. R.; Zürcher, S.; Tilley, T. D. J. Am. Chem. Soc. 2000, 122, 10345-10352. 
33 Kannan, R.; He, G. S.; Lin, T.-C.; Prasad, P. N.; Vaia, R. A.; Tan, L.-S. Chem. Mater. 
2004, 16, 185-194. 
 
 295 
 
 
 
 
 
 
Chapter 3 Appendix 
1H-NMR and 13C-NMR Spectra 
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Figure 3.A.1. 1H-NMR Spectrum of 1 in CDCl3 (500 MHz).  
 
Note: * EtOH. 
Figure 3.A.2. 13C-NMR Spectrum of 1 in CDCl3 (125 MHz). 
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Figure 3.A.3. 1H-NMR Spectrum of 2 in CDCl3 (500 MHz).  
 
Figure 3.A.4. 13C-NMR Spectrum of 2 in CDCl3 (125 MHz). 
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Figure 3.A.5. 1H-NMR Spectrum of 3 in CDCl3 (500 MHz).  
 
Figure 3.A.6. 13C-NMR Spectrum of 3 in CDCl3 (125 MHz). 
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Figure 3.A.7. 1H-NMR Spectrum of 4 in CDCl3 (300 MHz).  
 
Figure 3.A.8. 1H-NMR Spectrum of 4 in CDCl3 (125 MHz). 
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Figure 3.A.9. 1H-NMR Spectrum of 6-SiMe3 in CDCl3 (500 MHz).  
 
Figure 3.A.10. 13C-NMR Spectrum of 6-SiMe3 in CDCl3 (125 MHz). 
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Figure 3.A.11. 1H-NMR Spectrum of 6 in CDCl3 (300 MHz).  
 
Figure 3.A.12. 13C-NMR Spectrum of 6 in CDCl3 (125 MHz). 
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Figure 3.A.13. 1H-NMR Spectrum of 7 in CDCl3 (500 MHz).  
 
Note: * Water; * Acetone. 
 
Figure 3.A.14. 13C-NMR Spectrum of 7 in CDCl3 (75 MHz).  
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Figure 3.A.15. 1H-NMR Spectrum of 8 in CDCl3 (500 MHz).  
 
Note: * Water. 
 
Figure 3.A.16. 13C-NMR Spectrum of 8 in CDCl3 (75 MHz). 
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Figure 3.A.17. 1H-NMR Spectrum of 9 in (CD3)2SO (500 MHz).  
 
Note: * Water; * DMSO. 
Figure 3.A.18. 1H-NMR Spectrum of 9 in (CD3)2SO (125 MHz). 
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Figure 3.A.19. 1H-NMR Spectrum of 10 in CDCl3 (500 MHz).  
 
Note: * Water; * MeCN. 
Figure 3.A.20. 13C-NMR Spectrum of 10 in CDCl3 (125 MHz). 
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Figure 3.A.21. 1H-NMR Spectrum of 12 in CDCl3 (500 MHz).  
 
Figure 3.A.22. 13C-NMR Spectrum of 12 in CDCl3 (125 MHz). 
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Figure 3.A.23. 1H-NMR Spectrum of 13 in CDCl3 (300 MHz).  
 
Figure 3.A.24. 13C-NMR Spectrum of 13 in CDCl3 (125 MHz). 
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Figure 3.A.25. 1H-NMR Spectrum of 14 in CDCl3 (500 MHz).  
 
Figure 3.A.26. 13C-NMR Spectrum of 14 in CDCl3 (125 MHz). 
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Figure 3.A.27. 1H-NMR Spectrum of 15 in CDCl3 (500 MHz).  
 
Figure 3.A.28. 13C-NMR Spectrum of 15 in CDCl3 (125 MHz). 
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Figure 3.A.29. 1H-NMR Spectrum of 16 in (CD3)2SO (300 MHz).  
 
Note: * Water 
Figure 3.A.30. 13C-NMR Spectrum of 16 in (CD3)2SO  (125 MHz). 
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Figure 3.A.31. 1H-NMR Spectrum of 17 in CDCl3 (500 MHz).  
 
Figure 3.A.32. 13C-NMR Spectrum of 17 in CDCl3 (125 MHz). 
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Figure 3.A.33. 1H-NMR Spectrum of 19 in CDCl3 (500 MHz).  
 
Figure 3.A.34. 13C-NMR Spectrum of 19 in CDCl3 (125 MHz). 
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Figure 3.A.35. 1H-NMR Spectrum of 20 in CDCl3 (500 MHz).  
 
Figure 3.A.36. 13C-NMR Spectrum of 20 in CDCl3 (125 MHz). 
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Figure 3.A.37. 1H-NMR Spectrum of 21 in CDCl3 (300 MHz).  
 
Figure 3.A.38. 13C-NMR Spectrum of 21 in CDCl3 (75 MHz). 
 
I I
21
 315 
Figure 3.A.39. Thermal ellipsoid representation of 19. 
 
 
 
 
 
 
 
 
Chapter 4 
A Highly Selective Fluorescent Probe for  
Thiol Bioimaging 
 
Completed in collaboration with Dr. Youngmi Kim1 
 
Adapted in part from: 
Bouffard, J.; Kim, Y.; Swager, T. M., Weissleder, R., Hilderbrand, S. A.; manuscript 
submitted to Org. Lett. 
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4.1 Introduction: Utility and Need for Thiol Sensors 
 
The rapid, sensitive and selective sensing of thiols is of significant interest in 
areas ranging from the petrochemical industry,2 to food quality control and safety.3  The 
optical sensing of thiols is particularly relevant in biological systems. Intracellular thiols 
such as glutathione (GSH), cysteine (Cys) and homocysteine (HCys) play a crucial role in 
maintaining biological redox homeostasis through the equilibrium established at a given 
electrical potential between reduced free thiols (RSH) and oxidized disulfides (RSSR). 
Thiols may also act as active residues in the catalytic sites of enzymes (e.g. papain and 
other thiol proteases), or play other important roles in metabolic pathways.4 The levels of 
certain thiols, such as homocysteine, have been linked to a number of diseases, including 
cancers, Alzheimer's and cardiovascular diseases.5 Thiol levels may also be affected in 
response to the oxidative stress that has been associated with some of these conditions.6 
Furthermore, thiol probes are desirable for assaying enzymes that release a thiols upon 
reaction with a substrate (e.g. thioesterases) and for finding and evaluating new inhibitors 
of these enzymes.7, 14a 
 
4.2 Survey of Current Methods for the Optical Detection of Thiols  
 
Ellman's reagent (5,5'-dithiobis(2-nitrobenzoic acid)) is the classical probe for the 
determination of sulfhydryl groups by UV-Vis absorption spectrophotometry (Scheme 
4.1). 8  The iodine-azide reaction is catalyzed by thiols and other divalent sulfur 
compounds, and can serve as a very sensitive test for these compounds (Scheme 4.2).9 
However, the formation of gas bubbles is a poor transduction mechanism and, for the 
lack of a better readout, this method has largely been replaced by chromatographic (GC, 
HPLC) and optical methods. A large number of chromophores and fluorophores bearing 
electrophilic groups (e.g. iodoacetamides, maleimides and benzyl halides) to which thiols 
may be covalently attached have been developed for thiol bioconjugation and are 
commercially available. However, these often suffer from low on/off signal ratios that 
result in the need for washing and isolation steps, thus precluding rapid quantification 
(Scheme 4.3).10 Many of these also suffer from reactivity toward other good nucleophiles 
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such as amines, resulting in lower selectivity for the analyte of interest. Kosower's 
bimanes (1,5-diazabicyclo[3.3.0]octadienones) offer good turn-on fluorescence signals as 
thiol probes, and have been extensively used for protein thiol labeling, fluorescence 
microscopy and flow cytometry, but require excitation with UV light (Scheme 4.4).11 
 
Scheme 4.1. Detection of Thiols with Ellman's Reagent. 
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Scheme 4.2. Detection of Thiols by the Iodine-Azide Reaction. 
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Scheme 4.3. Examples of Commercially Available Electrophilic Dyes for the 
Conjugation of Thiols. 
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Scheme 4.4. Fluorescent Turn-On Probes for Thiols Based on Bimanes. 
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The area of thiol-sensitive sensors and imaging agents is undergoing a renaissance 
that is largely driven by the development of selective fluorescent turn-on probes. These 
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new probes generally fall in two categories: i) probes based on the interruption of an 
internal PET (photoinduced electron transfer) upon reaction with a thiol and ii) probes in 
which thiols cleave the 'protecting group' of a proto-fluorochrome to release an emissive 
dye after deprotection. The first construction requires a molecule or functional group that 
quenches the fluorescence to be located in close proximity to the fluorophore, usually 
through covalent attachment but not in direct electronic conjugation. If the energy levels 
of the two fragments are such that the lowest unoccupied molecular orbital (LUMO) of 
the quencher is sandwiched between the LUMO of fluorophore and its highest occupied 
molecular orbital (HOMO), an efficient and exergonic electron transfer from the excited 
fluorophore to the quencher occurs. The system then relaxes to its ground state through 
non-radiative pathways. Upon reaction with an analyte (thiol), either the quencher is 
cleaved and diffuses away from the fluorophore, or its energy levels are altered so that 
the PET is no more thermodynamically possible, or at least no more kinetically 
competent with respect to the rate of radiative decay. For thiol sensing, the quencher of 
choice is usually the maleimide group, whose low-lying π* LUMO is raised upon the 
conjugate addition of a thiol (Scheme 4.5).12  
 
Nitrobenzenesulfonyl protecting groups, introduced by Fukuyama et al., are 
selectively cleaved by thiols under mild conditions.13 The Maeda group has applied these 
protecting groups in turn-on sensing schemes for thiols and selenols in which the 
deprotection of an electron-poor arenesulfonate ester results in the release of a 
fluorophore (Scheme 4.6).14 The arenesulfonate ester group attached to the fluorescein 
dye favors a resonance hybrid in which electronic delocalization is less efficient, resulting 
in lower fluorescence quantum yields. Electron-poor arenesulfonate groups may in 
addition participate in PET quenching. Upon cleavage of the protecting group with a 
thiol, the fluorophore is released in its emissive form, resulting in a strong signal increase 
(turn-on). The attack of a thiol nucleophile on a Se-N bond leading to the release of a 
rhodamine fluorophore has also recently been reported (Scheme 4.7).15  
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Scheme 4.5. Fluorescent Turn-On Probes for Thiols Based on PET to a Maleimide. 
(adapted from ref. 12a) 
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Scheme 4.6. Fluorescent Turn-On Probes for Thiols Based on Arenesulfonate 
Deprotection (top) and Se-N Bond Cleavage (bottom). (adapted from refs. 14a and 15) 
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While the new generation of probes for thiols offers great advantages over 
previously available probes, some limitations remain. Many of these probes suffer from 
poor solubility in aqueous media, requiring the use of organic co-solvents. 16 
Arenesulfonate protecting groups and maleimides are also susceptible of attack by 
nitrogen or oxygen nucleophiles. These parasitic side-reactions (e.g. unspecific 
hydrolysis) lower both sensitivity (higher blank signals and lower signal-to-noise ratios) 
and selectivity for thiol analytes. Finally, few of these probes either absorb or emit in the 
red region of the spectrum, though this region is most suitable for biological 
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measurements due to lower scattering, reduced autofluorescence, higher transparency and 
greater photostability of biological media at these wavelengths. 
 
4.3 Design and Synthesis of Fluorescent Thiol Probe 3 
 
We have designed and synthesized a new fluorescent probe for thiols (3) based on 
the protecting group approach that addresses a number of these drawbacks. In order to 
improve the probe's inertness towards oxygen and nitrogen nucleophiles, and increase the 
selectivity towards thiols, the arenesulfonate deprotection approach of Maeda et al. was 
superseded by the use of the more resistant arenesulfonamide as a protecting group.17 We 
took advantage of the fact that deprotection releases a strongly electron-donating aniline 
to assemble the donor-π-acceptor dye 4. The p-phenylene vinylene π-conjugated bridge 
and the strongly electron-accepting TCF group18 complete the low optical band-gap 
fluorochrome design. The push-pull character of the dye is greatly increased upon 
cleavage of the electron-withdrawing sulfonyl group. As a consequence, in addition to an 
increase in fluorescence quantum yield, large hyper- and bathochromic shifts in the 
absorption and emission spectra occur upon deprotection. The triethyleneglycol methyl 
ether side-chain serves two purposes. First, it confers higher water solubility to probe 3. 
Second, the substitution of a free sulfonamide N-H by a side-chain extents the pH range 
in which probe 3 can used compared to the corresponding acidic secondary 2,4-
dinitrobenzenesulfonamides. The latter decompose to the corresponding 2,4-
dinitroanilines after extrusion of sulfur dioxide under basic conditions (Scheme 4.7).13b, 17  
 
Scheme 4.7. Decomposition of Secondary 2,4-Dinitrobenzenesulfonamides in Base. 
(adapted from ref. 13b) 
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The synthesis of probe 3 is presented in Scheme 4.8. The probe is prepared in 
moderate yield in three steps starting from an acetal-protected 4-aminobenzaldehyde. The 
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synthetic route emphasizes the modular nature of the design that allows for a variation at 
will of each of the constituents (arenesulfonyl group, side-chain, π-conjugated bridge, 
electron-acceptor). The modular nature facilitate the introduction of molecular or 
biological recognition elements (e.g. carbohydrate, peptide, etc.) on the probe's side-chain 
to result in probes that are specific to thiols in the presence or vicinity of the recognized 
target. The validity of the proposed sensing scheme (Scheme 4.9) was confirmed by the 
preparative-scale synthesis of the free dye 4 from 3 and thioglycolic acid.  
 
Scheme 4.8.  Synthesis of thiol probe 3 
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Scheme 4.9.  Cleavage of the sulfonamide 3 with thiols to release fluorochrome 4. 
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4.4 Thiol Sensing and Selectivity of Probe 3 
 
The sensory response of probe 3 was determined in collaboration with Dr. 
Youngmi Kim (Center for Molecular Imaging Research, Massachusetts General Hospital, 
Harvard Medical School),1 and is exemplified by its reaction with cysteine (Figure 4.1). 
Upon addition of cysteine to a solution of 3 in HEPES buffer (pH 7.4), the solution 
instantly turns from yellow to pink, and the absorption spectrum shows the rise of the 
absorption band of 4 that is red-shifted by 158 nm compared to that of 3. A remarkable 
increase in the fluorescence intensity of up to 120-fold, depending on the concentrations 
of the reagents, is also observed.  
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Figure 4.1. (a) Absorption and (b) emission spectra (λex = 560 nm) of probe 3 before 
(dotted line) and after (solid line) addition of cysteine in HEPES buffer solution (10 mM, 
pH 7.4). The spectra were obtained immediately after addition of cysteine. The final 
concentration of probe and cysteine are 10 µM and 1 mM, respectively.  
 
The selectivity of probe 3 for thiols was confirmed by screening its response in 
the presence biologically relevant analytes under physiological conditions (37˚C, 10 mM 
HEPES buffer, pH 7.4) (Figure 4.2). Probe 3 shows positive fluorescence response only 
in the presence of thiols (cysteine, reduced glutathione, dithiothreitol), for which 
fluorescence signals were increased 60-120 fold. No significant signal increases above 
blank levels were observed in the presence of amines (lysine), reactive oxygen species (t-
butylhydroperoxide, hydrogen peroxide, sodium hypochlorite) or reducing agents 
(ascorbic acid). Probe 3 also remains essentially unaffected by a hydrolytic enzyme 
(porcine liver esterase). It is worth noting that probe 3 is responsive to thiols at a pH 
lower than their pKa (~10-11), indicating that a complete deprotonation of the thiols is not 
required for their detection. 
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Figure 4.2. Relative response of probe 3 to different analytes. Relative fluorescence 
intensity of 10 µM of probe 3 at 627 nm (λex = 565 nm) before (white bars, left) and after 
(black bars, right) incubation at 37˚C for 15 min in the presence of 100 µM (final 
concentrations) of the analytes. Porcine liver esterase was added to a concentration of 
1.4 unit/mL. 
 
4.5 Photophysical Properties 
 
In aqueous media (10 mM HEPES buffer, pH 7.4), the probe 3 has an absorption 
maxima of λmax = 405 nm (ε = 21 200 mol L-1 cm-1) and is essentially non-fluorescent with 
a trace emission centered at λex = 560 nm (ΦF = 0.0008). The quenched fluorescence is 
attributed to the lack of charge-transfer character in the protected probe and to an 
efficient donor-excited photoinduced electron transfer (PET) to the 
dinitrobenzenesulfonyl group. Upon deprotection, free dye 4 exhibits significant batho- 
and hyperchromic shifts in its absorption spectra, with an absorption maxima of 
λmax = 563 nm (ε = 35 100 mol L-1 cm-1), indicative of the more efficient delocalization in 
the push-pull chromophore. The absorption and emission spectra of 3 and 4 remain 
essentially unchanged over a wide pH range (5.6-9.5) that is compatible with most 
biological applications (Figure 4.3). Furthermore, in aqueous buffer solution at pH 7.4, 
no hydrolysis of probe 3 is detected over 12 hours at 37˚C.  
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Figure 4.3. Absorption spectra of probe 3 in different pH buffers. 0.1 M acetate buffer 
for pH 5.6; 10 mM HEPES buffer for pH 7.4; 0.1 M phosphate buffer for pH 7.8; 0.1 M 
Tris buffer for pH 8.2; 0.1 M carbonate buffer for pH 9.5.  
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Figure 4.4. (A) Absorption and (B) emission spectra (λex = 560 nm) of free dye 4 in 
different pH buffer systems. 0.1 M acetate buffer for pH 5.6; 10 mM HEPES buffer for 
pH 7.4; 0.1 M phosphate buffer for pH 7.8; 0.1 M Tris buffer for pH 8.2; 0.1 M carbonate 
buffer for pH 9.5.  
 
In aqueous solution, the fluorescence quantum yield of 4 remains modest with a 
ΦF = 0.01, with a λem = 623 nm (Table 4.1). However, like other donor-acceptor 
fluorophores bearing dicyanomethylene-based acceptors groups, 19  the fluorescence 
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quantum yield jumps up in more viscous or rigid environment. In 90:10 
glycerol : methanol, the value of the quantum yield reaches the value of 0.18 
(Figure 4.5). This dependence on media can be advantageous for biological imaging. 
Upon interaction or adsorption with macromolecules and surfaces in cell environment, 
the ΦF of 4 increases. The photophysical properties of the free dye 4 in the presence of 
human serum albumin (HSA) illustrate this effect (Figure 4.6). The addition of 1% HSA 
to a solution of 4 in HEPES buffer increased its ΦF to 0.24. Small bathochromic and 
hyperchromic shifts are also observed upon addition of HSA. The beneficial influence on 
the fluorescence quantum yield of interactions between dye 4 and biological surfaces and 
macromolecules suggest that turn-on fluorescence signal improvements greater than the 
120-fold on/off ratios observed in ordinary aqueous solutions may be achieved in a 
number of biosensing schemes. Furthermore, the photophysical properties of 
fluorophores closely related to 4 suggest that this thiol probe could be adequate for 
single-molecule or 2-photon sensing schemes.19b 
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Figure 4.5. (A) Absorption and (B) fluorescence spectra (λex = 570 nm) of dye 4 (3.3 X 
10-6 M)  in glycerol/methanol solutions with increasing viscosity. 
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Figure 4.6. (A) Absorption and (B) fluorescence spectra (λex = 560 nm) of dye 4 
(3.3 X 10-6 M) in different concentrations of human serum albumin in HEPES buffer 
solution (10 mM, pH 7.4).  
 
Table 4.1. Photophysical properties of probe 3 and free dye 4.a  
 
λmax 
(nm) 
λem 
(nm) 
εmax 
(M-1cm-1) 
ΦF
b
 
 
Probe 3 405 560 21 200 0.0008 
Free dye 4 563 (587) 623 (627) 35 100 (40 400) 0.01 (0.24) 
a All measurements were done in HEPES buffer (10 mM, pH 7.4). Probe 3 and free dye 4 
were excited at 400 nm and 560 nm, respectively. Values in parenthesis () were measured 
in the presence of 1% human serum albumin (HSA) in HEPES buffer (10 mM, pH 7.4). 
b Quantum yields vs. quinine sulfate (0.54, 0.1 M H2SO4) for 3 and vs. cresyl violet (0.54, 
MeOH) for 4. 
 
4.6 Bioimaging Using Probe 3 
 
The monitoring of thiols in living cells by probe 3 was undertaken. Albino Swiss 
mouse embryo fibroblast cells (3T3 cell line) were incubated with a solution of probe 3 
(25 µM in 1:100 DMSO-PBS v/v, pH 7.4) for 10 minutes at 37˚C. Probe 3 was found to 
be cell-permeable and to react with thiols present in the cytoplasm, resulting in a bright 
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fluorescence image as observed by fluorescence microscopy (Figure 4.7C). In a control 
experiment, cells that were pretreated with an excess the thiol-reactive N-
methylmaleimide, which consumes all of the free thiols within the cells, and then 
incubated with probe 3 do not show a significant fluorescence signal (Figure 4.7G). This 
confirms the specificity of probe 3 for thiols over other cell analytes in vivo.  
 
A B C D
F G HE
 
Figure 4.7. Fluorescence microscopic images of live 3T3 cells: (a) brightfield image of 
cells incubated with probe 3 (25 µM) for 10 min at 37 oC and stained with Hoechst 
33342, a nucleus-staining dye; (b) fluorescence image of cells collected with a Hoechst 
dye filter set; (c) fluorescence image of cells collected with a Cy3 filter set; (d) overlay 
image of b and c; (e-h) corresponding control images of cells pretreated with N-
methylmaleimide (1 mM) for 60 min at 37˚C and then incubated with 3 as above. See 
experimental section for details. 
 
4.7 Conclusions 
Probe 3 has been shown to be a thiol-selective turn-on fluorescence probe with 
high on/off emission ratios (up to 120-fold) in the red region of the spectrum upon 
excitation in the visible (yellow-orange). It shows good resistance towards unspecific 
hydrolysis. The emissive free dye 4 released after reaction with a thiol exhibits large 
batho- and hyperchomic shifts with respect to 3, and features a fluorescence quantum 
efficiency that is greatly enhanced in the presence of biological macromolecules. The 
application of probe 3 for the bioimaging of thiols in live cells has been demonstrated. 
The modular nature of the probe's design opens the possibility of tailored probes for 
specific applications. Moreover, on the basis of available literature data, probe 3 also 
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appears to be a promising candidate for the selective imaging of selenols14b at pH 5.8, and 
for the 2-photon imaging of thiols. 16, 19b 
 
4.8 Experimental Section 
 
Materials 
All solvents were of ACS reagent grade or better unless otherwise noted. Anhydrous 
dichloromethane was dried on a solvent column purification system. Silica gel (40-63 µm) 
was obtained from SilliCycle Inc. All other reagents, compounds and chemicals were 
obtained from commercial suppliers and were used without further purification. Aqueous 
solutions were freshly prepared with deionized water from a Barnsted Nanopure four 
cartridge system. Human serum albumin (average molar mass is 69000 g mol-1) was 
purchased from Sigma. Hydrogen peroxide (H2O2), tert-butyl hydroperoxide (TBHP), and 
sodium hypochlorite (NaOCl) were delivered from 3%, 70%, and 10% aqueous solutions, 
respectively. Superoxide (O2•-) was added as solid KO2. 
 
General methods, instrumentation and measurements 
Synthetic manipulations that required an inert atmosphere (where noted) were carried out 
under nitrogen or argon using standard Schlenk techniques or in an inert-atmosphere 
glovebox. NMR (1H and 13C) spectra were recorded on 300 and 500 MHz spectrometers. 
The chemical shift data for each signal are given in units of δ (ppm) relative to 
tetramethylsilane (TMS) where δ (TMS) = 0, and referenced to the residual solvent 
resonances. Splitting patterns are denoted as s (singlet), d (doublet), t (triplet), q (quartet), 
m (multiplet), and br (broad).  High-resolution mass spectra (HR-MS) were obtained at 
the MIT Department of Chemistry Instrumentation Facility using electron impact 
ionization (EI) with a voltage of 70 V or electrospray ionization (ESI). Melting point 
(m.p.) determination was performed using open capillaries and measurements are 
reported uncorrected. Absorption spectra were obtained on a Varian Cary 50-Bio UV-
visible spectrophotometer (Palo Alto, CA). Fluorescence data were collected on a Horiba 
Jobin Yvon Fluorolog-3 spectrofluorimeter (Edison, NJ). The solution spectra were 
obtained at 25 °C using a quartz cuvette with a path length of 1 cm. The fluorescence 
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quantum yield (ΦF) of free dye 4 was determined against cresyl violet (ΦF = 0.54 in 
methanol).   
 
N-(4-(1,3-Dioxolan-2-yl)phenyl)-2,4-dinitrobenzenesulfonamide (1). To a stirred 
solution of 4-(1,3-dioxolan-2-yl)aniline20 (165 mg, 1.0 mmol) and 2,6-lutidine (0.15 mL, 
1.3 mmol) in dichloromethane (4 mL) at 0˚C is added 2,4-dinitrobenzenesulfonyl 
chloride by portions. The resulting red mixture is let to stir overnight as it slowly warms 
up to room temperature. The reaction is quenched and neutralized by adding a minimum 
of 2M HCl, and the product is extracted with dichloromethane. The combined organic 
layers are washed with anhydrous magnesium sulfate, filtered and the solvent is 
evaporated under reduced pressure. The crude product is purified by column 
chromatography on silica gel with 1:1:1 hexanes : dichloromethane : ethyl acetate (v/v/v) 
to afford 1 as a yellow solid (293 mg, 74%). Analytical samples may be obtained after 
recrystallization from heptane-PhMe or CHCl3. m. p. = 140-143˚C; 1H-NMR (500 MHz, 
(CD3)2CO): δ = 9.55 (s, 1H), 8.80 (d, 1H, J = 2.1 Hz), 8.60 (dd, 1H, J = 8.6, 2.2 Hz), 8.28 
(d, 1H, J = 8.7 Hz), 7.42 (d, 2H, J = 8.5 Hz), 7.36 (d, 2H, J = 9.0 Hz), 5.67 (s, 1H), 4.00 
(m, 4H); 13C-NMR (125 MHz, (CD3)2CO): δ = 156.3, 151.5, 149.4, 137.8, 137.4, 133.8, 
128.8, 127.9, 122.7, 121.5, 103.8, 66.0; HR-MS (ESI): calc for C15H13N3O8S [M+H]+ 
396.0496, found 396.0504. 
 
N-(4-Formylphenyl)-N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-2,4-
dinitrobenzenesulfonamide (2). To a Schlenk flask are added acetal 1 (198 mg, 
0.50 mmol), triphenylphosphine (262 mg, 1.00 mmol) and triethyleneglycol monomethyl 
ether (0.16 mL / 164 mg, 1.00 mmol). Contents are evacuated and back-filled with argon 
three times. Dry dichloromethane (3 mL) is added and the resulting solution is cooled to 
0˚C in an ice-water bath. To the solution is added diisopropyl azodicarboxylate (DIAD, 
0.2 mL / 202 mg, 1.00 mmol) dropwise, and the contents are stirred overnight as they 
slowly warm up to room temperature. The mixture is then directly subjected to column 
chromatography on silica gel with 1:1:1 hexanes : dichloromethane : ethyl acetate (v/v/v) 
as the mobile phase to yield fractions containing the crude N-alkylated acetal and 
triphenylphospine oxide. Without further purification, after evaporation of the solvent 
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from the chromatography, the intermediate is redissolved is ca. 5 mL of THF and the 
solution is cooled to 0˚C. To the stirred solution is added 1 mL of 2M HCl and the 
solution is stirred overnight as it slowly warms up to room temperature. The resulting 
mixture is neutralized with sat. NaHCO3, extracted with Et2O, washed with brine, dried 
over anhydrous MgSO4 and the solvents are evaporated under reduced pressure. 
Purification by column chromatography on silica gel using progressively more polar 9:1 
to 7:3 dichloromethane : ethyl acetate (v/v) as the mobile phase affords the aldehyde 2 as 
a viscous pale yellow oil (154 mg, 62% over 2 steps). 1H-NMR (500 MHz, CDCl3): 
δ = 10.03 (s, 1H) 8.47 (d, 1H, J = 2.5 Hz). 8.35 (dd, 1H, J = 8.5, 2.5 Hz), 7.93 (d, 1H, 
J = 8.5 Hz), 7.88 (d, 2H, J = 8.5 Hz), 7.49 (d, 2H, J = 8.5 Hz), 4.06 (t, 2H, J = 5.5 Hz), 
3.62-3-57 (m, 8H), 3.55-3.53 (m, 2H), 3.37 (s, 3H); 13C-NMR (125 MHz, CDCl3): 
δ = 191.0, 150.0, 143.1, 137.8, 136.2, 133.7, 131.0, 130.3, 126.1, 119.8, 72.1, 70.8, 70.7, 
70.5, 68.7, 59.2, 52.4; HR-MS (ESI): calc for C20H23N3O10S [M+Na]+ 520.0996, found 
520.1000. 
 
(E)-N-(4-(2-(4-Cyano-5-(dicyanomethylene)-2,2-dimethyl-2,5-dihydrofuran-3-
yl)vinyl)phenyl)-N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-2,4-
dinitrobenzenesulfonamide (3) Aldehyde 2 (145 mg, 0.29 mmol), 2-(3-cyano-4,5,5-
trimethylfuran-2(5H)-ylidene)propanedinitrile18b (TCF, 60 mg, 0.30 mmol) and 
ammonium acetate (23 mg, 0.30 mg) were stirred overnight in the dark at room 
temperature in a mixture of THF (1.0 mL) and EtOH (0.25 mL). The solution rapidly 
turns from pale yellow to reddish-orange. The mixture is diluted in water, extracted with 
ethyl acetate, washed with brine and dried over anh. MgSO4. Evaporation of the solvents 
under reduced pressure yields a crude product that is purified by column chromatography 
on silica gel using progressively more polar 2:1 to 3:1 ethyl acetate : hexanes as the 
mobile phase to afford the thiol-reactive probe 3 as an amorphous yellow solid (91 mg, 
47%). m. p. = 74-76˚C (softens)21; 1H-NMR (500 MHz, (CD3)2CO): δ = 8.79 (d, 1H, 
J = 2.0 Hz), 8.60 (dd, 1H, J = 8.5, 2.0 Hz), 8.22 (d, 1H, J = 8.5 Hz), 8.03 (d, 1H, J = 16.5 
Hz), 7.95 (d, 2H, J = 8.5 Hz), 7.51 (d, 2H, J = 8.5 Hz), 7.36 (d, 1H, J = 16.5 Hz), 4.07 (t, 
2H, J = 5.5 Hz), 3.57-3.51 (m, 8H), 3.46 (t, 2H, J = 5.5 Hz), 3.27 (s, 3H), 1.92 (s, 6H); 
13C-NMR (500 MHz, CDCl3): δ = 175.1, 173.3, 150.0, 145.3, 141.2, 137.8, 134.2, 133.6, 
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131.0, 130.6, 130.1, 126.1, 119.8, 116.5, 111.5, 110.8, 119.1, 101.4, 98.0, 72.1, 70.74, 
70.67, 70.5, 68.6, 59.2, 52.4, 26.6; HR-MS (ESI): calc for C31H30N6O10S [M+Na]+ 
701.1636, found 701.1610. 
 
(E)-2-(3-Cyano-4-(4-(2-(2-(2-methoxyethoxy)ethoxy)ethylamino)styryl)-5,5-
dimethylfuran-2(5H)-ylidene)propanedinitrile (4) To a stirred solution of sulfonamide 
3 (30 mg, 0.044 mmol) in CH2Cl2 (2 mL) were added HSCH2CO2H (5.3 mg, 
0.057 mmol), Et3N (8.4 mg, 0.088 mmol). Stirring was continued at room temperature for 
30 min. Solvents were evaporated under reduced pressure and the residue was dissolved 
in ether (50 mL) and washed with an aqueous NaHCO3 solution (20 mL X 3). The 
organic layer was dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure. The crude product was purified by column chromatography on silica gel using 
2:1 ethyl acetate : hexanes as the mobile phase to give free dye 4 (16.2 mg, 82%). 
m. p. = 133-135˚C; 1H-NMR (500 MHz, CDCl3): δ = 7.60 (d, 1H, J = 16.0 Hz), 7.51 (d, 
2H, J = 8.5 Hz), 6.75 (d, 1H, J = 15.5 Hz), 6.65 (d, 2H, J = 8.5 Hz), 5.37 (br, 1H), 3.76 (t, 
2H, J = 5.5 Hz), 3.68 (m, 6H), 3.59 (t, 2H, J = 5.5 Hz), 3.44 (q, 2H, J = 5.5 Hz), 3.41 (s, 
3H), 1.76 (s, 6H); 13C-NMR (500 MHz, CDCl3): δ = 176.4, 174.6, 153.3, 148.7, 132.6, 
123.1, 113.3, 112.8, 112.0, 111.5, 109.2, 97.0, 95.0, 72.1, 70.8, 70.7, 70.5, 69.1, 59.2, 
43.1, 30.5, 29.9, 27.0; HR-MS (ESI): calc for C25H28N4O4 [M+H]+ 449.2183, found 
449.2184 
 
Response of Probe 3 to Different Analytes  
A solution of probe 3 (0.125 mM in CH3CN, 20 µL) was diluted in HEPES buffer 
(180 µL, 10 mM, pH 7.4). Esterase (porcine liver, 27 unit/mg) was prepared to 
1.4 unit/mL in HEPES buffer (10 mM, pH 7.4). All other analytes were prepared as 
concentration of 0.5 mM. Analytes (50 µL) were added to solutions of probe 3 in 96-well 
flat bottom microliter plates, and the reactions were monitored at 37oC for 15 min. The 
fluorescence signal for each well was measured at 627 nm (λex = 565 nm).  
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Fluorescence Microscopy and Cell-Uptake Studies.  
For living cell imaging studies, fibroblast 3T3 cells were grown in DMEM (Dulbecco's 
Modified Eagle's Medium) in an atmosphere of 5% CO2, 95% air at 37 oC. Cells were 
plated on 24-well plate and allowed to adhere for 24 h. After 24 h, the cells were washed 
with DPBS (Dulbecco’s phosphate buffered saline) and then incubated at 37 °C in the 
presence of 25 µM probe 3 (1:100 DMSO/DPBS, v/v, pH 7) for 10 min. For the control 
experiment, living 3T3 cells were pretreated with 100 µM N-methylmaleimide in DMSO-
DPBS solution  (1:100, v/v, pH 7) for 1 h at 37 oC. After washing cells three times with 
DPBS buffer, maleimide pre-treated cells were incubated in the presence of 25 µM probe 
3 (1:100 DMSO/DPBS, v/v, pH 7) for 10 min at 37 °C. For both sets of cells, 
fluorescence imaging was performed after washing cells three times with DPBS buffer, 
fixing with 4% paraformaldehyde and staining of the cell nuclei with Hoechst 33342. The 
fluorescence images were obtained using an Nikon Eclipse TE2000-S fluorescence 
microscope with 100 x objective equipped with a Photometrics Cascade 512B CCD 
camera using excitation and emission filters from Chroma Technology. The Hoechst 
33342 (ex: 365/10 nm; em: 400 nm LP) and Cy3 (ex: 546/10 nm; em: 590 nm LP) filter 
sets were used for the collection of the fluorescence signals of the nucleus stain and probe 
3, respectively. 
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Figure 4.A.1. 1H-NMR Spectrum of 1 in (CD3)2CO (500 MHz). 
 
Figure 4.A.2. 13C-NMR Spectrum of 1 in (CD3)2CO (125 MHz). 
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Figure 4.A.3. 1H-NMR Spectrum of 2 in CDCl3 (500 MHz).  
 
Figure 4.A.4. 13C-NMR Spectrum of 2 in CDCl3 (125 MHz). 
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Figure 4.A.5. 1H-NMR Spectrum of 3 in (CD3)2CO (500 MHz). 
 
Figure 4.A.6. 13C-NMR Spectrum of 3 in CDCl3 (125 MHz). 
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Figure 4.A.7. 1H-NMR Spectrum of 4 in CDCl3 (500 MHz).  
 
Figure 4.A.8. 13C-NMR Spectrum of 4 in CDCl3 (125 MHz). 
 
 
 
HN
O
O
MeO
O
NC
CN
NC
 
 
 
 
 
 
 
Chapter 5 
Conjugated Polymers that Incorporate 
Disubstituted 2,1,3-Benzothiadiazoles and 
2,1,3-Benzooxadiazoles 
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5.1 Introduction 
 
 The electronic and optical properties of conjugated organic materials and 
polymers are largely dominated by the position of the HOMO and LUMO energy levels, 
and thus an adequate positioning of these levels is of foremost importance in the design 
of new materials for a given application. The HOMO-LUMO gap, often referred to as 
band gap by its relation to solid-state semiconductor physics, will for instance govern the 
color of the an OLED or PLED display and position of the energy levels will determine 
the analyte selectivity of a conjugated polymer sensor.1 A number of approaches have 
been developed for fine-tuning the energy levels of conjugated organic materials. 
Effective conjugation may be increased by inducing or enforcing planarity in a π-
conjugated system, 2  by facilitating delocalization through reduction of bond-length 
alternation, 3  or by the placement of substituents that increase molecular orbital 
coefficients on the atoms that are involved in π-conjugation.4  
 
Figure 5.1. Schematic representation of the donor-acceptor approach to band-gap 
engineering. 
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The donor-acceptor strategy5 is among the most popular approaches for the 
control of the band-gap of conjugated materials. In this approach, an organic π-
conjugated material is constructed by conjugating a π-electron rich moiety (donor) to a π-
electron poor moiety (acceptor), either directly or through a polarizable π-bridge. In the 
resulting construct, the electron-rich groups raise the HOMO and this molecular orbital 
will predominaltly reside on the electron-rich fragment. Conversely, the LUMO is 
lowered by the electron-withdrawing groups and this molecular orbital will 
predominantly reside on the electron-poor fragment, resulting in a lower HOMO-LUMO 
gap in the overall π-conjugated system (Figure 5.1). The judicious choice of donors, 
acceptors and, where applicable, π-conjugated bridge is warranted. When differences in 
the electronic characteristics of the donor and the acceptor are too large, electronic 
delocalization is disfavored and the HOMO-LUMO transitions develop significant 
charge-transfer character. As a result, the properties of the materials (e.g. conductivity, 
luminescence, etc.) are adversely affected. Among the most successfully utilized donor 
groups are found arylamines, aryl ethers and electron-rich heterocycles (thiophene, 
pyrrole, indole). Among the acceptor groups are often used cyanobenzenes (or 
cyanovinylenes) and electron-poor nitrogen heterocycles (quinoxaline, thieno[3,4-
b]pyrazine and 2,1,3-benzothiadiazole) (Scheme 5.1). 
 
Scheme 5.1. Popular electron-deficient heterocycles in donor-acceptor conjugated 
materials 
NN
quinoxaline
NN
S
thieno[3,4-b]pyrazine
N
S
N
2,1,3-benzothiadiazole  
 
 The latter heterocycle, 2,1,3-benzothiadiazole has been found to be the acceptor 
of choice for a growing number of materials and applications (Scheme 5.2) , in large part 
due to the ease of preparation of 4,7-dibromo-2,1,3-benzothiadiazole. In the field of light-
emitting materials, 2,1,3-benzothiadiazole has been incorporated in electroluminescent 
dyes6 and polymers7 to generate efficient green to red OLEDs. In the case of polymers 
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that incorporate this heterocycle, the color may be tuned as a function of the mole 
fraction of heterocycle incorporated. In these, high device external quantum efficiencies 
have been attributed to both the high photoluminescence quantum yields of the materials 
and to the ease electron injection at the polymer-electrode interface that is facilitated by 
the n-dopable heterocycle.8 Conjugated materials that incorporate 2,1,3-benzothiadiazoles 
also include fluorescent dichroics that align in liquid crystal matrices,9 electrochromic 
polymers10 and low band-gap poly(arylene ethynylene)s.11 Finally, energy transfer to a 
2,1,3-benzothiadiazole-centered lower-energy site upon analyte-triggered aggregation of 
conjugated polymers doped with a small mole fraction of this heterocycle as a 
comonomer has been utilized in the development of biosensors for single-strand DNA 
and alkaline phosphatase activity.12 
 
Scheme 5.2. Recent examples of π-conjugated materials that incorporate 2,1,3-
benzothiadiazole. 
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 In view of the broad utility and popularity of the 2,1,3-benzothiazole unit, it is 
surprising that the synthesis of analogues and/or derivatives of this electron-accepting 
unit and their successful application to conjugated materials have only rarely been 
reported. The selenium analogue, 2,1,3-benzoselenadiazole, has been incorporated in 
small number of conjugated polymers and organic light-emitting devices.13 We are aware 
of three examples of 1,2,3-benzotriazoles incorporated into conjugated polymers.14 
Interestingly, with the exception of three reports of ring-fused analogues, 
naphtothiadiazole 15 , naphtoselenadiazole13e and benzobis(thiadiazole)s, 16  no other 
analogues substituted at the 5- and/or 6- positions have been reported in materials 
applications so far to the best of our knowledge. Finally, the incorporation of the oxygen 
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analogue, 2,1,3-benzooxadiazole, into conjugated materials has only been reported or 
claimed in patents17 and in accounts of corporate research7a, b in which details of synthesis 
and characterization are scarce. That so few conjugated materials incorporating 2,1,3-
benzooxadiazole have been reported is surprising in view of the well-known intense 
fluorescence of some of its derivatives, such as NBD-Cl (4-chloro-7-nitrobenzo-2,1,3-
oxadiazole) that is widely employed as a fluorescent probe for amines.18  
 
 Herein, we report the synthesis of new electron-deficient monomers based on the 
2,1,3-benzothiadiazole and 2,1,3-benzooxadiazole heterocyclic cores, and their 
incorporation into conjugated polymers of the poly(fluorene) and the poly(arylene 
ethynylene) families. The new monomers bear side-chains at the 5- and 6- positions, 
resulting in improved solubility and reduced propensity to irreversibly aggregate. The 
spectroscopic properties of conjugated polymers that incorporate these new monomers 
are compared to those derived from an unsubstituted 2,1,3-benzooxadiazole heterocyclic 
core. 
 
5.2 Synthesis of 2,1,3-Benzothiadiazole and 2,1,3-Benzooxadiazole Monomers 
 
The unsubstituted 4,7-dibromo-2,1,3-benzooxadiazole monomer (4) is obtained in 
four steps starting from the inexpensive ortho-nitroaniline (Scheme 5.3). The synthetic 
route to this molecule has previously been reported in papers published in the early 20th 
century,19 for which characterization data (e.g. NMR) is lacking, and in a recent Chinese 
patent.17a We provide an English-language adaptation of the latter procedures in the 
experimental section. Ortho-nitroaniline is oxidatively cyclized to benzofuroxan (1) in 
excellent yield with commercial bleach, and the latter is deoxygenated to benzofurazan 
(2,1,3-benzooxadiazole, 2) with triethyl phosphite. The deoxygenation reaction results in 
a number of unidentified by-products, but benefits from the fact that 2 is easily purified 
by vacuum sublimation, allowing for its rapid preparation in large quantities. 
Bromination with molecular bromine in hydrobromic acid affords the terabromide 3 as 
undefined mixture of stereoisomers. We find that 1,8-diazabicyclo[5.4.0]undec-7-ene 
(DBU) in tetrahydrofuran is more efficient than aqueous base for the hydrodebromination 
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of 3 to 4, a reaction that is complete at room temperature within minutes. The moderate 
isolated yield for monomer 4 reflect some losses that occur during the double 
recrystallization to attain polymerisation-grade purity. 
 
Scheme 5.3. Synthesis of 2,1,3-benzooxadiazole monomer 4. 
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The 5,6-dialkoxy-4,7-dibromo-2,1,3-benzooxadiazole monomer 8 is prepared in 
good yields over 3 steps starting from the readily available 1,2-dialkoxy-4,5-
dinitrobenzene (5) (Scheme 5.4). Treatment of 5 with sodium azide in dimethylsulfoxide 
at 100˚C affords the benzofuroxan 6 in excellent yield, presumably through a o-nitroazide 
intermediate generated in-situ.20  Deoxygenation with triphenylphosphine in an aromatic 
solvent 21  was found to provide better yields of benzofurazan 7 than the use of 
triethylphosphite. For increased simplicity, these two steps can be combined in a single-
pot reaction by performing the reaction with sodium azide in toluene in the presence of a 
phase-transfer catalyst, and then directly adding of triphenylphosphine to the reaction 
mixture to result in the conversion of 5 to 7 in yields comparable to that of the 2-step (or 
2-pot) procedure. Electrophilic aromatic bromination with molecular bromine gives 
monomer 8. Substitution at the 5,6-positions markedly affects the reactivity of the 
benzofurazans, as 7 reacts as a typical arene with electrophilic reagents (SEAr) while 
unsubstituted 2 reacts with bromine as a conjugated diene.  
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Scheme 5.4. Synthesis of 2,1,3-benzooxadiazole monomer 8. 
C14H29O
C14H29O
1) HNO3, CH2Cl2,  
     0˚C to 23˚C
2) H2SO4-HNO3, 
    CH2Cl2, 0˚C to 23˚C
97%
C14H29O
C14H29O
NO2
NO2
NaN3, DMSO, 
100˚C
92%
C14H29O
C14H29O N
O
N+
O-
PPh3, xylenes, 
100-120˚C
77%
C14H29O
C14H29O N
O
N
Br2, CH2Cl2-
AcOH, 23˚C
77%
C14H29O
C14H29O N
O
N
Br
Br
1) NaN3, 20% nBu4NBr, PhMe, 110˚C
2) PPh3, PhMe, 110˚C
        63% (1-pot)
5 6 7
8  
 
 The 5,6-dialkoxy-4,7-dibromo-2,1,3-benzothiadiazole monomer 11, the sulfur 
analogue of 8, is obtained in three steps from the same starting material, 1,2-dialkoxy-
4,5-dinitrobenzene 5 (Scheme 5.5). Reduction of the nitro groups with tin(II) chloride 
gives the substituted o-phenylenediamine 9-HCl in excellent yields. The tin(II) chloride - 
hydrochloric acid reduction is preferred to catalytic hydrogenation of the nitro groups 
because the isolation of 9 as the hydrochloride salt reduces difficulties associated with the 
rapid oxidation of 9 in air. Treatment with N-thionylaniline affords 10, which is 
brominated as for 7 to provide monomer 8 in excellent yield. While 8 and 11 bear 
identical tetradecyloxy chains, the synthetic routes are predicted to be applicable to a 
variety of side-chains (e.g. linear and branched alkyl or alkoxy chains) in the 5- and/or 6- 
positions. 
 
Scheme 5.5. Synthesis of 2,1,3-benzothiadiazole monomer 11. 
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5.3 Synthesis of Conjugated Polymers that Incorporate 2,1,3-Benzothiadiazole and 
2,1,3-Benzooxadiazoles 
 
A series of conjugated polymers were prepared by palladium-catalyzed cross-
coupling polycondensation of dibromo monomers 4, 8, 11 and monomers 12, 13, 14 to 
investigate the influence of these new heterocycles on the polymer properties (Schemes 
5.6-5.8, Table 5.1). Monomers 12 and 14 are typical comonomers commonly employed 
in the synthesis of poly(arylene ethynylene)s and poly(fluorene)s. Monomer 13 has been 
popularized for its aptitude to generate poly(arylene ethynylene)s that do not aggregate in 
the solid state.22 
 
The high reactivity of monomers 4, 8 and 11 in palladium-catalyzed cross-
couplings is illustrated by the preparation of polymers P1-P6. Unactivated bromides are 
often insufficiently reactive in Sonogashira-Hagihara polymerizations, resulting in 
reduced yields and low molecular weights. Side-reactions such as homocouplings can 
then become predominant as the reactivity of monomers decrease.11, 23 The high yields 
and high molecular weights obtained using typical reaction conditions (5% Pd(PPh3)4 as 
catalyst, 65-75˚C) are indicative of the high reactivity of monomers 4, 8 and 11, and of 
their suitability for incorporation in conjugated polymers. Monomer 4 is in fact one of the 
most reactive dihalides that we have encountered. This reactivity is attributed to the 
exceptionally electron-deficient character of this monomer that activates it towards 
oxidative addition to the palladium catalyst. In the preparation of polymer P1, the 
reactivity of 4 is such that a dramatic change in the color of the reaction mixture from 
pale yellow to dark red is observed in less than 5 minutes at room temperature, and that 
insoluble high molecular weight material begins to precipitate out of solution within ~30 
minutes at room temperature.  
 
Polymers P1-P3 are isolated with high mass recovery as red solids (Scheme 5.6). 
As observed from the polymerization mixture, polymer P1 has a limited solubility in 
organic solvents and irreversibly aggregates upon precipitation from the reaction mixture 
into a poor solvent. Only traces quantities of P1 can be redissolved after prolonged 
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Soxhlet extraction with refluxing chlorobenzene. We attribute the exceptionally strong 
aggregation of P1 compared to a majority of poly(phenylene ethynylene)s that 
incorporate the solubilizing comonomer 12 to the strong π-π stacking between electron-
deficient (4) and electron-rich (12) arenes. By contrast, polymer P2 is soluble in 
chloroform at room temperature, which illustrate the beneficial effect of flexible side-
chains at the 5,6-positions of the heterocycle on the solubility of the resulting polymers. 
Polymer P2 is also fully soluble in hot tetrahydrofuran, but is insoluble in that solvent at 
room temperature, a factor that preclude the accurate measurement of its molecular 
weight by gel permeation chromatography. Finally, polymer P3, isolated in high yield 
with an average degree of polymerization of 20, is fully soluble in both solvents at room 
temperature. 
 
Scheme 5.6. Synthesis of poly(arylene ethynylene)s that incorporate 4, 8 and 11. 
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 Polymers P4-P6 that incorporate 6,13-diethynylpentiptycene (13) as a 
comonomer to prevent strong aggregation of the polymer chains were prepared according 
to the same procedures (Scheme 5.7). The absence of solubilizing side-chains in P4 result 
in the precipitation of insoluble oligomers from the reaction mixture, as for P1, and thus 
limits possibilities for characterization. However, polymers P5-P6 are obtained as fully 
soluble yellow-orange solids with high molecular weights (> 20 kg mol-1). 
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Scheme 5.7. Synthesis of non-aggregating poly(arylene ethynylene)s that incorporate 4, 8 
and 11. 
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 Polyfluorenes P7-P9 that incorporate monomers 4, 8 and 11 were copolymerized 
with monomer 14 under previously described biphasic conditions for Suzuki-Miyaura 
cross-coupling polymerizations of fluorene derivatives (Scheme 5.8).24 Polymers P7-P9 
are isolated as highly soluble bright yellow (P8-P9) or orange (P7) high molecular weight  
materials (DP ~ 50-60).25 
 
 353 
Scheme 5.8. Synthesis of poly(fluorene)s that incorporate 4, 8 and 11. 
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Table 5.1. Summary of polymer characterization. 
Monomer 
1 (ArM2) 
Monomer 
2 (ArX2) 
Polymer 
Yield 
(%) 
Mna  
(103 g mol-1) 
Mwa  
(103 g mol-1) 
PDIa DPna 
12 4 P1 > 98 > 2.8b > 3.3b 1.2b > 4b 
12 8 P2 88 > 5.4b > 8.3b 1.5b > 5b 
12 11 P3 86 21.0 84.3 2.4 20 
13 4 P4 > 95 > 1.5b > 5.1b 3.5b > 2-3b 
13 8 P5 63 29.7 66.3 2.2 29 
13 11 P6 74 24.6 59.8 2.4 24 
14 4 P7 97 30.0 77.9 2.6 59 
14 8 P8 86 46.7 102.0 2.2 50 
14 11 P9 83 55.6 135.9 2.4 59 
a Determined by GPC against PS standards (fraction soluble in THF). b Mostly insoluble in THF at room 
temperature; values given represent those of soluble short oligomers.  
 
5.4 Spectroscopic Properties of Conjugated Polymers that Incorporate 2,1,3-
Benzothiadiazoles and 2,1,3-Benzooxadiazoles 
 
 The absorption and fluorescence emission spectra for polymers P1-P9 in 
chloroform solution are shown in Figure 5.2, and the summarized spectroscopic data are 
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presented in Table 5.2. For the purpose of comparison, three conjugated polymers from 
the literature are presented (Scheme 5.9, Table 5.2). 
 
Table 5.2. UV-Vis absorption and emission properties of polymer P1-P9 and reference 
polymers from the literature. 
 λmax (nm) λ em (nm) Φf 
Polymer 
Solution  
(CHCl3) 
(ε / L mol-1 cm-1)b 
Thin Film 
Solution 
(CHCl3) 
Thin Film 
Solution 
(CHCl3) 
Thin Film 
P1 534 (20 000) 
588 (19 000)b 
581e 570 607e 0.14c < 0.012e, f 
P2 504 (34 000) 
[557 (23 000)]b 
554 554 586 0.31c 0.056f 
P3 499 (33 000) 543 550 579 0.35c 0.031f 
P4 478 (8 700)b 495e 519 498e 0.40c 0.023e, f 
P5 494 (49 000) 500 516 523 0.58c 0.18f 
P6 498 (50 500) 502 518 526 0.64c 0.30f 
P7 475 (38 000) 489 536 546 0.50c 0.37f 
P8 421 (28 000) 429 517 498 0.51d 0.41f 
P9 416 (20 000) 424 513 498 0.48d 0.33f 
PPE-122a 452 (27 500) - 482 - 0.40 - 
PPE-221 441 (-) 448 457 460 0.50 0.33 
PF-129 389 (-) 394 414 424 0.81 0.55 
a Molar absorptivity based on molecular weight of a repeating unit. b Aggregation band. 
Polymer is either not fully soluble or partially aggregated in CHCl3 solution (dispersion). 
See text for discussion. c Against coumarin 6 in EtOH (Φf = 0.78, λex = 460 nm).26 
d Against quinine sulfate in 1N H2SO4 (Φf = 0.546, λex = 366 nm).27 e Does not form high 
quality films due to its poor solubility. Interpretation of data is subject to caution. 
f Against perylene in PMMA (Φf = 0.87, λex = 412 nm).28 
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Figure 5.2. UV-Vis and fluorescence 
spectra of polymers P1-P9 in 
chloroform solution (top) and in thin 
films (bottom). The molar 
absorptivity is calculated on a 
repeating unit weight basis. 
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Scheme 5.9. Reference polymers for comparison of spectroscopic properties 
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 The influence of the donor-acceptor character of the transitions on the optical 
properties of polymer P1-P9 is significant. The polymers are considerably red-shifted in 
both absorption and emission maxima with respect to corresponding polymers that do not 
incorporate electron-deficient heterocycles, and the extent of the bathochromic shift is 
proportional to the strength of the donor and acceptor groups. Polymers P1-P3 are the 
most red-shifted due to the strong electron-donating character of monomer 12. By 
comparison to PPE-1, which has an absorption maximum at 452 nm and an emission 
maximum at 482 nm in chloroform,23 polymers P1-P3 are red-shifted by 50-90 nm.  In 
that, they resemble PPEs that incorporate p-dialkoxybenzenes (e.g. 12 or analogues) and 
2,1,3-benzothiadiazole, which exhibit absorption and emission maxima at 498 and 
562 nm, respectively.11 This analysis suggests that the electron-accepting strength of 
2,1,3-benzothiadiazole is between that of monomers 4 and 8, as it would be expected on 
the basis of the higher electronegativity of oxygen vs. sulfur and the presence of the 
electron-donating alkoxy groups in 8. Aggregation in polymer P1 is evidenced by the 
presence of a sharp, red-shifted absorption band (588 nm) at wavelengths higher than that 
of the band associated with the π-π* transition (534 nm), and by the poor emission 
quantum yields. Polymer P2 does not aggregate in dilute chloroform solutions (3 x 10-6 
mol L-1), however, an aggregation band centered at 557 nm appears and grows reversibly 
as concentration is raised (2 x 10-5 mol L-1). Finally, polymers P2 and P3 in their 
unaggregated state are efficient fluorophores, with a fluorescence quantum yield of 0.31-
0.35.  These values are only slightly lower than that of PPE-1 or analogues (Φf ~ 0.35-
0.40),23 and this lower efficiency may be attributed to the effects of the energy gap law.29  
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 Similar trends are observed with polymers P5 and P6 with respect to PPE-2. The 
donor-acceptor polymers have absorption and emission maxima that are red-shifted by 
60-70 nm with respect to PPE-2. Like the latter, they do not exhibit evidence of 
aggregation either in solution or in the solid state, and high fluorescence quantum 
efficiencies are preserved in the solid state. The spectroscopic properties of P4, which 
precipitates from the reaction mixture as a mixture of short oligomers, indicate that the 
polymer has not reached a degree of polymerization that exceeds the effective 
conjugation length for this π-conjugated system.  
 
 Polyfluorenes P7-P9 are obtained as bright yellow (P8-P9) and orange (P7) solids  
that are fully soluble in organic solvents, including P7 that incorporates monomer 4 and 
gave rise to the insoluble polymers P1 and P4. These heterocyclic polyfluorenes do not 
show evidence of aggregation either in solution or in the solid state. Aggregation is 
presumably limited by the presence of flexible side-chains that are perpendicular to the 
plane of the fluorene monomer 14, sterically preventing close stacking between the 
aromatic surfaces. As observed for the poly(arylene ethynylene)s, absorption and 
emission maxima are red-shifted by comparison to PF-1, 30 and the stronger electron-
accepting P7 is significantly more red-shifted than either P8 or P9. Interestingly, while 
most conjugated polymers exhibit bathochromic shifts from solution to the solid state, 
polymers P8 and P9 exhibit hypsochromic shifts in their emission maxima in thin films, 
which is indicative of a solid-state organization that disrupts the extent of conjugation. 
Nonetheless, polymers P7-P9 are efficient fluorophores both in solution and in the solid 
state, with fluorescence quantum yields of 0.33-0.51.  
 
Only small differences are found between the position of the absorption and 
emission maxima of polymers that incorporate monomer 8 (e.g. P2, P5, P8) and that of 
polymers that incorporate monomer 11 (e.g. P3, P6, P9). We consider this to be 
indicative of similar electronic properties of the two monomers. The two sets of polymers 
are distinguished, however, by differences in the ratio between the intensity of the main 
delocalized π-π* transition (λmax)  and that of second more localized transition (λ ~320-
350 nm). Polymers that incorporate monomer 8 show delocalized transitions with a much 
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greater intensity than for the localized transition, while polymers that incorporate 
monomer 11 show comparatively more intense localized transition. This is suggestive of 
a more effective electronic delocalization in polymers that incorporate 2,1,3-
 benzooxadiazoles over those that incorporate 2,1,3-benzothiadiazoles.  
 
5.5 Conclusions 
 
New 2,1,3-benzooxadiazole and 2,1,3-benzothiadiazole electron-deficient 
monomers bearing solubilizing side-chains have been synthesized in high yields over 
three steps from readily available starting materials. These monomers are efficiently 
incorporated with a variety of co-monomers in cross-coupling polymerizations to afford 
high molecular weight luminescent conjugated polymers that exhibit red-shifted 
absorption and emission maxima, greater solubility and reduced aggregation. The 
electronic properties of the new monomers and polymers are intermediate between those 
of common arylenes and those of unsubstituted 2,1,3-benzooxadiaxzoles and 2,1,3-
benzothiadiazoles, offering potential for the fine-tuning of electronic properties without 
having to rely on adjustments in the feed ratios of comonomers. The electron-deficient 
properties of these materials suggest as potential application as green-emitting polymers 
that facilitate electron injection in light-emitting devices.  
 
5.6 Experimental Section 
 
Materials 
All solvents were of ACS reagent grade or better unless otherwise noted. 
Anhydrous tetrahydrofuran, toluene and dichloromethane were dried on a solvent column 
purification system. Silica gel (40-63 µm) was obtained from SiliCycle Inc. 1,2-
bis(tetradecyloxy)-4,5-nitrobenzene (5), 31 1,2-bis(tetradecyloxy)-4,5-diaminobenzene (9 
as dihydrochloride salt, 9-HCl),31 1,4-diethynyl-2,5-bis(tetradecyloxy)benzene,32 were 
prepared according to literature procedures or slight modifications thereof. 6,13-
Diethynylpentiptycene (13) was purchased from Nomadics Inc. (Stillwater, OK, USA). 
 359 
Monomer 4 was prepared according to literature procedures,17a or slight modifications 
thereof. All other reagents, compounds and chemicals were obtained from commercial 
suppliers and used without further purification. 
 
General methods, instrumentation and measurements 
Synthetic manipulations that required an inert atmosphere (where noted) were 
carried out under nitrogen or argon using standard Schlenk techniques or in an inert-
atmosphere glovebox. NMR (1H and 13C) spectra were recorded on 300 and 500 MHz 
spectrometers. The chemical shift data for each signal are given in units of δ (ppm) 
relative to tetramethylsilane (TMS) where δ (TMS) = 0, and referenced to the residual 
solvent resonances. Splitting patterns are denoted as s (singlet), d (doublet), t (triplet), q 
(quartet), m (multiplet), and br (broad).  High-resolution mass spectra (HR-MS) were 
obtained at the MIT Department of Chemistry Instrumentation Facility using electron 
impact ionization (EI) with a voltage of 70 V or electrospray ionization (ESI). Melting 
point (m.p.) determination was performed using open capillaries and are reported 
uncorrected. Polymer molecular weights were determined in THF solutions on an Agilent 
1100 series HPLC/GPC system with three PLgel columns (103, 104, 105 Å) in series 
against narrow polystyrene standards. Polymer thin films were spin cast from ~1% by 
weight CHCl3 solutions on microscope coverslips or Si wafers using an EC101DT 
photoresist spinner (Headway Research, Inc.) at a 1000 rpm rate for 60 s. UV-Vis spectra 
of solutions and thin films were recorded with an Agilent 8453 diode array 
spectrophotometer. Fluorescence spectra were recorded on a Jobin Yvon Horiba SPEX 
Fluorolog fluorimeter (model FL-12, 450 W xenon lamp) using either front-face (films) 
or right angle detection (solutions). 
 
Benzo[c][1,2,5]oxadiazole 1-oxide (1).17a To a stirred, cooled solution of o-nitroaniline 
(41.7 g, 0.30 mol) in alcoholic potassium hydroxide (18 g, 0.32 mol in 255 mL EtOH) at 
0˚C is added a solution of commercial bleach (400 mL, 6% aq. NaOCl) dropwise. Stirring 
is continued an additional 10-20 mins after the addition is completed, and the mixture is 
filtered and washed with copious amounts of water to afford 1 as a  bright yellow solid 
with a characteristic aromatic odor. The partially moist solid is directly used in the 
 360 
following reaction without further purification and / or drying.33 m. p. 67.0-68.5˚C (lit.: 34 
68-69˚C); 1H-NMR (300 MHz, (CD3)2SO): δ = 7.69 (br, 2H), 7.48 (br, 2H); 13C-NMR (75 
MHz, (CD3)2SO): δ = 152.4 (br), 133.1 (br), 129.8 (br), 117.5 (br), 112.7 (br). Note: 
Broadening in the NMR spectra is attributed to the Boulton-Katritzky rearrangement that 
occurs at room temperature.35 
 
Benzo[c][1,2,5]oxadiazole (2).17a A stirred solution of the crude, moist33 1 (15 g, 0.11 
mol) in THF (80 mL) is degassed by bubbling nitrogen through for ca. 15 mins. To the 
resulting solution is added triethyl phosphite (37 mL, 0.23 mol) dropwise, and the 
resulting mixture is then stirred at 60˚C for 7 h, during which time the mixture darkens 
and the starting material is consumed (TLC). After cooling to room temperature, the 
mixture is diluted with water (350 mL), extracted with hexanes, washed with brine, dried 
over anh. MgSO4 and the solvents are then evaporated under reduced pressure to afford 
an orange semisolid. The crude product is purified by vacuum sublimation to afford 2 as 
a pale yellow solid with a characteristic aromatic odor (7.39 g, ~56%). m. p. 52.0-52.5˚C 
(lit.:21 52-53˚C) 1H-NMR (300 MHz, CDCl3): δ = 7.79 (dd, 2H, J = 7.1, 2.9 Hz), 7.38 (dd, 
2H, J = 7.1, 2.9 Hz); 13C-NMR (75 MHz, CDCl3): δ = 149.0, 131.5, 116.5. 
 
4,5,6,7-Tetrabromo-4,5,6,7-tetrahydrobenzo-2,1,3-oxadiazole (mixture of 
stereoisomers) (3).17a, 19 Benzofurazan (2) (5.3 g, 44 mmol) is stirred at 35˚C with conc. 
hydrobromic acid (48% aq., 45 mL) and molecular bromine (12 mL) for 32 h. The 
mixture is cooled to room temperature, and poured in water (300 mL). Sodium sulfite is 
then slowly added to the stirred suspension until the yellow color of molecular bromine is 
discharged. After filtration and washing with water, the resulting crude product is 
purified by recrystallization from ethanol to afford 3 as pale beige needles (11.05 g, 
57%). m. p. 142-144˚C (lit.:36 143-145˚C); 1H-NMR (300 MHz, CDCl3): δ = 5.77 (br, 
1H), 5.40 (br, 1H), 4.92 (br, 2H); 13C-NMR (75 MHz, (CD3)2SO): 150.5, 52.7 (br), 37.0 
(br). 
 
4,7-Dibromobenzo-2,1,3-oxadiazole (4).17a To a stirred solution of 
tetrabromotetrahydrobenzofurazan (3) (4.4 g, 10 mmol) in tetrahydrofuran (100 mL) at 
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room temperature is added 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU, 3.75 mL, 
25 mmol) dropwise. The resulting mixture is stirred for 15 minutes, and is then poured in 
aq. 2N HCl (100 mL). Extraction with ethyl acetate, followed by washing with brine and 
evaporation of the solvents under reduced pressure affords a crude solid that is purified 
first by column chromatography on silica gel using progressively more polar 9:1 to 8:2 
hexanes : dichloromethane (v/v) and then recrystallized twice from MeOH. Pure, 
monomer-grade 4 is isolated as shiny, colorless needles (1.15 g, 41%). m. p. 111-113˚C 
(lit.:37 112-112.5˚C) 1H-NMR (300 MHz, CDCl3): δ = 7.53 (s, 2H); 13C-NMR (75 MHz, 
CDCl3): δ = 149.5, 134.4, 108.8. 
 
5,6-Bis(tetradecyloxy)benzo-2,1,3-oxadiazole 1-oxide (6). A mixture of 1,2-
bis(tetradecyloxy)-3,4-dinitrobenzene (5)31 (2372 mg, 4.0 mmol) and sodium azide 
(1300 mg, 20 mmol) in dimethylsulfoxide (20 mL) is stirred at 100˚C for ca. 16h. The 
mixture is cooled to room temperature and poured in a large excess of water. The 
precipitate is filtered, and the crude product is recrystallized from EtOH to afford 6 as an 
off-white solid (2061 mg, 92%). m. p. 122-123˚C; 1H-NMR (500 MHz, CDCl3): δ = 6.59 
(s, 1H), 6.36 (s, 1H), 4.03 (m, 4H), 1.87 (m, 4H), 1.48 (m, 4H), 1.37-1.20 (m, 40H), 0.88 
(t, 6H, J = 7.0 Hz); 13C-NMR (125 MHz, CDCl3): δ = 156.2, 153.8, 150.8, 112.0, 92.7, 
87.9, 69.8, 32.1, 29.91, 29.89, 29.87, 29.79, 29.77, 29.6, 29.6, 28.7, 26.1, 22.9, 14.3; HR-
MS (ESI): calc for C34H60N2O4 [M+H]+ 561.4626, found 561.4612. 
 
5,6-Bis(tetradecyloxy)benzo-2,1,3-oxadiazole (7). Benzooxadiazole oxide 6 (1122 mg, 
2.0 mmol) and triphenylphosphine (786 mg, 3.0 mmol) are stirred in xylenes (25 mL) at 
100˚C for 1h, followed by 120˚C for an additional hour. The mixture is cooled to room 
temperature, filtered on a short silica gel plug and the plug is rinsed with 
dichloromethane. Evaporation of the solvents under reduced pressure affords a crude 
product that is purified by recystallization from EtOH to yield 7 as an off-white solid 
(836 mg, 77%). m. p. 105-106˚C; 1H-NMR (500 MHz, CDCl3): δ = 6.81 (s, 2H), 4.07 (t, 
4H, J = 6.5 Hz), 1.90 (m, 4H), 1.49 (m, 4H), 1.37-1.27 (m, 40H), 0.89 (t, 6H, J = 7.0 Hz); 
13C-NMR (125 MHz, CDCl3): δ = 155.4, 147.0, 90.9, 66.6, 32.1, 29.93, 29.89, 29.8, 29.6, 
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29.5, 28.8, 26.2, 22.9, 14.3; HR-MS (ESI): calc for C34H60N2O3 [M+Na]+ 567.4496, found 
567.4500. 
 
5,6-Bis(tetradecyloxy)benzo-2,1,3-oxadiazole (7) - Alternate preparation. A mixture 
of 1,2-bis(tetradecyloxy)-3,4-dinitrobenzene (5)31 (1186 mg, 2.0 mmol), sodium azide 
(650 mg, 10 mmol) and tetra-n-butylammonium bromide (130 mg, 0.4 mmol) is refluxed 
in toluene (10 mL) for 5 h. After this period during which the starting material is 
consumed (TLC), triphenylphosphine (630 mg, 2.4 mmol) is added and reflux is 
continued for an additional 2h. The reaction mixture is cooled to room temperature, 
filtered on a short silica plug, and the plug is rinsed with dichloromethane. Evaporation of 
the solvents under reduced pressure affords a crude solid that is purified by 
recrystallization from EtOH to yield 7 as an off-white solid (683 mg, 63%). The 
characterization data is identical to that obtained for the first preparation. 
 
4,7-Dibromo-5,6-bis(tetradecyloxy)benzo-2,1,3-oxadiazole (8). Benzooxadiazole 7 
(2180 mg, 4.0 mmol) is dissolved in dichloromethane (80 mL), and to the resulting 
solution is added first acetic acid (10 mL), and then molecular bromine (0.85 mL, 
16.6 mmol). The resulting mixture is stirred in the dark for 3 days at room temperature, 
and is then poured in an aq. NaOH solution (10g in 200 mL). Extraction with 
dichloromethane, washing with brine and evaporation of the solvents under reduced 
pressure affords a crude solid that is purified by column chromatography on silica gel 
using 9:1 hexanes : dichloromethane (v/v) to yield 8 as a white solid (2217 mg, 79%). 
m. p. 63-64˚C; 1H-NMR (500 MHz, CDCl3): δ = 4.15 (t, 4H, J = 6.5 Hz), 1.86 (m, 4H), 
1.51 (m, 4H), 1.38-1.27 (m, 40H), 0.89 (t, 6H, J = 7.0 Hz); 13C-NMR (75 MHz, CDCl3): 
δ = 155.9, 147.6, 99.8, 75.6, 32.1, 20.4, 29.92, 29.90, 29.84, 29.81, 29.6, 26.1, 22.9, 14.3; 
HR-MS (ESI): calc for C34H58Br2N2O3 [M+Na]+ 723.2706, found 723.2711. 
 
5,6-Bis(tetradecyloxy)benzo-2,1,3-thiadiazole (10). In a Schlenk flask equipped with a 
magnetic stirrer and connected to a reflux condenser is placed 4,5-
bis(tetradecyloxy)benzene-1,2-diamine, dihydrochloride (9-HCl)31 (9.08 g, 15 mmol). 
Contents are evacuated and back-filled with argon 5 times, and are added in order dry 
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degassed toluene (160 mL) and dry triethylamine (160 mL) that has been degassed by 3 
freeze-pump-thaw cycles. To the stirred mixture is then added N-thionylaniline (4.2 mL, 
37 mmol), upon which a deep red color develops. The mixture is stirred at room 
temperature under argon for ca. 16 h, and is then refluxed under argon for 3h. After 
cooling to room temperature and evaporation of the solvents under reduced pressure, the 
resulting crude product is triturated in water (400 mL) for ca. 30 minutes, filtered  and 
recrystallized from EtOH twice to yield the pure 10 as an off-white solid (7.76 g, 92%). 
m. p. 89-90˚C; 1H-NMR (500 MHz, CDCl3): δ = 7.13 (s, 2H), 4.09 (t, 4H, J = 6.5 Hz), 
1.91 (m, 4H), 1.52 (m, 4H), 1.39-1.26 (m, 40H), 0.88 (t, 6H, J = 7.0 Hz); 13C-NMR 
(75 MHz, CDCl3): δ = 154.3, 151.6, 98.5, 69.3, 32.1, 29.93, 29.89, 29.83, 29.5, 28.9, 
26.2, 22.9, 14.3; HR-MS (ESI): calc for C34H60N2O2S [M+H]+ 561.4448, found 561.4458. 
 
4,7-Dibromo-5,6-bis(tetradecyloxy)benzo-2,1,3-thiadiazole (11). To a solution of 
benzothiadiazole 10 (8.00 g, 14.3 mmol) in a mixture of dichloromethane (400 mL) and 
acetic acid (175 mL) is added molecular bromine (5 mL, 97.5 mmol), and the resulting 
mixture is stirred in the dark for ca. 48 h at room temperature. The mixture is then poured 
in water (500 mL), extracted with dichloromethane, sequentially washed with water, aq. 
NaHCO3, aq. Na2SO3 and the solvents are evaporated under reduced pressure. The crude 
product is purified by recrystallization from EtOH twice to yield 11 as fluffy needle-like 
microcrystals (9.60 g, 94%). m. p. 64-65˚C; 1H-NMR (300 MHz, CDCl3): δ = 4.16 (t, 4H, 
J = 6.6 Hz), 1.87 (m, 4H), 1.54 (m, 4H), 1.38-1.27 (m, 40H), 0.88 (t, 6H, J = 6.9 Hz); 
13C-NMR (75 MHz, CDCl3): δ = 154.7, 150.6, 106.5, 75.3, 32.1, 30.5, 29.92, 29.86, 
29.83, 29.65, 29.59, 26.2, 22.9, 14.4; HR-MS (ESI): calc for C34H58N2O2S [M+H]+ 
717.2659, found 717.2655. 
 
General procedure for the preparation of poly(arylene ethynylene)s 
Diyne monomer (12 or 13, 0.202 mmol), dibromo monomer (4, 8 or 11, 0.200 mmol), 
tetrakis(triphenylphosphine)palladium(0) (10 mg, 0.009 mmol) and copper(I) iodide 
(3 mg, 0.016 mg) are placed in a Schlenk flask equipped with a magnetic stirrer. Contents 
are evacuated and back-filled with argon 5 times. Degassed toluene (3 mL) and 
diisopropylamine (1 mL) are introduced, and after 5 more vacuum/back-fill cycles, the 
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resulting mixture is stirred at room temperature for 30 mins., followed by 48h at 65˚C and 
24h at 75˚C. After cooling to room temperature, contents are precipitated in MeOH, and 
isolated by centrifugation. The crude polymer is dissolved in chloroform, filtered on a 
short silica gel plug and eluted with chloroform. The polymer solution is concentrated by 
evaporation of the solvents under reduced pressure, and the polymer is reprecipitated 
from acetone (or MeOH for acetone-soluble polymers). The pure polymer is isolated by 
centrifugation and dried under reduced pressure. 
 
Polymer P1. Following the general procedure, with 12 (100.44 mg), 4 (55.76 mg). The 
resulting insoluble polymer is isolated as a dark red solid (132 mg, ~100%). 1H-NMR 
(500 MHz, CDCl3): δ = (soluble fraction) 7.58 (br, 2H), 7.14 (br, 2H), 4.11 (br, 4H), 1.93 
(m, 4H), 1.56-1.25 (m, 44H), 0.88 (m, 6H). GPC (THF vs. PS):  (soluble fraction) 
Mn = 2800, Mw = 3300. 
 
Polymer P2. Following the general procedure, with 12 (100.60 mg), 8 (141.45 mg). The 
resulting polymer is isolated as red solid (186 mg, 88%). 1H-NMR (500 MHz, CDCl3): δ 
= (soluble fraction) 7.09 (s, 2H), 4.60 (m, 4H), 4.07 (m, 4H), 1.88 (m, 8H), 1.56-1.20 (m, 
84H), 0.87 (m, 12H). GPC (THF vs. PS):  (soluble fraction) Mn = 5400, Mw = 8300. 
 
Polymer P3. Following the general procedure, with 12 (100.58 mg), 11 (143.88 mg). The 
resulting polymer is isolated as a dark orange solid (183 mg, 86%). 1H-NMR (500 MHz, 
CDCl3): δ =  7.15 (s, 2H), 4.48 (m, 4H), 4.10 (m, 4H), 1.91 (m, 8H), 1.55 (m, 8H), 1.38-
1.24 (m, 80H), 0.87 (m, 12H). GPC (THF vs. PS):  (soluble fraction) Mn = 21 000, 
Mw = 84 300. 
 
Polymer P4. Following the general procedure (1/2 stoichiometry), with 13 (48.3 mg), 4 
(27.8 mg). The resulting polymer is isolated as an orange solid (57 mg, 96%). 1H-NMR 
(500 MHz, CDCl3): (soluble fraction) δ = 7.65-7.48 (m, 8H), 7.23-7.04 (m, 8H), 6.12 (m, 
4H). GPC (THF vs. PS):  (soluble fraction) Mn = 1500, Mw = 5100. 
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Polymer P5. Following the general procedure (1/2 stoichiometry), with 13 (48.3 mg), 8 
(70.3 mg). The resulting polymer is isolated as an orange solid (64 mg, 63%). 1H-NMR 
(500 MHz, CDCl3): δ = 7.58 (m, 8H), 7.08 (m, 8H), 6.29 (m, 4H), 5.00 (m, 4H), 2.32 (m, 
4H), 1.83 (m, 4H), 1.56 (m, 4H), 1.39-1.24 (m, 36H), 0.89 (m, 6H). GPC (THF vs. PS): 
Mn = 29 700, Mw = 66 300. 
 
Polymer P6. Following the general procedure (1/2 stoichiometry), with 13 (48.3 mg), 11 
(71.9 mg). The resulting polymer is isolated as a yellow-orange solid (77 mg, 74%). 1H-
NMR (500 MHz, CDCl3): δ = 7.59 (m, 8H), 7.07 (m, 8H), 6.49 (m, 4H), 4.89 (m, 4H), 
2.36 (m, 4H), 1.82 (m, 4H), 1.55 (m, 4H), 1.36-1.24 (m, 36H), 0.89 (m, 6H). GPC (THF 
vs. PS): Mn = 24 600, Mw = 59 800. 
 
General procedure for the preparation of poly(fluorene)s 
2,2'-(9,9-Dioctyl-9H-fluorene-2,7-diyl)bis(1,3,2-dioxaborolane) (14, recrystallized from 
acetone, 111.7 mg, 0.200 mmol), dibromo monomer (4, 8 or 11, 0.200 mmol), and 
tetrakis(triphenylphosphine)palladium(0) (10 mg, 0.009 mmol) are placed in a Schlenk 
flask equipped with a magnetic stirrer. Contents are evacuated and back-filled with argon 
5 times. Degassed toluene (5 mL) is introduced, and after 3 more vacuum/back-fill 
cycles, the resulting mixture is stirred at room temperature for ~10 mins. to dissolve the 
reagents. A solution of Et4N+OH- (20% wt. in H2O, 2 mL), previously degassed by 
bubbling nitrogen through for ca. 30 mins, is then added, and the mixture is stirred for 1h 
at room temperature, followed by ca. 24h at 90˚C. After cooling to room temperature, 
contents are precipitated in MeOH, and isolated by centrifugation. The crude polymer is 
dissolved in chloroform, filtered on a short silica gel plug and eluted with chloroform. 
The polymer solution is concentrated by evaporation of the solvents under reduced 
pressure, and the polymer is reprecipitated from acetone (or MeOH for acetone-soluble 
polymers). The pure polymer is isolated by centrifugation and dried under reduced 
pressure. 
 
Polymer P7. Following the general procedure with 14 (111.7 mg), 4 (55.6 mg). The 
resulting polymer is isolated as an orange solid (98 mg, 97%). 1H-NMR (300 MHz, 
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CDCl3): δ = 8.15 (m, 4H), 7.97 (d, 2H, J = 7.2 Hz), 7.85 (m, 2H), 2.17 (m, 4H), 1.26-1.14 
(m, 18H), 0.80 (m, 12H). GPC (THF vs. PS): Mn = 30 000, Mw = 77 900. 
 
Polymer P8. Following the general procedure with 14 (111.7 mg), 8 (140.5 mg). The 
resulting polymer is isolated as a bright yellow solid (62 mg (acetone insoluble), 99 mg 
(acetone soluble) 86%). 1H-NMR (500 MHz, CDCl3): δ = 7.92-7.88 (m, 6H), 3.96 (m, 
4H), 2.06 (m, 4H), 1.66 (m, 4H), 1.31-1.15 (m, 68H), 0.88 (t, 6H, J = 6.5 Hz), 0.82 (t, 
6H, J = 7.5 Hz). GPC (THF vs. PS): Mn = 46 700, Mw = 102 000 (acetone insoluble 
fraction). 
 
Polymer P9. Following the general procedure with 14 (111.7 mg), 8 (143.7 mg). The 
resulting polymer is isolated as a bright yellow solid (124 mg (acetone insoluble), 34 mg 
(acetone soluble) 83%). 1H-NMR (500 MHz, CDCl3): δ = 7.95 (m, 2H), 7.80 (m, 4H), 
3.94 (m, 4H), 2.06 (m, 4H), 1.63 (m, 4H), 1.31-1.16 (m, 68H), 0.88 (t, 6H, J = 6.5 Hz), 
0.82 (t, 6H, J = 7.0 Hz). GPC (THF vs. PS): Mn = 55 600, Mw = 135 900. 
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Chapter 5 Appendix 
1H-NMR and 13C-NMR Spectra 
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Figure 5.A.1. 1H-NMR Spectrum of 1 in (CD3)2SO (300 MHz).  
 
Figure 5.A.2. 13C-NMR Spectrum of 1 in (CD3)2SO (75 MHz). 
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Figure 5.A.3. 1H-NMR Spectrum of 2 in CDCl3 (300 MHz).  
 
Figure 5.A.4. 13C-NMR Spectrum of 2 in CDCl3 (75 MHz). 
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Figure 5.A.5. 1H-NMR Spectrum of 3 in CDCl3 (300 MHz).  
 
Figure 5.A.6. 13C-NMR Spectrum of 3 in (CD3)2SO (75 MHz). 
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Figure 5.A.7. 1H-NMR Spectrum of 4 in CDCl3 (300 MHz).  
 
Figure 5.A.8. 13C-NMR Spectrum of 4 in CDCl3 (75 MHz). 
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Figure 5.A.9. 1H-NMR Spectrum of 6 in CDCl3 (500 MHz).  
 
Figure 5.A.10. 13C-NMR Spectrum of 6 in CDCl3 (125 MHz). 
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Figure 5.A.11. 1H-NMR Spectrum of 7 in CDCl3 (500 MHz).  
 
Figure 5.A.12. 13C-NMR Spectrum of 7 in CDCl3 (125 MHz). 
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Figure 5.A.13. 1H-NMR Spectrum of 8 in CDCl3 (500 MHz).  
 
Figure 5.A.14. 13C-NMR Spectrum of 8 in CDCl3 (75 MHz). 
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Figure 5.A.15. 1H-NMR Spectrum of 10 in CDCl3 (500 MHz).  
 
Figure 5.A.16. 13C-NMR Spectrum of 10 in CDCl3 (125 MHz). 
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Figure 5.A.17. 1H-NMR Spectrum of 11 in CDCl3 (300 MHz).  
 
Figure 5.A.18. 13C-NMR Spectrum of 11 in CDCl3 (75 MHz). 
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Figure 5.A.19. 1H-NMR Spectrum of P1 in CDCl3 (500 MHz).  
 
Figure 5.A.20. 1H-NMR Spectrum of P2 in CDCl3 (500 MHz).  
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Figure 5.A.21. 1H-NMR Spectrum of P3 in CDCl3 (500 MHz).  
 
Figure 5.A.22. 1H-NMR Spectrum of P4 in CDCl3 (500 MHz).  
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Figure 5.A.23. 1H-NMR Spectrum of P5 in CDCl3 (500 MHz).  
 
Figure 5.A.24. 1H-NMR Spectrum of P6 in CDCl3 (500 MHz).  
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Figure 5.A.25. 1H-NMR Spectrum of P7 in CDCl3 (300 MHz).  
 
Figure 5.A.26. 1H-NMR Spectrum of P8 in CDCl3 (500 MHz).  
 
* *
N
O
N
n
C8H17C8H17
P7
* *
N
O
N
n
C8H17C8H17
P8
C14H29O OC14H29
 383 
Figure 5.A.27. 1H-NMR Spectrum of P9 in CDCl3 (500 MHz).  
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Chapter 6 
Energy Transfer in Poly(phenylene 
ethynylene)s at the Air-Water Interface 
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6.1 Introduction 
 
Energy migration, the process by which an excited state is transferred from one 
site to another, and may be divided into intramolecular and intermolecular cases, is at the 
basis of some of the most useful properties of conjugated polymers. In conjugated 
polymer-based amplifying chemical sensors, improved sensory responses depend on the 
efficiency of energy migration either along the polymer backbone ("molecular wire" 
effect),1  between polymer chains in aggregates2 or in the solid state.3 Energy migration is 
also important in conjugated polymer-based light-emitting devices, where energy 
migration to the lowest energy emitter is generally observed. This property can be 
harnessed to prepare light-emitting devices of varying colors by the simple change of a 
low-energy emitting dopant in a common conjugated-polymer matrix.4 Energy migration 
processes can also be deleterious to the properties of conjugated polymer-based light-
emitting devices when energy is transferred either to an emissive, low-energy defect 
resulting in low color purity, or to non-emissive defects,5 thereby resulting in decreased 
luminescence quantum yields.  
 
 Energy migration in conjugated polymers has been studied by a number of 
methods, but commonly involves the migration of energy from a higher energy excited 
state to an emissive lower-energy group, which facilitates spectroscopic studies. The 
latter emitter may be located on-chain or dispersed in the polymer matrix, and may be a 
different chromophore or a local arrangement of polymer chains (e.g. more conjugated 
planar regions, aggregates, etc.) that results in a lower band gap. Efficient energy transfer 
(up to >95%) to lower-energy sites has been observed in poly(phenylene ethynylene)s 
that incorporate anthracene groups in solution,6 thin films,7 and microscopic aggregates.8 
These results, and evidence that exciton diffusion length is increased with longer excited 
state lifetimes,9 suggest that intramolecular energy transfer in these polymers is fast with 
respect to radiative and non-radiative deactivation pathways. Fast intramolecular energy 
migration has also been reported in poly(fluorene)s and analogues,5a, 10 poly(phenylene 
vinylene)s,11 and poly(diacetylene)s.12 For the former two families of polymers, this 
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picture is balanced by conflicting reports of slow and inefficient intramolecular though 
fast and dominant intermolecular energy migration.13 
 
 Conflicting evidence regarding the ease of intramolecular energy migration in 
conjugated polymers might be reconciled with a model that takes into account the precise 
structure of the excited polymer chain that undergo energy migration. Intermolecular 
energy migration through a dipole-dipole mechanism appears most efficient for short 
interpolymer distances (e.g. especially in solid films), and is independent of polymer 
chain conformation. Intramolecular energy migration, however, appears to depend on the 
conformation of polymer chains, with highly conjugated conformations (e.g. more planar) 
facilitating exciton migration.15 In the absence of a favored conjugated conformation, 
intramolecular energy migration is an endothermic process as rearrangement of the 
polymer microstructure and/or hopping over a conformationally induced energy barrier is 
required. Consequently, intramolecular energy transfer is usually more efficient at room 
temperatures than under cryogenic conditions. 14 
 
While such temperature dependence on the intramolecular energy migration has 
been experimentally verified, the influence of polymer conformation is more difficult to 
confirm by experiment since a majority of relevant spectroscopic experiments (e.g. laser-
pulse time-resolved single-molecule spectroscopy) are normally carried in spin-cast thin 
polymer films for which accurate structural control is very limited. Recently, Nesterov, 
Zhu and Swager have demonstrated that alignment and planarization of a non-
aggregating poly(phenylene ethynylene) in a nematic liquid crystal matrix results in 
increased energy migration to low-energy anthracene end-capping groups. 15 This result 
has been interpreted as evidence that rigidification and increased conjugation length of 
the polymer backbone in the LC matrix facilitates intramolecular energy migration. 
 
We sought to take advantage of the exquisite conformational control afforded in 
Langmuir monolayers of amphiphilic poly(phenyelne ethynylene)s at the air-water 
interface to further investigate intra- and intermolecular energy transfer in conjugated 
polymers end-capped with a red-shifted emissive chromophores. Confinement in a 2D-
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plane at the air-water interface reduces the degrees of freedom of the system in 
comparison to a random 3D organization, resulting in more highly planar and conjugated 
structures. Mechanical annealing of monolayers of these rigid-rod polymers results in 
their alignment in a 2D nematic liquid crystalline organization (Figure 6.1), in which the 
average chain-to-chain distance (or surface density) may be controlled as a function of 
the surface pressure. Pressure variation also permits the controlled switching between 
more conjugated ("Face-On") and less conjugated ("Zipper Phase") polymer chain 
conformations for polymers that incorporate asymmetrically substituted amphiphilic 
monomers (e.g. 10) (Figure 6.2). 16 Finally, a continuum of polymer chain densities 
intermediate between that of dilute solutions and that of solid films can be accessed by 
mechanical control of the density of polymer chains at the air-water interface. 
 
Figure 6.1. Pictorial representation of a 2D nematic liquid crystalline organization of an 
amphiphilic polymer at the air-water interface (orange: hydrophobic segments, purple: 
hydrophilic segments). 
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Figure 6.2. Switching between the red-shifted "Face-On" (left) and the blue-shifted 
"Zipper Phase" (right) conformations in amphiphilic poly(phenylene ethynylene)s at the 
air-water interface. 
 
 In this chapter, we present the synthesis of a series of perylene-monoimide end-
capped amphiphilic poly(phenylene ethynylene)s and in situ spectroscopic studies of 
these polymers at the air-water interface aimed at a better understanding of the factors 
that govern energy transfer to the red-emitting end-cap. These studies also aim to identify 
of the requirements for the development of sensing schemes in which energy transfer can 
be modulated by analytes or environmental stimuli.17 The polymers also appear promising 
for the development of biosensors immobilized on cell membranes that respond to 
variations in surface density (multivalent interactions, osmotic pressure, etc.). 
 
6.2 Synthesis and characterization of perylene monoimide end-capped amphiphilic 
poly(phenyelene ethynylene)s 
 
 Perylene monoimide dyes were selected as the low-energy acceptors for end-
capping the amphiphilic poly(phenylene ethynylene)s. These dyes possess high 
fluorescence quantum yields, high molecular extinction coefficients, high chemo- and 
photo-stability, the ability to be directly conjugated and most importantly a red-shifted 
fluorescence emission (λem = 550-600 nm in P1-P4) to facilitate the deconvolution of 
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their emission from the vibronic tail of the conjugated polymer emission. The synthesis 
of perylene monoimide end-caps 7 and 8 is presented in Scheme 6.1 below. The more 
hindered end-capping group 8 was prepared to guarantee solubility, prevent aggregation 
and maintain the orientation of the end-capping group parallel to the plane of the air-
water interface during Langmuir-Blodgett (LB) experiments. Selective monoimidation 
and decarboxylation of perylene-3,4,9,10-tetracarboxylic dianhydride with hindered 
anilines proceeds in acceptable yields following Langhals' optimized protocol using zinc 
acetate as a catalyst in imidazole-water under hyperbaric conditions. 18  Perylene 
monoimide 1 is selectively brominated according to literature procedures to afford either 
monobromide 219 or tribromide 3.20 Nucleophilic aromatic substitution reaction of 3 with 
p-tert-octylphenol affords the highly soluble perylene derivative 4,21 and both 2 and 4 are 
converted to the terminal alkynes 7 and 8 following standard protocols.  
 
Scheme 6.1. Synthesis of perylene monoimide dye end-capping groups 7 and 8. 
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The synthesis of perylene monoimide end-capped polymers P1-P4 is presented in 
Scheme 6.2. The synthetic route follows one previously developed for the end-capping of 
poly(phenylene ethynylene)s with anthracene end-groups.15 Monomers 916a (or 1016a) and 
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111a, b are polymerized under typical Sonogashira-Hagihara conditions6 with a slight 
(1.03) excess of the diiodide monomer, and an excess of an end-capping alkyne is added 
in a second stage. This approach to end-capping was found to be more successful than 
either the direct polymerization of diiodide, diacetylene and end-capping group, or the 
use of a slight excess diacetylene monomer followed by end-capping with a halogenated 
end-capping group. The greater success of the first approach is attributed to a low 
frequency of deleterious oxidative acetylene coupling side-reactions, and possibly to a 
better match between the reactivity of the monomers and end-groups. 
 
Scheme 6.2. Synthesis of perylene monoimide end-capped polymers P1-P4. 
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 The crude polymers as obtained after precipitation of the reaction mixture in 
methanol and isolation by centrifugation are contaminated with an excess of end-capping 
groups and other perylene monoimide-derived low molecular weight materials (short 
oligomers, etc.). It is necessary for meaningful energy migration studies to rigorously 
eliminate these by-products from the polymers. This was achieved by a column 
chromatography on silica gel followed by preparative-scale GPC and finally by 
reprecipitation from methanol or hexanes. The purified polymers P1-P4 are obtained as 
red solids, and their properties are summarized in Table 6.1. In addition to polymers P1-
P4 were prepared control polymer P0 that is identical to P1 but is not end-capped, and 
P1b, a duplicate of P1 prepared to ensure the reproducibility of the synthetic methods. 
The polymers have high molecular weights (Mn = 29 000 - 50 000 g mol-1) and their 
indices of polydispersity (1.9-2.8) are typical of poly(phenylene ethynylene)s prepared by 
cross-coupling polycondensations. The success of the end-capping reaction is evidenced 
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by an inspection of the GPC chromatograms at absorption wavelengths that correspond 
either to the polymer main band (254, 450 nm) or specifically to the end-capping group 
(530 nm) (Figure 6.3). In these chromatograms, the UV-Vis signals for the end-capping 
group track with the UV-Vis and refractive index signals for the polymer, with the 
difference that the endcap band is slightly shifted towards greater elution volumes 
corresponding to lower molecular weights. This behavior is expected since the absorption 
signal is proportional to the concentration of end-capping group in solution (Beer-
Lambert's Law) and since the mole fraction of end-capping group in the polymers is 
inversely proportional to its molecular weight, as evidenced by the numerical simulation 
presented in Figure 6.3. The simple numerical simulation contrasts a Gaussian 
distribution of polymer molecular weights with the signal expected for 2 end-capping 
groups per polymer chain. A low-MW shift of the molecular weight distribution tracking 
the end-capping group signal is apparent. The magnitude of the shift is more important in 
P1-P4 due to physical characteristics that are not taken into account in the numerical 
simulation (non-Gaussian distribution, larger polydispersity and non-linearity of the 
elution volume vs. molecular weight calibration curve for GPC signals). The extent of 
end-capping (e.g. the average number of perylene end-capping groups per polymer chain) 
was estimated by two methods. The ratio between the absorption bands attributed to the 
end-capping groups to that of the polymer main band (Figure 6.4) was compared to that 
expected on the basis of degree of polymerization determined by GPC and the molar 
extinction coefficient of a monomeric perylene monoimide dye. Comparisons were also 
established between the integration of the proton signals that correspond to the perylene 
end-capping groups in a region of the 1H-NMR spectra free of interfering signals (8.0-
10.0 ppm) and the integration of the polymer peaks. In both cases, the number obtained is 
an imprecise estimate due to the error associated with the measurements of small signals 
(absorbance, NMR integration) and due to the inaccuracy of molecular weight 
determination for rigid-rod conjugated polymers by gel permeation chromatography 
against polystyrene standards. The NMR integration method yields estimates that are 
systematically lower than those obtained from UV-Vis, and due to the lower S/N ratio in 
the former method, we judge the spectroscopic method to be more reliable, and conclude 
that polymers P1, P1b and P4 are probably fully end-capped as desired. It is, however, 
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likely that polymers P2 and P3 have on average only ~1 perylene monoimide group per 
polymer chain. 
 
Table 6.1. Summary of polymer characterization. 
Polymer 
Yield 
(%)b 
Mna  
(103 g mol-1) 
Mwa  
(103 g mol-1) 
PDIa DPna 
n endcap 
(UV-Vis) d 
n 
endcap 
(NMR) e 
χ endcap
f 
P0 88 69.4b 157.1 2.3 66 -  0 
P1 77 53.5b 
46.5c 
102.5b 
88.0c 
1.9b 
1.9c 
51b 
44c 
 
1.76 
 
0.97 
 
0.016 
P1b 98 37.0b 
39.7c 
90.5b 
95.1c 
2.4b 
2.4c 
35b 
38c 
 
2.31 
 
1.22 
 
0.023 
P2 34 57.0b 
48.7c 
131.9b 
108.3c 
2.3b 
2.2c 
54b 
46c 
 
1.16 
 
0.53 
 
0.009 
P3 90 37.9b 
50.0c 
80.8b 
142.8c 
2.1b 
2.8c 
36b 
47c 
 
0.70 
 
0.85 
 
0.008 
P4 98 35.8b 
28.8c 
84.8b 
76.0c 
2.4b 
2.6c 
34b 
27c 
 
2.20 
 
1.27 
 
0.032 
a Determined by GPC against PS standards. b After initial isolation by precipitation. c After purification by 
chromatography, preparative GPC and reprecipitation. d Average number of end-capping group per 
polymer chain estimated from the UV-Vis absorption of the endcap band vs. the polymer main band, and 
based on the literature value of ε = 39 800 L cm-1 mol-1 for a closely related monomeric perylene 
monoimide dye22 and the DPn determined by GPC. e Estimated by integration of signals attributed to the 
perylene dye fused rings (δ = 10-8 ppm) against those of the alkoxy side chain ether methylene groups and 
referenced to the DPn determined by GPC. f Average mole fraction of perylene endcap groups in the 
polymers: (nuv-vis+nnmr)/4DP 
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Figure 6.3. Gel permeation chromatography traces for P1-P4 (top row, left to right P1, 
P1b, P2; bottom row, left to right P3, P4, and numerical simulation (see text)). 
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Figure 6.4. Absorbance spectra of polymers P0-P4 in CHCl3 solution (top) and in thin 
films (bottom). 
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 The spectroscopic properties of polymers P1-P4 are summarized in Table 6.2. In 
chloroform solution, the absorption spectra of polymers P1-P4 (Figure 6.4) are 
characterized by a strong absorption band (ε ~ 40 000 L cm mol-1) centered at about 
420 mn, that is attributed to delocalized π-π* transition of the polymer main chain, and 
by a weaker band with a λmax of 530-540 nm attributed to the end-capping group. The 
ratio between the two bands that increases with higher mole fractions of perylene end-
capping groups in the polymers, as expected. The bands associated with these transitions 
are also observed in the solid state, with a sharp polymer aggregation band around 465-
470 nm and the endgroup absorption that also exhibits bathochromic shifts (15-20 nm).  
 
Table 6.2. UV-Vis absorption and emission properties of polymer P1-P9 and reference 
polymers from the literature. 
 λmax (nm) λ em (nm), τ (ns) Φf 
Polymer 
Solution in 
CHCl3  
(ε / L mol-1 cm-1)a 
Thin 
Film 
 
Solution (CHCl3) Thin Film 
Solutiond 
(CHCl3) 
Thin 
Filme 
P0 420 (40 900)b 470b 456 (100%),b 0.53 476 (100%),b 0.27 0.74 0.37 
P1 419 (42 400)b 
542 (1620)c 
470b 
560c 
456 (85%),b 0.43 
576 (15%) 
476 (7%),b < 0.10 
586 (93%),c 2.2 
0.54 0.20 
P1b 420 (41 800)b 
543 (2440)c 
471b 
560c 
456 (80%)b 
577 (20%)c 
477 (3%)b 
586 (97%)c 
0.54 0.19 
P2 416 (49 300)b 
531 (1010)c 
470b 
557c 
456 (88%)b 
- (12%)f 
477 (10%)b 
573 (90%)c 
0.55 0.15 
P3 417 (22 600)b 
543 (600)c 
468b 
559c 
453 (85%)b 
575 (15%)c 
474 (6%)b 
585 (94%)c 
0.59 0.31 
P4 417 (42 400)b 
537 (3220)c 
467b 
554c 
453 (76%)b 
567 (24%)c 
474 (3%)b 
584 (97%)c 
0.49 0.10 
a Molar absorptivity based on molecular weight of a repeating unit.  b Main polymer band. 
c Perylene endcap band. d Against quinine sulfate in 1N H2SO4 (Φf = 0.546, 
λex = 366 nm).23 e Against perylene in PMMA (Φf = 0.87, λex = 412 nm).24 f Perylene 
endcap emission band buried as a shoulder under main band vibronic structure. 
 
The fluorescence spectra of polymers P1-P4 in chloroform solution (Figure 6.5) 
match that of the control polymer P0, with an emission maximum at ca. 455 nm and a 
vibronic shoulder at ca. 490 nm. The end-capped polymers P1-P4 also show a second 
 396 
minor emission band attributed to energy transfer to the perylene monoimide 
fluorochrome (~ 570-580 nm). The energy transfer to the end-capping group in solution 
is not very efficient, with only 12-24% of the light being emitted by the endcap. As 
expected, the proportion of the light emitted by the perylene groups is higher for 
polymers that contain a higher mole fraction of perylene groups. Emission of the perylene 
endgroup must occur predominantly through an energy transfer mechanism as the 
emission of the red-shifted band is about one order of magnitude more intense when 
excited at the main chain absorption band (λex = 393 nm) than when directly excited at 
the endgroup absorption band (λex = 543 nm). Due to the red emission from the end-
capping perylene, solutions of polymers P1-P4 in chloroform have a white hue when 
irradiated with UV light, while solutions of the control polymer P0 display blue emission 
(Figure 6.6). Incorporation of the perylene endgroups lowers the fluorescence quantum 
yield of polymers P1-P4 (Φf = 0.49-0.59) compared to that of the control polymer P0 
(Φf = 0.74), an unexpected result in view of the excellent fluorescence quantum yields of 
these fluorochromes (Φf = 0.95-1.00).22, 25 The fluorescence lifetime of polymer P1 in 
solution (0.53 ns) is comparable to that reported for other similar poly(phenylene 
ethynylene)s in solution (0.51-0.54 ns).3, 9 Incorporation of a perylene monoimide 
endcapping group (P1) decreases the fluorescence lifetime to 0.43 ns, and the energy 
transfer efficiency calculated from the fluorescence lifetimes (19%) is comparable to the 
value obtained by steady-state measurements (15% of the light emitted by the endcap). 
Fluorescence emission spectra change dramatically for polymers P1-P4 in the solid state, 
where the efficiency of energy transfer to the perylene monoimide groups is greatly 
increased and low-energy emission (λem ~ 575-585) becomes the dominant feature of the 
emission spectra, with 90-97% of the light being emitted through the perylene endgroups. 
As a result, thin spin-cast films of polymers P1-P4 glow an orange light when irradiated 
with UV light, in stark contrast with control polymer P0 and polymers P1-P4 in solution 
(Figure 6.6). A reduction of the solid-state fluorescence quantum yields of polymers P1-
P4 (Φf = 0.10-0.31) with respect to that of control polymer P0 (Φf = 0.34) parallels the 
phenomenon observed for solutions. Polymers that contain the more sterically hindered 
end-capping group 8 (P1, P3; Φf = 0.19-0.31) are about twice as emissive than those 
containing end-capping group 7 (P2, P4; (Φf = 0.10-0.15), which suggests that the less 
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hindered end-capping group may participate in the formation of quenched aggregates. A 
decrease of the fluorescence lifetime from 0.27 ns for P0 in the solid state to less than 
0.10 ns (lower limit of the instrument used for the measurement) in thin films of P1 is 
also indicative of a more efficient energy transfer in the solid state. The fluorescence 
lifetime of the perylene monoimide endgroup in the solid state (2.2 ns) is slightly lower 
than that of monomeric perylene imide dyes (4.0-4.8 ns) and ethynyl-substituted 
monomeric perylene monomide dyes (3.4-4.9 ns), which provides evidence for effective 
delocalization and conjugation between the polymer main chain and the perylene 
endgroup.22, 23 
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Figure 6.5. Fluorescence emission spectra of polymers P0-P4 in CHCl3 solution (top, 
λex = 393 nm) and in thin films (bottom, λex = 412 nm). 
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Figure 6.6. Photographs of polymers P0, P1 and P4 in chloroform solution (top) under 
visible light (left), UV irradiation (right) and in thin films under UV irradiation (bottom). 
 
6.3 In situ spectroscopy at the air-water interface  
 
Chloroform solutions of polymers P1-P4 spread uniformly at the air-water 
interface in a Langmuir-Blodgett (LB) trough to form stable monolayers, as previously 
described for control polymer P0 and related poly(phenylene ethynylene)s.16 At low 
surface pressures, all polymers adopt a face-on conformation at the air-water interface, as 
evidenced by sharp main chain absorption bands that are red-shifted (λmax = 452-456 nm) 
with respect to solution values, and by smaller red-shifts in the emission wavelength of 
the main polymer emission band (λmax = 459-467 nm). These bathochromic shifts are a 
consequence of the more planar and conjugated conformation of the polymers that adopt 
a predominantly flat conformation with respect to the air-water interface. At low surface 
pressures, the typical distances between polymer chains are comparatively large and 
consequently intermolecular energy migration may be assumed to be small compared to 
intramolecular pathways. By comparison to chloroform solutions, the efficiency of 
energy migration to the perylene monoimide endgroups is significantly more efficient in 
Langmuir monolayers, with 36-71% of the light emitted originating from the endgroups 
(Figure 6.7). 
 
 399 
300 350 400 450 500 550 600
P1 Sol
P1a Sol
P1 Lang
P1b  Lang
N
o
rm
a
liz
e
d
 A
b
s
o
rb
a
n
c
e
Wavelength (nm)  
450 500 550 600 650
N
o
rm
a
liz
e
d
 E
m
is
s
io
n
Wavelength (nm)  
300 350 400 450 500 550 600
P2 Sol
P3 Sol
P2 Lang
P3 Lang
N
o
rm
a
liz
e
d
 A
b
s
o
rb
a
n
c
e
Wavelength (nm)  
450 500 550 600 650
N
o
rm
a
liz
e
d
 E
m
is
s
io
n
Wavelength (nm)  
300 350 400 450 500 550 600
P4 Sol
P4 Lang
N
o
rm
a
liz
e
d
 A
b
s
o
rb
a
n
c
e
Wavelength (nm)  
450 500 550 600 650
N
o
rm
a
liz
e
d
 E
m
is
s
io
n
Wavelength (nm)  
Figure 6.7. Comparison of the absorption (left) and fluorescence emission (right, 
λex = 400 nm) spectra of P1-P4 in chloroform solutions and in Langmuir monolayers 
(surface pressure ≤ 2 mN m-1) at the air-water interface. 
 
 A complete survey of the spectroscopic properties (absorption, emission and 
excitation) of Langmuir monolayers of polymers P1-P4 at the air-water interface as a 
function of the surface density was undertaken to elucidate in a controlled manner the 
effects of intermolecular distance on the efficiency of energy migration. The summary of 
these experiments is presented in Figures 6.8-6.12. All polymers follow the same general 
trends, which details as follows. The pressure-area isotherms of polymers P1-P4 were 
found to parallel those of corresponding polymers16 that are not end-capped, suggesting 
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that the introduction of these end-caps does not affect the phase behavior of the polymers. 
Hence, polymers P1-P2, incorporating the asymmetrically substituted monomer 9 adopt a 
face-on conformation at low surface pressures before undergoing a sharp transition to the 
zipper phase between surface pressures of 15 and 20 mN/m. The zipper phase is 
maintained up to ~35 mN/m, at which point the monolayer collapses and folds into 
multilayers. Polymers P3-P4, incorporating the symmetrically substituted monomer 10 
adopt a face-on conformation at all surface pressures before collapsing into multilayers at 
~30 mN/m. The phase behavior of the polymers is further supported by the characteristic 
hypsochromic shifts (or absence thereof for face-on polymers) in the absorption and 
excitation spectra that coincide with the transition from the face-on conformation to the 
less planar and conjugated zipper phase conformation. As expected, folding into 
multilayers is accompanied by the emergence of a sharp red-shifted band in the 
absorption and excitation spectra that correspond to aggregated polymer chains. 
 
 While the pressure-area isotherm, the excitation and absorption spectra of the 
polymers P1-P4 do not differ significantly from those of non-end-capped polymers, the 
emission spectra show important differences. As the polymer monolayer is compressed 
and the surface density of the polymer in the Langmuir film is increased, the relative 
intensity of the perylene fluorochrome increases compared to that of the polymer main 
band. For instance, in monolayers of P1, the proportion of light emitted by the endcaps 
goes from 48% at low pressures to 82% just below the pressure at which folding of the 
monolayer occurs. Other polymers also display the same behavior, providing evidence 
that a an intermolecular energy migration pathway that is inefficient at when interchain 
distances are high becomes the dominant energy migration pathway in dense monolayers. 
Interestingly, the transition from the face-on conformation to the zipper phase does not 
appear to result in a significant diminution of the efficiency of energy transfer to the low 
energy sites, despite the disruption of the planarity and the hypsochromic shifts 
associated with this disruption. Several hypotheses may explain these observations. At 
surface densities that coincide with the transition between the face-on and the zipper 
phase conformation, intermolecular energy transfer is probably dominant over 
intramolecular migration, and disruption of the conjugation probably affects the latter 
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minor component more than the former major component, resulting in a negligible 
overall reduction of the efficiency of energy transfer. Switching of the conformation will 
also affect the spectral overlap integral (J(λ), vide infra) parameter in both dipole-dipole 
and electron exchange energy transfer mechanisms, and should in principle contribute to 
a reduction of the efficiency of energy transfer. However, the shifts experienced by the 
donor emission band upon switching conformation are relatively small (~ 467 nm to 460 
nm) and the resulting small decrease in the spectral overlap integral is probably more 
than compensated by the reduction in average interpolymer distances that accompany the 
phase transition. 
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Figure 6.8. In situ spectroscopy of polymer P1 at the air-water interface: Pressure-area 
isotherm (1st quadrant); Fluorescence excitation spectra (λem = 600 nm, 2nd quadrant); 
Absorbance spectra (3rd quadrant); Fluorescence emission spectra (λex = 400 nm, 4th 
quadrant). 
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Figure 6.9. In situ spectroscopy of polymer P1b at the air-water interface: Pressure-area 
isotherm (1st quadrant); Fluorescence excitation spectra (λem = 600 nm, 2nd quadrant); 
Absorbance spectra (3rd quadrant); Fluorescence emission spectra (λex = 400 nm, 4th 
quadrant). 
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Figure 6.10. In situ spectroscopy of polymer P2 at the air-water interface: Pressure-area 
isotherm (1st quadrant); Fluorescence excitation spectra (λem = 600 nm, 2nd quadrant); 
Absorbance spectra (3rd quadrant); Fluorescence emission spectra (λex = 400 nm, 4th 
quadrant). 
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Figure 6.11. In situ spectroscopy of polymer P3 at the air-water interface: Pressure-area 
isotherm (1st quadrant); Fluorescence excitation spectra (λem = 600 nm, 2nd quadrant); 
Absorbance spectra (3rd quadrant); Fluorescence emission spectra (λex = 400 nm, 4th 
quadrant). 
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Figure 6.12. In situ spectroscopy of polymer P4 at the air-water interface: Pressure-area 
isotherm (1st quadrant); Fluorescence excitation spectra (λem = 600 nm, 2nd quadrant); 
Absorbance spectra (3rd quadrant); Fluorescence emission spectra (λex = 400 nm, 4th 
quadrant). 
 
6.4 Mixed poly(phenylene ethynylene)s-phospholipids monolayers  
 
 The in situ spectroscopy of monolayers of perylene monoimide end-capped 
polymers P1-P4 indicates that a variation of the surface density of these amphiphilic 
poly(phenylene ethynylene)s at the air-water interface affects the efficiency of 
intermolecular energy transfer to the low-energy emission site. This behavior is 
interesting as a transduction mechanism for the design of ratiometric (e.g. endcap / main 
band emission) conjugated polymer sensors. Variations in the surface tension of aqueous 
solutions may be assessed directly by spreading Langmuir films of the polymers, but 
more advanced sensor designs may be envisioned. Changes in osmotic pressure could be 
tracked by the radial contraction and expansion of suspended aqueous surfactant vesicles 
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with an external surface garnished with polymers such as P1-P4. Extension to biological 
vesicles (e.g. cells) is also an attractive way of the following of their exchanges with the 
environment. Biological applications also include the attachment of recognition groups 
on the conjugated polymers to identify multivalent interactions and local clusters of 
biologically relevant entities (e. g. membrane proteins, sugars, etc.) on the surface of 
cells.26 For such applications to be realized a number of requirements from the polymers 
must first be met. The polymers must freely disperse without phase segregation at the 
interface in the presence of other surfactants and thus freely dissolve in 2D-solutions of 
other amphiphiles at the interface. In addition, the transduction mechanism 
(intermolecular energy transfer to lower energy emissive sites) must not be hindered by 
the presence of other amphiphiles (e. g. intercalation of surfactants between polymer 
chains). 
 
 These requirements were evaluated by preparing mixed solutions containing both 
conjugated polymers and a surfactant, spreading at the air-water interface and performing 
in situ spectroscopic experiments as previously described for the pure polymers P1-P4 
above. Dimyristoyl phosphatidyl choline (DMPC), a typical biological membrane 
phospholipid27 (Scheme 6.3) was selected as diluent amphiphile for these experiments to 
help predict the applicability this approach in more complex biological systems. 
 
Scheme 6.3. Dimyristoyl phosphatidyl choline (DMPC) 
C13H27 O O
P
O-
O
O
O
C13H27
N+
O
O
 
 
 Dimyristoyl phosphatidyl choline forms stable Langmuir monolayers at the air-
water interface and exhibit a typical monomeric amphiphile phase behavior, as evidenced 
by the pressure-area isotherm of DPMC (Figure 6.13).28 Upon spreading on the LB 
trough, mixed chloroform solutions of P1 and DMPC form macroscopically uniform 
monolayers that do not exhibit phase separation when observed under UV irradiation. 
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Mixed monolayers corresponding to surface coverage ratios of 1:1 and 4:1 DMPC : P1  
exhibit pressure area-isotherms that approximately correspond to a weighed average of 
the pressure-area isotherms of the two pure components (Figure 6.13). The face-on to 
zipper transition is however less marked, suggesting that in the pure monolayers the 
phase transition may be more concerted due packing effects and the influence of 
neighboring chains. 29  The absorption, excitation and emission spectra of mixed 
monolayers of DMPC : P1 is shown in Figures 6.14-6.15 below. The spectroscopic 
properties of the mixed monolayers resemble that of pure P1, with a distinctive face-on to 
zipper phase transition visible in the absorption and excitation spectra, and band maxima 
that are not significantly shifted from their positions in pristine monolayers of P1. 
Furthermore, the emission spectra of the mixed monolayers also exhibit surface density 
dependence on the efficiency of energy transfer to the end-capping groups, with the 
notable difference that, as expected for surface polymer densities that are much lower 
than for the pure P1 monolayers, the relative importance of the perylene monoimide 
emission band is much lower. For the mixed 1:1 monolayer proportion of light that 
origins from the endcap band varies from 50% to 60% and that of the mixed 4:1 
DMPC:P1 monolayer varies from 35% to 40%. We take these results to be further 
evidence of the predominant importance of intermolecular energy transfer as the surface 
density of polymers is raised. 
 
0
10
20
30
40
50
20 40 60 80 100 120 140
S
ur
fa
ce
 P
re
ss
ur
e 
(m
N
 m
-1
)
Surface Area (Å2 per repeating unit)
0
10
20
30
40
50
200 300 400 500 600 700 800 900
S
ur
fa
ce
 P
re
ss
ur
e 
(m
N
 m
-1
)
Surface Area (Å2 per repeating unit)
0
10
20
30
40
50
50 100 150 200 250 300 350
S
ur
fa
ce
 P
re
ss
ur
e 
(m
N
 m
-1
)
Surface Area (Å2 per repeating unit)
0
5
10
15
20
25
30
35
50 100 150 200 250 300
S
ur
fa
ce
 P
re
ss
ur
e 
(m
N
 m
-1
)
Surface Area (Å2 per repeating unit)  
Figure 6.13. Pressure-area isotherms of dimyristoyl phosphatidylcholine with increasing 
fractions of polymer P1: (fractional area, left to right) 1:0; 4:1; 1:1 and 0:1 DMPC : P1. 
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Figure 6.14. In situ spectroscopy of mixed monolayers of polymer P1 and DMPC 
(surface coverage fractions 1:1) at the air-water interface: Pressure-area isotherm (1st 
quadrant); Fluorescence excitation spectra (λem = 600 nm, 2nd quadrant); Absorbance 
spectra (3rd quadrant); Fluorescence emission spectra (λex = 400 nm, 4th quadrant). 
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Figure 6.15. In situ spectroscopy of mixed monolayers of polymer P1 and DMPC 
(surface coverage fractions 1:4) at the air-water interface: Pressure-area isotherm (1st 
quadrant); Fluorescence excitation spectra (λem = 600 nm, 2nd quadrant); Absorbance 
spectra (3rd quadrant); Fluorescence emission spectra (λex = 400 nm, 4th quadrant). 
 
6.5 Mechanisms of energy transfer 
 
 A quantitative analysis of the dependence of intermolecular distance on the 
efficiency of energy transfer was undertaken to provide a better understanding of the 
underlying mechanisms that govern perylene monoimide emission on polymers P1-P4. 
From the in situ spectroscopic experiments were extracted the relative emission 
intensities of the main polymer and endcap emission bands as a function of the surface 
concentration of polymers at the air-water interface. These parameters were then modeled 
against the theoretical frameworks of dipole-dipole and electron exchange energy transfer 
mechanisms (Figure 6.16). A trivial energy transfer mechanism occuring by emission 
and reabsorption of light is inconsistent with the decrease in fluorescence lifetimes both 
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in solution and in the solid state that occur upon incorporation of the perylene monoimide 
endgroups (e.g. P0 vs. P1). Trivial reabsorption is also unlikely to be compatible with the 
high energy transfer efficiency observed in Langmuir monolayers due to geometrical 
considerations.32 
 
Donor* Acceptor Donor Acceptor*   Donor* Acceptor Donor Acceptor*  
Figure 6.16. Pictorial representation of energy transfer by the dipole-dipole (left) and 
electron-exchange (right) mechanisms 
 
 Dipole-dipole energy transfer, also known as Förster energy transfer, origins from 
the through-space coulombic interaction induced at the energy acceptor as the donor 
relaxes from its excited singlet state. The rate of dipole-dipole energy transfer according 
to Förster theory can be expressed as30 
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 where kT(r) is the rate of energy transfer; QD the quantum yield of the energy 
donor in the absence of an acceptor; κ2 a parameter related to the relative orientation of 
the transition dipoles of the donor and acceptor; τD the excited state lifetime of the energy 
donor in the absence of an acceptor; r the distance between the donor and the acceptor; N 
the Avogadro number; n the refractive index of the medium, and J(λ) the normalized 
spectral overlap integral between the emission spectra of the energy donor and absorption 
spectra of the energy acceptor. The distance dependence of the energy transfer is 
conveniently expressed as a function of the ratio of the fluorescence intensity of the 
donor in the presence (FDA) and in the absence (FD) of the acceptor 
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 where E is the efficiency of energy transfer and R06 the Förster radius, 
representing the distance at which the efficiency of energy transfer reaches 50%, a 
molecular property of the donor-acceptor pair. 
 
 These formula apply to the energy transfer by dipole-dipole mechanism between 
point dipoles (e.g. the distance between the chromophores r is much larger than the size 
of the chromophore's transition dipole) in space (3D). They are not directly applicable to 
restricted geometries, such as confinement in the plane formed by the monolayer at the 
air water interface (2D). Theoretical treatments have been expanded for a number of 
constrained geometries, including energy transfer from a point donor to a uniform plane 
of acceptors and from a delocalized plane of donors to a uniform plane of acceptors, for 
which distance dependence on the efficiency of energy transfer that scale with r-4 and r-2 
are respectively associated. 31 Models for dipole-dipole energy transfer for uniformly 
distributed point donor and acceptors confined to a plane (2D) 32  have also been 
developed, and the latter have been applied to energy transfer at the surface of biological 
membranes and in Langmuir monolayers. For these, analytical expressions of distance 
dependence of the efficiency of energy transfer are of great complexity, but have been 
evaluated numerically on the basis of a number of assumptions (e.g. random distribution 
of dipole orientations, large concentration of acceptors with respect to the concentration 
of excited-state donors, etc.): 
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 where λ is the ratio between the time after excitation and the fluorescence lifetime 
τ; Γ(2/3) the gamma function evaluated for the argument 2/3; R02 the square of the Förster 
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radius and c the two-dimensional concentration of acceptors per unit area. The distance-
dependence on energy transfer may also be expressed as a function of the fluorescence 
intensity of the acceptor: 
! 
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 where k is an adjustable parameter function of the relative quantum yields of the 
donor and the acceptor at the wavelengths used in a fluorescence experiment. 
 
 Electron exchange energy transfer, also know as Dexter energy transfer, 33 unlike 
coulombic dipole-dipole interaction, is a mechanism that requires contact between the 
electronic surfaces of the energy donor and acceptors. According to Dexter theory, the 
rate of energy transfer kET may be expressed as: 
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 where K is a constant related to the specific orbital interactions between the donor 
and the acceptor; J a normalized overlap integral; RDA the distance between the donor and 
the acceptor and L the van der Waals radius. As for the general expression of energy-
transfer rate according to the Förster theory, eq. 5 applies to uniformly distributed donor 
and acceptors in space (3D). We are not aware of detailed theoretical treatments of 
electron exchange energy transfer under constrained geometries34 under forms what 
would directly apply to two-dimensional monolayers at the air-water interface. However, 
the general tridimensional model has previously been applied without corrections to the 
analysis of energy transfer by electron-exchange in planar distributions of donors and 
acceptors.35 
 
Spectroscopic parameters for polymers P1-P4 at the air-water interface have been 
compared to the previously described theoretical models (dipole-dipole in 3D: point-to-
point, point-to-plane, plane-to-plane; dipole-dipole in 2D; electron exchange in 3D) to 
identify the most likely mechanism of energy transfer in the studied systems. Modeling of 
the experimental data is complicated by a number of considerations. Due to the low 
optical density of monolayers, absorption signals have a low signal-to-noise ratio, making 
the comparisons based on relative quantum yields unreliable. Instead, the emission 
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spectra were integrated for each emission band (main band: 425-525 nm; endcap band 
526-685 nm), the integrals were normalized to a total emission of 100%, and the 
evolution of the proportion of emission that originate for each band is tracked.  
Furthermore, the number of data points for each polymers is relatively low (5-6 
measurements at varying surface pressures) due to the imprecision in the measurement of 
the surface area per repeating unit for each measurement. This limited number of data 
points is not ideal for adequate curve fitting to the different models. For this reason, a 
better comparison to models is obtained for P1 because concatenation of data from the 
pure and mixed DMPC monolayers provided an extended data set. Examples of curve 
fittings for P1 (pure and mixed with DMPC) are presented in Figure 6.17 below, and 
similar plots for polymers P1-P4 are presented in the appendix of this chapter. In these 
plots the ratio FDA/FD is plotted against the square root of the surface area per repeating 
unit, a parameter proportional to the average interchain distance (dipole-dipole and 
electron exchange models in 3D) or against the surface area per repeating unit, a 
parameter inversely proportional to the surface concentration (dipole-dipole model in 
2D).  Since the value of FD, corresponding to the fluorescence emission of the donor in 
the absence of acceptors is impossible to access in the end-capped polymers (e.g. the 
acceptor is covalently linked to the donor), the fluorescence emission at the lowest 
surface concentrations was taken as FD under the assumption that at large interpolymer 
distances intermolecular energy transfer is inefficient and intramolecular pathways 
contribute most to the energy transfer at these concentrations. Consequently, the analysis 
of the experimental data against theoretical models applies only to the intermolecular 
component to energy transfer. 
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Figure 6.17. Fitting of spectroscopic data for P1 (pure monolayers and mixed P1:DMPC) 
with energy transfer models (left to right, top to bottom: plane-to-plane dipole-dipole ET 
in 3D; point-to-plane dipole-dipole ET in 3D; point-to-point dipole-dipole ET in 2D and 
electron exchange ET in 3D). 
 
For all polymers, poor fits are obtained with tridimensional models of dipole-
dipole energy transfer in either point-to-point, point-to-plane and plane-to-plane 
geometries, leading to the conclusion that these models are inappropriate for the studied 
systems. Reasonably good fits are obtained with both the models of dipole-dipole energy 
transfer in 2D (biexponential curve fit following eq. 3-4) and electron exchange energy 
transfer in 3D (monoexponential curve fit following eq. 5), with each model providing a 
better fit to some data sets and inferior ones to others. The two models are overall 
comparable to each other in terms of the fit over all polymer samples. Consequently, 
neither of these two mechanisms of energy transfer may be ruled out on the basis of in 
situ spectroscopic experiments. Nonetheless, since it is known that the 2D Förster model 
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is adapted to the specific geometry of Langmuir monolayers and the Dexter model 
presented herein is not, it appears more likely that the former is more relevant to the 
investigated polymers. Furthermore, a number of assumptions made in the establishment 
of the theoretical 2D dipole-dipole ET model, such as that of a random distribution of 
chromophores and orientations in the plane are also known to be inexact for the 
mechanically annealed polymer monolayers under study where polymer chains organize 
in a nematic liquid-crystalline fashion. A refinement of the geometric model for dipole-
dipole energy transfer taking into account the particularities of the system should lead to 
a better agreement with the experimental results, but falls beyond the scope of this work. 
 
6.6 Conclusions 
 
New amphiphilic poly(phenylene ethynylene)s that are fully end-capped with 
perylene monoimide dyes were synthesized. In these, energy transfer from the excited 
polymer main band to the lower-energy endgroup is inefficient in solution, but efficiency 
improves upon planarization at the air-water interface, supporting the assertion 
intermolecular energy migration is facilitated by increasing the effective degree of 
conjugation. Intermolecular energy transfer is less important in solutions or at low surface 
concentrations in Langmuir monolayers, but becomes the predominant energy transfer 
pathway in the solid state and at high surface concentrations at the air-water interface. 
The surface concentration dependence of energy transfer was compared to theoretical 
models and supports the participation of either (or both) dipole-dipole and electron 
exchange energy transfer mechanisms. The polymers are miscible in monolayers with 
phospholipid surfactants, forming homogenous Langmuir. The combination of 
concentration-dependent spectroscopic response and the compatibility with biological 
amphiphiles make these polymers attractive platforms for the development of new 
biosensors that exploit surface interactions as a transduction mechanism. 
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6.7 Experimental Section 
 
Materials 
All solvents were of ACS reagent grade or better unless otherwise noted. 
Anhydrous tetrahydrofuran, toluene and dichloromethane were dried on a solvent column 
purification system. N,N-Dimethylformamide was dried by storage over 4Å molecular 
sieves for 48h, followed by vacuum distillation and storage over 3Å molecular sieves for a 
minimum of 48h prior to use. Silica gel (40-63 µm) was obtained from SiliCycle Inc. N-
(2,6-Diisopropylphenyl)perylene-3,4-dicarboximide (1),18 9-bromo N-(2,6-
diisopropylphenyl)-perylene-3,4-dicarboximide (2),19 1,6,9-tribromo N-(2,6-
diisopropylphenyl)-perylene-3,4-dicarboximide (3),20 9-bromo-1,6-bis(4-tert-
octylphenoxy)-N-(2,6-diisopropylphenyl)-perylene-3,4-dicarboximide (4),21 1-decyloxy-
2,5-diethynyl-4-(3,6,9-trioxadecyloxy)benzene (9),16a 2,5-diethynyl-1,4-bis(3,6,9-
trioxadecyloxy)benzene (10)16a and 2,5-diiodo-N1,N1,N4,N4-tetraoctylbenzene-1,4-
dicarbamide (11)1a, b were prepared according to literature procedures or slight 
modifications thereof. All other reagents, compounds and chemicals were obtained from 
commercial suppliers and used without further purification. 
 
General methods, instrumentation and measurements 
Synthetic manipulations that required an inert atmosphere (where noted) were 
carried out under nitrogen or argon using standard Schlenk techniques or in an inert-
atmosphere glovebox. NMR (1H and 13C) spectra were recorded on 300 and 500 MHz 
spectrometers. The chemical shift data for each signal are given in units of δ (ppm) 
relative to tetramethylsilane (TMS) where δ (TMS) = 0, and referenced to the residual 
solvent resonances. Splitting patterns are denoted as s (singlet), d (doublet), t (triplet), q 
(quartet), m (multiplet), and br (broad).  High-resolution mass spectra (HR-MS) were 
obtained at the MIT Department of Chemistry Instrumentation Facility using electron 
impact ionization (EI) with a voltage of 70 V or electrospray ionization (ESI). Melting 
point (m.p.) determination was performed using open capillaries and are reported 
uncorrected. Polymer molecular weights were determined in THF solutions on an Agilent 
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1100 series HPLC/GPC system with three PLgel columns (103, 104, 105 Å) in series 
against narrow polystyrene standards. Polymer thin films were spin cast from ~1% by 
weight CHCl3 solutions on microscope coverslips or Si wafers using an EC101DT 
photoresist spinner (Headway Research, Inc.) at a 1000 rpm rate for 60 s. UV-Vis spectra 
of solutions and thin films were recorded with an Agilent 8453 diode array 
spectrophotometer. Fluorescence spectra of films and solutions were recorded on a Jobin 
Yvon Horiba SPEX Fluorolog fluorimeter (model FL-12, 450 W xenon lamp) using 
either front-face (films) or right angle detection (solutions). Excited state lifetimes were 
measured using a phase modulation technique on a Jobin Yvon Horiba SPEX Fluorolog 
τ3 fluorimeter (model FL-321) and referenced to an aqueous colloidal silica (LUDOX) 
scattering suspension. LB experiments were performed using a Nima 102M trough 
equipped with a fused silica (quartz) window for in situ spectroscopy. Langmuir 
monolayers were spread on a >18 MΩ cm-1 water subphase (purified on a Milipore water 
purifier) from spectroscopic-grade chloroform solutions of polymers (~1 mg/mL). 
Solvent was allowed to evaporate 5-10 mins, and the monolayers were mechanically 
annealed by 5 cycles of compression-decompression before spectroscopic measurements. 
Absorption spectra of Langmuir monolayers were acquired using a Cary 50 UV-Vis 
spectrophotometer with fiber optics linking to the air-water interface. Fluorescence 
spectra of Langmuir monolayers were recorded a Jobin Yvon Horiba SPEX Fluorolog 
fluorimeter (model FL-12, 450 W xenon lamp) using fiber optics linking to the air-water 
interface. 
 
9-Bromo-1,6-bis(4-tert-octylphenoxy)-N-(2,6-diisopropylphenyl)-perylene-3,4-
dicarboximide (4).21 1,6,9-tribromo-N-(2,6-diisopropylphenyl)-perylene-3,4-
dicarboximide (3) (1.436 g, 2.0 mmol), tert-octylphenol (0.865 g, 4.2 mmol) and 
potassium carbonate (2.20 g, 16 mmol) were placed in a Schlenk flask equipped with a 
magnetic stirrer. Contents were evacuated and back-filled with argon 5 times before 
adding dry DMF (40 mL). After 5 more vacuum/back-fill cycles, the resulting mixture 
was stirred at 100˚C for 2.5h, then cooled to room temperature and poured in an excess of 
2N aq. HCl. Organics were extracted with EtOAc, washed with brine and solvents were 
evaporated under reduced pressure to afford a crude product that is purified by column 
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chromatography on silica gel using progressively more polar 98:2 to 95:0 hexanes ethyl 
acetate (v/v) as the mobile phase to afford 4 as a red solid (643 mg, 33%). m. p. 147-
149˚C; 1H-NMR (300 MHz, CDCl3): δ = 9.39 (d, 1H, J = 7.8 Hz), 9.15 (d, 1H, J = 7.8 
Hz), 8.35 (d, 1H, J = 7.8 Hz), 8.30 (d, 2H, J = 3.6 Hz), 7.90 (d, 1H, J = 8.7 Hz), 7.70 (t, 
1H, J = 8.2 Hz), 7.48-7.38 (m, 5H), 7.31-7.27 (m, 2H), 7.05 (dd, 4H, J = 8.7, 3.6 Hz), 
2.71 (m, 2H), 1.73 (s, 4H), 1.38 (s, 12H), 1.14 (d, 12H, J = 6.9 Hz), 0.73 (s, 18H); 13C-
NMR (125 MHz, CDCl3): δ = 163.28, 163.26, 154.1, 154.0, 153.3, 153.2, 146.63, 146.62, 
145.8, 132.1, 131.7, 131.2, 131.0, 130.8, 129.7, 129.5, 129.4, 128.9, 128.20, 128.17, 
128.0, 127.7, 126.7, 126.6, 125.5, 124.6, 124.5, 124.2, 123.1, 122.07, 122.04, 118.5, 
118.4, 114.0, 57.3, 38.5, 32.6, 32.0, 31.8, 31.7, 29.3, 24.2; HR-MS (ESI): calc for 
C62H66BrNO4 [M+H]+ 968.4253, found 968.4242. 
 
9-Trimethylsilylethynyl-N-(2,6-diisopropylphenyl)-perylene-3,4-dicarboximide (5). 
9-bromo-N-(2,6-diisopropylphenyl)-perylene-3,4-dicarboximide (3) (1.122 g, 2.0 mmol), 
dichlorobis(triphenylphosphine)palladium(II) (72 mg, 0.10 mmol) and copper(I) iodide 
(20 mg, 0.10 mmol) were placed in a Schlenk flask equipped with a magnetic stirrer. 
Contents were evacuated and back-filled with argon 5 times before adding a degassed, 
premixed solution of PhMe-iPr2NH 3:1 v/v (15 mL), After 5 more vacuum/back-fill 
cycles, trimethylsilylacetylene (0.6 mL, 4.3 mmol) was added and the resulting mixture 
was stirred at 70˚C for ca 16h, then cooled to room temperature. To the mixture was 
added silica gel (few grams) and solvents were evaporated under reduced pressure. The 
resulting crude solid adsorbed on silica gel was purified by column chromatography on 
silica gel using 15:4:1 hexanes : dichloromethane : ethyl acetate (v/v/v) as the mobile 
phase to afford 5 as a red solid (796 mg, 69%). m. p. > 330˚C; 1H-NMR (500 MHz, 
CDCl3): δ = 8.66 (d, 1H, J = 8.0 Hz), 8.65 (d, 1H, J = 8.0), 8.45 (d, 1H, J = 8.0 Hz), 8.44 
(d, 1H, J = 8.5 Hz), 8.40 (dd, 2H, J = 8.5, 5.0 Hz), 8.33 (d, 1H, J = 8.0 Hz), 7.79 (d, 1H, J 
= 3.0 Hz), 7.70 (t, 1H, J = 8.0 Hz), 7.50 (t, 1H, J = 7.5 Hz), 7.36 (d, 2H, J = 8.0 Hz), 2.78 
(m, 2H), 1.20 (d, 12H, J = 7.0 Hz), 0.40 (s, 9H); 13C-NMR (125 MHz, CDCl3): δ = 
164.12, 164.09, 145.8, 137.3, 136.9, 134.5, 123.2, 132.1, 131.7, 131.2, 130.6, 129.7, 
129.6, 129.42, 129.35, 127.79, 127.76, 126.8, 124.3, 124.2, 123.8, 123.1, 121.4, 121.2, 
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120.9, 120.6, 103.6, 102.7, 29.4, 24.2, 0.25; HR-MS (ESI): calc for C39H35NO2Si [M+H]+ 
578.2510, found 578.2506. 
 
9-Trimethylsilylethynyl-1,6-bis(4-tert-octylphenoxy)-N-(2,6-diisopropylphenyl)-
perylene-3,4-dicarboximide (6). 9-bromo-1,6-bis(4-tert-octylphenoxy)-N-(2,6-
diisopropylphenyl)-perylene-3,4-dicarboximide (4) (0.485 g, 0.50 mmol), 
dichlorobis(triphenylphosphine)palladium(II) (18 mg, 0.025 mmol) and copper(I) iodide 
(5 mg, 0.025mmol) were placed in a Schlenk flask equipped with a magnetic stirrer. 
Contents were evacuated and back-filled with argon 5 times before adding a degassed, 
premixed solution of PhMe-iPr2NH 3:1 v/v (5 mL). After 5 more vacuum/back-fill 
cycles, trimethylsilylacetylene (150 µL, 1.1 mmol) was added the resulting mixture was 
stirred at 70˚C for ca 20h, then cooled to room temperature. To the mixture was added 
silica gel (few grams) and solvents were evaporated under reduced pressure. The 
resulting crude solid adsorbed on silica gel was purified by column chromatography on 
silica gel using 95:5 hexanes : ethyl acetate (v/v) as the mobile phase to afford 6 as an 
amorphous red solid (525 mg, 100%). m. p. 151-154˚C; 1H-NMR (500 MHz, CDCl3): δ = 
9.39 (d, 1H, J = 7.5 Hz), 9.25 (d, 1H, J = 8.0 Hz), 8.47 (d, 1H, J = 8.0 Hz), 8.33 (d, 2H, J 
= 2.0 Hz), 7.78 (d, 1H, J = 8.0 Hz), 7.69 (t, 1H, J = 8.0 Hz), 7.46 (t, 1H, J = 8.0 Hz), 7.40 
(dd, 4H, J = 8.5, 7.0 Hz), 7.31 (d, 2H, J = 7.5 Hz), 7.08 (d, 2H, J = 8.5 Hz), 7.05 (d, 2H, J 
= 7.5 Hz), 2.74 (m, 2H), 1.75 (s, 4H), 1.40 (s, 12H), 1.15 (d, 12H, J = 7.0 Hz), 0.75 (s, 
18H), 0.38 (s, 9H); 13C-NMR (125 MHz, CDCl3): δ = 154.09, 154.05, 153.40, 153.35, 
146.52, 146.46, 145.8, 133.6, 131.8, 131.7, 130.9, 129.7, 129.4, 129.3, 128.7, 128.4, 
128.1, 128.0, 127.6, 127.1, 126.9, 124.6, 124.2, 123.2, 122.8, 122.1, 121.8, 118.5, 118.3, 
103.2, 102.6, 57.3, 38.5, 32.6, 32.0, 31.8, 31.7, 29.3, 24.2, 0.26; HR-MS (ESI): calc for 
C67H75NO4Si [M+Na]+ 1008.5358, found 1008.5389. 
 
9-Ethynyl-N-(2,6-diisopropylphenyl)-perylene-3,4-dicarboximide (7). A solution of  9-
trimethylsilylethynyl-N-(2,6-diisopropylphenyl)-perylene-3,4-dicarboximide (5) (0.578 g, 
1.0 mmol) in THF (20 mL) was degassed by bubbling nitrogen through for ca. 15 mins. 
To this stirred solution is added a solution of KOH in MeOH (1g/10 mL, 2 mL added), 
and the mixture is stirred under nitrogen at room temperature for 1h. The mixture is 
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poured in an excess of aq. NH4Cl, extracted with dichloromethane, washed with brine and 
solvents are evaporated under reduced pressure. The residue is purified by column 
chromatography on silica gel using 10:4:1 hexanes : dichloromethane : ethyl acetate to 
afford 7 as a red solid (181 mg, 36%). m. p. >330˚C; 1H-NMR (500 MHz, CDCl3): δ = 
8.68 (d, 1H, J = 4.0 Hz), 8.66 (d, 1H, J = 4.0 Hz), 8.47 (t, 2H, J = 8.5 Hz), 8.43 (dd, 4H, J 
= 8.0, 5.0 Hz), 8.37 (d, 1H, J = 8.0 Hz), 7.84 (d, 1H, J = 7.5 Hz), 7.72 (t, 1H, J = 8.0 Hz), 
7.50 (t, 1H, J = 8.0 Hz), 7.36 (d, 2H, J = 7.5 Hz), 3.69 (s, 1H), 2.78 (m, 2H), 1.20 (d, 
12H, J = 7.0 Hz); 13C-NMR (125 MHz, CDCl3): δ = 164.1, 145.9, 137.3, 136.8, 134.7, 
132.3, 132.2, 131.3, 130.6, 130.1, 129.7, 129.6, 129.2, 127.9, 127.8, 126.9, 124.4, 124.3, 
123.0, 122.7, 121.6, 121.4, 121.0, 120.7, 85.3, 81.5, 29.4, 24.2; HR-MS (ESI): calc for 
C36H27NO2 [M+H]+ 506.2115, found 506.2117. 
 
9-Ethynyl-1,6-bis(4-tert-octylphenoxy)-N-(2,6-diisopropylphenyl)-perylene-3,4-
dicarboximide (8). A solution of  9-trimethylsilylethynyl-1,6-bis(4-tert-octylphenoxy)-
N-(2,6-diisopropylphenyl)-perylene-3,4-dicarboximide (6) (0.400 g, 0.41 mmol) in THF 
(10 mL) was degassed by bubbling nitrogen through for ca. 15 mins. To this stirred 
solution is added a solution of NaOH in MeOH (1g/10 mL, 1 mL added), and the mixture 
is stirred under nitrogen at room temperature for 1h. The mixture is poured in an excess 
of aq. NH4Cl, extracted with dichloromethane, washed with brine, dried over anh. Na2SO4 
and solvents are evaporated under reduced pressure. The residue is purified by column 
chromatography on silica gel using progressively more polar 3:1 to 2:1 hexanes : 
dichloromethane to afford 8 as an amorphous red solid (332 mg, 90%). m. p. 165-169˚C; 
1H-NMR (300 MHz, CDCl3): δ = 9.37 (d, 1H, J = 7.8 Hz), 9.26 (d, 1H, J = 8.4 Hz), 8.46 
(d, 1H, J = 7.8 Hz), 8.32 (d, 2H, J = 3.6 Hz), 7.80 (d, 1H, J = 8.1 Hz), 7.67 (t, 1H, J = 8.1 
Hz), 7.50-7.38 (m, 5H), 7.32 (d, 2H, J = 7.8 Hz), 7.07 (dd, 4H, J = 8.7, 3.3 Hz), 3.63 (s, 
1H), 2.74 (m, 2H), 1.75 (s, 4H), 1.40 (s, 12H), 1.16 (d, 12H, J = 6.6 Hz), 0.75 (s, 18H); 
13C-NMR (75 MHz, CDCl3): δ = 154.3, 154.1, 153.4, 153.3, 146.62, 146.55, 145.8, 
133.7, 132.0, 131.8, 130.9, 129.7, 129.3, 128.8, 128.4, 128.1, 127.9, 127.6, 127.0, 126.5, 
124.5, 124.4, 124.2, 123.1, 122.2, 121.9, 121.7, 118.5, 84.5, 82.0, 57.3, 38.5, 32.6, 32.0, 
31.7, 29.3, 24.2; HR-MS (ESI): calc for C34H67NO4 [M+Na]+ 936.4962, found 936.4993. 
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General procedure for the preparation of poly(arylene ethynylene)s 
Inside a nitrogen atmosphere glovebox, diyne monomer (9 or 10, 0.100 mmol), diiodo 
monomer (11, 0.103 mmol), tetrakis(triphenylphosphine)palladium(0) (6 mg, 0.005 
mmol) and copper(I) iodide (2 mg, 0.010 mmol) are placed in a Schlenk flask equipped 
with a magnetic stirrer. Toluene (3 mL) and diisopropylamine (1 mL) are added, and 
contents are stirred at room temperature for ca. 30 mins to ensure complete dissolution. 
Contents are then stirred at 65˚C for 24h, followed by 75˚C for 24h. Then, a solution of 
the end-capping group (7 or 8, 0.009 mmol) in toluene (1 mL) is added, and the reaction 
is pursued for another 48 h at 75˚C. The mixture is then cooled to room temperature, 
precipitated in an excess of methanol and isolated by centrifugation. The crude polymer 
is dissolved in a minimum of chloroform and purfied by column chromatography on 
silica gel in the following manner. The polymer is first eluted with chloroform until the 
solvent flowing at the end of the column is colorless, and then elution is pursued with 
acetone. The chlorform fractions are concentrated under reduced pressure and re-
submitted to the chloroform → acetone chromatographic procedure. Acetone fractions 
are then combined and concentrated under reduced pressure to afford a purified polymer 
that still contains traces of excess end-capping groups and related by-products. The 
combined acetone fractions further purified by preparative gel permeation 
chromatography (GPC) with THF as the mobile phase. A final reprecipitation from 
MeOH of hexanes affords the pure end-capped polymer. 
 
Polymer P0. Following the general procedure with monomers 9 and 11, without addition 
of the end-capping group. Polymer P0 is obtained as a yellow-green solid (93 mg, 88%). 
The NMR spectra of P0 match that reported in the literature.16 GPC (THF vs. PS):  
(soluble fraction) Mn = 69 400, Mw = 157 100. 
 
Polymer P1. Following the general procedure with monomers 9, 11 and endcap 8. 
Polymer P1 is obtained as a red solid (81 mg, 77%). 1H-NMR (500 MHz, CDCl3): δ = 
7.45 (s, 2H), 6.93 (s, 1H), 6.88 (s, 1H), 4.14 (br, 2H), 3.95 (br, 2H), 3.88 (br, 2H), 3.77 
(m, 2H), 3.69-3.65 (m, 6H), 3.55 (t, 2H, J = 4.5 Hz), 3.37 (s, 3H), 3.18 (br, 4H), 1.82 (br, 
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2H), 1.60-1.10 (m, 62H), 0.90-0.82 (m, 15H); GPC (THF vs. PS): Mn = 46 500, Mw = 
88 000. 
 
Polymer P1b. Following the general procedure with monomers 9, 11 and endcap 8. 
Polymer P1b is obtained as a red solid (103 mg, 77%). 1H-NMR (500 MHz, CDCl3): δ = 
7.45 (s, 2H), 6.93 (s, 1H), 6.88 (s, 1H), 4.14 (br, 2H), 3.95 (br, 2H), 3.88 (br, 2H), 3.77 
(m, 2H), 3.69-3.65 (m, 6H), 3.55 (t, 2H, J = 4.5 Hz), 3.37 (s, 3H), 3.18 (br, 4H), 1.82 (br, 
2H), 1.60-1.10 (m, 62H), 0.90-0.82 (m, 15H); GPC (THF vs. PS): Mn = 39 700, Mw = 
95 100. 
 
Polymer P2. Following the general procedure with monomers 9, 11 and endcap 7. 
Polymer P2 is obtained as a red solid (45 mg, 77%). 1H-NMR (500 MHz, CDCl3): δ = 
7.45 (s, 2H), 6.93 (s, 1H), 6.88 (s, 1H), 4.14 (br, 2H), 3.95 (br, 2H), 3.88 (br, 2H), 3.77 
(m, 2H), 3.69-3.65 (m, 6H), 3.55 (t, 2H, J = 4.5 Hz), 3.37 (s, 3H), 3.18 (br, 4H), 1.82 (br, 
2H), 1.60-1.10 (m, 62H), 0.90-0.82 (m, 15H); GPC (THF vs. PS): Mn = 48 700, Mw = 
108 300. 
 
Polymer P3. Following the general procedure with monomers 10, 11 and endcap 8. 
Polymer P3 is obtained as a red solid (95 mg, 90%). 1H-NMR (500 MHz, CDCl3): δ = 
7.45 (s, 2H), 6.93 (s, 2H), 4.14 (br, 4H), 3.88 (br, 4H), 3.76 (br, 4H), 3.66 (br, 8H), 3.55 
(m, 4H), 3.38 (s, 6H), 3.17 (m, 4H), 1.80-1.10 (m, 48H), 1.00-0.80 (m, 12H); GPC (THF 
vs. PS): Mn = 50 000, Mw = 142 800. 
 
Polymer P4. Following the general procedure with monomers 10, 11 and endcap 7. 
Polymer P4 is obtained as a red solid (104 mg, 98%). 1H-NMR (500 MHz, CDCl3): δ = 
7.45 (s, 2H), 6.93 (s, 2H), 4.14 (br, 4H), 3.88 (br, 4H), 3.76 (br, 4H), 3.66 (br, 8H), 3.55 
(m, 4H), 3.38 (s, 6H), 3.17 (m, 4H), 1.80-1.10 (m, 48H), 1.00-0.80 (m, 12H); GPC (THF 
vs. PS): Mn = 28 800, Mw = 76 000. 
 423 
 
                                                
6.8 References and Notes 
 
1 (a) Zhou, Q.; Swager, T. M. J. Am. Chem. Soc. 1995, 117, 7017-7018. (b) Zhou, Q.; 
Swager, T. M. J. Am. Chem. Soc. 1995, 117, 12593-12602. (c) Swager, T. M. Acc. Chem. 
Res. 1998, 31, 201-207. 
2 Zahn, S.; Swager, T. M. Angew. Chem. Int. Ed. 2002, 41, 4226-4230 
3 Yang, J.-S.; Swager, T. M. J. Am. Chem. Soc. 1998, 120, 5321-5322. (b) Yang, J.-S.; 
Swager, T. M. J. Am. Chem. Soc. 1998, 120, 11864-11873. 
4 For example: Ego, C.; Marsitzky, D.; Becker, S.; Zhang, J.; Grimsdale, A. C.; Müllen, 
K.; MacKenzie, J. D.; Silva, C.; Friend, R. H. J. Am. Chem. Soc. 2003, 125, 437-443. 
5 (a) Lupton, J. M.; Craig, M. R.; Meijer, E. W. App. Phys. Lett. 2002, 80, 4489-4491. (b) 
Yan, M.; Rothberg, L. J.; Papadimitrakopoulos, F.; Galvin, M. E.; Miller, T. M. Phys. 
Rev. Lett. 1994, 73, 744-747. (c) List, E. J.; Guentner, R.; Scanducci de Freitas, P; Scherf, 
U. Adv. Mater. 2002, 14, 374-378. (s) Gaal, M.; List, E. J. W.; Scherf, U. 
Macromolecules 2003, 36, 4236-4237. (e) Craig, M. R.; de Kok, M. M.; Hofstraat, J. W.; 
Schenning, A. P. H. J.; Meijer, E. W. J. Mater. Chem. 2003, 13, 2861-2862. 
6 Swager, T. M.; Gil, C. J.; Wrighton, M. S. J. Phys. Chem. 1995, 99, 4866-4893. 
7 Zhu, Z.; Swager, T. M. unpublished results. 
8 Satrijo, A.; Swager, T. M. unpublished results. 
9 Rose, A.; Lugmair, C.; Swager, T. M. J. Am. Chem. Soc. 2001, 123,11298-11299. 
10 (a) Müller, J. G.; Lemmer, U.; Raschke, G.; Anni, M.; Scherf, U.; Lupton, J. M.; 
Feldmann, J. Phys. Rev. Lett. 2003, 91, 267403. (b) Müller, J. G.; Lupton, J. M.; 
Feldmann, J.; Lemmer, U.; Scherf, U. App. Phys. Lett. 2004, 84, 1183-1185. 
11 (a) Padmanaban, G.; Ramakrishnan, S. J. Am. Chem. Soc. 2000, 122, 2244-2251. (b) 
Vanden Bout, D. A.; Yip, W.-T.; Hu, D.; Fu, D.-K.; Swager, T. M.; Barbara, P. F. 
Science 1997, 277, 1074-1077.  
12 Guillet, T.; Berréhar, J.; Grousson, R.; Kovensky, J.; Lapersonne-Meyer, C.; Schott, 
M.; Voliotis, V. Phys. Rev. Lett. 2001, 87, 087401. 
13 (a) Beljonne, D.; Pourtois, G.; Silva, C.; Hennebicq, E.; Herz, L. M.; Friend, R. H.; 
Scholes, G. D.; Müllen, K.; Brédas, J. L. Proc. Nat. Acad. Sci. USA 2002, 99, 10982-
10987. (b) Nguyen, T.-Q.; Wu, J.; Doan, V.; Schwarcz, B. J.; Tolbert, S. H. Science 
2000, 288, 652-656. (c) Nguyen, T.-Q.; Wu, J.; Tolbert, S. H.; Schwarcz, B. J. Adv. 
Mater. 2001, 13, 609-611. (d) Wang, C. F.; White, J. D.; Lim, T. L.; Hsu, J. H.; Yang, S. 
C.; Fann, W. S.; Peng, K. Y.; Chen, S. A. Phys. Rev. B 2003, 67, 035202. (e) Hennebicq, 
E.; Pourtois, G.; Scholes, G. D.; Herz, L. M.; Russel, D. M.; Silva, C.; Setayesh, S.; 
Grimsdale, A. C.; Müllen, K.; Brédas, J.-L.; Beljonne, D. J. Am. Chem. Soc. 2005, 127, 
4744-4762. 
14 (a) Heun, S.; Mahrt, R. F.; Greiner, A.; Lemmer, U.; Bässler, H.; Halliday, D. A.; 
Bradley, D. D. C.; Burn, P. L.; Holmes, A. B. J. Phys.: Condens. Matter 1993, 5 247-
260. (b) Herz, L. M.; Silva, C.; Grimsdale, A. C.; Müllen, K.; Phillips, R. T. Phys. Rev. B. 
2004, 70, 165207.  
15 Nesterov, E. E.; Zhu, Z.; Swager, T. M. J. Am. Chem. Soc. 2005, 127, 10083-10088. 
16 (a) Kim, J.; Swager, T. M. Nature 2001, 411, 1030-1034. (b) Kim, J.; Levitsky, I. A.; 
McQuade, D. T.; Swager, T. M. J. Am. Chem. Soc. 2002, 124, 7710-7718. 
 424 
                                                                                                                                            
17 For a recent example of this approach: Coskun, A.; Akkaya, E. U. J. Am. Chem. Soc. 
2006, 128, 14474-14475. 
18 Feiler, L.; Langhals, H.; Polborn, K. Liebigs Ann. 1995, 1229-1244. 
19 (a) Quante, H.; Müllen, K. Angew. Chem. Int. Ed. 1995, 34, 1323-1325. (b) Geerts, Y.; 
Quante, H.; Platz, H.; Mahrt, R.; Hopmeier, M.; Böhm, A.; Müllen, K. J. Mater Chem. 
1998, 8, 2357-2369. 
20 (a) Rohr, U.; Kohl, C.; Müllen, K.; van de Craats, A.; Warman, J. J. Mater. Chem. 
2001, 11, 1789-1799. (b) Schlichting, P.; Duchscherer, B.; Seisenberger, G.; Basché, T.; 
Bräuchle, C.; Müllen, K. Chem. Eur. J. 1999, 5, 2388-2395. 
21 (a) Kohl, C.; Becker, S.; Müllen, K. Chem. Commun. 2002, 2778-2779. (b) Pschirer, N. 
G.; Kohl, C.; Nolde, F.; Qu, J.; Müllen, K. Angew. Chem. Int. Ed. 2006, 45, 1401-1404. 
22 
N
O
O  ε = 39 800 L cm-1 mol-1 (λmax = 531 nm). (a) Miller, M. A.; 
Lammi, R. K.; Prathapan, S.; Holten, D.; Lindsey, J. S. J. Org. Chem. 2000, 65, 6634-
6649. (b) Yang, S. I.; Lammi, R. K.; Prathapan, S.; Miller, M. A.; Seth, J.; Diers, J. R.; 
Bocian, D. F.; Lindsey, J. S.; Holten, D. J. Mater. Chem. 2001, 11, 2420-2430. 
23 (a) Olmsted, J., III J. Phys. Chem. 1979, 83, 2581-2584. (b) Demas, J. N.; Crosby, G. 
A. J. Phys. Chem. 1971, 75, 991-1024. (c) Melhuish, W. H. J. Phys. Chem. 1961, 65, 
229-235. (d) Dawson, W. R.; Windsor, M. W. J. Phys. Chem. 1968, 72, 3251-3260. (e)  
24 Melhuish, W. H. J. Opt. Soc. Am. 1964, 52, 183-186. 
25 Langhals, H.; Karolin, J.; Johansson, L. B.-Å. J. Chem. Soc., Faraday Trans. 1998, 94, 
2919-2922. 
26 (a) Kiessling, L. L.; Gestwicki, J. E.; Strong, L. E. Curr. Opin. Chem. Biol. 2000, 4, 
696-703. (b) Kiessling, L. L.; Gestwicki, J. E.; Strong, L. E. Angew. Chem. Int. Ed. 2006, 
45, 2348-2368. 
27 Stryer, L. Biochemistry, 3rd. ed.; W. H. Freeman & Sons: New York, 1988. 
28 Tamm, L. K.; McConnell, H. M. Biophys. J. 1985, 47, 105-113 and references therein. 
29 Similarly, the face-on to zipper phase transition is less marked on the pressure-area 
isotherms of zipper phase poly(phenylene ethynylene)s that contain a high number of 
defects (e.g. diacetylene couplings, non-amphiphilic comonomers or lower molecular 
weight materials). 
30  (a) Lakowicz, J. R. Principles of Fluorescence Spectroscopy, 2nd. ed.; Kluwer 
Academic/Plenum: New York, 1999. (b) Turro, N. J. Modern Molecular Photochemistry; 
University Science Books: Sausalito, 1991. 
31 (a) Kuhn, H. J. Chem. Phys. 1970, 53, 101-108. (b) Penner, T. L. Thin Solid Films, 
1988, 160, 241-250. 
32 (a) Wolber, P. K.; Hudson, B. S. Biophys. J. 1979, 28, 197-210. (b) Urquhart, R. S.; 
Hall, R. A.; Thistlethwaite, P. J.; Grieser, F. J. Phys. Chem. 1990, 94, 4173-4182. 
33 Dexter, D. L. J. Chem. Phys. 1953, 21, 836-850. 
34 Blumen, A. J. Chem. Phys. 1980, 72, 2632-2640. 
35 Yatsue, T.; Miyashita, T. J. Phys. Chem. 1995, 99, 16047-16051. 
 425 
 
 
 
 
 
 
Chapter 6 Appendix 
1H-NMR and 13C-NMR Spectra, Electron 
Transfer Modeling 
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Figure 6.A.1. 1H-NMR Spectrum of 4 in CDCl3 (300 MHz).   
 
Note: * Residual CH2Cl2 and EtOAc. 
Figure 6.A.2. 13C-NMR Spectrum of 4 in CDCl3 (125 MHz). 
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Figure 6.A.3. 1H-NMR Spectrum of 5 in CDCl3 (500 MHz).  
 
Figure 6.A.4. 13C-NMR Spectrum of 5 in CDCl3 (125 MHz). 
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Figure 6.A.5. 1H-NMR Spectrum of 6 in CDCl3 (500 MHz).  
 
Figure 6.A.6. 13C-NMR Spectrum of 6 in CDCl3 (125 MHz). 
 
N
O
O
6
O
O
Me3Si
 429 
Figure 6.A.7. 1H-NMR Spectrum of 7 in CDCl3 (500 MHz).  
 
Figure 6.A.8. 13C-NMR Spectrum of 7 in CDCl3 (125 MHz). 
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Figure 6.A.9. 1H-NMR Spectrum of 8 in CDCl3 (300 MHz).  
 
Note: * Residual CH2Cl2. 
Figure 6.A.10. 13C-NMR Spectrum of 8 in CDCl3 (75 MHz). 
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Figure 6.A.11. 1H-NMR Spectrum of P1 in CDCl3 (500 MHz).  
 
Figure 6.A.12. 1H-NMR Spectrum of P1 (endgroup region) in CDCl3 (500 MHz). 
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Figure 6.A.13. 1H-NMR Spectrum of P1b in CDCl3 (500 MHz). 
 
Figure 6.A.14. 1H-NMR Spectrum of P1b (endgroup region) in CDCl3 (500 MHz).  
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Figure 6.A.15. 1H-NMR Spectrum of P2 in CDCl3 (500 MHz). 
 
Figure 6.A.16. 1H-NMR Spectrum of P2 (endgroup region) in CDCl3 (500 MHz).  
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Figure 6.A.17. 1H-NMR Spectrum of P3 in CDCl3 (500 MHz).  
 
Figure 6.A.18. 1H-NMR Spectrum of P3 (endgroup region) in CDCl3 (500 MHz). 
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Figure 6.A.19. 1H-NMR Spectrum of P4 in CDCl3 (500 MHz). 
 
Figure 6.A.20. 1H-NMR Spectrum of P4 (endgroup region) in CDCl3 (500 MHz). 
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Energy Transfer Modeling 
 
Figures 6.A.21 - 6.A.28 detail the fitting of spectroscopic data for monolayers of 
polymer P1-P4 against models of distance dependence (or surface concentration 
dependence) for the efficiency of energy transfer from the polymer main emission band 
(425-525 nm) to the perylene monoimide endgroup emission band (526-685 nm). The 
least-squares itetrative fitting were conducted as follows. In these plots the ratio FDA/FD is 
plotted against the square root of the surface area per repeating unit, a parameter 
proportional to the average interchain distance (dipole-dipole and electron exchange 
models in 3D) or against the surface area per repeating unit, a parameter inversely 
proportional to the surface concentration (dipole-dipole model in 2D).  Since the value of 
FD, corresponding to the fluorescence emission of the donor in the absence of acceptors is 
impossible to access in the end-capped polymers (e.g. the acceptor is covalently linked to 
the donor), the fluorescence emission at the lowest surface concentrations was taken as 
FD under the assumption that at large interpolymer distances intermolecular energy 
transfer is inefficient and intramolecular pathways contribute most to the energy transfer 
at these concentrations. Consequently, the analysis of the experimental data against 
theoretical models applies only to the intermolecular component to energy transfer. 
 
 In addition, plots of the ratio of the emission bands are fitted with the same 
models. Plots for the point-to-point Förster ET in 3D model (r-6) are not shown for they 
are clearly less appropriate (steeper curvature) than the corresponding plots for the point-
to-plane Förster ET in 3D model (r-4). The coefficients of correlation (r) for the series of 
fits are shown in Table 6.A.2, in which the best fits are highlighted.  
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Table 6.A.1. Summary of ET modeling. 
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Figure 6.A.21. ET Model fitting for P1 
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Figure 6.A.22. ET Model fitting for P1b 
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Figure 6.A.23. ET Model fitting for P2 
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Figure 6.A.24. ET Model fitting for P3 
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Figure 6.A.25. ET Model fitting for P4 
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Figure 6.A.26. ET Model fitting for P1-DMPC 
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Table 6.A.2. Coefficients of correlation for ET Model fitting (Fig. 6.A.21-6.A.26, for 
FDA/FD (first row) and FAD/FD (second row) 
 (Ro/R)2 (Ro/R)4 2D-Förster exp(-Ro/R) 
P1 0.9404 
0.9404 
0.8626 
0.8626 
0.9949 
0.9796 
0.9957 
0.9813 
P1b 0.9173 
0.9173 
0.8242 
0.8242 
0.9947 
0.9947 
0.9911 
0.9560 
P2 0.9931 
0.9931 
0.9860 
0.9860 
0.9929 
0.9930 
0.9961 
0.9961 
P3 0.8292 
0.8292 
0.7667 
0.7667 
0.9615 
0.9615 
0.9352 
0.8913 
P4 0.9536 
0.9536 
0.9191 
0.9191 
0.9999 
0.9777 
0.9935 
0.9855 
P1-DMPC 0.9298 
0.9298 
0.8068 
0.8068 
0.9912 
0.9912 
0.9905 
0.9905 
 
Figure 6.A.27. ET Model fitting for P1 
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Figure 6.A.28. ET Model fitting for P1b 
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Figure 6.A.29. ET Model fitting for P2 
Förster r-2   Förster r-4 
0,0
1,0
2,0
3,0
4,0
5,0
6,0
7,0
8 9 10 11 12 13 14 15 16
Peak Height
Integration
E
nd
ca
p 
/ M
ai
n 
B
an
d 
R
at
io
(Surface Area per Repeating Unit)1/2 (Å)  
0,0
1,0
2,0
3,0
4,0
5,0
6,0
7,0
8 9 10 11 12 13 14 15 16
Peak Height
Integration
E
nd
ca
p 
/ M
ai
n 
B
an
d 
R
at
io
(Surface Area per Repeating Unit)1/2 (Å)   
Förster 2D   Dexter e-n 
0,0
1,0
2,0
3,0
4,0
5,0
6,0
7,0
50 100 150 200 250
Integration
Peak Height
E
nd
ca
p 
/ M
ai
n 
B
an
d 
R
at
io
Surface Area per Repeating Unit (Å2)  
0,0
1,0
2,0
3,0
4,0
5,0
6,0
7,0
8 9 10 11 12 13 14 15 16
Peak Height
Integration
E
nd
ca
p 
/ M
ai
n 
B
an
d 
R
at
io
(Surface Area per Repeating Unit)1/2 (Å)  
 443 
Figure 6.A.30. ET Model fitting for P3 
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Figure 6.A.31. ET Model fitting for P4 
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Figure 6.A.32. ET Model fitting for P1-DMPC 
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